data_2n4p_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n4p _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 23.2 p90 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.861 0.362 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.1 tt -108.49 123.48 64.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.153 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.68 104.16 11.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.054 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.3 m -145.43 154.33 13.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.344 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.9 152.23 48.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.128 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.86 -49.46 15.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.848 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -100.42 158.46 15.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -82.21 -31.89 30.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.223 0.535 . . . . 0.0 111.314 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -69.64 -26.56 64.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.874 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.65 -178.93 7.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.847 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -105.14 158.52 31.93 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.398 0.618 . . . . 0.0 111.266 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.9 114.66 3.8 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.38 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.4 tp -79.51 141.36 15.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.919 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -99.17 119.59 38.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.738 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.96 160.21 60.5 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.632 0.73 . . . . 0.0 111.122 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 155.35 66.06 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.699 2.266 . . . . 0.0 112.32 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 m -143.88 -175.99 4.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.839 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -88.63 172.96 8.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.945 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -78.49 -35.31 46.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.827 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -64.61 -19.03 65.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.853 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.69 -13.66 14.98 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.499 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 28.8 p -82.62 -174.08 5.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.851 0.357 . . . . 0.0 111.142 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.3 t -139.46 125.24 22.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.143 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.22 141.94 58.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 tt -60.56 -22.76 64.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.6 p -64.43 -29.72 70.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.788 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 58.0 m -87.1 -30.55 21.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.538 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.5 t -65.14 -39.91 87.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.992 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.9 p -77.41 -14.86 59.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.011 0.434 . . . . 0.0 111.569 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.04 -47.02 81.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.959 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 63.2 mm-40 -111.88 -21.71 11.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.116 0.484 . . . . 0.0 111.367 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -123.84 74.67 56.24 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 121.662 0.744 . . . . 0.0 110.878 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 129.99 18.61 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.66 2.24 . . . . 0.0 112.386 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.56 -9.68 70.07 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.51 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.73 99.27 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.744 0.307 . . . . 0.0 111.075 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.9 t -82.5 -43.77 16.78 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.093 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -130.27 134.82 8.0 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.399 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.68 130.02 56.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.074 0.464 . . . . 0.0 110.623 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -107.13 170.35 8.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.705 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -106.16 126.09 51.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -129.27 121.53 27.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.907 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 121.609 0.718 . . . . 0.0 110.897 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.484 -0.247 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.61 134.39 30.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.818 0.342 . . . . 0.0 111.143 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -77.43 138.46 39.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -121.33 124.43 44.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.948 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.6 p -149.47 124.41 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.114 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 57.92 22.62 8.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.23 -24.88 20.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.496 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mt -82.8 122.79 37.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 0.0 111.139 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.22 119.56 24.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.936 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -91.88 135.76 33.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -87.68 160.05 48.15 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.55 0.69 . . . . 0.0 111.107 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.99 -172.59 0.62 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.678 2.252 . . . . 0.0 112.306 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -77.16 -2.28 33.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.224 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.23 -31.52 8.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.95 -164.38 15.93 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.499 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -85.28 -59.24 2.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.758 0.313 . . . . 0.0 110.933 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.55 -161.77 37.27 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.456 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -125.91 37.75 4.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.906 0.384 . . . . 0.0 110.919 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.75 -175.85 5.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.5 t -102.46 136.07 36.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.155 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -102.56 146.28 28.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.986 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 84.6 t -106.89 131.0 57.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.061 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 t -81.51 132.48 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.129 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -145.85 140.81 27.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.973 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.1 p90 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.807 0.337 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.1 tt -120.44 123.48 70.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.086 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -120.29 104.1 9.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.042 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.1 m -145.0 152.29 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.351 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.31 157.47 39.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.138 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.42 -49.95 10.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.838 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -101.27 163.11 12.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -84.39 -29.71 25.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.211 0.529 . . . . 0.0 111.265 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -67.53 -26.6 66.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.868 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -94.41 163.43 13.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.871 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -89.16 159.92 44.01 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.677 0.751 . . . . 0.0 110.888 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.86 116.77 4.72 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.63 2.22 . . . . 0.0 112.367 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.3 tp -76.68 137.98 21.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.867 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.05 119.77 37.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.802 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -126.43 159.89 60.77 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.627 0.727 . . . . 0.0 111.159 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 148.82 66.08 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.643 2.229 . . . . 0.0 112.307 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 p -133.29 -175.69 3.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -84.66 169.94 13.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -75.57 -30.55 59.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -72.34 -17.5 61.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.787 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.13 -20.84 11.24 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.451 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 22.7 p -75.57 -174.24 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.796 0.331 . . . . 0.0 111.181 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 50.5 t -141.0 119.53 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.141 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.2 tp -56.94 145.34 30.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.874 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 tt -61.44 -19.61 62.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.9 t -66.29 -37.72 86.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.9 m -77.06 -34.87 57.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.136 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.4 t -64.3 -34.94 72.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.027 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.0 p -80.06 -15.78 56.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.559 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.65 -43.65 88.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.995 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -111.92 -23.95 10.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.305 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -129.69 75.66 79.47 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.647 0.736 . . . . 0.0 110.918 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 125.28 11.95 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.675 2.25 . . . . 0.0 112.382 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.46 6.5 64.26 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.517 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.13 116.11 21.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.774 0.321 . . . . 0.0 111.135 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.8 t -100.45 -52.92 3.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -122.08 127.04 6.66 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.545 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.31 139.73 49.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.953 0.406 . . . . 0.0 110.759 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -112.21 171.0 7.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.692 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -104.13 126.04 50.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.946 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.1 tpt180 -128.94 103.32 6.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.9 t30 . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 121.635 0.731 . . . . 0.0 110.935 -179.986 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.7 t -62.79 143.33 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.786 0.326 . . . . 0.0 111.151 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -91.97 138.55 31.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.885 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -118.03 117.98 30.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.7 p -138.93 122.8 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.138 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 58.12 22.58 9.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.33 -25.08 19.44 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.516 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.3 mp -83.32 114.13 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.889 0.376 . . . . 0.0 111.076 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.78 116.09 13.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.956 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -91.33 135.7 33.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.08 158.85 55.18 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.554 0.692 . . . . 0.0 111.124 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.89 -172.94 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.689 2.26 . . . . 0.0 112.325 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -77.32 -2.15 33.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.266 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.74 -29.45 9.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.114 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.94 -168.86 14.65 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.514 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -82.49 -59.47 2.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.774 0.321 . . . . 0.0 110.866 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.11 -167.54 29.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.525 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -128.03 38.48 4.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.844 0.354 . . . . 0.0 110.895 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.439 ' C ' ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.61 -175.55 3.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.58 144.28 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.106 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -111.31 146.35 37.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.959 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.5 t -95.48 125.55 48.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.139 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 t -74.48 135.98 26.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.108 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -145.11 106.48 4.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.884 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.976 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 27.4 p90 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.812 0.339 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.0 tt -120.78 123.3 69.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.138 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -120.65 104.44 9.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.058 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 10.2 m -146.3 153.31 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.371 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.91 156.63 41.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.176 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.15 -50.18 13.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -102.54 166.44 10.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.912 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -79.53 -32.85 42.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.152 0.501 . . . . 0.0 111.279 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -74.75 -25.79 59.33 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.855 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -86.28 129.01 35.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.921 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -60.46 155.0 51.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.638 0.732 . . . . 0.0 110.884 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 114.91 3.85 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.717 2.278 . . . . 0.0 112.317 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.9 tp -76.75 139.43 18.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -102.04 120.06 39.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.712 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.91 159.7 60.33 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.692 0.758 . . . . 0.0 111.051 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 142.77 49.05 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.652 2.235 . . . . 0.0 112.349 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.5 p -132.94 161.63 33.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.831 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -61.11 162.74 6.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.82 -31.85 65.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.849 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -65.2 -18.4 65.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.36 -19.37 11.68 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.461 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.5 p -81.05 -174.38 4.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.348 . . . . 0.0 111.145 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.5 t -137.76 124.56 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.154 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.8 tp -59.49 146.88 38.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.06 -25.19 68.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.7 t -64.44 -39.13 93.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.7 m -74.13 -31.02 62.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.176 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.7 t -66.16 -37.22 79.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.011 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.1 p -79.09 -15.84 57.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.578 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.13 -44.81 87.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.983 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -112.14 -20.86 11.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.118 0.485 . . . . 0.0 111.352 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -131.38 75.45 77.3 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 121.643 0.735 . . . . 0.0 110.849 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 131.87 22.19 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.619 2.213 . . . . 0.0 112.415 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.36 -8.87 72.57 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.518 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.06 119.73 15.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.807 0.337 . . . . 0.0 111.139 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.4 t -102.05 -53.01 3.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -121.07 130.25 8.14 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.494 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.69 137.81 51.71 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.992 0.425 . . . . 0.0 110.678 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -108.64 170.71 7.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.735 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -105.29 125.69 51.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -129.56 105.28 7.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.7 t30 . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 121.551 0.691 . . . . 0.0 110.909 -179.932 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 64.5 t -54.77 138.62 14.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.748 0.309 . . . . 0.0 111.181 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -88.15 138.49 31.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -117.3 115.05 24.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.6 p -134.32 120.28 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.141 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 57.51 23.53 9.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.9 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.39 -24.93 23.13 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.467 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.2 mp -80.83 112.72 19.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.973 0.416 . . . . 0.0 111.089 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.72 111.24 9.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.911 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -86.65 135.41 33.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -87.98 159.87 47.64 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.467 0.651 . . . . 0.0 111.209 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.94 -173.09 0.67 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.698 2.265 . . . . 0.0 112.285 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -77.2 -2.25 33.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.244 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.27 -29.81 9.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.99 -165.35 14.85 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.469 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -86.71 -59.6 2.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.82 0.343 . . . . 0.0 110.849 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.72 -165.8 29.83 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.466 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -128.16 38.24 4.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 0.0 110.861 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.432 ' C ' ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.29 -175.81 3.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.912 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 38.3 t -93.85 144.44 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.191 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -114.61 145.9 41.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.939 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.4 t -99.65 126.74 52.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.121 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.8 t -72.58 145.35 12.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.17 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -145.08 87.75 1.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.963 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.4 p90 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 -179.883 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.4 p90 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.891 0.376 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.1 tt -119.35 123.47 71.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.098 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.4 mtm180 -119.48 104.69 10.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.109 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.5 m -145.71 153.44 13.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.3 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.76 155.33 39.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.167 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.06 -49.73 22.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.928 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -105.31 173.43 6.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.861 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -79.21 -46.6 17.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.283 0.564 . . . . 0.0 111.283 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -68.84 -26.8 65.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.878 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -72.79 126.98 31.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.93 149.89 63.27 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.695 0.759 . . . . 0.0 110.856 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.78 120.2 7.02 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.763 2.308 . . . . 0.0 112.311 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.1 tp -87.54 143.4 11.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.99 123.15 48.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -127.39 160.57 59.5 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.656 0.741 . . . . 0.0 111.151 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.67 144.65 55.19 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.704 2.269 . . . . 0.0 112.426 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 m -133.18 -175.88 3.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.859 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -86.06 174.25 9.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.836 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -80.68 -35.39 33.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.806 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -63.36 -19.83 64.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.827 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.43 -12.55 13.87 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.441 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.6 p -85.38 -174.72 5.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.829 0.347 . . . . 0.0 111.182 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.7 t -136.7 135.08 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.208 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 tp -70.81 141.39 51.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.48 -31.95 69.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.965 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -58.85 -29.23 66.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.792 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.4 m -83.97 -30.86 25.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.156 0.503 . . . . 0.0 111.619 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.1 t -65.16 -35.29 75.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.025 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.3 p -79.7 -15.39 57.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.465 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.26 -45.33 84.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.982 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -111.97 -18.28 12.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.016 0.436 . . . . 0.0 111.287 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -134.11 74.55 67.78 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.633 0.73 . . . . 0.0 110.864 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 129.5 17.75 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.698 2.265 . . . . 0.0 112.39 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.26 6.03 78.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.522 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.78 114.96 20.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.758 0.314 . . . . 0.0 111.129 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.2 t -95.79 -53.05 3.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -124.81 132.06 8.02 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.559 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.41 138.86 50.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.986 0.422 . . . . 0.0 110.745 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.17 170.78 7.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.715 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -111.07 125.75 54.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.974 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -129.41 104.01 7.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.934 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t30 . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 121.632 0.73 . . . . 0.0 110.902 -179.908 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.6 t -58.29 135.7 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.828 0.347 . . . . 0.0 111.069 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -83.26 138.54 33.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.867 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -118.62 120.8 38.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.1 p -145.21 121.56 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.173 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 58.16 22.53 9.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.858 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.96 -25.23 17.64 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.466 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.1 mp -82.29 114.57 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.847 0.356 . . . . 0.0 111.144 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.86 120.54 19.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -91.4 139.48 30.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -91.55 160.22 37.14 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.575 0.702 . . . . 0.0 111.092 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.88 -172.79 0.63 Allowed 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.687 2.258 . . . . 0.0 112.304 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -77.02 -2.56 34.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.269 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.44 -29.43 9.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.78 -164.72 14.06 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.526 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -85.59 -59.42 2.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.775 0.322 . . . . 0.0 110.861 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.92 -162.17 38.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.493 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.49 36.99 4.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.851 0.358 . . . . 0.0 110.883 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -88.91 -173.85 4.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.891 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.07 138.31 29.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.079 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -108.31 146.05 33.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.6 t -100.8 127.22 54.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.14 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.3 t -71.1 146.24 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.145 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -145.11 104.01 3.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.953 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.959 -179.888 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.5 p90 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.866 0.365 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.5 tt -109.1 123.16 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.095 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -118.45 104.51 10.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.005 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 7.4 m -147.35 153.17 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.336 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.1 151.18 48.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.082 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.07 -49.11 30.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -106.65 167.32 9.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.942 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -78.9 -38.05 38.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.202 0.525 . . . . 0.0 111.34 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -69.25 -26.57 64.84 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.936 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.85 130.47 34.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -62.15 156.26 60.28 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.603 0.715 . . . . 0.0 110.918 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 119.14 6.14 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.656 2.237 . . . . 0.0 112.388 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.49 142.72 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.156 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -106.82 122.71 46.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.82 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.2 159.56 64.47 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.641 0.734 . . . . 0.0 111.092 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.86 145.59 57.03 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.667 2.245 . . . . 0.0 112.31 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.1 p -135.73 171.7 14.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -74.2 167.09 22.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -73.41 -27.34 61.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.847 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -71.03 -19.58 62.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.857 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.84 -8.28 21.67 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.448 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.0 p -86.18 -178.04 6.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.9 0.381 . . . . 0.0 111.125 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.4 t -135.35 127.68 47.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.186 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.0 143.78 57.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.67 -30.44 70.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.0 t -62.8 -37.24 85.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.863 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 17.9 m -76.24 -23.51 54.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.094 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.6 t -72.25 -38.68 62.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.188 0.518 . . . . 0.0 111.341 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.9 p -77.82 -15.2 59.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.575 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.12 -46.69 86.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.941 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -112.18 -21.13 11.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.094 0.473 . . . . 0.0 111.265 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -124.98 75.01 66.83 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 121.647 0.737 . . . . 0.0 110.896 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.77 131.12 20.55 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.647 2.231 . . . . 0.0 112.379 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.76 5.91 89.46 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.488 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.98 114.3 23.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 0.0 111.093 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 m -98.86 -53.03 3.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.14 130.92 8.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.49 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.79 139.96 49.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.026 0.441 . . . . 0.0 110.705 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -109.04 170.74 7.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.751 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -107.48 126.7 52.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.86 103.04 7.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 121.654 0.74 . . . . 0.0 110.926 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.6 t -58.12 136.94 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.878 0.371 . . . . 0.0 111.104 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -86.32 138.41 31.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -119.16 114.29 22.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.9 p -135.46 121.05 30.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.181 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 57.77 23.05 9.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.94 -24.84 22.56 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.509 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.2 mp -80.22 111.52 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 111.173 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.12 109.06 6.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.924 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -84.24 137.22 33.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -89.29 160.32 42.81 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.552 0.691 . . . . 0.0 111.104 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.92 -172.92 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.724 2.283 . . . . 0.0 112.292 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -76.98 -2.45 33.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.317 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.33 -29.64 9.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.097 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.38 -164.87 14.46 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.496 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -86.75 -59.42 2.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.758 0.313 . . . . 0.0 110.898 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.08 -163.19 32.98 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.484 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.34 37.69 4.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.806 0.336 . . . . 0.0 110.9 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -92.42 -175.8 4.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 43.8 t -99.47 136.2 31.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.099 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -104.16 145.86 29.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.969 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.7 t -101.8 116.59 45.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.087 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.7 m -63.21 143.23 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.156 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -144.96 106.08 4.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.938 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 -179.909 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 26.0 p90 . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.849 0.357 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.7 tt -109.91 123.83 66.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.103 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.66 103.64 10.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.042 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 8.3 m -147.91 155.32 10.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.38 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.41 153.57 47.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.11 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.79 -49.88 11.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.41 143.61 32.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -67.9 -30.8 70.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.929 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -67.04 -26.55 66.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.876 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -90.14 170.23 10.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.832 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -94.37 159.61 33.54 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.662 0.744 . . . . 0.0 110.853 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 112.85 3.2 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.675 2.25 . . . . 0.0 112.367 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.0 tp -77.72 140.13 17.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.898 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -101.77 117.52 35.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.762 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -123.94 159.58 55.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.645 0.736 . . . . 0.0 111.148 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 152.13 68.82 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.659 2.239 . . . . 0.0 112.357 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.3 155.91 45.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.863 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -57.51 166.4 1.28 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -70.18 -33.19 71.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -63.68 -20.25 65.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 113.57 -12.94 23.09 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.451 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.2 p -82.48 -177.16 6.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.833 0.349 . . . . 0.0 111.128 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.3 t -130.9 123.3 53.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.179 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -61.89 145.57 52.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -61.04 -24.24 66.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.901 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.8 p -67.52 -44.16 79.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.5 m -71.16 -30.42 66.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.156 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.3 t -65.47 -35.2 74.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.989 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.7 p -79.6 -15.74 57.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.581 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.12 90.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -112.11 -25.57 9.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.091 0.472 . . . . 0.0 111.342 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -125.35 75.63 68.68 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.609 0.719 . . . . 0.0 110.89 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 133.03 24.62 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.694 2.263 . . . . 0.0 112.311 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.33 6.02 89.46 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.511 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.02 117.22 23.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.8 0.333 . . . . 0.0 111.083 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 2.4 m -101.22 -53.22 3.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.846 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -121.23 135.0 10.39 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.427 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 mt -122.93 146.27 47.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.781 0.324 . . . . 0.0 110.919 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.5 mtt180 -116.59 171.71 7.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -106.06 126.65 52.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.95 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -128.3 107.23 9.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.842 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 121.684 0.754 . . . . 0.0 110.866 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.3 t -85.11 143.05 12.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.784 0.326 . . . . 0.0 111.133 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -99.62 138.56 36.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.836 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -116.28 115.97 26.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.0 p -134.03 121.12 37.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.147 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 58.92 23.65 11.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.19 -24.56 24.43 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.509 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.6 mp -82.73 114.62 23.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.857 0.36 . . . . 0.0 111.151 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.64 100.29 3.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.969 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -76.96 136.48 38.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.845 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.36 159.67 55.68 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.582 0.706 . . . . 0.0 111.092 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -70.02 -173.22 0.71 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.618 2.212 . . . . 0.0 112.317 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -77.32 -1.98 32.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.182 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.91 -32.95 8.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.108 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.17 -165.18 19.47 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.51 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -86.64 -59.55 2.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.868 0.366 . . . . 0.0 110.844 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.71 -164.37 32.81 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.491 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -127.68 36.73 4.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.851 0.358 . . . . 0.0 110.858 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.8 OUTLIER -91.87 -173.71 3.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.907 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.9 t -101.12 136.69 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.121 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -101.33 139.59 36.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.943 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.5 t -97.49 114.76 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.149 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.3 m -61.29 147.82 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.108 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -145.36 96.8 2.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.916 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 45.6 p90 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.933 -179.922 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 34.1 p90 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.827 0.346 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.1 tt -121.46 123.32 69.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.098 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -121.97 103.76 9.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.095 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.3 m -143.53 149.64 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.355 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.18 151.13 40.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.145 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.59 -49.97 11.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.951 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.28 139.49 37.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -65.67 -33.34 75.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.829 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -71.78 -26.51 62.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -78.31 -171.01 2.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.79 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.4 154.92 43.55 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.382 0.611 . . . . 0.0 111.273 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.87 126.15 12.9 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.806 2.338 . . . . 0.0 112.362 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.7 tp -98.69 131.92 44.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -99.03 123.12 43.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.724 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -127.02 159.67 63.5 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.614 0.721 . . . . 0.0 111.093 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 152.32 69.43 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.663 2.242 . . . . 0.0 112.374 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.98 163.37 33.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -68.34 161.56 27.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -67.09 -27.17 67.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.803 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.63 -18.9 65.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.799 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.04 -12.81 34.32 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.481 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.2 p -83.65 -172.42 4.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.853 0.359 . . . . 0.0 111.102 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.0 t -137.66 119.23 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.089 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.3 tp -59.71 142.4 53.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.937 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.0 tp -59.0 -21.12 58.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.953 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.4 t -68.39 -34.69 76.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.947 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.8 m -80.57 -30.65 36.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.179 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.5 t -64.84 -36.43 77.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.032 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.1 p -79.95 -15.46 57.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.537 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.74 -44.64 85.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.956 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -111.35 -23.59 10.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.003 0.43 . . . . 0.0 111.261 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -124.82 74.9 65.33 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.669 0.747 . . . . 0.0 110.896 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 131.52 21.41 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.627 2.218 . . . . 0.0 112.326 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.9 5.52 89.71 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.431 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.69 114.86 22.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.724 0.297 . . . . 0.0 111.059 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 2.5 t -91.64 -52.87 4.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.881 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.18 136.17 9.19 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.543 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.65 137.56 51.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.052 0.453 . . . . 0.0 110.652 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -107.47 170.41 7.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.682 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -108.0 126.37 52.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.957 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -128.68 122.22 30.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 121.544 0.687 . . . . 0.0 110.877 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 112.613 -0.195 . . . . 0.0 112.613 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 50.5 t -72.36 134.95 28.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.849 0.357 . . . . 0.0 111.11 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -77.2 138.77 39.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.867 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -116.38 107.56 14.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.1 t -115.77 105.96 19.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.19 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 50.52 40.19 22.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.31 -25.9 11.55 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.537 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.7 mp -78.18 110.38 13.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.842 0.353 . . . . 0.0 111.116 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.93 102.97 4.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -83.61 136.25 34.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.809 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.4 160.15 57.4 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.594 0.711 . . . . 0.0 111.108 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.95 -171.85 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.711 2.274 . . . . 0.0 112.302 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.12 -2.32 33.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.294 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.86 -30.95 8.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.125 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.86 -165.73 14.7 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.441 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -86.59 -59.18 2.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.807 0.337 . . . . 0.0 110.936 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.2 -167.13 48.96 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.456 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -117.88 38.81 3.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.896 0.379 . . . . 0.0 110.862 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -87.22 -175.33 5.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.993 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.6 t -106.71 134.33 48.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.102 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -100.75 146.03 27.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 63.4 t -106.47 112.77 40.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.089 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.7 m -53.87 143.73 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.135 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -145.13 105.68 4.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.915 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.4 p90 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.884 0.373 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.0 tt -126.95 121.28 57.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.024 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -119.32 101.53 8.04 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.231 0.539 . . . . 0.0 110.442 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.7 m -139.77 159.84 27.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.062 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.19 156.95 47.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.155 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.7 -57.87 3.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.28 164.26 14.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -85.35 -28.5 25.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.099 0.476 . . . . 0.0 111.287 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -70.05 -44.42 69.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.839 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -65.02 -170.57 0.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.841 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -116.96 160.53 36.61 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.383 0.611 . . . . 0.0 111.297 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.94 106.45 1.7 Allowed 'Trans proline' 0 C--O 1.23 0.109 0 C-N-CA 122.664 2.243 . . . . 0.0 112.255 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.0 tp -74.65 138.5 20.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.929 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.02 118.62 37.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.732 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.44 159.22 56.02 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.594 0.711 . . . . 0.0 111.174 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 162.46 42.0 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.727 2.285 . . . . 0.0 112.338 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.55 175.4 11.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -75.11 178.83 5.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.843 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -81.47 -34.5 31.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.047 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.5 -29.94 70.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.105 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 121.47 16.67 4.15 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.601 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 52.4 p -111.18 178.84 4.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.851 0.358 . . . . 0.0 111.166 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 73.3 t -133.75 106.04 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.086 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.63 144.18 22.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.001 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.23 -31.25 13.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.946 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.0 p -52.81 -45.13 67.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.913 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.4 m -75.39 -30.92 60.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.123 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.3 t -66.92 -43.14 89.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.986 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.2 p -74.42 -6.34 47.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.501 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.53 -46.62 63.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.949 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -114.85 -23.34 9.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.314 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -119.2 74.93 15.03 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.601 0.715 . . . . 0.0 110.852 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 130.25 19.06 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.706 2.271 . . . . 0.0 112.307 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.34 3.76 89.85 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.446 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.9 118.91 24.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.782 0.325 . . . . 0.0 111.077 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.3 m -100.51 -58.14 1.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.91 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -117.75 130.17 8.65 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.514 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.5 140.96 48.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.93 0.395 . . . . 0.0 110.738 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.42 176.09 5.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.83 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -111.73 134.69 53.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.932 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -144.31 117.93 9.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 121.734 0.778 . . . . 0.0 110.887 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.414 -0.274 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.3 t -54.5 128.77 14.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.819 0.343 . . . . 0.0 111.152 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -77.91 149.77 34.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -127.61 126.37 41.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.936 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.9 p -149.01 123.42 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.172 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 58.11 22.81 9.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.877 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.91 -14.63 59.87 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.526 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.0 mp -92.94 110.37 22.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.808 0.337 . . . . 0.0 111.131 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -66.18 121.67 15.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.998 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -93.42 126.56 38.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.81 160.48 73.28 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.587 0.708 . . . . 0.0 111.195 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.94 -170.92 0.44 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.69 2.26 . . . . 0.0 112.331 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.12 53.48 2.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.278 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -173.79 -40.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.837 0.351 . . . . 0.0 111.136 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.68 -176.03 21.73 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.439 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -76.09 -74.96 0.2 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.743 0.306 . . . . 0.0 110.91 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.27 -161.78 24.44 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.476 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -127.0 95.81 4.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 110.96 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.26 -176.23 5.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.986 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.8 p -101.65 127.83 54.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.128 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -98.62 156.25 16.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.921 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.8 t -113.14 122.37 67.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.203 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.9 m -66.54 150.81 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.161 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -144.51 92.14 2.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 44.4 p90 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.954 -179.885 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.0 p90 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.939 0.4 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.1 tt -118.14 123.28 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.105 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.43 103.82 10.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.09 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 12.4 m -147.49 150.79 14.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.409 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.06 155.83 33.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.195 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -71.28 -48.32 51.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.1 170.85 8.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.923 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -87.18 -24.52 24.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.207 0.527 . . . . 0.0 111.447 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -66.15 -26.29 67.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.836 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -96.68 -171.42 2.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.809 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -108.72 159.36 31.23 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.343 0.592 . . . . 0.0 111.309 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.96 124.63 11.18 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.671 2.247 . . . . 0.0 112.367 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.6 tp -92.83 137.41 22.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.897 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -99.31 122.02 41.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.731 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.82 159.9 61.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.616 0.722 . . . . 0.0 111.11 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 142.55 48.39 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.731 2.287 . . . . 0.0 112.361 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.3 p -131.63 168.45 17.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.835 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -72.31 156.7 38.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -64.87 -30.49 71.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -67.01 -19.46 65.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.63 -16.35 16.64 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.469 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.6 p -81.54 -172.84 4.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.362 . . . . 0.0 111.134 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.9 t -140.74 120.45 12.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.1 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.8 mt -58.7 144.0 44.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 tt -61.23 -21.99 64.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.944 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.8 m -65.61 -37.65 87.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.7 m -77.51 -30.43 52.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.15 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.6 t -65.58 -37.71 80.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.048 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.8 p -78.19 -15.32 58.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.614 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.02 -45.98 83.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.887 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -111.94 -16.96 13.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.969 0.414 . . . . 0.0 111.223 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -132.39 75.22 74.48 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.62 0.724 . . . . 0.0 110.887 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 127.54 14.73 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.737 2.291 . . . . 0.0 112.323 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.7 -15.89 59.39 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.538 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.35 110.18 1.57 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.697 0.284 . . . . 0.0 111.096 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.7 t -92.87 -42.86 9.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.187 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -129.43 137.29 9.47 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.406 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.27 133.34 55.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.988 0.423 . . . . 0.0 110.707 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -107.02 171.91 7.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.71 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -107.99 125.75 51.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.918 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -129.22 104.22 7.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 121.615 0.721 . . . . 0.0 110.88 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.78 143.14 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.839 0.352 . . . . 0.0 111.087 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -90.63 130.72 36.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -110.93 114.54 27.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.7 p -137.82 124.68 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.125 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 57.17 22.77 7.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.97 -24.94 18.87 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.501 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.3 mp -83.05 121.05 35.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.816 0.341 . . . . 0.0 111.176 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.13 109.85 14.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.913 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -86.76 135.54 33.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.09 159.85 58.87 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.543 0.687 . . . . 0.0 111.199 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.84 -172.26 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.72 2.28 . . . . 0.0 112.376 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -76.98 -2.49 34.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.253 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.92 -29.09 9.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.21 -168.07 14.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.527 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -82.78 -59.23 2.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.809 0.338 . . . . 0.0 110.875 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.35 -166.61 32.06 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.492 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -127.91 38.28 4.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 0.0 110.9 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.429 ' C ' ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.55 -175.73 3.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.2 t -94.64 146.92 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -116.9 146.15 43.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.976 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 88.8 t -96.41 130.18 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.113 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.1 t -85.16 133.08 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.084 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -145.39 136.17 24.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.883 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.975 -179.943 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 42.5 p90 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.886 0.374 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 tt -115.54 125.51 72.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.153 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -120.64 104.99 10.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.01 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.1 m -148.74 148.01 16.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.325 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.46 153.81 38.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.11 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.9 -49.73 23.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -115.4 144.17 44.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -63.89 -25.27 68.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -72.5 -26.71 61.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -88.93 172.3 9.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.825 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -89.92 153.34 47.24 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.658 0.742 . . . . 0.0 110.864 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 116.44 4.57 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.697 2.264 . . . . 0.0 112.284 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 1.0 OUTLIER -72.12 162.48 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.119 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.77 111.66 8.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.7 pt -126.79 155.6 75.02 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.648 0.737 . . . . 0.0 111.076 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 145.6 57.51 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.631 2.221 . . . . 0.0 112.319 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.68 171.45 8.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -67.62 -179.32 1.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -73.24 -43.56 60.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.986 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -65.33 -17.04 64.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.855 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.17 -24.57 9.23 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.536 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.6 p -61.78 -173.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.801 0.334 . . . . 0.0 111.166 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.1 t -137.21 122.13 24.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.5 tp -61.12 146.57 46.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -62.34 -34.24 76.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.851 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.5 t -60.91 -27.89 68.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.796 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.8 m -87.35 -26.65 23.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.101 0.477 . . . . 0.0 111.549 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.2 t -66.87 -40.06 84.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.061 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.2 p -71.91 -13.58 61.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.169 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.98 -48.49 81.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -112.36 -19.14 12.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.298 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -125.44 74.96 69.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.623 0.725 . . . . 0.0 110.901 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 136.28 32.8 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.703 2.269 . . . . 0.0 112.343 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.71 6.44 66.89 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.487 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.52 123.01 29.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.722 0.296 . . . . 0.0 111.134 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.1 m -101.07 -52.88 3.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.893 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -122.35 132.69 8.91 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.458 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.24 138.25 51.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.948 0.404 . . . . 0.0 110.759 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -107.51 171.28 7.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.648 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -110.34 126.39 54.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -128.78 108.74 10.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 121.607 0.717 . . . . 0.0 110.859 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.11 136.1 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.811 0.339 . . . . 0.0 111.166 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -84.07 138.41 33.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.931 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -119.98 124.21 45.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.954 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.2 p -147.32 121.84 2.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.165 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 58.36 22.52 9.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.872 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.72 -24.78 22.16 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.491 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.9 mt -82.54 115.69 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.794 0.331 . . . . 0.0 111.134 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.69 111.62 11.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.966 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -86.45 135.97 33.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.84 160.07 56.38 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.589 0.709 . . . . 0.0 111.135 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -70.0 -173.37 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.702 2.268 . . . . 0.0 112.35 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.3 -2.41 34.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.3 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.78 -28.69 9.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.136 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.78 -169.23 13.78 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.444 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -82.87 -58.79 2.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.851 0.358 . . . . 0.0 110.935 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.04 -160.91 34.1 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.43 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -127.36 37.19 4.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.821 0.343 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -91.57 -175.71 4.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.914 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.0 t -100.04 140.07 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -105.62 146.12 30.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.011 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 87.4 t -103.92 124.91 58.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.107 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.0 t -69.83 147.39 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.147 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -145.21 96.71 2.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.95 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.913 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.4 p90 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.843 0.354 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.1 tt -119.48 122.95 70.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.222 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.2 103.84 10.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.107 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.7 m -147.61 153.18 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.33 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.77 149.78 49.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.067 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.51 -50.0 15.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -101.88 149.66 23.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -75.32 -31.5 60.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.139 0.495 . . . . 0.0 111.215 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -66.93 -26.69 66.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.89 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -87.46 -175.92 5.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.88 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -107.27 159.69 29.2 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.374 0.606 . . . . 0.0 111.304 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.92 118.98 6.0 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.686 2.257 . . . . 0.0 112.386 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.27 143.52 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.156 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.69 121.28 43.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.89 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.1 159.95 62.19 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.71 . . . . 0.0 111.213 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 148.84 65.79 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.658 2.239 . . . . 0.0 112.326 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.3 m -140.35 168.41 19.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.889 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -75.71 158.34 32.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -65.82 -29.61 70.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.856 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -65.28 -19.42 65.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.885 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 113.4 -14.26 23.0 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.466 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 22.3 p -85.24 -176.77 6.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.761 0.315 . . . . 0.0 111.222 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 70.0 t -138.23 122.57 21.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.176 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 30.3 mt -58.88 146.77 36.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.6 tp -62.76 -23.25 67.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.952 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.8 t -65.1 -33.51 76.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.934 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.2 m -82.9 -29.64 29.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.199 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.0 t -66.99 -40.96 86.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.985 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 p -76.88 -14.81 59.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.533 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.79 -47.77 79.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.915 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -112.12 -20.34 11.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.998 0.428 . . . . 0.0 111.325 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -124.38 75.4 61.53 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.639 0.733 . . . . 0.0 110.857 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 131.91 22.22 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.72 2.28 . . . . 0.0 112.339 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.17 6.33 89.25 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.524 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.81 107.76 18.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.78 0.324 . . . . 0.0 111.094 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.5 t -93.72 -52.93 4.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -118.9 129.12 7.97 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.477 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.69 136.85 52.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.02 0.438 . . . . 0.0 110.65 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.7 ttm-85 -107.39 171.17 7.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.779 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -105.96 126.34 52.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.91 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -128.43 103.62 7.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 121.703 0.764 . . . . 0.0 110.863 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.23 142.57 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.889 0.376 . . . . 0.0 111.132 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -91.21 138.54 31.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.775 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -116.15 117.13 29.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.2 p -138.07 122.18 21.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.123 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 57.65 22.64 8.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.65 -24.8 21.83 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.538 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.4 mt -82.53 112.79 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.822 0.344 . . . . 0.0 111.127 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -73.18 111.22 8.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -84.65 135.58 34.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -88.83 159.74 45.33 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.516 0.674 . . . . 0.0 111.174 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.92 -173.12 0.68 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.698 2.266 . . . . 0.0 112.387 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -77.28 -2.12 33.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.272 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.13 -30.27 8.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.101 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.55 -164.69 15.47 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.521 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -85.64 -59.54 2.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.807 0.337 . . . . 0.0 110.918 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.16 -165.63 30.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.585 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -128.44 38.5 3.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.873 0.368 . . . . 0.0 110.908 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.443 ' C ' ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.42 -175.66 3.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.919 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.6 t -95.43 140.39 17.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.162 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -109.9 145.46 36.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.979 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.3 t -101.28 119.77 49.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.051 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.2 m -66.63 150.98 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.092 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -145.06 102.5 3.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 -179.915 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.5 p90 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.876 0.37 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.3 tt -121.2 123.29 69.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.149 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.21 103.89 10.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 9.6 m -147.49 150.17 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.262 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.12 148.92 46.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.197 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -72.56 -49.56 31.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -114.49 139.55 49.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.858 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.69 -18.27 58.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -73.87 -26.57 60.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.67 137.42 41.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.902 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -58.32 159.85 10.73 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.589 0.709 . . . . 0.0 110.925 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 124.27 10.94 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.612 2.208 . . . . 0.0 112.339 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.34 143.53 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.144 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -105.89 121.45 44.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.15 159.6 64.14 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.611 0.72 . . . . 0.0 111.124 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 153.72 68.77 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.675 2.25 . . . . 0.0 112.373 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.1 p -142.25 162.4 35.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.818 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -68.9 159.59 32.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -65.65 -26.41 67.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -68.93 -19.38 64.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 113.08 -16.13 22.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.48 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 38.7 p -82.23 -172.44 3.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.815 0.34 . . . . 0.0 111.162 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.9 t -139.39 119.08 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.119 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.43 148.54 27.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 tt -63.02 -23.08 67.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.922 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.8 p -65.22 -36.41 84.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.2 m -80.13 -27.93 39.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.119 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.2 t -67.89 -42.03 85.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.027 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.1 p -76.12 -14.62 60.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.567 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.16 -48.0 77.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.902 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -112.13 -17.4 12.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.335 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -127.88 75.49 78.17 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.564 0.697 . . . . 0.0 110.853 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.78 131.44 21.22 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.701 2.267 . . . . 0.0 112.33 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.48 6.27 89.39 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.531 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.17 107.01 18.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.826 0.346 . . . . 0.0 111.099 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.6 t -91.78 -53.07 4.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.874 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.34 130.74 8.67 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.514 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.28 139.74 49.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.082 0.468 . . . . 0.0 110.664 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.39 171.07 7.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.751 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -106.14 126.81 52.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.921 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -125.5 103.75 8.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.808 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 121.597 0.713 . . . . 0.0 110.94 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.385 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.9 t -68.31 144.2 14.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 0.0 111.188 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -90.03 138.94 31.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -122.23 116.48 24.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.887 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.0 p -137.82 123.47 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.174 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 58.6 22.75 10.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.817 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.47 -24.99 20.29 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.529 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.8 mp -82.01 115.34 24.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.841 0.353 . . . . 0.0 111.146 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.23 108.75 7.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.948 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -85.9 135.76 33.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.22 159.74 58.75 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.604 0.716 . . . . 0.0 111.054 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -70.0 -172.88 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.677 2.251 . . . . 0.0 112.286 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -77.17 -2.0 32.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.301 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.38 -30.45 8.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.108 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.16 -169.21 16.24 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.505 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -81.24 -59.29 2.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.792 0.33 . . . . 0.0 110.895 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.71 -170.14 36.31 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.473 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -127.1 38.51 4.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.863 0.363 . . . . 0.0 110.901 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.439 ' C ' ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.25 -175.0 3.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.982 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.6 t -94.61 145.2 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.129 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -116.14 146.05 42.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.988 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 99.0 t -101.44 120.91 51.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.103 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.2 m -67.48 148.98 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -145.01 107.07 4.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.93 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.895 -179.886 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 35.6 p90 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.885 0.374 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.5 tt -120.14 123.39 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.138 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.95 104.41 10.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.112 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.9 m -144.96 157.42 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.367 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.61 146.67 42.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.173 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.22 -50.12 20.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.842 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -102.42 137.52 40.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -69.49 -26.63 64.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -66.55 -26.33 67.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -91.74 -174.61 3.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.99 154.95 37.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.64 0.733 . . . . 0.0 110.907 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 110.84 2.66 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.738 2.292 . . . . 0.0 112.27 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.18 144.2 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.189 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.21 122.26 46.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.862 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.32 159.98 62.5 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.624 0.725 . . . . 0.0 111.153 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 147.95 64.11 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.717 2.278 . . . . 0.0 112.347 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.1 m -139.42 163.62 32.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -67.1 164.75 17.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.839 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -71.58 -28.07 63.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.897 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -68.44 -19.29 64.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.855 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.14 -14.43 21.24 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.452 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.0 p -82.93 -177.55 6.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.814 0.34 . . . . 0.0 111.111 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.5 t -138.09 125.81 29.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.124 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 tp -63.44 146.2 54.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.9 tp -61.52 -27.96 68.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.4 m -64.02 -30.13 71.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.795 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.5 m -84.48 -24.71 29.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.51 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.7 t -72.54 -50.13 36.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.112 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.5 p -67.69 -13.78 62.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.183 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.49 -47.81 80.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.96 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -112.17 -8.8 13.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.233 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -138.35 75.9 38.5 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.621 0.724 . . . . 0.0 110.834 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.87 127.04 13.95 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.613 2.208 . . . . 0.0 112.345 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.18 -16.4 57.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.498 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.95 98.11 0.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.712 0.292 . . . . 0.0 111.13 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 t -84.41 -52.64 6.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.946 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -115.01 129.71 8.77 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.465 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.07 134.81 54.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.072 0.463 . . . . 0.0 110.683 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -108.88 167.68 9.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.709 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -104.77 125.98 51.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.964 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -129.32 109.07 10.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.94 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 121.613 0.721 . . . . 0.0 110.912 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.5 t -61.65 135.53 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 111.192 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -81.22 138.77 35.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.861 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -120.17 122.37 40.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.951 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.1 p -145.72 121.36 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 58.01 22.86 9.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.19 -25.17 18.62 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.482 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.3 mt -82.03 112.64 20.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.805 0.336 . . . . 0.0 111.212 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -73.88 120.0 18.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -92.32 135.59 33.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -87.65 159.74 48.86 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.487 0.66 . . . . 0.0 111.201 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.98 -173.43 0.75 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.644 2.229 . . . . 0.0 112.332 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -77.07 -2.56 34.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.263 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.72 -28.4 9.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.118 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.56 -169.11 13.66 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.51 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -81.38 -58.98 2.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.835 0.35 . . . . 0.0 110.893 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.77 -159.89 30.81 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.453 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -127.83 37.86 4.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.864 0.364 . . . . 0.0 110.814 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.22 -176.27 4.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 m -100.96 135.97 34.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.096 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -99.84 144.2 29.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.3 t -101.7 118.16 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.119 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.9 m -66.82 137.03 25.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.168 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -145.17 127.6 15.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.901 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.5 p90 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.932 -179.942 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 34.9 p90 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.857 0.36 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.3 tt -116.75 124.08 72.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.076 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.17 103.77 10.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.023 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.8 m -147.0 155.54 11.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.38 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.94 151.8 50.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.215 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.37 -50.07 13.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -107.01 143.11 35.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.51 -25.45 65.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.834 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -72.31 -26.45 61.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.85 -176.98 5.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.881 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -103.97 155.49 37.01 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.426 0.631 . . . . 0.0 111.218 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.87 106.82 1.75 Allowed 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.718 2.278 . . . . 0.0 112.309 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.45 142.87 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.155 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -109.57 123.91 50.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.21 159.75 63.49 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.626 0.727 . . . . 0.0 111.092 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 134.36 27.86 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.743 2.295 . . . . 0.0 112.334 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.04 158.19 35.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.806 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -61.82 159.86 13.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.9 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -65.63 -27.39 68.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.803 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -67.62 -19.47 65.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.86 1.25 32.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.534 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.6 p -97.25 -176.07 3.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.855 0.359 . . . . 0.0 111.158 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 73.7 t -136.07 121.54 28.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.129 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.71 146.37 36.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.69 -29.16 69.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.2 t -64.2 -39.89 94.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.4 m -73.29 -29.67 62.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.0 t -66.42 -37.8 80.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.013 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 67.2 p -78.09 -15.21 59.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.525 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.76 -47.9 81.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.965 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -112.59 -19.68 11.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.038 0.447 . . . . 0.0 111.294 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -126.75 75.34 75.37 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.651 0.739 . . . . 0.0 110.84 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.87 131.62 21.47 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.668 2.246 . . . . 0.0 112.28 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.21 6.79 89.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.49 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.17 107.95 19.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.735 0.302 . . . . 0.0 111.072 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.4 t -95.41 -53.24 3.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.936 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -115.8 131.32 9.58 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.478 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.4 mt -120.88 140.83 51.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.017 0.437 . . . . 0.0 110.756 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.41 ' HB2' ' HB ' ' A' ' 86' ' ' VAL . 49.0 mtm180 -107.33 171.86 7.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.705 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -111.06 126.9 55.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.1 tpm_? -127.91 103.61 7.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.878 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 121.567 0.699 . . . . 0.0 110.951 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.376 0 N-CA-C 112.584 -0.207 . . . . 0.0 112.584 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.1 142.72 15.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.78 0.324 . . . . 0.0 111.155 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -92.28 137.56 32.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -116.25 115.72 26.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.8 p -138.46 121.18 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.172 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 58.65 22.71 10.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.67 -24.64 22.65 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.489 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mt -81.41 114.8 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.842 0.353 . . . . 0.0 111.198 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -73.77 101.82 3.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.903 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -75.16 143.21 43.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.83 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -93.57 159.98 33.83 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.573 0.702 . . . . 0.0 111.133 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.06 -173.45 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.689 2.259 . . . . 0.0 112.294 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -77.12 -2.37 33.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.327 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.42 -31.23 8.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.086 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.9 -164.84 16.96 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.426 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -84.91 -59.58 2.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.749 0.309 . . . . 0.0 110.9 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.55 -162.79 36.52 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.488 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.22 37.93 4.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.912 0.387 . . . . 0.0 110.909 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.14 -175.8 4.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.914 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.3 t -102.05 131.94 49.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.074 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -97.24 141.62 30.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.935 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.41 ' HB ' ' HB2' ' A' ' 54' ' ' ARG . 15.5 t -99.64 115.31 40.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.118 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.3 m -61.8 145.14 13.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.064 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -145.05 110.78 5.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.96 -179.898 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.7 p90 . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.786 0.327 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.9 tt -122.85 123.38 68.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.169 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.58 103.44 9.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.066 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 6.4 m -147.31 155.66 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.308 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.66 153.34 49.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.215 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.53 -49.64 14.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.839 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -100.78 147.49 26.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.26 -34.21 72.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -68.99 -25.4 64.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -85.11 164.5 18.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -89.93 155.13 47.68 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.619 0.724 . . . . 0.0 110.925 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 112.34 3.05 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.661 2.24 . . . . 0.0 112.343 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.0 tp -76.67 140.01 17.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.92 116.57 32.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.704 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.52 160.13 52.14 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.61 0.719 . . . . 0.0 111.151 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 154.11 68.25 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.69 2.26 . . . . 0.0 112.341 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.15 163.98 31.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -64.16 165.78 8.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -66.17 -38.33 87.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.873 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.77 -19.29 64.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.61 -29.26 6.71 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.505 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.2 p -64.66 -176.24 0.24 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 0.0 111.137 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.6 t -131.67 125.76 56.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.146 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.8 tp -62.11 143.25 56.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -59.85 -23.97 63.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.88 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.0 m -67.72 -45.97 73.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.832 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.3 m -69.13 -30.32 68.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.138 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.3 t -65.82 -35.93 76.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.992 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.4 p -79.04 -15.65 57.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.036 0.446 . . . . 0.0 111.629 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.26 -45.57 87.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.896 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -112.09 -24.16 10.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.092 0.472 . . . . 0.0 111.243 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -126.56 76.95 73.83 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 121.659 0.742 . . . . 0.0 110.87 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 134.5 28.05 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.696 2.264 . . . . 0.0 112.322 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.92 6.75 86.03 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.542 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.19 112.54 21.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.847 0.356 . . . . 0.0 111.094 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.9 t -99.13 -53.31 3.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.888 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -116.9 134.72 11.47 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.52 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.4 mt -124.06 141.2 52.25 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.048 0.452 . . . . 0.0 110.672 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -107.52 171.29 7.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.722 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -108.83 125.53 52.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.962 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -129.3 99.62 5.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.869 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.3 t30 . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 121.634 0.731 . . . . 0.0 110.869 179.969 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.8 t -62.2 144.43 14.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.817 0.342 . . . . 0.0 111.155 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -95.27 138.64 32.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.877 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -114.83 121.44 43.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.0 p -139.12 120.22 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.119 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 55.42 25.9 8.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.21 -23.24 30.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.475 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.3 mp -82.15 116.74 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.877 0.37 . . . . 0.0 111.103 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.24 101.58 8.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -76.37 141.94 41.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.83 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -91.6 159.37 38.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.553 0.692 . . . . 0.0 111.102 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.03 -173.46 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.635 2.223 . . . . 0.0 112.32 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -77.27 -1.99 32.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.242 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.23 -30.13 8.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.094 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.48 -165.35 15.23 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.487 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -85.67 -59.79 2.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.851 0.358 . . . . 0.0 110.917 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.82 -163.88 32.35 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.487 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -128.09 38.55 3.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.827 0.346 . . . . 0.0 110.876 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.446 ' C ' ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -95.31 -175.76 3.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.963 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.5 t -98.15 136.23 29.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -101.53 141.35 34.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.96 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.0 t -96.34 114.39 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.4 m -60.77 142.25 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.09 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -144.97 109.9 5.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.851 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.931 -179.986 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.3 p90 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.849 0.357 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.4 tt -119.43 122.92 70.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.089 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.02 103.57 9.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.043 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.8 m -146.87 154.28 12.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.327 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.56 155.81 41.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.187 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.51 -50.04 19.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -114.45 146.7 40.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -64.63 -26.82 68.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.848 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -68.99 -25.15 64.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -95.4 159.64 14.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.869 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -81.73 154.9 70.98 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.639 0.733 . . . . 0.0 110.887 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 114.99 3.9 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.687 2.258 . . . . 0.0 112.283 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.3 tp -80.33 136.65 22.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.32 120.18 39.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.745 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -126.61 159.63 62.63 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.616 0.722 . . . . 0.0 111.093 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.8 147.64 63.09 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.65 2.233 . . . . 0.0 112.351 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.8 p -133.18 179.05 6.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.829 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -80.53 166.11 21.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -71.82 -33.53 68.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -66.21 -18.79 65.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.853 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.66 -20.93 11.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.46 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.2 p -78.51 -175.45 4.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.855 0.36 . . . . 0.0 111.139 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.4 t -138.61 120.51 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.104 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.8 147.96 21.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.905 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.8 tp -62.57 -20.22 64.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.9 m -66.06 -36.58 83.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.7 m -80.01 -34.04 38.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.183 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.1 t -64.31 -36.31 76.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.984 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.5 p -80.25 -15.52 56.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.579 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.5 -44.98 85.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.947 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -111.86 -23.58 10.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.069 0.462 . . . . 0.0 111.245 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -124.73 75.1 64.57 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 121.66 0.743 . . . . 0.0 110.903 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 133.23 25.04 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.645 2.23 . . . . 0.0 112.324 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.34 4.07 89.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.508 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.6 118.22 23.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.322 . . . . 0.0 111.103 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.8 m -102.19 -52.81 3.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -120.03 129.15 7.83 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.532 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.97 138.26 51.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.038 0.447 . . . . 0.0 110.663 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -107.32 170.8 7.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.665 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -110.47 126.06 53.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.976 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -129.14 103.78 7.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.864 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 121.567 0.699 . . . . 0.0 110.991 -179.946 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.4 t -69.86 144.58 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.839 0.352 . . . . 0.0 111.086 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -92.27 138.29 31.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.873 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -118.01 121.7 41.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.0 p -142.67 121.36 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 57.06 23.9 8.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.03 -24.93 22.39 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.529 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.5 mp -81.05 117.49 27.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.912 0.387 . . . . 0.0 111.079 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.63 111.73 16.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.934 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -84.66 135.84 34.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.946 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -87.86 159.75 48.24 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.572 0.701 . . . . 0.0 111.151 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.94 -173.82 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.72 2.28 . . . . 0.0 112.325 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -77.32 -2.42 34.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.264 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -108.37 -27.6 9.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.053 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 118.15 -172.49 14.45 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.479 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -77.77 -59.3 2.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.775 0.322 . . . . 0.0 110.922 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.55 -162.76 30.7 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.498 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.91 38.1 4.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.877 0.37 . . . . 0.0 110.876 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.45 ' C ' ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -94.64 -175.72 3.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 p -100.57 132.31 46.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.15 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -99.86 145.64 27.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.947 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.2 t -102.04 120.08 51.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.103 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.9 m -64.94 145.79 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.123 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -145.02 99.89 3.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 45.9 p90 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 -179.894 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 27.6 p90 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.826 0.346 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.7 tt -117.1 123.58 72.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.138 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -119.9 104.03 9.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.063 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.2 m -147.6 152.23 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.37 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.12 152.95 42.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.151 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.8 -48.06 60.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -128.89 155.95 44.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.815 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -63.32 -26.19 68.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -66.59 -26.39 67.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.849 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -104.01 139.54 38.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -65.42 160.17 61.23 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.68 0.752 . . . . 0.0 110.841 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 114.76 3.82 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.687 2.258 . . . . 0.0 112.345 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.5 tp -81.5 136.51 22.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.85 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -101.7 120.39 40.27 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.735 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -126.71 159.22 65.06 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.662 0.744 . . . . 0.0 111.084 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 147.72 63.75 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.649 2.233 . . . . 0.0 112.367 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.5 p -137.58 163.93 30.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.855 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -64.09 159.31 20.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.954 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.13 -29.23 69.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.877 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.84 -19.37 65.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.895 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.7 -8.37 27.95 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.499 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.7 p -90.01 179.9 5.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.825 0.345 . . . . 0.0 111.12 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 68.9 t -133.58 118.18 29.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.121 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.14 149.54 41.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -19.42 55.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.936 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 t -66.47 -39.22 88.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.989 0.423 . . . . 0.0 110.924 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.0 m -78.63 -32.34 47.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.124 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.3 t -64.69 -36.68 78.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.981 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.2 p -79.99 -15.32 57.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.55 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.92 -45.92 83.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.939 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -111.94 -24.51 9.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.979 0.418 . . . . 0.0 111.198 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -122.89 74.39 47.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.631 0.729 . . . . 0.0 110.933 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 129.07 16.93 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.663 2.242 . . . . 0.0 112.345 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.79 6.37 82.79 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.491 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.39 113.79 22.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 111.165 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.6 t -95.78 -53.32 3.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -120.69 140.09 14.01 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.512 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.4 mp -127.8 138.25 52.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.06 0.457 . . . . 0.0 110.682 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -106.73 170.39 7.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.702 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -110.38 124.69 52.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.897 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -130.45 109.01 10.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.897 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 t30 . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 121.666 0.746 . . . . 0.0 110.885 -179.981 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.9 t -67.74 151.15 10.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.79 0.329 . . . . 0.0 111.15 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -97.96 119.32 36.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -94.25 106.47 18.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.943 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.408 HG11 ' HG3' ' A' ' 70' ' ' GLU . 4.3 t -119.17 106.94 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.141 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.408 ' HG3' HG11 ' A' ' 69' ' ' VAL . 22.1 mt-10 51.62 34.96 13.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.935 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.13 -24.99 19.15 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.516 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.1 mp -81.34 108.32 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.822 0.344 . . . . 0.0 111.083 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -73.69 102.45 3.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -78.72 135.55 37.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.52 160.39 61.98 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.641 0.734 . . . . 0.0 111.046 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -70.0 -173.55 0.78 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.722 2.281 . . . . 0.0 112.297 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -77.32 -1.99 32.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.322 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.67 -29.48 9.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.073 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.25 -170.36 15.09 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.441 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -81.45 -59.18 2.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.775 0.322 . . . . 0.0 110.941 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.36 -161.94 36.05 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.488 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.44 37.01 4.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.84 0.353 . . . . 0.0 110.854 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -88.2 -174.75 4.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.6 p -104.03 131.11 53.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.151 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -95.77 146.62 24.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.922 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 68.9 t -106.34 114.67 46.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.192 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.2 t -57.87 154.75 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.095 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -145.41 88.14 1.84 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.91 -179.9 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.3 p90 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.831 0.348 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.8 tt -106.16 123.17 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.099 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -121.25 103.73 9.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.049 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 13.1 m -148.03 151.74 13.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.281 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.35 154.75 31.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.175 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.25 -41.2 94.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.855 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -139.36 167.37 22.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -75.95 -24.15 55.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.108 0.48 . . . . 0.0 111.318 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -66.4 -26.51 67.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.85 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -98.66 -175.5 3.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.823 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.6 mp0 -103.83 157.07 34.69 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.611 0.72 . . . . 0.0 110.918 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 126.95 13.92 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.655 2.237 . . . . 0.0 112.416 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.5 tp -100.36 131.64 47.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.795 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -97.07 122.46 40.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.722 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -127.23 159.74 63.56 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.643 0.735 . . . . 0.0 111.14 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.68 145.89 59.02 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.714 2.276 . . . . 0.0 112.345 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.2 p -130.12 176.82 7.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -77.84 166.41 22.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.938 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -72.19 -27.44 62.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.873 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.86 -19.19 60.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.921 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.21 -15.03 13.42 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.484 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.1 p -80.62 -171.09 2.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.923 0.392 . . . . 0.0 111.092 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.4 t -140.12 118.99 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.139 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.8 mt -56.47 139.43 49.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 28.4 tp -57.98 -22.1 47.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.952 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -66.72 -34.64 78.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.2 m -81.6 -32.88 31.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.127 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.94 -36.0 75.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.032 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.5 p -79.4 -15.46 57.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.501 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.09 -46.63 83.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.933 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -112.02 -22.62 10.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.25 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -126.37 75.85 73.4 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.626 0.727 . . . . 0.0 110.914 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 131.19 20.67 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.656 2.238 . . . . 0.0 112.302 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.81 6.47 88.98 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.416 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.32 111.93 21.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.726 0.298 . . . . 0.0 111.108 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.1 t -99.3 -53.41 3.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -115.8 132.76 10.44 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.539 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.8 mt -123.81 141.1 52.34 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.979 0.419 . . . . 0.0 110.734 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 45.5 mtt-85 -108.73 171.84 7.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.673 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -107.66 125.36 51.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.63 110.16 11.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.0 t30 . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 121.596 0.712 . . . . 0.0 110.878 -179.958 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.9 t -59.0 144.97 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.845 0.355 . . . . 0.0 111.12 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -96.64 138.58 34.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -111.9 114.24 27.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.432 ' O ' ' CG ' ' A' ' 70' ' ' GLU . 5.4 p -127.13 127.35 69.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.153 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 69' ' ' VAL . 7.2 pt-20 45.92 32.0 1.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.36 -29.18 6.27 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.517 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.4 mp -79.5 112.91 18.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.821 0.343 . . . . 0.0 111.113 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -72.62 106.58 4.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.405 ' HD1' ' N ' ' A' ' 75' ' ' ALA . 5.4 t-80 -82.42 137.44 34.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.405 ' N ' ' HD1' ' A' ' 74' ' ' HIS . . . -87.86 160.21 47.28 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.591 0.71 . . . . 0.0 111.064 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.96 -173.33 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.667 2.245 . . . . 0.0 112.343 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -77.31 -2.02 32.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.222 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.17 -30.22 8.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.115 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.77 -165.25 15.47 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.473 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -87.23 -59.89 2.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.799 0.333 . . . . 0.0 110.869 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.0 -166.74 30.07 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.443 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -124.36 36.99 4.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.89 0.376 . . . . 0.0 110.922 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.8 OUTLIER -94.42 -173.08 2.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.7 t -102.26 131.95 49.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.134 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -96.23 142.49 28.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.95 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.1 t -95.54 114.88 33.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.093 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.8 m -61.59 135.55 26.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.153 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -144.98 103.21 3.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 -179.847 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 14.7 p90 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.925 0.393 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.2 tt -95.21 122.71 46.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.131 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -116.33 103.44 10.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.143 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.8 m -147.15 147.7 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.38 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.4 t -122.94 158.8 29.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.807 0.337 . . . . 0.0 111.153 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.81 -47.37 19.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.879 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.86 163.24 13.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -79.96 -30.31 39.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.223 0.535 . . . . 0.0 111.292 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.8 m-20 -66.49 -24.43 66.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.91 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -101.54 141.09 34.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.866 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.53 160.91 77.45 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.598 0.714 . . . . 0.0 110.893 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 133.68 26.02 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.639 2.226 . . . . 0.0 112.333 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.3 tp -97.13 133.72 37.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -93.54 122.62 36.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.735 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.87 159.95 61.65 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.649 0.737 . . . . 0.0 111.086 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 133.34 25.33 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.627 2.218 . . . . 0.0 112.345 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.2 p -122.05 -175.53 3.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -85.22 174.29 9.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -79.16 -33.39 44.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.83 -19.3 65.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.44 -11.18 19.28 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.489 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.2 p -86.21 -176.1 5.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.799 0.333 . . . . 0.0 111.138 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 66.9 t -138.46 121.37 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.4 mt -59.25 149.7 27.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.31 -21.98 65.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.911 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.1 p -66.55 -37.6 85.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.812 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.5 m -76.56 -35.02 58.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.154 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.4 t -64.88 -37.89 81.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.043 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.8 p -77.96 -15.55 58.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.57 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.97 -46.69 83.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.974 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -112.05 -15.96 13.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.313 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -132.88 76.69 70.16 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.622 0.725 . . . . 0.0 110.822 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 128.14 15.58 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.686 2.257 . . . . 0.0 112.332 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.83 -15.96 57.91 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.462 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.04 108.89 1.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.766 0.317 . . . . 0.0 111.1 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.4 t -94.5 -52.79 4.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -117.83 128.53 7.83 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.522 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.99 137.97 51.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.022 0.439 . . . . 0.0 110.679 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -107.3 170.43 7.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.759 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -109.64 125.62 52.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.479 ' HE ' ' N ' ' A' ' 57' ' ' ASN . 8.9 tpm_? -129.38 108.72 10.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.893 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.479 ' N ' ' HE ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 121.635 0.731 . . . . 0.0 110.907 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.3 t -56.6 139.18 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 111.129 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -88.63 136.88 32.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -114.56 122.48 46.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.5 p -146.4 122.42 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.164 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 58.0 22.62 9.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.864 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.46 -25.03 20.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.453 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.1 mp -83.07 123.39 38.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.349 . . . . 0.0 111.195 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.33 115.57 20.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.946 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -88.41 135.84 33.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.881 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.46 159.84 52.18 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.58 0.705 . . . . 0.0 111.132 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -70.07 -172.64 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.68 2.253 . . . . 0.0 112.28 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -77.06 -2.6 34.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.299 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.18 -29.53 9.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.11 -167.39 14.69 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.461 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -81.77 -59.39 2.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.854 0.359 . . . . 0.0 110.913 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.75 -167.66 38.76 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.538 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -125.0 38.31 4.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.918 0.389 . . . . 0.0 110.916 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.448 ' C ' ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -93.44 -175.48 3.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.935 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 p -99.6 138.56 23.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.157 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -108.36 146.28 33.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.954 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 68.3 t -99.53 125.03 53.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.111 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.3 m -74.84 135.85 26.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -145.62 139.49 26.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.913 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 35.7 p90 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.816 0.341 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.5 tt -120.13 122.87 69.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.092 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.14 103.65 9.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.039 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 13.4 m -147.29 153.5 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.344 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.83 153.55 40.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.199 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.72 -39.14 90.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -139.23 -177.42 4.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -83.66 -29.43 27.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.194 0.521 . . . . 0.0 111.333 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -66.43 -24.16 66.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.887 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -105.4 128.81 53.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.789 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -57.91 159.69 9.87 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.554 0.693 . . . . 0.0 110.846 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 122.85 9.51 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.645 2.23 . . . . 0.0 112.349 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.7 tp -91.46 137.11 22.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.931 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.54 121.77 42.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.812 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -127.16 159.44 65.01 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.594 0.712 . . . . 0.0 111.179 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 141.65 45.62 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.638 2.225 . . . . 0.0 112.345 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.2 p -129.77 -179.64 5.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.82 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -82.86 159.94 22.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -67.72 -29.83 69.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -68.62 -19.5 64.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.57 -12.1 21.12 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.443 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.4 p -86.19 -175.41 5.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.863 0.363 . . . . 0.0 111.135 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.8 t -139.78 120.26 14.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.109 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.7 mt -60.31 146.6 43.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.2 tp -60.84 -20.8 62.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.6 t -65.62 -35.49 80.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.804 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.4 m -82.23 -32.31 29.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.148 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.6 t -64.12 -35.53 74.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.004 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.3 p -80.45 -15.36 56.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.006 0.431 . . . . 0.0 111.612 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.59 -45.25 83.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.909 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -112.0 -22.75 10.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.094 0.473 . . . . 0.0 111.282 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -127.04 75.17 76.75 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 121.608 0.718 . . . . 0.0 110.854 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 130.46 19.29 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.652 2.235 . . . . 0.0 112.363 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.49 6.07 87.89 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.448 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.61 115.69 23.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.348 . . . . 0.0 111.122 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 2.0 m -98.98 -52.9 3.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -121.25 130.74 8.31 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.501 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.46 142.08 47.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.824 0.345 . . . . 0.0 110.856 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -108.27 170.71 7.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.846 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -110.11 126.03 53.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.942 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -129.27 105.58 8.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 121.552 0.691 . . . . 0.0 110.941 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.8 t -52.2 147.4 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 0.0 111.164 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -101.06 124.08 46.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.904 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -97.46 114.88 26.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.426 ' O ' ' CG ' ' A' ' 70' ' ' GLU . 6.3 p -135.15 128.78 49.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.12 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.426 ' CG ' ' O ' ' A' ' 69' ' ' VAL . 7.6 pt-20 45.9 29.95 0.81 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.24 -28.04 6.48 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.543 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.0 mt -83.99 118.64 31.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.916 0.389 . . . . 0.0 111.177 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -76.49 118.89 19.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -90.61 135.56 33.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.884 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.36 160.66 50.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.63 0.728 . . . . 0.0 111.039 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.98 -173.67 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.662 2.241 . . . . 0.0 112.311 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.09 -2.07 32.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.332 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -108.68 -27.55 9.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.103 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 118.53 -172.44 14.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.523 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -78.49 -59.71 2.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.812 0.339 . . . . 0.0 110.905 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.86 -162.94 30.44 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.464 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -127.78 38.16 4.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.867 0.365 . . . . 0.0 110.893 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.439 ' C ' ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -95.95 -175.25 3.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 p -98.37 140.46 18.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.187 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -110.05 145.79 36.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 53.7 t -98.05 121.08 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.137 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.6 m -68.78 141.93 16.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.126 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -144.02 119.5 10.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.938 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.866 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 mtp . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.786 0.327 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.57 41.43 7.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.103 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -157.51 122.87 1.21 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.467 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.9 m -140.66 145.67 36.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.893 0.378 . . . . 0.0 110.863 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.0 m170 -67.9 -26.39 65.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -57.07 -27.53 61.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -62.17 107.33 0.87 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.029 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -146.55 133.96 20.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -126.62 166.33 17.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.719 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -74.08 142.35 45.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.843 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.1 20.98 16.56 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.448 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.8 t -56.9 144.51 33.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.862 0.363 . . . . 0.0 110.843 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.5 ptm -111.36 164.47 12.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m -133.7 124.8 27.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.875 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.49 -171.91 2.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.859 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -122.0 161.88 22.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.91 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.1 tt -108.49 123.48 64.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.153 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.68 104.16 11.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.054 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.3 m -145.43 154.33 13.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.344 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.9 152.23 48.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.128 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.86 -49.46 15.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.848 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -100.42 158.46 15.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -82.21 -31.89 30.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.223 0.535 . . . . 0.0 111.314 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -69.64 -26.56 64.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.874 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.65 -178.93 7.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.847 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -105.14 158.52 31.93 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.398 0.618 . . . . 0.0 111.266 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.9 114.66 3.8 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.38 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.4 tp -79.51 141.36 15.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.919 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -99.17 119.59 38.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.738 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.96 160.21 60.5 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.632 0.73 . . . . 0.0 111.122 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 155.35 66.06 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.699 2.266 . . . . 0.0 112.32 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 m -143.88 -175.99 4.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.839 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -88.63 172.96 8.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.945 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -78.49 -35.31 46.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.827 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -64.61 -19.03 65.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.853 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.69 -13.66 14.98 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.499 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 28.8 p -82.62 -174.08 5.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.851 0.357 . . . . 0.0 111.142 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.3 t -139.46 125.24 22.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.143 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.22 141.94 58.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 tt -60.56 -22.76 64.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.6 p -64.43 -29.72 70.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.788 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 58.0 m -87.1 -30.55 21.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.538 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.5 t -65.14 -39.91 87.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.992 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.9 p -77.41 -14.86 59.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.011 0.434 . . . . 0.0 111.569 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.04 -47.02 81.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.959 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 63.2 mm-40 -111.88 -21.71 11.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.116 0.484 . . . . 0.0 111.367 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -123.84 74.67 56.24 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 121.662 0.744 . . . . 0.0 110.878 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 129.99 18.61 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.66 2.24 . . . . 0.0 112.386 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.56 -9.68 70.07 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.51 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.73 99.27 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.744 0.307 . . . . 0.0 111.075 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.9 t -82.5 -43.77 16.78 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.093 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -130.27 134.82 8.0 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.399 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.68 130.02 56.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.074 0.464 . . . . 0.0 110.623 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -107.13 170.35 8.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.705 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -106.16 126.09 51.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -129.27 121.53 27.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.907 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -138.63 118.49 9.68 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.609 0.718 . . . . 0.0 110.897 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -27.88 25.85 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.644 2.23 . . . . 0.0 112.328 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.5 m -86.58 -29.23 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.125 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.3 m -88.11 -27.24 22.04 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.061 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 59.75 22.42 11.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.046 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 6.7 m -90.69 -179.25 5.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.866 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.3 ptm -142.28 27.28 1.76 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.005 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -56.07 177.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.735 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.99 143.09 9.7 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.484 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.61 134.39 30.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.818 0.342 . . . . 0.0 111.143 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -77.43 138.46 39.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -121.33 124.43 44.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.948 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.6 p -149.47 124.41 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.114 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 57.92 22.62 8.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.23 -24.88 20.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.496 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mt -82.8 122.79 37.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 0.0 111.139 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.22 119.56 24.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.936 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -91.88 135.76 33.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -87.68 160.05 48.15 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.55 0.69 . . . . 0.0 111.107 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.99 -172.59 0.62 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.678 2.252 . . . . 0.0 112.306 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -77.16 -2.28 33.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.224 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.23 -31.52 8.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.95 -164.38 15.93 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.499 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -85.28 -59.24 2.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.758 0.313 . . . . 0.0 110.933 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.55 -161.77 37.27 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.456 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -125.91 37.75 4.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.906 0.384 . . . . 0.0 110.919 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.75 -175.85 5.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.5 t -102.46 136.07 36.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.155 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -102.56 146.28 28.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.986 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 84.6 t -106.89 131.0 57.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.061 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 t -81.51 132.48 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.129 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -145.85 140.81 27.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.973 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 ptm . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.768 0.318 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.4 109.1 20.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.148 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.47 58.57 1.62 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.53 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.8 p -106.45 -35.76 7.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.867 0.365 . . . . 0.0 110.852 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -104.86 33.92 3.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -105.31 -35.11 7.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.871 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -156.47 167.45 30.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.895 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -106.62 158.83 16.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.721 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 -101.02 -30.68 11.48 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.604 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -69.31 -27.75 65.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.834 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.91 159.39 22.89 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.508 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -99.33 141.46 32.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.807 0.337 . . . . 0.0 110.818 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.4 ptt? -57.93 171.4 0.51 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.864 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.0 p -98.32 143.36 28.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -96.07 -177.79 4.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.893 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -128.99 168.42 16.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.932 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.1 tt -120.44 123.48 70.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.086 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -120.29 104.1 9.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.042 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.1 m -145.0 152.29 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.351 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.31 157.47 39.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.138 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.42 -49.95 10.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.838 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -101.27 163.11 12.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -84.39 -29.71 25.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.211 0.529 . . . . 0.0 111.265 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -67.53 -26.6 66.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.868 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -94.41 163.43 13.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.871 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -89.16 159.92 44.01 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.677 0.751 . . . . 0.0 110.888 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.86 116.77 4.72 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.63 2.22 . . . . 0.0 112.367 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.3 tp -76.68 137.98 21.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.867 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.05 119.77 37.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.802 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -126.43 159.89 60.77 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.627 0.727 . . . . 0.0 111.159 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 148.82 66.08 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.643 2.229 . . . . 0.0 112.307 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 p -133.29 -175.69 3.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -84.66 169.94 13.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -75.57 -30.55 59.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -72.34 -17.5 61.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.787 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.13 -20.84 11.24 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.451 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 22.7 p -75.57 -174.24 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.796 0.331 . . . . 0.0 111.181 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 50.5 t -141.0 119.53 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.141 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.2 tp -56.94 145.34 30.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.874 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 tt -61.44 -19.61 62.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.9 t -66.29 -37.72 86.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.9 m -77.06 -34.87 57.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.136 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.4 t -64.3 -34.94 72.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.027 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.0 p -80.06 -15.78 56.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.559 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.65 -43.65 88.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.995 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -111.92 -23.95 10.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.305 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -129.69 75.66 79.47 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.647 0.736 . . . . 0.0 110.918 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 125.28 11.95 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.675 2.25 . . . . 0.0 112.382 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.46 6.5 64.26 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.517 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.13 116.11 21.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.774 0.321 . . . . 0.0 111.135 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.8 t -100.45 -52.92 3.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -122.08 127.04 6.66 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.545 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.31 139.73 49.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.953 0.406 . . . . 0.0 110.759 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -112.21 171.0 7.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.692 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -104.13 126.04 50.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.946 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.1 tpt180 -128.94 103.32 6.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -139.17 119.15 9.41 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.635 0.731 . . . . 0.0 110.935 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 -23.73 30.45 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.727 2.285 . . . . 0.0 112.295 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.7 m -84.31 -27.68 7.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.178 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.2 m -84.28 -27.0 28.17 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.013 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 59.16 23.55 11.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.058 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 21.9 p -108.85 165.38 11.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.8 ptt? -125.18 26.15 7.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.651 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -59.34 176.5 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.706 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.71 145.63 12.71 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.528 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.7 t -62.79 143.33 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.786 0.326 . . . . 0.0 111.151 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -91.97 138.55 31.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.885 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -118.03 117.98 30.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.7 p -138.93 122.8 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.138 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 58.12 22.58 9.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.33 -25.08 19.44 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.516 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.3 mp -83.32 114.13 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.889 0.376 . . . . 0.0 111.076 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.78 116.09 13.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.956 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -91.33 135.7 33.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.08 158.85 55.18 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.554 0.692 . . . . 0.0 111.124 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.89 -172.94 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.689 2.26 . . . . 0.0 112.325 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -77.32 -2.15 33.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.266 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.74 -29.45 9.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.114 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.94 -168.86 14.65 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.514 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -82.49 -59.47 2.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.774 0.321 . . . . 0.0 110.866 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.11 -167.54 29.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.525 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -128.03 38.48 4.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.844 0.354 . . . . 0.0 110.895 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.439 ' C ' ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.61 -175.55 3.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.58 144.28 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.106 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -111.31 146.35 37.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.959 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.5 t -95.48 125.55 48.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.139 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 t -74.48 135.98 26.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.108 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -145.11 106.48 4.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.884 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.976 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 mtt . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.783 0.325 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.97 -63.11 1.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.155 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -169.15 -103.95 0.17 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.509 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.5 m -117.52 132.56 56.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.937 0.398 . . . . 0.0 110.81 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 -86.23 -55.87 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.811 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -88.58 165.77 14.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.65 -27.56 58.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.757 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -148.5 165.05 32.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.989 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -67.37 105.45 1.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.693 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -85.88 -42.7 13.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -162.51 167.29 36.97 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.503 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -116.43 135.81 53.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.884 0.373 . . . . 0.0 110.911 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -64.59 -24.96 67.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.895 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.7 p -60.89 153.56 24.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.774 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -108.82 -176.62 3.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.942 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -129.75 166.9 18.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.932 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.0 tt -120.78 123.3 69.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.138 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -120.65 104.44 9.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.058 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 10.2 m -146.3 153.31 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.371 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.91 156.63 41.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.176 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.15 -50.18 13.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -102.54 166.44 10.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.912 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -79.53 -32.85 42.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.152 0.501 . . . . 0.0 111.279 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -74.75 -25.79 59.33 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.855 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -86.28 129.01 35.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.921 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -60.46 155.0 51.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.638 0.732 . . . . 0.0 110.884 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 114.91 3.85 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.717 2.278 . . . . 0.0 112.317 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.9 tp -76.75 139.43 18.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -102.04 120.06 39.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.712 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.91 159.7 60.33 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.692 0.758 . . . . 0.0 111.051 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 142.77 49.05 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.652 2.235 . . . . 0.0 112.349 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.5 p -132.94 161.63 33.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.831 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -61.11 162.74 6.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.82 -31.85 65.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.849 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -65.2 -18.4 65.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.36 -19.37 11.68 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.461 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.5 p -81.05 -174.38 4.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.348 . . . . 0.0 111.145 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.5 t -137.76 124.56 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.154 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.8 tp -59.49 146.88 38.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.06 -25.19 68.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.7 t -64.44 -39.13 93.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.7 m -74.13 -31.02 62.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.176 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.7 t -66.16 -37.22 79.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.011 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.1 p -79.09 -15.84 57.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.578 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.13 -44.81 87.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.983 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -112.14 -20.86 11.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.118 0.485 . . . . 0.0 111.352 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -131.38 75.45 77.3 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 121.643 0.735 . . . . 0.0 110.849 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 131.87 22.19 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.619 2.213 . . . . 0.0 112.415 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.36 -8.87 72.57 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.518 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.06 119.73 15.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.807 0.337 . . . . 0.0 111.139 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.4 t -102.05 -53.01 3.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -121.07 130.25 8.14 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.494 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.69 137.81 51.71 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.992 0.425 . . . . 0.0 110.678 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -108.64 170.71 7.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.735 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -105.29 125.69 51.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -129.56 105.28 7.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -138.67 118.65 9.69 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.551 0.691 . . . . 0.0 110.909 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -24.67 29.3 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.687 2.258 . . . . 0.0 112.323 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.1 m -85.03 -29.49 6.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.045 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.1 t -87.83 -27.29 22.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.047 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 58.0 22.35 8.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.022 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 2.1 t -93.55 160.31 14.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.894 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 58.7 mmm -125.19 26.89 6.79 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.745 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.98 174.56 3.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.668 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.18 136.06 5.26 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.511 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 64.5 t -54.77 138.62 14.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.748 0.309 . . . . 0.0 111.181 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -88.15 138.49 31.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -117.3 115.05 24.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.6 p -134.32 120.28 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.141 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 57.51 23.53 9.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.9 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.39 -24.93 23.13 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.467 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.2 mp -80.83 112.72 19.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.973 0.416 . . . . 0.0 111.089 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.72 111.24 9.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.911 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -86.65 135.41 33.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -87.98 159.87 47.64 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.467 0.651 . . . . 0.0 111.209 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.94 -173.09 0.67 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.698 2.265 . . . . 0.0 112.285 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -77.2 -2.25 33.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.244 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.27 -29.81 9.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.99 -165.35 14.85 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.469 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -86.71 -59.6 2.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.82 0.343 . . . . 0.0 110.849 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.72 -165.8 29.83 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.466 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -128.16 38.24 4.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 0.0 110.861 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.432 ' C ' ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.29 -175.81 3.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.912 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 38.3 t -93.85 144.44 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.191 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -114.61 145.9 41.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.939 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.4 t -99.65 126.74 52.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.121 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.8 t -72.58 145.35 12.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.17 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -145.08 87.75 1.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.963 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.4 p90 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 -179.883 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttp . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.776 0.322 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.48 -35.23 3.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.095 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 152.04 -150.13 21.94 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.517 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.6 t -99.2 109.0 21.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.844 0.354 . . . . 0.0 110.878 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -55.18 -63.79 1.04 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.809 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.39 165.46 23.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.806 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -94.34 145.71 24.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.3 t60 -81.91 -35.42 29.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.936 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -64.45 152.19 42.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -76.22 139.21 41.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.834 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.16 107.91 2.16 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.537 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -83.74 -27.51 28.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.908 0.385 . . . . 0.0 110.866 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.3 tpt -80.2 112.92 17.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.83 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.3 m -63.74 144.35 57.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.881 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -89.85 140.53 29.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -91.27 167.76 12.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.881 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.1 tt -119.35 123.47 71.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.098 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.4 mtm180 -119.48 104.69 10.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.109 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.5 m -145.71 153.44 13.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.3 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.76 155.33 39.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.167 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.06 -49.73 22.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.928 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -105.31 173.43 6.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.861 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -79.21 -46.6 17.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.283 0.564 . . . . 0.0 111.283 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -68.84 -26.8 65.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.878 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -72.79 126.98 31.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.93 149.89 63.27 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.695 0.759 . . . . 0.0 110.856 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.78 120.2 7.02 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.763 2.308 . . . . 0.0 112.311 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.1 tp -87.54 143.4 11.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.99 123.15 48.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -127.39 160.57 59.5 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.656 0.741 . . . . 0.0 111.151 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.67 144.65 55.19 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.704 2.269 . . . . 0.0 112.426 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 m -133.18 -175.88 3.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.859 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -86.06 174.25 9.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.836 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -80.68 -35.39 33.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.806 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -63.36 -19.83 64.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.827 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.43 -12.55 13.87 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.441 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.6 p -85.38 -174.72 5.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.829 0.347 . . . . 0.0 111.182 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.7 t -136.7 135.08 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.208 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 tp -70.81 141.39 51.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.48 -31.95 69.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.965 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -58.85 -29.23 66.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.792 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.4 m -83.97 -30.86 25.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.156 0.503 . . . . 0.0 111.619 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.1 t -65.16 -35.29 75.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.025 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.3 p -79.7 -15.39 57.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.465 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.26 -45.33 84.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.982 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -111.97 -18.28 12.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.016 0.436 . . . . 0.0 111.287 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -134.11 74.55 67.78 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.633 0.73 . . . . 0.0 110.864 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 129.5 17.75 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.698 2.265 . . . . 0.0 112.39 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.26 6.03 78.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.522 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.78 114.96 20.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.758 0.314 . . . . 0.0 111.129 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.2 t -95.79 -53.05 3.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -124.81 132.06 8.02 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.559 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.41 138.86 50.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.986 0.422 . . . . 0.0 110.745 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.17 170.78 7.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.715 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -111.07 125.75 54.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.974 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -129.41 104.01 7.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.934 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -139.18 118.6 9.25 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.632 0.73 . . . . 0.0 110.902 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 -34.97 13.35 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.681 2.254 . . . . 0.0 112.355 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.0 m -74.08 -34.05 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.14 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.2 t -80.79 -27.09 36.78 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.026 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 60.07 20.11 9.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.092 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 22.7 m -83.84 162.94 20.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.924 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.5 28.24 3.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.043 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.06 -177.52 4.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.676 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.5 155.47 26.36 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.462 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.6 t -58.29 135.7 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.828 0.347 . . . . 0.0 111.069 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -83.26 138.54 33.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.867 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -118.62 120.8 38.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.1 p -145.21 121.56 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.173 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 58.16 22.53 9.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.858 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.96 -25.23 17.64 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.466 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.1 mp -82.29 114.57 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.847 0.356 . . . . 0.0 111.144 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.86 120.54 19.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -91.4 139.48 30.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -91.55 160.22 37.14 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.575 0.702 . . . . 0.0 111.092 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.88 -172.79 0.63 Allowed 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.687 2.258 . . . . 0.0 112.304 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -77.02 -2.56 34.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.269 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.44 -29.43 9.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.78 -164.72 14.06 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.526 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -85.59 -59.42 2.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.775 0.322 . . . . 0.0 110.861 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.92 -162.17 38.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.493 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.49 36.99 4.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.851 0.358 . . . . 0.0 110.883 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -88.91 -173.85 4.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.891 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.07 138.31 29.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.079 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -108.31 146.05 33.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.6 t -100.8 127.22 54.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.14 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.3 t -71.1 146.24 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.145 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -145.11 104.01 3.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.953 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.959 -179.888 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ptt? . . . . . 0 CA--C 1.526 0.032 0 CA-C-O 120.777 0.322 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.31 106.14 0.18 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.109 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 96.04 69.01 1.01 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.448 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.9 m -63.35 -55.19 26.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.893 0.377 . . . . 0.0 110.838 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -81.87 -66.05 0.94 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -152.61 176.53 11.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -61.94 135.07 57.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.983 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -149.27 116.22 5.99 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -157.15 153.96 28.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.761 0.315 . . . . 0.0 110.881 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -124.5 176.56 6.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.844 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.66 47.62 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.499 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.8 m -147.7 166.81 26.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.858 0.361 . . . . 0.0 110.854 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.0 tpt -113.71 117.47 31.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.93 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.5 m -56.76 139.41 50.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.799 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -96.42 -178.38 4.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -129.31 153.9 47.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.869 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.5 tt -109.1 123.16 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.095 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -118.45 104.51 10.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.005 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 7.4 m -147.35 153.17 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.336 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.1 151.18 48.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.082 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.07 -49.11 30.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -106.65 167.32 9.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.942 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -78.9 -38.05 38.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.202 0.525 . . . . 0.0 111.34 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -69.25 -26.57 64.84 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.936 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.85 130.47 34.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -62.15 156.26 60.28 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.603 0.715 . . . . 0.0 110.918 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 119.14 6.14 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.656 2.237 . . . . 0.0 112.388 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.49 142.72 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.156 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -106.82 122.71 46.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.82 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.2 159.56 64.47 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.641 0.734 . . . . 0.0 111.092 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.86 145.59 57.03 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.667 2.245 . . . . 0.0 112.31 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.1 p -135.73 171.7 14.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -74.2 167.09 22.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -73.41 -27.34 61.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.847 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -71.03 -19.58 62.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.857 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.84 -8.28 21.67 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.448 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.0 p -86.18 -178.04 6.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.9 0.381 . . . . 0.0 111.125 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.4 t -135.35 127.68 47.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.186 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.0 143.78 57.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.67 -30.44 70.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.0 t -62.8 -37.24 85.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.863 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 17.9 m -76.24 -23.51 54.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.094 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.6 t -72.25 -38.68 62.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.188 0.518 . . . . 0.0 111.341 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.9 p -77.82 -15.2 59.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.575 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.12 -46.69 86.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.941 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -112.18 -21.13 11.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.094 0.473 . . . . 0.0 111.265 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -124.98 75.01 66.83 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 121.647 0.737 . . . . 0.0 110.896 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.77 131.12 20.55 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.647 2.231 . . . . 0.0 112.379 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.76 5.91 89.46 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.488 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.98 114.3 23.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 0.0 111.093 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 m -98.86 -53.03 3.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.14 130.92 8.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.49 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.79 139.96 49.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.026 0.441 . . . . 0.0 110.705 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -109.04 170.74 7.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.751 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -107.48 126.7 52.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.86 103.04 7.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -139.22 121.89 10.45 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.654 0.74 . . . . 0.0 110.926 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -49.09 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.678 2.252 . . . . 0.0 112.333 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.1 m -61.58 -37.01 76.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.111 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.5 t -67.89 -26.68 66.12 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.01 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 58.28 23.76 10.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.08 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 64.5 m -116.12 -179.15 3.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 28.0 ttp -145.17 38.41 1.17 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -178.97 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.746 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.02 134.43 4.44 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.488 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.6 t -58.12 136.94 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.878 0.371 . . . . 0.0 111.104 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -86.32 138.41 31.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -119.16 114.29 22.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.9 p -135.46 121.05 30.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.181 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 57.77 23.05 9.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.94 -24.84 22.56 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.509 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.2 mp -80.22 111.52 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 111.173 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.12 109.06 6.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.924 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -84.24 137.22 33.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -89.29 160.32 42.81 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.552 0.691 . . . . 0.0 111.104 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.92 -172.92 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.724 2.283 . . . . 0.0 112.292 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -76.98 -2.45 33.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.317 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.33 -29.64 9.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.097 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.38 -164.87 14.46 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.496 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -86.75 -59.42 2.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.758 0.313 . . . . 0.0 110.898 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.08 -163.19 32.98 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.484 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.34 37.69 4.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.806 0.336 . . . . 0.0 110.9 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -92.42 -175.8 4.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 43.8 t -99.47 136.2 31.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.099 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -104.16 145.86 29.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.969 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.7 t -101.8 116.59 45.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.087 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.7 m -63.21 143.23 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.156 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -144.96 106.08 4.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.938 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 -179.909 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.793 0.33 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.18 148.17 22.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.111 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 73.0 62.42 3.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.442 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.4 m -85.78 -51.05 6.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.904 0.383 . . . . 0.0 110.841 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -130.65 125.54 34.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.86 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -72.36 -36.57 68.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -107.52 150.97 26.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.811 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -92.33 123.3 35.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -90.43 -26.75 19.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -69.2 145.07 53.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.64 35.12 3.36 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.472 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.8 t -126.24 145.3 50.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.91 0.386 . . . . 0.0 110.846 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.4 171.89 4.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.925 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.7 p -160.62 152.05 19.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -119.84 179.45 4.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.931 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -120.52 163.36 18.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.934 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.7 tt -109.91 123.83 66.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.103 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.66 103.64 10.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.042 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 8.3 m -147.91 155.32 10.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.38 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.41 153.57 47.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.11 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.79 -49.88 11.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.41 143.61 32.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -67.9 -30.8 70.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.929 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -67.04 -26.55 66.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.876 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -90.14 170.23 10.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.832 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -94.37 159.61 33.54 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.662 0.744 . . . . 0.0 110.853 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 112.85 3.2 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.675 2.25 . . . . 0.0 112.367 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.0 tp -77.72 140.13 17.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.898 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -101.77 117.52 35.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.762 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -123.94 159.58 55.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.645 0.736 . . . . 0.0 111.148 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 152.13 68.82 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.659 2.239 . . . . 0.0 112.357 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.3 155.91 45.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.863 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -57.51 166.4 1.28 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -70.18 -33.19 71.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -63.68 -20.25 65.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 113.57 -12.94 23.09 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.451 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.2 p -82.48 -177.16 6.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.833 0.349 . . . . 0.0 111.128 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.3 t -130.9 123.3 53.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.179 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -61.89 145.57 52.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -61.04 -24.24 66.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.901 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.8 p -67.52 -44.16 79.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.5 m -71.16 -30.42 66.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.156 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.3 t -65.47 -35.2 74.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.989 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.7 p -79.6 -15.74 57.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.581 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.12 90.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -112.11 -25.57 9.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.091 0.472 . . . . 0.0 111.342 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -125.35 75.63 68.68 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.609 0.719 . . . . 0.0 110.89 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 133.03 24.62 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.694 2.263 . . . . 0.0 112.311 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.33 6.02 89.46 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.511 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.02 117.22 23.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.8 0.333 . . . . 0.0 111.083 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 2.4 m -101.22 -53.22 3.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.846 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -121.23 135.0 10.39 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.427 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 mt -122.93 146.27 47.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.781 0.324 . . . . 0.0 110.919 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.5 mtt180 -116.59 171.71 7.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -106.06 126.65 52.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.95 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -128.3 107.23 9.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.842 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -140.1 148.74 55.85 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.684 0.754 . . . . 0.0 110.866 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.67 -40.54 5.35 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.711 2.274 . . . . 0.0 112.396 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.4 m -85.73 -22.71 7.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.057 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.0 m -87.97 -20.98 25.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.87 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.459 ' O ' ' C ' ' A' ' 62' ' ' CYS . 10.1 mm100 62.04 35.54 15.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.934 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 61' ' ' GLN . 26.9 p 32.87 49.77 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.921 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 5.4 tpt -92.39 -16.31 26.1 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.999 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.32 -175.11 2.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.731 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.78 168.45 39.64 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.492 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.3 t -85.11 143.05 12.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.784 0.326 . . . . 0.0 111.133 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -99.62 138.56 36.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.836 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -116.28 115.97 26.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.0 p -134.03 121.12 37.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.147 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 58.92 23.65 11.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.19 -24.56 24.43 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.509 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.6 mp -82.73 114.62 23.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.857 0.36 . . . . 0.0 111.151 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.64 100.29 3.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.969 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -76.96 136.48 38.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.845 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.36 159.67 55.68 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.582 0.706 . . . . 0.0 111.092 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -70.02 -173.22 0.71 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.618 2.212 . . . . 0.0 112.317 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -77.32 -1.98 32.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.182 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.91 -32.95 8.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.108 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.17 -165.18 19.47 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.51 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -86.64 -59.55 2.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.868 0.366 . . . . 0.0 110.844 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.71 -164.37 32.81 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.491 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -127.68 36.73 4.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.851 0.358 . . . . 0.0 110.858 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.8 OUTLIER -91.87 -173.71 3.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.907 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.9 t -101.12 136.69 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.121 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -101.33 139.59 36.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.943 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.5 t -97.49 114.76 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.149 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.3 m -61.29 147.82 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.108 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -145.36 96.8 2.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.916 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 45.6 p90 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.933 -179.922 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.6 mmt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.747 0.308 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.71 153.05 37.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.092 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -137.87 -164.47 10.01 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.499 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.2 p -134.66 170.02 16.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.883 0.373 . . . . 0.0 110.836 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -158.25 158.17 33.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.913 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.33 162.6 37.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -129.34 174.7 9.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.95 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -137.15 132.5 34.07 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.859 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -151.49 117.67 5.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.784 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 23.3 m170 -74.8 166.07 24.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -163.66 -49.91 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.407 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.2 m -115.94 176.25 5.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.355 . . . . 0.0 110.845 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 18.4 ttt -85.42 128.62 34.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.7 t -61.01 135.01 57.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.791 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -103.38 147.45 27.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.856 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -102.31 160.7 14.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.991 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.1 tt -121.46 123.32 69.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.098 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -121.97 103.76 9.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.095 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.3 m -143.53 149.64 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.355 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.18 151.13 40.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.145 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.59 -49.97 11.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.951 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.28 139.49 37.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -65.67 -33.34 75.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.829 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -71.78 -26.51 62.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -78.31 -171.01 2.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.79 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.4 154.92 43.55 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.382 0.611 . . . . 0.0 111.273 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.87 126.15 12.9 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.806 2.338 . . . . 0.0 112.362 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.7 tp -98.69 131.92 44.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -99.03 123.12 43.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.724 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -127.02 159.67 63.5 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.614 0.721 . . . . 0.0 111.093 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 152.32 69.43 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.663 2.242 . . . . 0.0 112.374 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.98 163.37 33.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -68.34 161.56 27.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -67.09 -27.17 67.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.803 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.63 -18.9 65.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.799 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.04 -12.81 34.32 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.481 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.2 p -83.65 -172.42 4.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.853 0.359 . . . . 0.0 111.102 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.0 t -137.66 119.23 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.089 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.3 tp -59.71 142.4 53.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.937 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.0 tp -59.0 -21.12 58.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.953 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.4 t -68.39 -34.69 76.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.947 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.8 m -80.57 -30.65 36.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.179 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.5 t -64.84 -36.43 77.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.032 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.1 p -79.95 -15.46 57.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.537 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.74 -44.64 85.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.956 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -111.35 -23.59 10.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.003 0.43 . . . . 0.0 111.261 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -124.82 74.9 65.33 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.669 0.747 . . . . 0.0 110.896 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 131.52 21.41 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.627 2.218 . . . . 0.0 112.326 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.9 5.52 89.71 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.431 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.69 114.86 22.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.724 0.297 . . . . 0.0 111.059 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 2.5 t -91.64 -52.87 4.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.881 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.18 136.17 9.19 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.543 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.65 137.56 51.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.052 0.453 . . . . 0.0 110.652 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -107.47 170.41 7.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.682 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -108.0 126.37 52.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.957 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -128.68 122.22 30.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -138.99 118.8 9.44 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.544 0.687 . . . . 0.0 110.877 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.74 -28.51 25.26 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.657 2.238 . . . . 0.0 112.366 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.6 m -86.37 -29.4 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.176 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.8 m -87.69 -27.75 22.23 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.991 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 59.82 24.87 13.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.023 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -98.37 168.7 10.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.958 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 13.3 mtt -129.85 33.6 4.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.669 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.8 ttt85 -57.32 179.51 0.05 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.698 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.83 147.35 16.58 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.613 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 50.5 t -72.36 134.95 28.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.849 0.357 . . . . 0.0 111.11 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -77.2 138.77 39.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.867 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -116.38 107.56 14.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.1 t -115.77 105.96 19.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.19 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 50.52 40.19 22.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.31 -25.9 11.55 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.537 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.7 mp -78.18 110.38 13.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.842 0.353 . . . . 0.0 111.116 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.93 102.97 4.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -83.61 136.25 34.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.809 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.4 160.15 57.4 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.594 0.711 . . . . 0.0 111.108 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.95 -171.85 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.711 2.274 . . . . 0.0 112.302 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.12 -2.32 33.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.294 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.86 -30.95 8.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.125 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.86 -165.73 14.7 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.441 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -86.59 -59.18 2.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.807 0.337 . . . . 0.0 110.936 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.2 -167.13 48.96 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.456 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -117.88 38.81 3.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.896 0.379 . . . . 0.0 110.862 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -87.22 -175.33 5.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.993 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.6 t -106.71 134.33 48.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.102 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -100.75 146.03 27.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 63.4 t -106.47 112.77 40.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.089 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.7 m -53.87 143.73 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.135 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -145.13 105.68 4.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.915 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.817 0.341 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.13 126.8 3.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.155 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -172.96 66.29 0.12 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.453 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.4 p -158.64 -48.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.959 0.409 . . . . 0.0 110.84 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.5 m80 -71.04 146.92 49.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 57.28 93.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -60.04 148.8 34.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -119.27 112.55 19.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -151.95 155.08 37.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -129.28 141.87 50.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.857 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.56 112.77 0.46 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.481 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 93.7 p -174.8 121.69 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.816 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.4 ptt? -139.95 147.53 40.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.891 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.4 p -175.59 158.93 2.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.818 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -84.75 156.99 21.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -116.18 163.7 15.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.86 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.0 tt -126.95 121.28 57.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.024 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -119.32 101.53 8.04 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.231 0.539 . . . . 0.0 110.442 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.7 m -139.77 159.84 27.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.062 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.19 156.95 47.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.155 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.7 -57.87 3.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.28 164.26 14.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -85.35 -28.5 25.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.099 0.476 . . . . 0.0 111.287 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -70.05 -44.42 69.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.839 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -65.02 -170.57 0.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.841 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -116.96 160.53 36.61 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.383 0.611 . . . . 0.0 111.297 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.94 106.45 1.7 Allowed 'Trans proline' 0 C--O 1.23 0.109 0 C-N-CA 122.664 2.243 . . . . 0.0 112.255 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.0 tp -74.65 138.5 20.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.929 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.02 118.62 37.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.732 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.44 159.22 56.02 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.594 0.711 . . . . 0.0 111.174 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 162.46 42.0 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.727 2.285 . . . . 0.0 112.338 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.55 175.4 11.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -75.11 178.83 5.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.843 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -81.47 -34.5 31.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.047 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.5 -29.94 70.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.105 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 121.47 16.67 4.15 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.601 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 52.4 p -111.18 178.84 4.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.851 0.358 . . . . 0.0 111.166 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 73.3 t -133.75 106.04 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.086 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.63 144.18 22.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.001 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.23 -31.25 13.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.946 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.0 p -52.81 -45.13 67.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.913 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.4 m -75.39 -30.92 60.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.123 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.3 t -66.92 -43.14 89.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.986 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.2 p -74.42 -6.34 47.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.501 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.53 -46.62 63.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.949 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -114.85 -23.34 9.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.314 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -119.2 74.93 15.03 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.601 0.715 . . . . 0.0 110.852 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 130.25 19.06 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.706 2.271 . . . . 0.0 112.307 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.34 3.76 89.85 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.446 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.9 118.91 24.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.782 0.325 . . . . 0.0 111.077 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.3 m -100.51 -58.14 1.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.91 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -117.75 130.17 8.65 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.514 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.5 140.96 48.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.93 0.395 . . . . 0.0 110.738 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.42 176.09 5.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.83 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -111.73 134.69 53.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.932 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -144.31 117.93 9.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -177.99 148.51 0.66 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.734 0.778 . . . . 0.0 110.887 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -46.84 1.09 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.642 2.228 . . . . 0.0 112.362 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.1 m -64.65 -18.26 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.181 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.1 t -68.73 -40.42 79.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.105 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 62.18 25.35 15.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.097 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.72 164.46 33.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 14.8 ttt -115.77 36.33 4.05 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.076 0.465 . . . . 0.0 110.801 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.01 173.42 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.723 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -145.64 131.52 4.2 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.414 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.3 t -54.5 128.77 14.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.819 0.343 . . . . 0.0 111.152 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -77.91 149.77 34.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -127.61 126.37 41.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.936 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.9 p -149.01 123.42 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.172 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 58.11 22.81 9.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.877 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.91 -14.63 59.87 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.526 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.0 mp -92.94 110.37 22.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.808 0.337 . . . . 0.0 111.131 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -66.18 121.67 15.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.998 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -93.42 126.56 38.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.81 160.48 73.28 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.587 0.708 . . . . 0.0 111.195 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.94 -170.92 0.44 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.69 2.26 . . . . 0.0 112.331 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.12 53.48 2.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.278 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -173.79 -40.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.837 0.351 . . . . 0.0 111.136 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.68 -176.03 21.73 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.439 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -76.09 -74.96 0.2 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.743 0.306 . . . . 0.0 110.91 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.27 -161.78 24.44 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.476 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -127.0 95.81 4.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 110.96 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.26 -176.23 5.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.986 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.8 p -101.65 127.83 54.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.128 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -98.62 156.25 16.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.921 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.8 t -113.14 122.37 67.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.203 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.9 m -66.54 150.81 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.161 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -144.51 92.14 2.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 44.4 p90 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.954 -179.885 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.769 0.319 . . . . 0.0 110.815 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.74 -178.88 6.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.6 160.59 19.42 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.553 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.2 t -69.88 108.98 4.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.919 0.39 . . . . 0.0 110.816 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -86.42 -26.49 24.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -113.07 173.97 6.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.807 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -122.79 165.9 15.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.96 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 26.3 p-80 -127.26 136.9 52.63 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.969 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -102.95 163.25 12.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.685 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -84.07 -41.5 17.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.59 113.89 0.51 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.518 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.7 p -145.61 140.49 27.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.819 0.342 . . . . 0.0 110.863 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.59 161.4 12.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.805 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.7 p -145.51 142.09 28.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.842 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -85.91 -174.54 5.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -134.35 160.95 36.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.956 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.1 tt -118.14 123.28 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.105 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.43 103.82 10.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.09 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 12.4 m -147.49 150.79 14.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.409 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.06 155.83 33.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.195 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -71.28 -48.32 51.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.1 170.85 8.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.923 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -87.18 -24.52 24.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.207 0.527 . . . . 0.0 111.447 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -66.15 -26.29 67.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.836 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -96.68 -171.42 2.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.809 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -108.72 159.36 31.23 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.343 0.592 . . . . 0.0 111.309 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.96 124.63 11.18 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.671 2.247 . . . . 0.0 112.367 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.6 tp -92.83 137.41 22.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.897 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -99.31 122.02 41.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.731 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.82 159.9 61.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.616 0.722 . . . . 0.0 111.11 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 142.55 48.39 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.731 2.287 . . . . 0.0 112.361 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.3 p -131.63 168.45 17.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.835 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -72.31 156.7 38.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -64.87 -30.49 71.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -67.01 -19.46 65.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.63 -16.35 16.64 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.469 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.6 p -81.54 -172.84 4.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.362 . . . . 0.0 111.134 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.9 t -140.74 120.45 12.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.1 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.8 mt -58.7 144.0 44.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 tt -61.23 -21.99 64.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.944 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.8 m -65.61 -37.65 87.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.7 m -77.51 -30.43 52.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.15 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.6 t -65.58 -37.71 80.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.048 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.8 p -78.19 -15.32 58.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.614 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.02 -45.98 83.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.887 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -111.94 -16.96 13.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.969 0.414 . . . . 0.0 111.223 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -132.39 75.22 74.48 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.62 0.724 . . . . 0.0 110.887 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 127.54 14.73 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.737 2.291 . . . . 0.0 112.323 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.7 -15.89 59.39 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.538 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.35 110.18 1.57 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.697 0.284 . . . . 0.0 111.096 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.7 t -92.87 -42.86 9.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.187 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -129.43 137.29 9.47 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.406 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.27 133.34 55.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.988 0.423 . . . . 0.0 110.707 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -107.02 171.91 7.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.71 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -107.99 125.75 51.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.918 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -129.22 104.22 7.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.36 117.41 29.23 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.615 0.721 . . . . 0.0 110.88 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 -27.09 27.24 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.695 2.263 . . . . 0.0 112.371 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.7 m -86.17 -29.4 6.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.131 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.1 m -88.88 -27.31 21.1 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.009 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 59.39 25.85 14.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.039 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.8 m -94.1 176.15 6.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 23.7 mtp -135.2 29.37 3.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.923 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -60.4 -174.61 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.755 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.3 143.18 8.25 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.526 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.78 143.14 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.839 0.352 . . . . 0.0 111.087 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -90.63 130.72 36.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -110.93 114.54 27.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.7 p -137.82 124.68 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.125 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 57.17 22.77 7.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.97 -24.94 18.87 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.501 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.3 mp -83.05 121.05 35.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.816 0.341 . . . . 0.0 111.176 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.13 109.85 14.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.913 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -86.76 135.54 33.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.09 159.85 58.87 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.543 0.687 . . . . 0.0 111.199 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.84 -172.26 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.72 2.28 . . . . 0.0 112.376 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -76.98 -2.49 34.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.253 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.92 -29.09 9.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.21 -168.07 14.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.527 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -82.78 -59.23 2.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.809 0.338 . . . . 0.0 110.875 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.35 -166.61 32.06 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.492 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -127.91 38.28 4.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 0.0 110.9 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.429 ' C ' ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.55 -175.73 3.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.2 t -94.64 146.92 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -116.9 146.15 43.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.976 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 88.8 t -96.41 130.18 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.113 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.1 t -85.16 133.08 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.084 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -145.39 136.17 24.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.883 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.975 -179.943 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.841 0.353 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.54 123.56 25.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.108 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 157.12 -84.96 0.13 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.511 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.3 p -80.44 121.18 25.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.866 0.365 . . . . 0.0 110.892 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -113.77 118.0 33.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -85.55 136.81 33.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.841 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -123.85 115.56 21.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.907 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -92.45 -27.04 17.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 59.1 42.08 19.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.85 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -149.49 164.52 34.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.6 140.34 45.8 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.451 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -136.47 162.51 32.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.9 0.381 . . . . 0.0 110.858 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 mpp? -112.45 26.07 10.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.838 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.6 t -66.99 -69.71 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -148.24 130.07 15.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.88 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -86.22 162.61 18.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 tt -115.54 125.51 72.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.153 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -120.64 104.99 10.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.01 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.1 m -148.74 148.01 16.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.325 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.46 153.81 38.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.11 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.9 -49.73 23.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -115.4 144.17 44.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -63.89 -25.27 68.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -72.5 -26.71 61.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -88.93 172.3 9.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.825 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -89.92 153.34 47.24 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.658 0.742 . . . . 0.0 110.864 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 116.44 4.57 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.697 2.264 . . . . 0.0 112.284 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 1.0 OUTLIER -72.12 162.48 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.119 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.77 111.66 8.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.7 pt -126.79 155.6 75.02 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.648 0.737 . . . . 0.0 111.076 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 145.6 57.51 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.631 2.221 . . . . 0.0 112.319 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.68 171.45 8.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -67.62 -179.32 1.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -73.24 -43.56 60.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.986 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -65.33 -17.04 64.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.855 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.17 -24.57 9.23 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.536 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.6 p -61.78 -173.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.801 0.334 . . . . 0.0 111.166 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.1 t -137.21 122.13 24.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.5 tp -61.12 146.57 46.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -62.34 -34.24 76.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.851 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.5 t -60.91 -27.89 68.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.796 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.8 m -87.35 -26.65 23.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.101 0.477 . . . . 0.0 111.549 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.2 t -66.87 -40.06 84.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.061 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.2 p -71.91 -13.58 61.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.169 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.98 -48.49 81.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -112.36 -19.14 12.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.298 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -125.44 74.96 69.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.623 0.725 . . . . 0.0 110.901 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 136.28 32.8 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.703 2.269 . . . . 0.0 112.343 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.71 6.44 66.89 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.487 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.52 123.01 29.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.722 0.296 . . . . 0.0 111.134 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.1 m -101.07 -52.88 3.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.893 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -122.35 132.69 8.91 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.458 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.24 138.25 51.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.948 0.404 . . . . 0.0 110.759 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -107.51 171.28 7.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.648 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -110.34 126.39 54.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -128.78 108.74 10.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.7 114.79 26.84 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.607 0.717 . . . . 0.0 110.859 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -26.12 27.79 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.659 2.24 . . . . 0.0 112.326 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.2 m -86.34 -30.4 6.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.2 t -86.18 -27.11 24.75 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.031 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 61.64 26.04 15.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.061 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 63.0 m -101.04 176.27 5.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.8 ptt? -135.75 40.41 2.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -174.33 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.701 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.79 134.78 3.63 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.464 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.11 136.1 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.811 0.339 . . . . 0.0 111.166 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -84.07 138.41 33.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.931 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -119.98 124.21 45.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.954 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.2 p -147.32 121.84 2.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.165 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 58.36 22.52 9.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.872 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.72 -24.78 22.16 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.491 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.9 mt -82.54 115.69 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.794 0.331 . . . . 0.0 111.134 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.69 111.62 11.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.966 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -86.45 135.97 33.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.84 160.07 56.38 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.589 0.709 . . . . 0.0 111.135 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -70.0 -173.37 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.702 2.268 . . . . 0.0 112.35 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.3 -2.41 34.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.3 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.78 -28.69 9.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.136 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.78 -169.23 13.78 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.444 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -82.87 -58.79 2.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.851 0.358 . . . . 0.0 110.935 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.04 -160.91 34.1 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.43 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -127.36 37.19 4.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.821 0.343 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -91.57 -175.71 4.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.914 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.0 t -100.04 140.07 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -105.62 146.12 30.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.011 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 87.4 t -103.92 124.91 58.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.107 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.0 t -69.83 147.39 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.147 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -145.21 96.71 2.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.95 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.913 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.5 ttp . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.723 0.297 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.75 -67.9 0.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 132.53 -140.28 11.68 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.521 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.3 t -61.35 161.14 9.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.932 0.396 . . . . 0.0 110.866 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -85.98 -26.69 25.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.865 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -52.15 161.05 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.829 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -62.17 149.39 41.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.838 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -91.02 -25.93 19.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -58.15 114.97 2.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.831 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -115.19 26.05 10.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.836 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.16 141.37 37.49 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.503 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.2 p -132.82 171.05 14.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 0.0 110.85 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 10.8 ptm -52.63 137.57 30.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.807 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.8 p -151.5 153.39 34.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -96.76 132.71 42.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -86.53 172.42 10.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.1 tt -119.48 122.95 70.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.222 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.2 103.84 10.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.107 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.7 m -147.61 153.18 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.33 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.77 149.78 49.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.067 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.51 -50.0 15.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -101.88 149.66 23.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -75.32 -31.5 60.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.139 0.495 . . . . 0.0 111.215 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -66.93 -26.69 66.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.89 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -87.46 -175.92 5.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.88 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -107.27 159.69 29.2 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.374 0.606 . . . . 0.0 111.304 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.92 118.98 6.0 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.686 2.257 . . . . 0.0 112.386 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.27 143.52 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.156 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.69 121.28 43.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.89 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.1 159.95 62.19 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.71 . . . . 0.0 111.213 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 148.84 65.79 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.658 2.239 . . . . 0.0 112.326 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.3 m -140.35 168.41 19.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.889 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -75.71 158.34 32.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -65.82 -29.61 70.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.856 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -65.28 -19.42 65.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.885 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 113.4 -14.26 23.0 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.466 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 22.3 p -85.24 -176.77 6.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.761 0.315 . . . . 0.0 111.222 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 70.0 t -138.23 122.57 21.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.176 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 30.3 mt -58.88 146.77 36.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.6 tp -62.76 -23.25 67.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.952 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.8 t -65.1 -33.51 76.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.934 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.2 m -82.9 -29.64 29.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.199 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.0 t -66.99 -40.96 86.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.985 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 p -76.88 -14.81 59.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.533 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.79 -47.77 79.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.915 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -112.12 -20.34 11.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.998 0.428 . . . . 0.0 111.325 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -124.38 75.4 61.53 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.639 0.733 . . . . 0.0 110.857 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 131.91 22.22 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.72 2.28 . . . . 0.0 112.339 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.17 6.33 89.25 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.524 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.81 107.76 18.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.78 0.324 . . . . 0.0 111.094 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.5 t -93.72 -52.93 4.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -118.9 129.12 7.97 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.477 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.69 136.85 52.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.02 0.438 . . . . 0.0 110.65 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.7 ttm-85 -107.39 171.17 7.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.779 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -105.96 126.34 52.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.91 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -128.43 103.62 7.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.8 115.29 24.58 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.703 0.764 . . . . 0.0 110.863 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -25.78 28.2 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.623 2.215 . . . . 0.0 112.365 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.4 m -86.4 -29.75 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.18 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.0 m -88.15 -27.16 22.05 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.107 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 60.36 26.22 15.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.097 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.4 t -96.86 167.14 11.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.875 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -126.93 25.57 6.27 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.704 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.5 ttt-85 -58.06 179.28 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.785 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.09 142.48 8.12 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.524 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.23 142.57 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.889 0.376 . . . . 0.0 111.132 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -91.21 138.54 31.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.775 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -116.15 117.13 29.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.2 p -138.07 122.18 21.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.123 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 57.65 22.64 8.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.65 -24.8 21.83 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.538 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.4 mt -82.53 112.79 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.822 0.344 . . . . 0.0 111.127 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -73.18 111.22 8.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -84.65 135.58 34.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -88.83 159.74 45.33 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.516 0.674 . . . . 0.0 111.174 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.92 -173.12 0.68 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.698 2.266 . . . . 0.0 112.387 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -77.28 -2.12 33.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.272 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.13 -30.27 8.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.101 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.55 -164.69 15.47 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.521 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -85.64 -59.54 2.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.807 0.337 . . . . 0.0 110.918 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.16 -165.63 30.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.585 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -128.44 38.5 3.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.873 0.368 . . . . 0.0 110.908 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.443 ' C ' ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.42 -175.66 3.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.919 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.6 t -95.43 140.39 17.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.162 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -109.9 145.46 36.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.979 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.3 t -101.28 119.77 49.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.051 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.2 m -66.63 150.98 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.092 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -145.06 102.5 3.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 -179.915 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 tpt . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.723 0.297 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.79 176.74 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.097 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -156.03 -150.39 5.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.528 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 t -137.35 152.05 49.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.905 0.384 . . . . 0.0 110.869 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -115.6 156.57 25.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.869 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -112.34 152.29 28.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.821 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -138.16 148.18 44.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.905 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -110.86 156.55 20.99 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.697 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -81.39 159.87 24.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.673 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 26.7 p80 -104.71 -30.0 10.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.856 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -53.66 166.7 1.75 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.455 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.1 t -76.14 158.27 31.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 110.919 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.8 ptp -85.91 154.27 21.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 94.3 p -103.48 159.86 15.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.85 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -93.09 -176.15 4.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -134.1 165.17 25.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.984 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.3 tt -121.2 123.29 69.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.149 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.21 103.89 10.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 9.6 m -147.49 150.17 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.262 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.12 148.92 46.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.197 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -72.56 -49.56 31.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -114.49 139.55 49.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.858 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.69 -18.27 58.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -73.87 -26.57 60.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.67 137.42 41.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.902 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -58.32 159.85 10.73 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.589 0.709 . . . . 0.0 110.925 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 124.27 10.94 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.612 2.208 . . . . 0.0 112.339 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.34 143.53 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.144 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -105.89 121.45 44.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.15 159.6 64.14 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.611 0.72 . . . . 0.0 111.124 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 153.72 68.77 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.675 2.25 . . . . 0.0 112.373 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.1 p -142.25 162.4 35.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.818 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -68.9 159.59 32.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -65.65 -26.41 67.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -68.93 -19.38 64.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 113.08 -16.13 22.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.48 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 38.7 p -82.23 -172.44 3.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.815 0.34 . . . . 0.0 111.162 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.9 t -139.39 119.08 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.119 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.43 148.54 27.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 tt -63.02 -23.08 67.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.922 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.8 p -65.22 -36.41 84.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.2 m -80.13 -27.93 39.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.119 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.2 t -67.89 -42.03 85.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.027 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.1 p -76.12 -14.62 60.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.567 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.16 -48.0 77.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.902 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -112.13 -17.4 12.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.335 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -127.88 75.49 78.17 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.564 0.697 . . . . 0.0 110.853 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.78 131.44 21.22 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.701 2.267 . . . . 0.0 112.33 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.48 6.27 89.39 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.531 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.17 107.01 18.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.826 0.346 . . . . 0.0 111.099 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.6 t -91.78 -53.07 4.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.874 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.34 130.74 8.67 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.514 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.28 139.74 49.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.082 0.468 . . . . 0.0 110.664 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.39 171.07 7.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.751 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -106.14 126.81 52.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.921 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -125.5 103.75 8.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.808 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.415 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 0.2 OUTLIER -132.44 105.32 13.26 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.597 0.713 . . . . 0.0 110.94 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 57' ' ' ASN . 53.7 Cg_endo -69.66 -21.31 34.13 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.696 2.264 . . . . 0.0 112.405 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.6 m -86.64 -16.65 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.128 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 62.0 m -89.64 -27.06 20.42 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.041 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 62.17 32.78 17.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.114 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 37.5 m -131.42 -177.14 4.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.861 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -139.44 98.57 3.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.197 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.59 -174.2 2.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.817 0.341 . . . . 0.0 110.901 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.26 142.84 8.15 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.499 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.9 t -68.31 144.2 14.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 0.0 111.188 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -90.03 138.94 31.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -122.23 116.48 24.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.887 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.0 p -137.82 123.47 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.174 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 58.6 22.75 10.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.817 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.47 -24.99 20.29 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.529 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.8 mp -82.01 115.34 24.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.841 0.353 . . . . 0.0 111.146 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.23 108.75 7.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.948 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -85.9 135.76 33.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.22 159.74 58.75 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.604 0.716 . . . . 0.0 111.054 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -70.0 -172.88 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.677 2.251 . . . . 0.0 112.286 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -77.17 -2.0 32.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.301 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.38 -30.45 8.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.108 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.16 -169.21 16.24 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.505 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -81.24 -59.29 2.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.792 0.33 . . . . 0.0 110.895 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.71 -170.14 36.31 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.473 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -127.1 38.51 4.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.863 0.363 . . . . 0.0 110.901 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.439 ' C ' ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.25 -175.0 3.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.982 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.6 t -94.61 145.2 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.129 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -116.14 146.05 42.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.988 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 99.0 t -101.44 120.91 51.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.103 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.2 m -67.48 148.98 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -145.01 107.07 4.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.93 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.895 -179.886 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 mtt . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.797 0.332 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.3 160.27 11.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.104 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.83 -72.16 1.24 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.479 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 p -82.72 172.73 12.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.886 0.374 . . . . 0.0 110.874 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -83.14 110.92 18.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.819 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.9 m170 -79.37 120.47 23.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.851 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -88.76 -53.87 4.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.739 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -154.93 139.09 16.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.756 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -141.5 155.44 45.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.744 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -61.66 -37.08 82.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -54.62 149.12 20.47 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.543 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.0 t -116.29 120.44 38.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.892 0.377 . . . . 0.0 110.88 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.3 ptm -92.81 -29.01 16.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.901 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 87.6 p -63.01 117.09 5.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.839 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -92.15 145.83 24.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.919 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -89.8 174.1 7.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.959 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.5 tt -120.14 123.39 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.138 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.95 104.41 10.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.112 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.9 m -144.96 157.42 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.367 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.61 146.67 42.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.173 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.22 -50.12 20.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.842 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -102.42 137.52 40.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -69.49 -26.63 64.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -66.55 -26.33 67.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -91.74 -174.61 3.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.99 154.95 37.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.64 0.733 . . . . 0.0 110.907 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 110.84 2.66 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.738 2.292 . . . . 0.0 112.27 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.18 144.2 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.189 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.21 122.26 46.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.862 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.32 159.98 62.5 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.624 0.725 . . . . 0.0 111.153 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 147.95 64.11 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.717 2.278 . . . . 0.0 112.347 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.1 m -139.42 163.62 32.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -67.1 164.75 17.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.839 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -71.58 -28.07 63.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.897 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -68.44 -19.29 64.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.855 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.14 -14.43 21.24 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.452 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.0 p -82.93 -177.55 6.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.814 0.34 . . . . 0.0 111.111 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.5 t -138.09 125.81 29.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.124 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 tp -63.44 146.2 54.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.9 tp -61.52 -27.96 68.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.4 m -64.02 -30.13 71.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.795 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.5 m -84.48 -24.71 29.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.51 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.7 t -72.54 -50.13 36.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.112 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.5 p -67.69 -13.78 62.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.183 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.49 -47.81 80.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.96 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -112.17 -8.8 13.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.233 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -138.35 75.9 38.5 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.621 0.724 . . . . 0.0 110.834 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.87 127.04 13.95 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.613 2.208 . . . . 0.0 112.345 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.18 -16.4 57.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.498 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.95 98.11 0.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.712 0.292 . . . . 0.0 111.13 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 t -84.41 -52.64 6.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.946 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -115.01 129.71 8.77 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.465 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.07 134.81 54.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.072 0.463 . . . . 0.0 110.683 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -108.88 167.68 9.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.709 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -104.77 125.98 51.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.964 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -129.32 109.07 10.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.94 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.46 109.32 13.51 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.613 0.721 . . . . 0.0 110.912 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -22.5 31.9 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.699 2.266 . . . . 0.0 112.29 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.6 m -86.31 -18.78 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.6 m -92.52 -24.99 18.59 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.991 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 60.62 22.14 11.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.007 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -111.83 -177.41 3.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.84 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -144.3 94.55 2.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.087 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.14 -175.02 2.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.897 0.379 . . . . 0.0 110.834 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.34 133.62 3.43 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.504 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.5 t -61.65 135.53 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 111.192 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -81.22 138.77 35.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.861 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -120.17 122.37 40.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.951 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.1 p -145.72 121.36 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 58.01 22.86 9.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.19 -25.17 18.62 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.482 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.3 mt -82.03 112.64 20.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.805 0.336 . . . . 0.0 111.212 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -73.88 120.0 18.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -92.32 135.59 33.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -87.65 159.74 48.86 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.487 0.66 . . . . 0.0 111.201 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.98 -173.43 0.75 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.644 2.229 . . . . 0.0 112.332 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -77.07 -2.56 34.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.263 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.72 -28.4 9.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.118 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.56 -169.11 13.66 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.51 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -81.38 -58.98 2.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.835 0.35 . . . . 0.0 110.893 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.77 -159.89 30.81 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.453 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -127.83 37.86 4.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.864 0.364 . . . . 0.0 110.814 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.22 -176.27 4.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 m -100.96 135.97 34.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.096 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -99.84 144.2 29.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.3 t -101.7 118.16 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.119 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.9 m -66.82 137.03 25.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.168 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -145.17 127.6 15.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.901 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.5 p90 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.932 -179.942 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 ptm . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.745 0.307 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.52 -36.31 9.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.57 -115.04 4.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.447 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.0 m -148.9 125.63 11.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.969 0.414 . . . . 0.0 110.81 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -111.59 -26.43 9.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.881 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -56.44 163.91 1.57 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.79 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -89.65 -33.77 16.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 50.0 m170 -60.43 159.16 10.69 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.712 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -136.0 158.03 45.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.794 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -80.55 -41.56 23.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.83 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.28 164.31 24.25 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.553 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 t -90.01 112.26 23.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.832 0.349 . . . . 0.0 110.843 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 34.4 tpp -113.81 -26.54 8.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.896 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.9 p -73.56 152.75 40.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -93.55 173.54 7.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -122.83 159.89 27.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.912 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.3 tt -116.75 124.08 72.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.076 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.17 103.77 10.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.023 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.8 m -147.0 155.54 11.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.38 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.94 151.8 50.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.215 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.37 -50.07 13.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -107.01 143.11 35.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.51 -25.45 65.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.834 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -72.31 -26.45 61.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.85 -176.98 5.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.881 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -103.97 155.49 37.01 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.426 0.631 . . . . 0.0 111.218 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.87 106.82 1.75 Allowed 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.718 2.278 . . . . 0.0 112.309 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.45 142.87 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.155 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -109.57 123.91 50.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.21 159.75 63.49 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.626 0.727 . . . . 0.0 111.092 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 134.36 27.86 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.743 2.295 . . . . 0.0 112.334 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.04 158.19 35.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.806 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -61.82 159.86 13.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.9 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -65.63 -27.39 68.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.803 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -67.62 -19.47 65.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.86 1.25 32.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.534 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.6 p -97.25 -176.07 3.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.855 0.359 . . . . 0.0 111.158 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 73.7 t -136.07 121.54 28.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.129 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.71 146.37 36.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.69 -29.16 69.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.2 t -64.2 -39.89 94.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.4 m -73.29 -29.67 62.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.0 t -66.42 -37.8 80.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.013 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 67.2 p -78.09 -15.21 59.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.525 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.76 -47.9 81.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.965 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -112.59 -19.68 11.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.038 0.447 . . . . 0.0 111.294 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -126.75 75.34 75.37 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.651 0.739 . . . . 0.0 110.84 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.87 131.62 21.47 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.668 2.246 . . . . 0.0 112.28 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.21 6.79 89.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.49 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.17 107.95 19.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.735 0.302 . . . . 0.0 111.072 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.4 t -95.41 -53.24 3.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.936 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -115.8 131.32 9.58 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.478 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.4 mt -120.88 140.83 51.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.017 0.437 . . . . 0.0 110.756 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.41 ' HB2' ' HB ' ' A' ' 86' ' ' VAL . 49.0 mtm180 -107.33 171.86 7.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.705 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -111.06 126.9 55.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.1 tpm_? -127.91 103.61 7.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.878 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -130.79 110.58 15.89 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.567 0.699 . . . . 0.0 110.951 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -22.81 31.66 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.665 2.243 . . . . 0.0 112.348 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.6 m -86.96 -20.75 7.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.163 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.1 m -93.87 -27.47 16.39 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.078 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 61.21 25.76 15.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.132 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 2.2 m -93.89 179.1 5.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 7.3 ttm -144.91 37.27 1.16 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.989 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.3 ptp85 -88.81 -177.14 5.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.752 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.82 160.26 28.93 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.584 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.1 142.72 15.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.78 0.324 . . . . 0.0 111.155 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -92.28 137.56 32.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -116.25 115.72 26.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.8 p -138.46 121.18 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.172 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 58.65 22.71 10.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.67 -24.64 22.65 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.489 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mt -81.41 114.8 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.842 0.353 . . . . 0.0 111.198 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -73.77 101.82 3.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.903 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -75.16 143.21 43.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.83 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -93.57 159.98 33.83 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.573 0.702 . . . . 0.0 111.133 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.06 -173.45 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.689 2.259 . . . . 0.0 112.294 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -77.12 -2.37 33.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.327 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.42 -31.23 8.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.086 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.9 -164.84 16.96 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.426 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -84.91 -59.58 2.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.749 0.309 . . . . 0.0 110.9 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.55 -162.79 36.52 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.488 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.22 37.93 4.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.912 0.387 . . . . 0.0 110.909 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.14 -175.8 4.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.914 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.3 t -102.05 131.94 49.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.074 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -97.24 141.62 30.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.935 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.41 ' HB ' ' HB2' ' A' ' 54' ' ' ARG . 15.5 t -99.64 115.31 40.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.118 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.3 m -61.8 145.14 13.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.064 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -145.05 110.78 5.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.96 -179.898 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.9 mmt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.802 0.334 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.35 37.26 24.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.167 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -113.53 120.77 5.26 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.536 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m -81.0 145.67 31.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.366 . . . . 0.0 110.817 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -100.91 -32.8 10.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.822 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -62.05 161.41 10.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.853 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -136.19 149.9 48.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.853 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 -82.89 151.88 25.79 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.687 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -60.85 130.81 48.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.712 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -86.51 119.06 26.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.861 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 166.92 73.73 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.487 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.2 t -161.38 159.78 28.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 0.0 110.874 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 14.8 tpt -110.51 141.25 43.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.843 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.3 t -84.67 137.64 33.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -92.59 150.95 20.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.823 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -103.08 165.31 11.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.934 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.9 tt -122.85 123.38 68.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.169 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.58 103.44 9.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.066 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 6.4 m -147.31 155.66 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.308 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.66 153.34 49.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.215 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.53 -49.64 14.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.839 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -100.78 147.49 26.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.26 -34.21 72.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -68.99 -25.4 64.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -85.11 164.5 18.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -89.93 155.13 47.68 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.619 0.724 . . . . 0.0 110.925 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 112.34 3.05 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.661 2.24 . . . . 0.0 112.343 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.0 tp -76.67 140.01 17.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.92 116.57 32.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.704 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.52 160.13 52.14 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.61 0.719 . . . . 0.0 111.151 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 154.11 68.25 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.69 2.26 . . . . 0.0 112.341 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.15 163.98 31.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -64.16 165.78 8.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -66.17 -38.33 87.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.873 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.77 -19.29 64.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.61 -29.26 6.71 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.505 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.2 p -64.66 -176.24 0.24 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 0.0 111.137 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.6 t -131.67 125.76 56.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.146 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.8 tp -62.11 143.25 56.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -59.85 -23.97 63.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.88 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.0 m -67.72 -45.97 73.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.832 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.3 m -69.13 -30.32 68.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.138 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.3 t -65.82 -35.93 76.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.992 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.4 p -79.04 -15.65 57.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.036 0.446 . . . . 0.0 111.629 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.26 -45.57 87.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.896 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -112.09 -24.16 10.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.092 0.472 . . . . 0.0 111.243 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -126.56 76.95 73.83 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 121.659 0.742 . . . . 0.0 110.87 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 134.5 28.05 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.696 2.264 . . . . 0.0 112.322 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.92 6.75 86.03 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.542 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.19 112.54 21.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.847 0.356 . . . . 0.0 111.094 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.9 t -99.13 -53.31 3.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.888 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -116.9 134.72 11.47 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.52 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.4 mt -124.06 141.2 52.25 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.048 0.452 . . . . 0.0 110.672 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -107.52 171.29 7.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.722 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -108.83 125.53 52.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.962 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -129.3 99.62 5.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.869 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -139.43 119.45 9.32 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.634 0.731 . . . . 0.0 110.869 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.87 -22.61 31.36 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.651 2.234 . . . . 0.0 112.331 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.9 m -85.56 -31.9 6.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.136 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.2 m -77.15 -27.28 53.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.01 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 58.92 21.69 9.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.069 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 97.6 m -102.2 162.5 12.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.916 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 36.5 mtm -129.14 26.5 5.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.765 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -78.94 -176.56 5.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.712 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.82 154.92 25.84 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.52 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.8 t -62.2 144.43 14.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.817 0.342 . . . . 0.0 111.155 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -95.27 138.64 32.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.877 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -114.83 121.44 43.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.0 p -139.12 120.22 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.119 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 55.42 25.9 8.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.21 -23.24 30.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.475 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.3 mp -82.15 116.74 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.877 0.37 . . . . 0.0 111.103 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.24 101.58 8.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -76.37 141.94 41.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.83 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -91.6 159.37 38.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.553 0.692 . . . . 0.0 111.102 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.03 -173.46 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.635 2.223 . . . . 0.0 112.32 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -77.27 -1.99 32.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.242 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.23 -30.13 8.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.094 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.48 -165.35 15.23 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.487 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -85.67 -59.79 2.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.851 0.358 . . . . 0.0 110.917 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.82 -163.88 32.35 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.487 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -128.09 38.55 3.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.827 0.346 . . . . 0.0 110.876 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.446 ' C ' ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -95.31 -175.76 3.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.963 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.5 t -98.15 136.23 29.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -101.53 141.35 34.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.96 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.0 t -96.34 114.39 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.4 m -60.77 142.25 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.09 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -144.97 109.9 5.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.851 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.931 -179.986 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.0 mtm . . . . . 0 N--CA 1.46 0.051 0 CA-C-O 120.841 0.353 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.7 -64.23 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.139 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.72 -24.76 3.3 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.519 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.6 p -142.56 152.23 42.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.988 0.423 . . . . 0.0 110.838 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -117.27 140.45 49.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -82.35 161.63 22.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -85.04 136.6 33.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.869 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.1 m170 -64.72 -66.06 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.77 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -69.95 170.71 10.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -68.02 -38.74 82.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 74.77 171.82 28.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.481 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.59 156.82 1.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.829 0.347 . . . . 0.0 110.908 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.9 ttt -128.77 117.94 21.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.0 m -142.88 123.6 14.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.837 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -109.56 -172.32 2.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -129.8 165.66 21.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.867 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.4 tt -119.43 122.92 70.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.089 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.02 103.57 9.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.043 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.8 m -146.87 154.28 12.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.327 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.56 155.81 41.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.187 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.51 -50.04 19.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -114.45 146.7 40.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -64.63 -26.82 68.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.848 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -68.99 -25.15 64.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -95.4 159.64 14.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.869 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -81.73 154.9 70.98 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.639 0.733 . . . . 0.0 110.887 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 114.99 3.9 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.687 2.258 . . . . 0.0 112.283 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.3 tp -80.33 136.65 22.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.32 120.18 39.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.745 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -126.61 159.63 62.63 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.616 0.722 . . . . 0.0 111.093 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.8 147.64 63.09 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.65 2.233 . . . . 0.0 112.351 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.8 p -133.18 179.05 6.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.829 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -80.53 166.11 21.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -71.82 -33.53 68.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -66.21 -18.79 65.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.853 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.66 -20.93 11.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.46 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.2 p -78.51 -175.45 4.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.855 0.36 . . . . 0.0 111.139 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.4 t -138.61 120.51 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.104 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.8 147.96 21.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.905 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.8 tp -62.57 -20.22 64.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.9 m -66.06 -36.58 83.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.7 m -80.01 -34.04 38.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.183 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.1 t -64.31 -36.31 76.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.984 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.5 p -80.25 -15.52 56.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.579 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.5 -44.98 85.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.947 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -111.86 -23.58 10.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.069 0.462 . . . . 0.0 111.245 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -124.73 75.1 64.57 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 121.66 0.743 . . . . 0.0 110.903 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 133.23 25.04 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.645 2.23 . . . . 0.0 112.324 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.34 4.07 89.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.508 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.6 118.22 23.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.322 . . . . 0.0 111.103 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.8 m -102.19 -52.81 3.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -120.03 129.15 7.83 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.532 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.97 138.26 51.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.038 0.447 . . . . 0.0 110.663 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -107.32 170.8 7.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.665 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -110.47 126.06 53.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.976 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -129.14 103.78 7.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.864 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -140.26 121.63 9.43 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.567 0.699 . . . . 0.0 110.991 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -49.11 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.673 2.248 . . . . 0.0 112.332 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.0 m -61.4 -36.81 75.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.122 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.5 t -68.42 -27.11 65.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.053 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 60.28 24.46 13.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.066 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 28.8 p -110.06 178.25 4.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.887 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.82 38.66 0.68 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -81.71 -174.3 4.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.763 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -149.78 154.78 25.92 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.52 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.4 t -69.86 144.58 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.839 0.352 . . . . 0.0 111.086 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -92.27 138.29 31.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.873 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -118.01 121.7 41.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.0 p -142.67 121.36 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 57.06 23.9 8.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.03 -24.93 22.39 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.529 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.5 mp -81.05 117.49 27.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.912 0.387 . . . . 0.0 111.079 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.63 111.73 16.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.934 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -84.66 135.84 34.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.946 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -87.86 159.75 48.24 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.572 0.701 . . . . 0.0 111.151 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.94 -173.82 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.72 2.28 . . . . 0.0 112.325 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -77.32 -2.42 34.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.264 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -108.37 -27.6 9.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.053 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 118.15 -172.49 14.45 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.479 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -77.77 -59.3 2.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.775 0.322 . . . . 0.0 110.922 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.55 -162.76 30.7 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.498 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.91 38.1 4.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.877 0.37 . . . . 0.0 110.876 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.45 ' C ' ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -94.64 -175.72 3.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 p -100.57 132.31 46.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.15 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -99.86 145.64 27.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.947 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.2 t -102.04 120.08 51.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.103 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.9 m -64.94 145.79 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.123 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -145.02 99.89 3.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 45.9 p90 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 -179.894 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.743 0.306 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.26 102.03 9.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.153 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.77 -75.26 0.96 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.478 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.2 m -66.56 129.27 39.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.86 0.362 . . . . 0.0 110.84 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -119.98 116.4 25.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -61.64 120.31 10.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -154.1 166.51 32.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.911 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -67.28 -38.2 84.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.822 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -55.83 -26.21 45.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.846 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -52.5 -44.74 65.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.862 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.2 82.72 0.32 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.522 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.8 t -156.61 161.22 39.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.859 0.361 . . . . 0.0 110.822 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 15.8 ptt? -63.57 168.17 4.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.902 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.5 m -64.72 133.2 51.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.847 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -86.22 179.75 6.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -124.74 163.26 22.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.944 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.7 tt -117.1 123.58 72.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.138 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -119.9 104.03 9.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.063 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.2 m -147.6 152.23 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.37 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.12 152.95 42.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.151 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.8 -48.06 60.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -128.89 155.95 44.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.815 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -63.32 -26.19 68.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -66.59 -26.39 67.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.849 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -104.01 139.54 38.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -65.42 160.17 61.23 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.68 0.752 . . . . 0.0 110.841 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 114.76 3.82 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.687 2.258 . . . . 0.0 112.345 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.5 tp -81.5 136.51 22.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.85 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -101.7 120.39 40.27 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.735 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -126.71 159.22 65.06 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.662 0.744 . . . . 0.0 111.084 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 147.72 63.75 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.649 2.233 . . . . 0.0 112.367 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.5 p -137.58 163.93 30.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.855 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -64.09 159.31 20.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.954 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.13 -29.23 69.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.877 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.84 -19.37 65.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.895 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.7 -8.37 27.95 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.499 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.7 p -90.01 179.9 5.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.825 0.345 . . . . 0.0 111.12 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 68.9 t -133.58 118.18 29.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.121 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.14 149.54 41.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -19.42 55.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.936 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 t -66.47 -39.22 88.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.989 0.423 . . . . 0.0 110.924 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.0 m -78.63 -32.34 47.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.124 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.3 t -64.69 -36.68 78.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.981 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.2 p -79.99 -15.32 57.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.55 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.92 -45.92 83.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.939 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -111.94 -24.51 9.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.979 0.418 . . . . 0.0 111.198 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -122.89 74.39 47.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.631 0.729 . . . . 0.0 110.933 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 129.07 16.93 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.663 2.242 . . . . 0.0 112.345 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.79 6.37 82.79 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.491 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.39 113.79 22.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 111.165 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.6 t -95.78 -53.32 3.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -120.69 140.09 14.01 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.512 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.4 mp -127.8 138.25 52.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.06 0.457 . . . . 0.0 110.682 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -106.73 170.39 7.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.702 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -110.38 124.69 52.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.897 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -130.45 109.01 10.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.897 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -139.35 118.82 9.18 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.666 0.746 . . . . 0.0 110.885 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -24.38 30.01 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.689 2.259 . . . . 0.0 112.375 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.2 m -85.04 -32.02 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.116 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.1 t -79.7 -26.82 40.78 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.069 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 61.96 23.73 14.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.047 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.9 t -106.53 159.91 15.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -128.2 27.63 5.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.68 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.78 -179.94 2.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.656 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -145.41 160.54 28.1 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.507 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.9 t -67.74 151.15 10.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.79 0.329 . . . . 0.0 111.15 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -97.96 119.32 36.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -94.25 106.47 18.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.943 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.408 HG11 ' HG3' ' A' ' 70' ' ' GLU . 4.3 t -119.17 106.94 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.141 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.408 ' HG3' HG11 ' A' ' 69' ' ' VAL . 22.1 mt-10 51.62 34.96 13.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.935 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.13 -24.99 19.15 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.516 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.1 mp -81.34 108.32 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.822 0.344 . . . . 0.0 111.083 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -73.69 102.45 3.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -78.72 135.55 37.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.52 160.39 61.98 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.641 0.734 . . . . 0.0 111.046 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -70.0 -173.55 0.78 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.722 2.281 . . . . 0.0 112.297 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -77.32 -1.99 32.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.322 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.67 -29.48 9.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.073 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.25 -170.36 15.09 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.441 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -81.45 -59.18 2.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.775 0.322 . . . . 0.0 110.941 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.36 -161.94 36.05 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.488 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.44 37.01 4.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.84 0.353 . . . . 0.0 110.854 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -88.2 -174.75 4.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.6 p -104.03 131.11 53.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.151 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -95.77 146.62 24.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.922 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 68.9 t -106.34 114.67 46.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.192 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.2 t -57.87 154.75 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.095 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -145.41 88.14 1.84 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.91 -179.9 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 mmt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.806 0.336 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.53 120.02 28.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.103 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.03 -69.89 1.28 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.472 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.4 m -83.09 118.98 23.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.955 0.407 . . . . 0.0 110.821 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -129.37 166.27 19.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.849 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 52.1 47.34 24.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -83.36 -57.2 3.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.832 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -63.44 178.5 0.55 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.828 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -155.01 162.95 40.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -155.66 142.94 19.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.849 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -112.08 85.9 0.41 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.5 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.0 m -66.32 -52.39 47.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 0.0 110.81 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.9 mtp -72.59 -34.96 67.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.2 m -69.42 132.7 46.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -121.35 149.96 42.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -85.93 160.34 19.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.947 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.8 tt -106.16 123.17 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.099 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -121.25 103.73 9.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.049 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 13.1 m -148.03 151.74 13.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.281 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.35 154.75 31.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.175 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.25 -41.2 94.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.855 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -139.36 167.37 22.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -75.95 -24.15 55.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.108 0.48 . . . . 0.0 111.318 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -66.4 -26.51 67.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.85 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -98.66 -175.5 3.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.823 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.6 mp0 -103.83 157.07 34.69 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.611 0.72 . . . . 0.0 110.918 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 126.95 13.92 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.655 2.237 . . . . 0.0 112.416 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.5 tp -100.36 131.64 47.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.795 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -97.07 122.46 40.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.722 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -127.23 159.74 63.56 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.643 0.735 . . . . 0.0 111.14 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.68 145.89 59.02 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.714 2.276 . . . . 0.0 112.345 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.2 p -130.12 176.82 7.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -77.84 166.41 22.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.938 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -72.19 -27.44 62.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.873 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.86 -19.19 60.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.921 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.21 -15.03 13.42 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.484 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.1 p -80.62 -171.09 2.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.923 0.392 . . . . 0.0 111.092 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.4 t -140.12 118.99 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.139 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.8 mt -56.47 139.43 49.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 28.4 tp -57.98 -22.1 47.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.952 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -66.72 -34.64 78.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.2 m -81.6 -32.88 31.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.127 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.94 -36.0 75.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.032 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.5 p -79.4 -15.46 57.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.501 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.09 -46.63 83.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.933 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -112.02 -22.62 10.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.25 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -126.37 75.85 73.4 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.626 0.727 . . . . 0.0 110.914 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 131.19 20.67 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.656 2.238 . . . . 0.0 112.302 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.81 6.47 88.98 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.416 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.32 111.93 21.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.726 0.298 . . . . 0.0 111.108 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.1 t -99.3 -53.41 3.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -115.8 132.76 10.44 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.539 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.8 mt -123.81 141.1 52.34 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.979 0.419 . . . . 0.0 110.734 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 45.5 mtt-85 -108.73 171.84 7.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.673 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -107.66 125.36 51.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.63 110.16 11.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -139.19 119.3 9.45 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.596 0.712 . . . . 0.0 110.878 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -23.21 31.22 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.701 2.267 . . . . 0.0 112.371 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.0 m -85.79 -31.09 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.16 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.1 m -86.89 -27.29 23.49 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.983 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 58.61 22.77 10.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.028 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 32.8 m -95.24 164.31 12.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 4.7 tpt -124.84 25.46 7.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.793 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -178.78 0.14 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.722 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.68 138.29 5.28 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.495 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.9 t -59.0 144.97 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.845 0.355 . . . . 0.0 111.12 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -96.64 138.58 34.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -111.9 114.24 27.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.432 ' O ' ' CG ' ' A' ' 70' ' ' GLU . 5.4 p -127.13 127.35 69.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.153 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 69' ' ' VAL . 7.2 pt-20 45.92 32.0 1.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.36 -29.18 6.27 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.517 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.4 mp -79.5 112.91 18.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.821 0.343 . . . . 0.0 111.113 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -72.62 106.58 4.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.405 ' HD1' ' N ' ' A' ' 75' ' ' ALA . 5.4 t-80 -82.42 137.44 34.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.405 ' N ' ' HD1' ' A' ' 74' ' ' HIS . . . -87.86 160.21 47.28 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.591 0.71 . . . . 0.0 111.064 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.96 -173.33 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.667 2.245 . . . . 0.0 112.343 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -77.31 -2.02 32.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.222 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.17 -30.22 8.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.115 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.77 -165.25 15.47 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.473 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -87.23 -59.89 2.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.799 0.333 . . . . 0.0 110.869 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.0 -166.74 30.07 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.443 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -124.36 36.99 4.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.89 0.376 . . . . 0.0 110.922 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.8 OUTLIER -94.42 -173.08 2.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.7 t -102.26 131.95 49.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.134 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -96.23 142.49 28.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.95 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.1 t -95.54 114.88 33.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.093 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.8 m -61.59 135.55 26.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.153 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -144.98 103.21 3.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 -179.847 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 tpp . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.73 0.3 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.04 178.55 6.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.145 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 73.76 23.96 75.43 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.503 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 p -64.62 -32.15 73.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.938 0.399 . . . . 0.0 110.869 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -79.39 158.5 27.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.2 m170 53.97 47.72 22.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.832 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -128.31 147.96 50.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.832 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -72.47 127.96 34.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -141.41 151.09 43.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.86 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -110.54 165.69 11.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.849 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.47 55.84 0.54 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.481 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 m -75.43 -34.99 61.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.84 0.352 . . . . 0.0 110.813 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.4 ptp -96.02 -25.9 15.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.875 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.9 m -53.62 148.24 9.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.831 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -94.95 179.78 5.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.891 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -120.68 140.13 52.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.2 tt -95.21 122.71 46.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.131 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -116.33 103.44 10.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.143 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.8 m -147.15 147.7 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.38 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.4 t -122.94 158.8 29.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.807 0.337 . . . . 0.0 111.153 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.81 -47.37 19.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.879 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.86 163.24 13.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -79.96 -30.31 39.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.223 0.535 . . . . 0.0 111.292 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.8 m-20 -66.49 -24.43 66.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.91 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -101.54 141.09 34.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.866 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.53 160.91 77.45 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.598 0.714 . . . . 0.0 110.893 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 133.68 26.02 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.639 2.226 . . . . 0.0 112.333 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.3 tp -97.13 133.72 37.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -93.54 122.62 36.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.735 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.87 159.95 61.65 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.649 0.737 . . . . 0.0 111.086 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 133.34 25.33 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.627 2.218 . . . . 0.0 112.345 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.2 p -122.05 -175.53 3.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -85.22 174.29 9.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -79.16 -33.39 44.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.83 -19.3 65.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.44 -11.18 19.28 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.489 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.2 p -86.21 -176.1 5.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.799 0.333 . . . . 0.0 111.138 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 66.9 t -138.46 121.37 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.4 mt -59.25 149.7 27.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.31 -21.98 65.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.911 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.1 p -66.55 -37.6 85.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.812 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.5 m -76.56 -35.02 58.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.154 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.4 t -64.88 -37.89 81.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.043 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.8 p -77.96 -15.55 58.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.57 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.97 -46.69 83.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.974 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -112.05 -15.96 13.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.313 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -132.88 76.69 70.16 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.622 0.725 . . . . 0.0 110.822 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 128.14 15.58 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.686 2.257 . . . . 0.0 112.332 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.83 -15.96 57.91 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.462 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.04 108.89 1.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.766 0.317 . . . . 0.0 111.1 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.4 t -94.5 -52.79 4.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -117.83 128.53 7.83 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.522 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.99 137.97 51.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.022 0.439 . . . . 0.0 110.679 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -107.3 170.43 7.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.759 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -109.64 125.62 52.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.479 ' HE ' ' N ' ' A' ' 57' ' ' ASN . 8.9 tpm_? -129.38 108.72 10.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.893 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.479 ' N ' ' HE ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -128.75 113.79 19.1 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.635 0.731 . . . . 0.0 110.907 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -23.55 30.53 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.695 2.264 . . . . 0.0 112.343 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.8 m -86.87 -27.36 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.199 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.5 t -90.28 -27.53 19.38 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.064 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 60.7 23.59 13.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.121 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 18.2 m -96.19 174.03 7.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.924 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.0 ttt -135.45 54.43 1.92 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.838 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.44 -174.8 5.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.679 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.52 135.59 3.87 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.492 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.3 t -56.6 139.18 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 111.129 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -88.63 136.88 32.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -114.56 122.48 46.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.5 p -146.4 122.42 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.164 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 58.0 22.62 9.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.864 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.46 -25.03 20.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.453 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.1 mp -83.07 123.39 38.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.349 . . . . 0.0 111.195 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.33 115.57 20.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.946 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -88.41 135.84 33.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.881 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.46 159.84 52.18 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.58 0.705 . . . . 0.0 111.132 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -70.07 -172.64 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.68 2.253 . . . . 0.0 112.28 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -77.06 -2.6 34.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.299 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.18 -29.53 9.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.11 -167.39 14.69 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.461 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -81.77 -59.39 2.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.854 0.359 . . . . 0.0 110.913 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.75 -167.66 38.76 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.538 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -125.0 38.31 4.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.918 0.389 . . . . 0.0 110.916 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.448 ' C ' ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -93.44 -175.48 3.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.935 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 p -99.6 138.56 23.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.157 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -108.36 146.28 33.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.954 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 68.3 t -99.53 125.03 53.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.111 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.3 m -74.84 135.85 26.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -145.62 139.49 26.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.913 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.854 0.359 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.98 148.96 1.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.34 -145.46 12.14 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.462 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.0 m -110.15 113.29 25.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.927 0.394 . . . . 0.0 110.876 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -104.3 30.69 5.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.842 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -118.95 133.43 55.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 55.5 m80 -98.84 154.82 17.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.843 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -80.39 137.78 36.57 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.595 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -109.09 27.57 9.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.747 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -68.11 -33.93 75.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.847 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.7 -145.09 0.21 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.455 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.1 p -120.63 174.45 6.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.856 0.36 . . . . 0.0 110.869 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 14.8 mtt -93.14 133.18 36.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 93.8 p -62.54 126.15 26.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.91 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -97.48 -176.46 3.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.895 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -124.69 170.23 11.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.95 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.5 tt -120.13 122.87 69.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.092 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.14 103.65 9.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.039 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 13.4 m -147.29 153.5 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.344 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.83 153.55 40.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.199 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.72 -39.14 90.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -139.23 -177.42 4.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -83.66 -29.43 27.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.194 0.521 . . . . 0.0 111.333 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -66.43 -24.16 66.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.887 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -105.4 128.81 53.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.789 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -57.91 159.69 9.87 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.554 0.693 . . . . 0.0 110.846 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 122.85 9.51 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.645 2.23 . . . . 0.0 112.349 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.7 tp -91.46 137.11 22.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.931 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.54 121.77 42.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.812 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -127.16 159.44 65.01 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.594 0.712 . . . . 0.0 111.179 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 141.65 45.62 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.638 2.225 . . . . 0.0 112.345 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.2 p -129.77 -179.64 5.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.82 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -82.86 159.94 22.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -67.72 -29.83 69.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -68.62 -19.5 64.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.57 -12.1 21.12 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.443 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.4 p -86.19 -175.41 5.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.863 0.363 . . . . 0.0 111.135 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.8 t -139.78 120.26 14.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.109 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.7 mt -60.31 146.6 43.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.2 tp -60.84 -20.8 62.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.6 t -65.62 -35.49 80.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.804 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.4 m -82.23 -32.31 29.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.148 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.6 t -64.12 -35.53 74.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.004 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.3 p -80.45 -15.36 56.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.006 0.431 . . . . 0.0 111.612 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.59 -45.25 83.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.909 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -112.0 -22.75 10.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.094 0.473 . . . . 0.0 111.282 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -127.04 75.17 76.75 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 121.608 0.718 . . . . 0.0 110.854 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 130.46 19.29 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.652 2.235 . . . . 0.0 112.363 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.49 6.07 87.89 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.448 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.61 115.69 23.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.348 . . . . 0.0 111.122 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 2.0 m -98.98 -52.9 3.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -121.25 130.74 8.31 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.501 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.46 142.08 47.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.824 0.345 . . . . 0.0 110.856 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -108.27 170.71 7.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.846 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -110.11 126.03 53.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.942 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -129.27 105.58 8.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -126.75 115.75 22.52 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.552 0.691 . . . . 0.0 110.941 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 -24.94 28.95 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.607 2.205 . . . . 0.0 112.354 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.1 m -86.63 -30.79 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.119 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.7 m -85.56 -27.16 25.73 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.028 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 59.97 24.04 13.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.016 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 84.4 m -94.0 -176.79 4.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.88 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.9 ptt? -143.67 32.26 1.3 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.926 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -174.56 0.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.715 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.01 135.55 3.75 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.488 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.8 t -52.2 147.4 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 0.0 111.164 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -101.06 124.08 46.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.904 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -97.46 114.88 26.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.426 ' O ' ' CG ' ' A' ' 70' ' ' GLU . 6.3 p -135.15 128.78 49.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.12 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.426 ' CG ' ' O ' ' A' ' 69' ' ' VAL . 7.6 pt-20 45.9 29.95 0.81 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.24 -28.04 6.48 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.543 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.0 mt -83.99 118.64 31.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.916 0.389 . . . . 0.0 111.177 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -76.49 118.89 19.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -90.61 135.56 33.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.884 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.36 160.66 50.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.63 0.728 . . . . 0.0 111.039 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.98 -173.67 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.662 2.241 . . . . 0.0 112.311 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.09 -2.07 32.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.332 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -108.68 -27.55 9.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.103 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 118.53 -172.44 14.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.523 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -78.49 -59.71 2.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.812 0.339 . . . . 0.0 110.905 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.86 -162.94 30.44 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.464 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -127.78 38.16 4.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.867 0.365 . . . . 0.0 110.893 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.439 ' C ' ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -95.95 -175.25 3.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 p -98.37 140.46 18.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.187 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -110.05 145.79 36.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 53.7 t -98.05 121.08 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.137 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.6 m -68.78 141.93 16.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.126 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -144.02 119.5 10.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.938 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.866 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 23.2 p90 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.861 0.362 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.752 HG23 HG13 ' A' ' 30' ' ' ILE . 6.1 tt -108.49 123.48 64.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.153 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.68 104.16 11.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.054 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.672 HG12 HD12 ' A' ' 83' ' ' LEU . 6.3 m -145.43 154.33 13.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.344 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.522 ' CG2' HG22 ' A' ' 84' ' ' VAL . 0.6 OUTLIER -128.9 152.23 48.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.128 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.86 -49.46 15.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.848 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -100.42 158.46 15.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -82.21 -31.89 30.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.223 0.535 . . . . 0.0 111.314 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -69.64 -26.56 64.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.874 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.65 -178.93 7.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.847 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -105.14 158.52 31.93 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.398 0.618 . . . . 0.0 111.266 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.9 114.66 3.8 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.38 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 19' ' ' VAL . 5.4 tp -79.51 141.36 15.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.919 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.443 ' H ' HD12 ' A' ' 28' ' ' ILE . 2.6 mt-10 -99.17 119.59 38.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.738 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.752 HG13 HG23 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -126.96 160.21 60.5 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.632 0.73 . . . . 0.0 111.122 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 155.35 66.06 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.699 2.266 . . . . 0.0 112.32 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.554 ' HB3' HG22 ' A' ' 38' ' ' VAL . 1.5 m -143.88 -175.99 4.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.839 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -88.63 172.96 8.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.945 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -78.49 -35.31 46.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.827 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -64.61 -19.03 65.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.853 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.69 -13.66 14.98 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.499 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.643 HG22 ' HA ' ' A' ' 74' ' ' HIS . 28.8 p -82.62 -174.08 5.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.851 0.357 . . . . 0.0 111.142 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.596 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 54.3 t -139.46 125.24 22.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.143 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.22 141.94 58.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.767 HD12 ' CA ' ' A' ' 71' ' ' GLY . 1.7 tt -60.56 -22.76 64.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.6 p -64.43 -29.72 70.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.788 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 58.0 m -87.1 -30.55 21.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.538 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.494 HG21 HD23 ' A' ' 73' ' ' LEU . 38.5 t -65.14 -39.91 87.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.992 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.582 HG23 HD23 ' A' ' 40' ' ' LEU . 42.9 p -77.41 -14.86 59.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.011 0.434 . . . . 0.0 111.569 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.04 -47.02 81.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.959 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 63.2 mm-40 -111.88 -21.71 11.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.116 0.484 . . . . 0.0 111.367 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -123.84 74.67 56.24 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 121.662 0.744 . . . . 0.0 110.878 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 129.99 18.61 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.66 2.24 . . . . 0.0 112.386 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.56 -9.68 70.07 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.51 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.688 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -67.73 99.27 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.744 0.307 . . . . 0.0 111.075 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.9 t -82.5 -43.77 16.78 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.093 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.575 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -130.27 134.82 8.0 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.399 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.688 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -115.68 130.02 56.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.074 0.464 . . . . 0.0 110.623 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -107.13 170.35 8.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.705 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.519 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 7.4 m-85 -106.16 126.09 51.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -129.27 121.53 27.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.907 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 121.609 0.718 . . . . 0.0 110.897 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.484 -0.247 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.519 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 21.2 t -67.61 134.39 30.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.818 0.342 . . . . 0.0 111.143 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -77.43 138.46 39.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.478 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.7 tm? -121.33 124.43 44.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.948 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.459 ' N ' HD22 ' A' ' 68' ' ' LEU . 7.6 p -149.47 124.41 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.114 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.446 ' HG3' HG22 ' A' ' 69' ' ' VAL . 11.0 mt-10 57.92 22.62 8.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.767 ' CA ' HD12 ' A' ' 40' ' ' LEU . . . 92.23 -24.88 20.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.496 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.512 HG22 ' HB ' ' A' ' 37' ' ' THR . 3.2 mt -82.8 122.79 37.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 0.0 111.139 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.673 ' HG ' HD23 ' A' ' 53' ' ' LEU . 4.3 mm? -82.22 119.56 24.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.936 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.643 ' HA ' HG22 ' A' ' 37' ' ' THR . 41.9 t60 -91.88 135.76 33.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.568 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -87.68 160.05 48.15 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.55 0.69 . . . . 0.0 111.107 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.568 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.5 Cg_endo -69.99 -172.59 0.62 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.678 2.252 . . . . 0.0 112.306 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -77.16 -2.28 33.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.224 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.23 -31.52 8.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.95 -164.38 15.93 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.499 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.596 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 86.2 m95 -85.28 -59.24 2.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.758 0.313 . . . . 0.0 110.933 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.55 -161.77 37.27 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.456 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -125.91 37.75 4.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.906 0.384 . . . . 0.0 110.919 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.672 HD12 HG12 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -87.75 -175.85 5.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.522 HG22 ' CG2' ' A' ' 20' ' ' THR . 40.5 t -102.46 136.07 36.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.155 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.576 ' CD2' HD12 ' A' ' 53' ' ' LEU . 3.7 p90 -102.56 146.28 28.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.986 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 84.6 t -106.89 131.0 57.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.061 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.475 HG22 ' CE2' ' A' ' 85' ' ' TYR . 2.4 t -81.51 132.48 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.129 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -145.85 140.81 27.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.973 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.1 p90 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.807 0.337 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.77 HG23 HG13 ' A' ' 30' ' ' ILE . 6.1 tt -120.44 123.48 70.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.086 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -120.29 104.1 9.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.042 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.476 ' O ' HG22 ' A' ' 28' ' ' ILE . 6.1 m -145.0 152.29 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.351 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.528 HG23 HG22 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -127.31 157.47 39.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.138 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.42 -49.95 10.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.838 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -101.27 163.11 12.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -84.39 -29.71 25.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.211 0.529 . . . . 0.0 111.265 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -67.53 -26.6 66.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.868 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -94.41 163.43 13.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.871 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -89.16 159.92 44.01 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.677 0.751 . . . . 0.0 110.888 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.86 116.77 4.72 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.63 2.22 . . . . 0.0 112.367 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.476 HG22 ' O ' ' A' ' 19' ' ' VAL . 5.3 tp -76.68 137.98 21.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.867 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.05 119.77 37.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.802 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.77 HG13 HG23 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -126.43 159.89 60.77 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.627 0.727 . . . . 0.0 111.159 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.406 ' O ' HG21 ' A' ' 42' ' ' THR . 54.2 Cg_endo -69.73 148.82 66.08 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.643 2.229 . . . . 0.0 112.307 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.534 ' HB2' HG22 ' A' ' 38' ' ' VAL . 19.8 p -133.29 -175.69 3.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -84.66 169.94 13.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -75.57 -30.55 59.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -72.34 -17.5 61.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.787 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.13 -20.84 11.24 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.451 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.524 ' HB ' HG22 ' A' ' 72' ' ' ILE . 22.7 p -75.57 -174.24 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.796 0.331 . . . . 0.0 111.181 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.586 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 50.5 t -141.0 119.53 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.141 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.2 tp -56.94 145.34 30.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.874 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.737 HD12 ' CA ' ' A' ' 71' ' ' GLY . 1.3 tt -61.44 -19.61 62.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.9 t -66.29 -37.72 86.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.406 HG21 ' O ' ' A' ' 31' ' ' PRO . 8.9 m -77.06 -34.87 57.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.136 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.598 HG21 HD23 ' A' ' 73' ' ' LEU . 22.4 t -64.3 -34.94 72.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.027 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.579 HG23 ' O ' ' A' ' 40' ' ' LEU . 39.0 p -80.06 -15.78 56.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.559 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.65 -43.65 88.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.995 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -111.92 -23.95 10.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.305 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -129.69 75.66 79.47 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.647 0.736 . . . . 0.0 110.918 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 125.28 11.95 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.675 2.25 . . . . 0.0 112.382 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.46 6.5 64.26 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.517 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.718 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -82.13 116.11 21.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.774 0.321 . . . . 0.0 111.135 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.8 t -100.45 -52.92 3.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.633 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -122.08 127.04 6.66 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.545 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.778 HD12 ' CE1' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -115.31 139.73 49.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.953 0.406 . . . . 0.0 110.759 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -112.21 171.0 7.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.692 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -104.13 126.04 50.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.946 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.1 tpt180 -128.94 103.32 6.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.9 t30 . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 121.635 0.731 . . . . 0.0 110.935 -179.986 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.7 t -62.79 143.33 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.786 0.326 . . . . 0.0 111.151 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -91.97 138.55 31.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.885 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.482 HD22 ' N ' ' A' ' 69' ' ' VAL . 2.2 tm? -118.03 117.98 30.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.682 HG22 ' HG2' ' A' ' 70' ' ' GLU . 6.7 p -138.93 122.8 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.138 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.682 ' HG2' HG22 ' A' ' 69' ' ' VAL . 36.3 mm-40 58.12 22.58 9.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.737 ' CA ' HD12 ' A' ' 40' ' ' LEU . . . 92.33 -25.08 19.44 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.516 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.524 HG22 ' HB ' ' A' ' 37' ' ' THR . 4.3 mp -83.32 114.13 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.889 0.376 . . . . 0.0 111.076 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.598 HD23 HG21 ' A' ' 43' ' ' VAL . 4.1 mm? -73.78 116.09 13.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.956 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.46 ' HA ' HG22 ' A' ' 37' ' ' THR . 5.5 t60 -91.33 135.7 33.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.607 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -86.08 158.85 55.18 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.554 0.692 . . . . 0.0 111.124 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.525 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.9 Cg_endo -69.89 -172.94 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.689 2.26 . . . . 0.0 112.325 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -77.32 -2.15 33.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.266 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.74 -29.45 9.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.114 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.94 -168.86 14.65 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.514 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.607 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 98.0 m95 -82.49 -59.47 2.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.774 0.321 . . . . 0.0 110.866 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.11 -167.54 29.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.525 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -128.03 38.48 4.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.844 0.354 . . . . 0.0 110.895 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.677 ' H ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.61 -175.55 3.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.528 HG22 HG23 ' A' ' 20' ' ' THR . 21.9 t -93.58 144.28 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.106 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.778 ' CE1' HD12 ' A' ' 53' ' ' LEU . 1.7 p90 -111.31 146.35 37.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.959 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.5 t -95.48 125.55 48.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.139 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 t -74.48 135.98 26.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.108 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -145.11 106.48 4.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.884 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.976 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 27.4 p90 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.812 0.339 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.75 HG23 HG13 ' A' ' 30' ' ' ILE . 6.0 tt -120.78 123.3 69.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.138 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -120.65 104.44 9.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.058 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.456 ' O ' HG22 ' A' ' 28' ' ' ILE . 10.2 m -146.3 153.31 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.371 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.561 HG23 HG22 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -126.91 156.63 41.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.176 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.15 -50.18 13.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -102.54 166.44 10.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.912 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -79.53 -32.85 42.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.152 0.501 . . . . 0.0 111.279 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -74.75 -25.79 59.33 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.855 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -86.28 129.01 35.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.921 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -60.46 155.0 51.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.638 0.732 . . . . 0.0 110.884 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 114.91 3.85 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.717 2.278 . . . . 0.0 112.317 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.474 HD12 ' H ' ' A' ' 29' ' ' GLU . 4.9 tp -76.75 139.43 18.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.474 ' H ' HD12 ' A' ' 28' ' ' ILE . 1.7 pm0 -102.04 120.06 39.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.712 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.75 HG13 HG23 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -125.91 159.7 60.33 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.692 0.758 . . . . 0.0 111.051 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.409 ' O ' HG21 ' A' ' 42' ' ' THR . 53.7 Cg_endo -69.71 142.77 49.05 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.652 2.235 . . . . 0.0 112.349 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.565 ' CB ' HG22 ' A' ' 38' ' ' VAL . 53.5 p -132.94 161.63 33.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.831 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -61.11 162.74 6.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.82 -31.85 65.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.849 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -65.2 -18.4 65.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.36 -19.37 11.68 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.461 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.457 ' HB ' HG22 ' A' ' 72' ' ' ILE . 20.5 p -81.05 -174.38 4.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.348 . . . . 0.0 111.145 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.608 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 53.5 t -137.76 124.56 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.154 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.8 tp -59.49 146.88 38.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.623 HD13 ' O ' ' A' ' 40' ' ' LEU . 3.1 tm? -63.06 -25.19 68.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.7 t -64.44 -39.13 93.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.409 HG21 ' O ' ' A' ' 31' ' ' PRO . 10.7 m -74.13 -31.02 62.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.176 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.909 HG21 HD23 ' A' ' 73' ' ' LEU . 17.7 t -66.16 -37.22 79.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.011 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.1 p -79.09 -15.84 57.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.578 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.13 -44.81 87.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.983 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -112.14 -20.86 11.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.118 0.485 . . . . 0.0 111.352 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -131.38 75.45 77.3 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 121.643 0.735 . . . . 0.0 110.849 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 131.87 22.19 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.619 2.213 . . . . 0.0 112.415 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.36 -8.87 72.57 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.518 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.593 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -71.06 119.73 15.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.807 0.337 . . . . 0.0 111.139 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.4 t -102.05 -53.01 3.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.584 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -121.07 130.25 8.14 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.494 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.709 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -115.69 137.81 51.71 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.992 0.425 . . . . 0.0 110.678 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -108.64 170.71 7.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.735 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -105.29 125.69 51.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -129.56 105.28 7.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.7 t30 . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 121.551 0.691 . . . . 0.0 110.909 -179.932 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 64.5 t -54.77 138.62 14.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.748 0.309 . . . . 0.0 111.181 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -88.15 138.49 31.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.517 HD21 ' HA2' ' A' ' 71' ' ' GLY . 2.2 tm? -117.3 115.05 24.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.555 HG22 ' HG2' ' A' ' 70' ' ' GLU . 5.6 p -134.32 120.28 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.141 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.555 ' HG2' HG22 ' A' ' 69' ' ' VAL . 17.4 mm-40 57.51 23.53 9.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.9 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.517 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . 93.39 -24.93 23.13 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.467 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.457 HG22 ' HB ' ' A' ' 37' ' ' THR . 4.2 mp -80.83 112.72 19.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.973 0.416 . . . . 0.0 111.089 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.909 HD23 HG21 ' A' ' 43' ' ' VAL . 4.1 mm? -74.72 111.24 9.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.911 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -86.65 135.41 33.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.649 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -87.98 159.87 47.64 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.467 0.651 . . . . 0.0 111.209 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.557 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.2 Cg_endo -69.94 -173.09 0.67 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.698 2.265 . . . . 0.0 112.285 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -77.2 -2.25 33.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.244 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.27 -29.81 9.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.99 -165.35 14.85 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.469 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.649 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 97.5 m95 -86.71 -59.6 2.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.82 0.343 . . . . 0.0 110.849 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.72 -165.8 29.83 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.466 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -128.16 38.24 4.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 0.0 110.861 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.693 ' H ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.29 -175.81 3.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.912 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.561 HG22 HG23 ' A' ' 20' ' ' THR . 38.3 t -93.85 144.44 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.191 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.709 ' CE2' HD12 ' A' ' 53' ' ' LEU . 3.6 p90 -114.61 145.9 41.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.939 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.4 t -99.65 126.74 52.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.121 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.8 t -72.58 145.35 12.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.17 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -145.08 87.75 1.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.963 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.4 p90 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 -179.883 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.4 p90 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.891 0.376 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.707 HG23 HG13 ' A' ' 30' ' ' ILE . 6.1 tt -119.35 123.47 71.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.098 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.4 mtm180 -119.48 104.69 10.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.109 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.543 HG12 HD23 ' A' ' 83' ' ' LEU . 6.5 m -145.71 153.44 13.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.3 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.716 ' CG2' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -124.76 155.33 39.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.167 179.701 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.06 -49.73 22.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.928 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -105.31 173.43 6.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.861 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -79.21 -46.6 17.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.283 0.564 . . . . 0.0 111.283 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -68.84 -26.8 65.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.878 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -72.79 126.98 31.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.93 149.89 63.27 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.695 0.759 . . . . 0.0 110.856 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.78 120.2 7.02 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.763 2.308 . . . . 0.0 112.311 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 19' ' ' VAL . 6.1 tp -87.54 143.4 11.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.99 123.15 48.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.707 HG13 HG23 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -127.39 160.57 59.5 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.656 0.741 . . . . 0.0 111.151 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.67 144.65 55.19 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.704 2.269 . . . . 0.0 112.426 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.571 ' HB3' HG22 ' A' ' 38' ' ' VAL . 1.5 m -133.18 -175.88 3.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.859 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -86.06 174.25 9.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.836 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -80.68 -35.39 33.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.806 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -63.36 -19.83 64.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.827 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.43 -12.55 13.87 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.441 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.439 ' HB ' HG22 ' A' ' 72' ' ' ILE . 20.6 p -85.38 -174.72 5.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.829 0.347 . . . . 0.0 111.182 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.606 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 53.7 t -136.7 135.08 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.208 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 tp -70.81 141.39 51.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.696 HD13 ' O ' ' A' ' 40' ' ' LEU . 2.6 tm? -59.48 -31.95 69.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.965 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -58.85 -29.23 66.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.792 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.4 m -83.97 -30.86 25.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.156 0.503 . . . . 0.0 111.619 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.618 HG21 HD23 ' A' ' 73' ' ' LEU . 20.1 t -65.16 -35.29 75.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.025 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.3 p -79.7 -15.39 57.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.465 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.26 -45.33 84.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.982 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -111.97 -18.28 12.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.016 0.436 . . . . 0.0 111.287 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -134.11 74.55 67.78 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.633 0.73 . . . . 0.0 110.864 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 129.5 17.75 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.698 2.265 . . . . 0.0 112.39 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.26 6.03 78.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.522 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.657 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -81.78 114.96 20.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.758 0.314 . . . . 0.0 111.129 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.2 t -95.79 -53.05 3.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.598 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -124.81 132.06 8.02 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.559 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.684 HD12 ' CE1' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -115.41 138.86 50.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.986 0.422 . . . . 0.0 110.745 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.17 170.78 7.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.715 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.696 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 10.3 m-85 -111.07 125.75 54.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.974 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -129.41 104.01 7.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.934 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t30 . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 121.632 0.73 . . . . 0.0 110.902 -179.908 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.696 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 21.6 t -58.29 135.7 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.828 0.347 . . . . 0.0 111.069 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -83.26 138.54 33.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.867 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.49 ' C ' HD13 ' A' ' 68' ' ' LEU . 3.2 tm? -118.62 120.8 38.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.666 HG22 ' HG2' ' A' ' 70' ' ' GLU . 6.1 p -145.21 121.56 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.173 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.666 ' HG2' HG22 ' A' ' 69' ' ' VAL . 10.7 mm-40 58.16 22.53 9.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.858 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.96 -25.23 17.64 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.466 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.439 HG22 ' HB ' ' A' ' 37' ' ' THR . 2.1 mp -82.29 114.57 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.847 0.356 . . . . 0.0 111.144 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.618 HD23 HG21 ' A' ' 43' ' ' VAL . 4.1 mm? -73.86 120.54 19.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.428 ' HA ' HG22 ' A' ' 37' ' ' THR . 47.8 t60 -91.4 139.48 30.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.582 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -91.55 160.22 37.14 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.575 0.702 . . . . 0.0 111.092 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.582 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.2 Cg_endo -69.88 -172.79 0.63 Allowed 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.687 2.258 . . . . 0.0 112.304 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -77.02 -2.56 34.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.269 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.44 -29.43 9.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.78 -164.72 14.06 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.526 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.606 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 94.7 m95 -85.59 -59.42 2.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.775 0.322 . . . . 0.0 110.861 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.92 -162.17 38.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.493 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.49 36.99 4.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.851 0.358 . . . . 0.0 110.883 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.543 HD23 HG12 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -88.91 -173.85 4.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.891 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.716 HG22 ' CG2' ' A' ' 20' ' ' THR . 61.3 t -104.07 138.31 29.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.079 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.684 ' CE1' HD12 ' A' ' 53' ' ' LEU . 2.7 p90 -108.31 146.05 33.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.6 t -100.8 127.22 54.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.14 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.3 t -71.1 146.24 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.145 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -145.11 104.01 3.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.953 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.959 -179.888 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.5 p90 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.866 0.365 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.738 HG23 HG13 ' A' ' 30' ' ' ILE . 6.5 tt -109.1 123.16 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.095 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -118.45 104.51 10.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.005 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.57 HG12 HD12 ' A' ' 83' ' ' LEU . 7.4 m -147.35 153.17 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.336 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.579 ' CG2' HG22 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -127.1 151.18 48.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.082 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.07 -49.11 30.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -106.65 167.32 9.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.942 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -78.9 -38.05 38.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.202 0.525 . . . . 0.0 111.34 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -69.25 -26.57 64.84 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.936 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.85 130.47 34.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -62.15 156.26 60.28 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.603 0.715 . . . . 0.0 110.918 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 119.14 6.14 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.656 2.237 . . . . 0.0 112.388 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.843 HD11 HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -83.49 142.72 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.156 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -106.82 122.71 46.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.82 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.843 HG23 HD11 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -127.2 159.56 64.47 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.641 0.734 . . . . 0.0 111.092 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.86 145.59 57.03 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.667 2.245 . . . . 0.0 112.31 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.579 ' HB2' HG22 ' A' ' 38' ' ' VAL . 1.1 p -135.73 171.7 14.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.403 ' HG2' HD23 ' A' ' 39' ' ' LEU . 7.7 mm-40 -74.2 167.09 22.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -73.41 -27.34 61.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.847 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -71.03 -19.58 62.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.857 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.84 -8.28 21.67 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.448 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.488 ' HB ' HG22 ' A' ' 72' ' ' ILE . 20.0 p -86.18 -178.04 6.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.9 0.381 . . . . 0.0 111.125 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.608 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 55.4 t -135.35 127.68 47.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.186 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.403 HD23 ' HG2' ' A' ' 33' ' ' GLU . 3.6 mm? -63.0 143.78 57.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.693 HD13 ' O ' ' A' ' 40' ' ' LEU . 3.3 tm? -61.67 -30.44 70.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.0 t -62.8 -37.24 85.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.863 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 17.9 m -76.24 -23.51 54.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.094 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.828 HG21 HD23 ' A' ' 73' ' ' LEU . 25.6 t -72.25 -38.68 62.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.188 0.518 . . . . 0.0 111.341 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.9 p -77.82 -15.2 59.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.575 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.12 -46.69 86.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.941 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -112.18 -21.13 11.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.094 0.473 . . . . 0.0 111.265 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -124.98 75.01 66.83 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 121.647 0.737 . . . . 0.0 110.896 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.77 131.12 20.55 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.647 2.231 . . . . 0.0 112.379 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.76 5.91 89.46 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.488 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.572 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -86.98 114.3 23.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 0.0 111.093 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 m -98.86 -53.03 3.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.547 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -119.14 130.92 8.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.49 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.584 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -115.79 139.96 49.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.026 0.441 . . . . 0.0 110.705 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -109.04 170.74 7.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.751 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.45 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 7.8 m-85 -107.48 126.7 52.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.86 103.04 7.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.1 t30 . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 121.654 0.74 . . . . 0.0 110.926 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.45 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 59.6 t -58.12 136.94 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.878 0.371 . . . . 0.0 111.104 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -86.32 138.41 31.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.481 HD21 ' HA2' ' A' ' 71' ' ' GLY . 2.2 tm? -119.16 114.29 22.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.884 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.662 HG22 ' HG3' ' A' ' 70' ' ' GLU . 5.9 p -135.46 121.05 30.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.181 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.662 ' HG3' HG22 ' A' ' 69' ' ' VAL . 4.1 mt-10 57.77 23.05 9.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.481 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . 92.94 -24.84 22.56 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.509 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.488 HG22 ' HB ' ' A' ' 37' ' ' THR . 4.2 mp -80.22 111.52 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 111.173 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.828 HD23 HG21 ' A' ' 43' ' ' VAL . 4.1 mm? -73.12 109.06 6.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.924 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -84.24 137.22 33.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.625 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -89.29 160.32 42.81 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.552 0.691 . . . . 0.0 111.104 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.572 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.0 Cg_endo -69.92 -172.92 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.724 2.283 . . . . 0.0 112.292 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -76.98 -2.45 33.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.317 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.33 -29.64 9.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.097 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.38 -164.87 14.46 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.496 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.625 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 94.5 m95 -86.75 -59.42 2.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.758 0.313 . . . . 0.0 110.898 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.08 -163.19 32.98 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.484 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.34 37.69 4.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.806 0.336 . . . . 0.0 110.9 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.57 HD12 HG12 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -92.42 -175.8 4.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.579 HG22 ' CG2' ' A' ' 20' ' ' THR . 43.8 t -99.47 136.2 31.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.099 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.584 ' CE2' HD12 ' A' ' 53' ' ' LEU . 6.4 p90 -104.16 145.86 29.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.969 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.7 t -101.8 116.59 45.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.087 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.7 m -63.21 143.23 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.156 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -144.96 106.08 4.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.938 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 -179.909 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 26.0 p90 . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.849 0.357 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.754 HG23 HG13 ' A' ' 30' ' ' ILE . 5.7 tt -109.91 123.83 66.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.103 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.66 103.64 10.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.042 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.528 HG12 HD23 ' A' ' 83' ' ' LEU . 8.3 m -147.91 155.32 10.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.38 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.601 ' CG2' HG22 ' A' ' 84' ' ' VAL . 0.8 OUTLIER -129.41 153.57 47.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.11 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.568 ' HG2' HG13 ' A' ' 87' ' ' VAL . 0.5 OUTLIER -79.79 -49.88 11.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.41 143.61 32.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -67.9 -30.8 70.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.929 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -67.04 -26.55 66.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.876 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -90.14 170.23 10.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.832 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -94.37 159.61 33.54 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.662 0.744 . . . . 0.0 110.853 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 112.85 3.2 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.675 2.25 . . . . 0.0 112.367 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.512 HD12 ' H ' ' A' ' 29' ' ' GLU . 5.0 tp -77.72 140.13 17.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.898 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.512 ' H ' HD12 ' A' ' 28' ' ' ILE . 3.0 mp0 -101.77 117.52 35.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.762 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.754 HG13 HG23 ' A' ' 17' ' ' ILE . 0.6 OUTLIER -123.94 159.58 55.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.645 0.736 . . . . 0.0 111.148 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 152.13 68.82 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.659 2.239 . . . . 0.0 112.357 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.653 ' HB2' HG22 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -142.3 155.91 45.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.863 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.597 ' HG2' HD23 ' A' ' 39' ' ' LEU . 4.0 mm-40 -57.51 166.4 1.28 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -70.18 -33.19 71.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -63.68 -20.25 65.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 113.57 -12.94 23.09 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.451 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.577 HG22 ' HA ' ' A' ' 74' ' ' HIS . 33.2 p -82.48 -177.16 6.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.833 0.349 . . . . 0.0 111.128 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.653 HG22 ' HB2' ' A' ' 32' ' ' SER . 53.3 t -130.9 123.3 53.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.179 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.597 HD23 ' HG2' ' A' ' 33' ' ' GLU . 1.9 mm? -61.89 145.57 52.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.64 ' O ' HG23 ' A' ' 44' ' ' THR . 3.0 tm? -61.04 -24.24 66.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.901 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.8 p -67.52 -44.16 79.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.5 m -71.16 -30.42 66.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.156 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.859 HG21 HD23 ' A' ' 73' ' ' LEU . 21.3 t -65.47 -35.2 74.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.989 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.64 HG23 ' O ' ' A' ' 40' ' ' LEU . 21.7 p -79.6 -15.74 57.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.581 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.12 90.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -112.11 -25.57 9.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.091 0.472 . . . . 0.0 111.342 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -125.35 75.63 68.68 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.609 0.719 . . . . 0.0 110.89 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 133.03 24.62 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.694 2.263 . . . . 0.0 112.311 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.33 6.02 89.46 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.511 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.578 ' HB1' HD21 ' A' ' 53' ' ' LEU . . . -84.02 117.22 23.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.8 0.333 . . . . 0.0 111.083 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 2.4 m -101.22 -53.22 3.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.846 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.611 ' O ' HD23 ' A' ' 53' ' ' LEU . . . -121.23 135.0 10.39 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.427 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.665 HD13 ' CD2' ' A' ' 85' ' ' TYR . 12.9 mt -122.93 146.27 47.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.781 0.324 . . . . 0.0 110.919 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.404 ' HB2' ' HB ' ' A' ' 86' ' ' VAL . 24.5 mtt180 -116.59 171.71 7.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.648 ' CD1' HD11 ' A' ' 83' ' ' LEU . 5.6 m-85 -106.06 126.65 52.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.95 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -128.3 107.23 9.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.842 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 121.684 0.754 . . . . 0.0 110.866 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.533 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 91.3 t -85.11 143.05 12.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.784 0.326 . . . . 0.0 111.133 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -99.62 138.56 36.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.836 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.522 HD21 ' HA2' ' A' ' 71' ' ' GLY . 1.9 tm? -116.28 115.97 26.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.669 HG22 ' HG3' ' A' ' 70' ' ' GLU . 6.0 p -134.03 121.12 37.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.147 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.669 ' HG3' HG22 ' A' ' 69' ' ' VAL . 4.1 mt-10 58.92 23.65 11.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.522 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . 93.19 -24.56 24.43 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.509 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.575 HG22 ' HB ' ' A' ' 37' ' ' THR . 4.6 mp -82.73 114.62 23.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.857 0.36 . . . . 0.0 111.151 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.859 HD23 HG21 ' A' ' 43' ' ' VAL . 4.0 mm? -74.64 100.29 3.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.969 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.577 ' HA ' HG22 ' A' ' 37' ' ' THR . 6.4 t60 -76.96 136.48 38.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.845 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.553 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -85.36 159.67 55.68 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.582 0.706 . . . . 0.0 111.092 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.553 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.8 Cg_endo -70.02 -173.22 0.71 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.618 2.212 . . . . 0.0 112.317 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -77.32 -1.98 32.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.182 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.91 -32.95 8.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.108 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.17 -165.18 19.47 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.51 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.621 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 83.8 m95 -86.64 -59.55 2.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.868 0.366 . . . . 0.0 110.844 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.71 -164.37 32.81 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.491 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.68 36.73 4.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.851 0.358 . . . . 0.0 110.858 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.648 HD11 ' CD1' ' A' ' 55' ' ' TYR . 0.8 OUTLIER -91.87 -173.71 3.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.907 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.601 HG22 ' CG2' ' A' ' 20' ' ' THR . 42.9 t -101.12 136.69 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.121 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.665 ' CD2' HD13 ' A' ' 53' ' ' LEU . 4.4 p90 -101.33 139.59 36.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.943 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 54' ' ' ARG . 20.5 t -97.49 114.76 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.149 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.568 HG13 ' HG2' ' A' ' 21' ' ' GLU . 23.3 m -61.29 147.82 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.108 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -145.36 96.8 2.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.916 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 45.6 p90 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.933 -179.922 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 34.1 p90 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.827 0.346 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.763 HG23 HG13 ' A' ' 30' ' ' ILE . 5.1 tt -121.46 123.32 69.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.098 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -121.97 103.76 9.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.095 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.732 HG12 HD12 ' A' ' 83' ' ' LEU . 16.3 m -143.53 149.64 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.355 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.558 HG23 HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -121.18 151.13 40.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.145 179.746 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.411 ' CG ' HG13 ' A' ' 87' ' ' VAL . 0.5 OUTLIER -79.59 -49.97 11.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.951 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.28 139.49 37.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -65.67 -33.34 75.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.829 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -71.78 -26.51 62.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -78.31 -171.01 2.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.79 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.4 154.92 43.55 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.382 0.611 . . . . 0.0 111.273 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.87 126.15 12.9 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.806 2.338 . . . . 0.0 112.362 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.413 HD12 ' H ' ' A' ' 29' ' ' GLU . 3.7 tp -98.69 131.92 44.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.413 ' H ' HD12 ' A' ' 28' ' ' ILE . 16.1 pt-20 -99.03 123.12 43.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.724 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.763 HG13 HG23 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -127.02 159.67 63.5 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.614 0.721 . . . . 0.0 111.093 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 152.32 69.43 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.663 2.242 . . . . 0.0 112.374 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.658 ' HB2' HG22 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -141.98 163.37 33.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -68.34 161.56 27.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -67.09 -27.17 67.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.803 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.63 -18.9 65.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.799 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.04 -12.81 34.32 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.481 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.517 HG22 ' HA ' ' A' ' 74' ' ' HIS . 43.2 p -83.65 -172.42 4.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.853 0.359 . . . . 0.0 111.102 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.658 HG22 ' HB2' ' A' ' 32' ' ' SER . 45.0 t -137.66 119.23 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.089 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.3 tp -59.71 142.4 53.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.937 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 44' ' ' THR . 23.0 tp -59.0 -21.12 58.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.953 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.4 t -68.39 -34.69 76.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.947 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.8 m -80.57 -30.65 36.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.179 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.959 HG21 HD23 ' A' ' 73' ' ' LEU . 25.5 t -64.84 -36.43 77.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.032 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 40' ' ' LEU . 32.1 p -79.95 -15.46 57.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.537 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.74 -44.64 85.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.956 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -111.35 -23.59 10.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.003 0.43 . . . . 0.0 111.261 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -124.82 74.9 65.33 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.669 0.747 . . . . 0.0 110.896 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 131.52 21.41 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.627 2.218 . . . . 0.0 112.326 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.9 5.52 89.71 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.431 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.56 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -84.69 114.86 22.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.724 0.297 . . . . 0.0 111.059 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 2.5 t -91.64 -52.87 4.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.881 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.533 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -127.18 136.17 9.19 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.543 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.576 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.8 OUTLIER -115.65 137.56 51.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.052 0.453 . . . . 0.0 110.652 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -107.47 170.41 7.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.682 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.593 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 9.8 m-85 -108.0 126.37 52.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.957 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -128.68 122.22 30.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 121.544 0.687 . . . . 0.0 110.877 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 112.613 -0.195 . . . . 0.0 112.613 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.593 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 50.5 t -72.36 134.95 28.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.849 0.357 . . . . 0.0 111.11 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.458 ' HE ' HG23 ' A' ' 69' ' ' VAL . 4.4 tpt180 -77.2 138.77 39.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.867 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.504 ' C ' HD13 ' A' ' 68' ' ' LEU . 3.3 tm? -116.38 107.56 14.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.458 HG23 ' HE ' ' A' ' 67' ' ' ARG . 15.1 t -115.77 105.96 19.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.19 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 50.52 40.19 22.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.436 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . 90.31 -25.9 11.55 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.537 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.461 HG22 ' HB ' ' A' ' 37' ' ' THR . 2.7 mp -78.18 110.38 13.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.842 0.353 . . . . 0.0 111.116 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.959 HD23 HG21 ' A' ' 43' ' ' VAL . 4.1 mm? -73.93 102.97 4.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.517 ' HA ' HG22 ' A' ' 37' ' ' THR . 6.6 t60 -83.61 136.25 34.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.809 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.649 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -84.4 160.15 57.4 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.594 0.711 . . . . 0.0 111.108 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.569 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.2 Cg_endo -69.95 -171.85 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.711 2.274 . . . . 0.0 112.302 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.12 -2.32 33.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.294 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.86 -30.95 8.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.125 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.86 -165.73 14.7 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.441 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.649 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 95.4 m95 -86.59 -59.18 2.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.807 0.337 . . . . 0.0 110.936 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.2 -167.13 48.96 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.456 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -117.88 38.81 3.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.896 0.379 . . . . 0.0 110.862 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.732 HD12 HG12 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -87.22 -175.33 5.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.993 179.884 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.558 HG22 HG23 ' A' ' 20' ' ' THR . 39.6 t -106.71 134.33 48.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.102 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.576 ' CE2' HD12 ' A' ' 53' ' ' LEU . 3.7 p90 -100.75 146.03 27.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 63.4 t -106.47 112.77 40.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.089 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.411 HG13 ' CG ' ' A' ' 21' ' ' GLU . 4.7 m -53.87 143.73 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.135 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -145.13 105.68 4.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.915 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.4 p90 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.884 0.373 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.735 HG23 HG13 ' A' ' 30' ' ' ILE . 7.0 tt -126.95 121.28 57.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.024 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -119.32 101.53 8.04 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.231 0.539 . . . . 0.0 110.442 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.595 HG12 ' CD2' ' A' ' 83' ' ' LEU . 6.7 m -139.77 159.84 27.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.062 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.19 156.95 47.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.155 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.429 ' OE2' HG22 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -83.7 -57.87 3.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.28 164.26 14.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -85.35 -28.5 25.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.099 0.476 . . . . 0.0 111.287 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -70.05 -44.42 69.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.839 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -65.02 -170.57 0.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.841 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -116.96 160.53 36.61 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.383 0.611 . . . . 0.0 111.297 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.94 106.45 1.7 Allowed 'Trans proline' 0 C--O 1.23 0.109 0 C-N-CA 122.664 2.243 . . . . 0.0 112.255 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.477 HD12 ' H ' ' A' ' 29' ' ' GLU . 5.0 tp -74.65 138.5 20.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.929 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.477 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -101.02 118.62 37.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.732 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.735 HG13 HG23 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -123.44 159.22 56.02 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.594 0.711 . . . . 0.0 111.174 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.42 ' O ' HG21 ' A' ' 42' ' ' THR . 54.2 Cg_endo -69.79 162.46 42.0 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.727 2.285 . . . . 0.0 112.338 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.593 ' HB2' HG22 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -149.55 175.4 11.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -75.11 178.83 5.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.843 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -81.47 -34.5 31.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.047 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.5 -29.94 70.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.105 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 121.47 16.67 4.15 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.601 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.651 HG22 ' HA ' ' A' ' 74' ' ' HIS . 52.4 p -111.18 178.84 4.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.851 0.358 . . . . 0.0 111.166 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.649 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 73.3 t -133.75 106.04 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.086 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.63 144.18 22.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.001 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.542 HD12 ' HA3' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -50.23 -31.25 13.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.946 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.0 p -52.81 -45.13 67.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.913 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.42 HG21 ' O ' ' A' ' 31' ' ' PRO . 14.4 m -75.39 -30.92 60.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.123 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.962 HG21 HD23 ' A' ' 73' ' ' LEU . 40.3 t -66.92 -43.14 89.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.986 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.2 p -74.42 -6.34 47.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.501 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.53 -46.62 63.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.949 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -114.85 -23.34 9.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.314 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -119.2 74.93 15.03 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.601 0.715 . . . . 0.0 110.852 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 130.25 19.06 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.706 2.271 . . . . 0.0 112.307 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.34 3.76 89.85 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.446 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.605 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -83.9 118.91 24.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.782 0.325 . . . . 0.0 111.077 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.3 m -100.51 -58.14 1.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.91 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.564 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -117.75 130.17 8.65 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.514 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.666 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.5 OUTLIER -114.5 140.96 48.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.93 0.395 . . . . 0.0 110.738 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.42 176.09 5.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.83 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.427 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 10.4 m-85 -111.73 134.69 53.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.932 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -144.31 117.93 9.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 121.734 0.778 . . . . 0.0 110.887 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.414 -0.274 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.456 HG12 HD12 ' A' ' 73' ' ' LEU . 27.3 t -54.5 128.77 14.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.819 0.343 . . . . 0.0 111.152 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -77.91 149.77 34.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 69' ' ' VAL . 2.7 tm? -127.61 126.37 41.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.936 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.507 HG22 ' HG2' ' A' ' 70' ' ' GLU . 6.9 p -149.01 123.42 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.172 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.507 ' HG2' HG22 ' A' ' 69' ' ' VAL . 72.8 mm-40 58.11 22.81 9.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.877 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.542 ' HA3' HD12 ' A' ' 40' ' ' LEU . . . 88.91 -14.63 59.87 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.526 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.524 HG22 ' HB ' ' A' ' 37' ' ' THR . 2.0 mp -92.94 110.37 22.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.808 0.337 . . . . 0.0 111.131 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.962 HD23 HG21 ' A' ' 43' ' ' VAL . 4.2 mm? -66.18 121.67 15.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.998 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.651 ' HA ' HG22 ' A' ' 37' ' ' THR . 2.8 t60 -93.42 126.56 38.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.597 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -67.81 160.48 73.28 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.587 0.708 . . . . 0.0 111.195 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.597 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.1 Cg_endo -69.94 -170.92 0.44 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.69 2.26 . . . . 0.0 112.331 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.12 53.48 2.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.278 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -173.79 -40.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.837 0.351 . . . . 0.0 111.136 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.68 -176.03 21.73 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.439 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.649 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 90.9 m95 -76.09 -74.96 0.2 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.743 0.306 . . . . 0.0 110.91 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.27 -161.78 24.44 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.476 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.573 ' C ' HD13 ' A' ' 83' ' ' LEU . 2.2 m-20 -127.0 95.81 4.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 110.96 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.629 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -151.26 -176.23 5.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.986 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.8 p -101.65 127.83 54.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.128 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.666 ' CE2' HD12 ' A' ' 53' ' ' LEU . 3.4 p90 -98.62 156.25 16.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.921 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.8 t -113.14 122.37 67.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.203 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.429 HG22 ' OE2' ' A' ' 21' ' ' GLU . 27.9 m -66.54 150.81 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.161 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -144.51 92.14 2.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 44.4 p90 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.954 -179.885 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.0 p90 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.939 0.4 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.753 HG23 HG13 ' A' ' 30' ' ' ILE . 6.1 tt -118.14 123.28 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.105 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.43 103.82 10.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.09 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.416 ' O ' HG22 ' A' ' 28' ' ' ILE . 12.4 m -147.49 150.79 14.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.409 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.698 ' CG2' HG22 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -121.06 155.83 33.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.195 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -71.28 -48.32 51.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.1 170.85 8.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.923 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -87.18 -24.52 24.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.207 0.527 . . . . 0.0 111.447 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -66.15 -26.29 67.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.836 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -96.68 -171.42 2.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.809 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -108.72 159.36 31.23 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.343 0.592 . . . . 0.0 111.309 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.96 124.63 11.18 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.671 2.247 . . . . 0.0 112.367 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.484 HD12 ' H ' ' A' ' 29' ' ' GLU . 4.6 tp -92.83 137.41 22.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.897 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.484 ' H ' HD12 ' A' ' 28' ' ' ILE . 1.4 pp20? -99.31 122.02 41.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.731 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.753 HG13 HG23 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -126.82 159.9 61.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.616 0.722 . . . . 0.0 111.11 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 142.55 48.39 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.731 2.287 . . . . 0.0 112.361 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.543 ' HB2' HG22 ' A' ' 38' ' ' VAL . 6.3 p -131.63 168.45 17.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.835 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -72.31 156.7 38.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -64.87 -30.49 71.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -67.01 -19.46 65.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.63 -16.35 16.64 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.469 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.578 ' HB ' HG22 ' A' ' 72' ' ' ILE . 30.6 p -81.54 -172.84 4.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.362 . . . . 0.0 111.134 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.6 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 55.9 t -140.74 120.45 12.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.1 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.8 mt -58.7 144.0 44.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.762 HD12 ' CA ' ' A' ' 71' ' ' GLY . 1.6 tt -61.23 -21.99 64.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.944 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.8 m -65.61 -37.65 87.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.7 m -77.51 -30.43 52.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.15 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.728 HG21 HD23 ' A' ' 73' ' ' LEU . 25.6 t -65.58 -37.71 80.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.048 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 40' ' ' LEU . 33.8 p -78.19 -15.32 58.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.614 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.02 -45.98 83.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.887 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -111.94 -16.96 13.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.969 0.414 . . . . 0.0 111.223 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -132.39 75.22 74.48 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.62 0.724 . . . . 0.0 110.887 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 127.54 14.73 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.737 2.291 . . . . 0.0 112.323 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.7 -15.89 59.39 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.538 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.517 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -62.35 110.18 1.57 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.697 0.284 . . . . 0.0 111.096 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.7 t -92.87 -42.86 9.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.187 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.686 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -129.43 137.29 9.47 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.406 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.792 HD12 ' CE1' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -120.27 133.34 55.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.988 0.423 . . . . 0.0 110.707 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -107.02 171.91 7.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.71 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -107.99 125.75 51.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.918 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -129.22 104.22 7.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.499 ' OD1' HD12 ' A' ' 83' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 121.615 0.721 . . . . 0.0 110.88 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.78 143.14 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.839 0.352 . . . . 0.0 111.087 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -90.63 130.72 36.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.497 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.8 tm? -110.93 114.54 27.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.69 HG22 ' HG2' ' A' ' 70' ' ' GLU . 7.7 p -137.82 124.68 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.125 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.69 ' HG2' HG22 ' A' ' 69' ' ' VAL . 5.3 mm-40 57.17 22.77 7.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.762 ' CA ' HD12 ' A' ' 40' ' ' LEU . . . 91.97 -24.94 18.87 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.501 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.578 HG22 ' HB ' ' A' ' 37' ' ' THR . 3.3 mp -83.05 121.05 35.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.816 0.341 . . . . 0.0 111.176 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.728 HD23 HG21 ' A' ' 43' ' ' VAL . 3.9 mm? -80.13 109.85 14.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.913 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.55 ' HA ' HG22 ' A' ' 37' ' ' THR . 6.0 t60 -86.76 135.54 33.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.596 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -84.09 159.85 58.87 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.543 0.687 . . . . 0.0 111.199 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.562 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.6 Cg_endo -69.84 -172.26 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.72 2.28 . . . . 0.0 112.376 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -76.98 -2.49 34.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.253 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.92 -29.09 9.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.21 -168.07 14.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.527 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.6 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 93.8 m95 -82.78 -59.23 2.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.809 0.338 . . . . 0.0 110.875 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.35 -166.61 32.06 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.492 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -127.91 38.28 4.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 0.0 110.9 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.692 ' H ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.55 -175.73 3.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.698 HG22 ' CG2' ' A' ' 20' ' ' THR . 48.2 t -94.64 146.92 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.792 ' CE1' HD12 ' A' ' 53' ' ' LEU . 3.4 p90 -116.9 146.15 43.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.976 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 88.8 t -96.41 130.18 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.113 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.51 HG22 ' CE1' ' A' ' 85' ' ' TYR . 2.1 t -85.16 133.08 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.084 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -145.39 136.17 24.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.883 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.975 -179.943 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 42.5 p90 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.886 0.374 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.4 ' CG2' HG13 ' A' ' 30' ' ' ILE . 2.6 tt -115.54 125.51 72.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.153 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -120.64 104.99 10.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.01 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.543 HG12 HD23 ' A' ' 83' ' ' LEU . 16.1 m -148.74 148.01 16.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.325 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.59 HG23 HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -122.46 153.81 38.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.11 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.9 -49.73 23.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -115.4 144.17 44.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -63.89 -25.27 68.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -72.5 -26.71 61.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -88.93 172.3 9.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.825 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -89.92 153.34 47.24 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.658 0.742 . . . . 0.0 110.864 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.425 ' HA ' ' HB ' ' A' ' 20' ' ' THR . 53.3 Cg_endo -69.79 116.44 4.57 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.697 2.264 . . . . 0.0 112.284 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.537 HD13 ' HG3' ' A' ' 46' ' ' GLN . 1.0 OUTLIER -72.12 162.48 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.119 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.431 ' N ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -136.77 111.66 8.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.437 HD12 HG22 ' A' ' 42' ' ' THR . 6.7 pt -126.79 155.6 75.02 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.648 0.737 . . . . 0.0 111.076 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 145.6 57.51 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.631 2.221 . . . . 0.0 112.319 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.477 ' HB2' HG22 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -119.68 171.45 8.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -67.62 -179.32 1.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -73.24 -43.56 60.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.986 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -65.33 -17.04 64.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.855 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.17 -24.57 9.23 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.536 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.609 HG22 ' HA ' ' A' ' 74' ' ' HIS . 43.6 p -61.78 -173.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.801 0.334 . . . . 0.0 111.166 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.601 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 47.1 t -137.21 122.13 24.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.5 tp -61.12 146.57 46.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.682 HD13 ' O ' ' A' ' 40' ' ' LEU . 2.6 tm? -62.34 -34.24 76.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.851 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.5 t -60.91 -27.89 68.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.796 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.437 HG22 HD12 ' A' ' 30' ' ' ILE . 8.8 m -87.35 -26.65 23.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.101 0.477 . . . . 0.0 111.549 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.848 HG21 HD23 ' A' ' 73' ' ' LEU . 12.2 t -66.87 -40.06 84.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.061 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.2 p -71.91 -13.58 61.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.169 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.98 -48.49 81.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.537 ' HG3' HD13 ' A' ' 28' ' ' ILE . 66.7 mm-40 -112.36 -19.14 12.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.298 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -125.44 74.96 69.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.623 0.725 . . . . 0.0 110.901 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 136.28 32.8 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.703 2.269 . . . . 0.0 112.343 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.71 6.44 66.89 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.487 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.52 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -83.52 123.01 29.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.722 0.296 . . . . 0.0 111.134 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.1 m -101.07 -52.88 3.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.893 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.577 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -122.35 132.69 8.91 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.458 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.631 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -115.24 138.25 51.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.948 0.404 . . . . 0.0 110.759 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -107.51 171.28 7.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.648 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.639 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 10.9 m-85 -110.34 126.39 54.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -128.78 108.74 10.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 121.607 0.717 . . . . 0.0 110.859 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.639 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 21.3 t -59.11 136.1 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.811 0.339 . . . . 0.0 111.166 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -84.07 138.41 33.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.931 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.487 HD22 ' N ' ' A' ' 69' ' ' VAL . 2.6 tm? -119.98 124.21 45.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.954 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.613 HG22 ' HG2' ' A' ' 70' ' ' GLU . 6.2 p -147.32 121.84 2.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.165 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.613 ' HG2' HG22 ' A' ' 69' ' ' VAL . 8.5 mm-40 58.36 22.52 9.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.872 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.72 -24.78 22.16 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.491 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.528 HG22 ' HB ' ' A' ' 37' ' ' THR . 3.9 mt -82.54 115.69 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.794 0.331 . . . . 0.0 111.134 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.848 HD23 HG21 ' A' ' 43' ' ' VAL . 4.2 mm? -75.69 111.62 11.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.966 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.609 ' HA ' HG22 ' A' ' 37' ' ' THR . 6.7 t60 -86.45 135.97 33.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.614 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -84.84 160.07 56.38 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.589 0.709 . . . . 0.0 111.135 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.559 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.6 Cg_endo -70.0 -173.37 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.702 2.268 . . . . 0.0 112.35 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.3 -2.41 34.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.3 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.78 -28.69 9.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.136 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.78 -169.23 13.78 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.444 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.614 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 98.0 m95 -82.87 -58.79 2.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.851 0.358 . . . . 0.0 110.935 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.04 -160.91 34.1 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.43 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -127.36 37.19 4.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.821 0.343 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.543 HD23 HG12 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -91.57 -175.71 4.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.914 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.59 HG22 HG23 ' A' ' 20' ' ' THR . 47.0 t -100.04 140.07 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.631 ' CE2' HD12 ' A' ' 53' ' ' LEU . 2.9 p90 -105.62 146.12 30.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.011 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 87.4 t -103.92 124.91 58.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.107 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.0 t -69.83 147.39 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.147 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -145.21 96.71 2.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.95 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.913 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.4 p90 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.843 0.354 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.752 HG23 HG13 ' A' ' 30' ' ' ILE . 6.1 tt -119.48 122.95 70.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.222 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.2 103.84 10.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.107 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.462 ' O ' HG22 ' A' ' 28' ' ' ILE . 6.7 m -147.61 153.18 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.33 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.581 ' CG2' HG22 ' A' ' 84' ' ' VAL . 0.6 OUTLIER -126.77 149.78 49.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.067 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.51 -50.0 15.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -101.88 149.66 23.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -75.32 -31.5 60.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.139 0.495 . . . . 0.0 111.215 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -66.93 -26.69 66.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.89 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -87.46 -175.92 5.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.88 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -107.27 159.69 29.2 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.374 0.606 . . . . 0.0 111.304 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.92 118.98 6.0 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.686 2.257 . . . . 0.0 112.386 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.859 HD11 HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -85.27 143.52 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.156 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.69 121.28 43.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.89 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.859 HG23 HD11 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -127.1 159.95 62.19 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.71 . . . . 0.0 111.213 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 148.84 65.79 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.658 2.239 . . . . 0.0 112.326 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.548 ' HB3' HG22 ' A' ' 38' ' ' VAL . 1.3 m -140.35 168.41 19.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.889 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -75.71 158.34 32.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -65.82 -29.61 70.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.856 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -65.28 -19.42 65.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.885 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 113.4 -14.26 23.0 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.466 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.489 ' HB ' HG22 ' A' ' 72' ' ' ILE . 22.3 p -85.24 -176.77 6.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.761 0.315 . . . . 0.0 111.222 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.622 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 70.0 t -138.23 122.57 21.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.176 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 30.3 mt -58.88 146.77 36.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.4 ' O ' HG23 ' A' ' 44' ' ' THR . 22.6 tp -62.76 -23.25 67.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.952 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.8 t -65.1 -33.51 76.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.934 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.2 m -82.9 -29.64 29.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.199 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.839 HG21 HD23 ' A' ' 73' ' ' LEU . 40.0 t -66.99 -40.96 86.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.985 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 40' ' ' LEU . 30.8 p -76.88 -14.81 59.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.533 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.79 -47.77 79.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.915 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -112.12 -20.34 11.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.998 0.428 . . . . 0.0 111.325 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -124.38 75.4 61.53 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.639 0.733 . . . . 0.0 110.857 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 131.91 22.22 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.72 2.28 . . . . 0.0 112.339 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.17 6.33 89.25 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.524 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.708 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -86.81 107.76 18.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.78 0.324 . . . . 0.0 111.094 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.5 t -93.72 -52.93 4.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.554 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -118.9 129.12 7.97 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.477 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.708 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -115.69 136.85 52.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.02 0.438 . . . . 0.0 110.65 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.7 ttm-85 -107.39 171.17 7.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.779 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -105.96 126.34 52.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.91 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -128.43 103.62 7.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.478 ' OD1' HD12 ' A' ' 83' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 121.703 0.764 . . . . 0.0 110.863 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.23 142.57 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.889 0.376 . . . . 0.0 111.132 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -91.21 138.54 31.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.775 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.476 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.4 tm? -116.15 117.13 29.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.641 HG22 ' HG3' ' A' ' 70' ' ' GLU . 6.2 p -138.07 122.18 21.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.123 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.641 ' HG3' HG22 ' A' ' 69' ' ' VAL . 5.2 mt-10 57.65 22.64 8.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.424 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . 92.65 -24.8 21.83 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.538 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.489 HG22 ' HB ' ' A' ' 37' ' ' THR . 3.4 mt -82.53 112.79 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.822 0.344 . . . . 0.0 111.127 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.839 HD23 HG21 ' A' ' 43' ' ' VAL . 4.2 mm? -73.18 111.22 8.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.473 ' HA ' HG22 ' A' ' 37' ' ' THR . 5.6 t60 -84.65 135.58 34.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.557 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -88.83 159.74 45.33 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.516 0.674 . . . . 0.0 111.174 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.557 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.5 Cg_endo -69.92 -173.12 0.68 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.698 2.266 . . . . 0.0 112.387 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -77.28 -2.12 33.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.272 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.13 -30.27 8.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.101 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.55 -164.69 15.47 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.521 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.622 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 95.1 m95 -85.64 -59.54 2.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.807 0.337 . . . . 0.0 110.918 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.16 -165.63 30.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.585 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -128.44 38.5 3.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.873 0.368 . . . . 0.0 110.908 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.704 ' H ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.42 -175.66 3.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.919 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.581 HG22 ' CG2' ' A' ' 20' ' ' THR . 45.6 t -95.43 140.39 17.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.162 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.618 ' CE2' HD12 ' A' ' 53' ' ' LEU . 7.2 p90 -109.9 145.46 36.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.979 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.3 t -101.28 119.77 49.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.051 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.2 m -66.63 150.98 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.092 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -145.06 102.5 3.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 -179.915 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.5 p90 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.876 0.37 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.716 HG23 HG13 ' A' ' 30' ' ' ILE . 6.3 tt -121.2 123.29 69.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.149 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.21 103.89 10.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.45 ' O ' HG22 ' A' ' 28' ' ' ILE . 9.6 m -147.49 150.17 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.262 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.421 HG23 HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -124.12 148.92 46.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.197 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -72.56 -49.56 31.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -114.49 139.55 49.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.858 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.69 -18.27 58.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -73.87 -26.57 60.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.67 137.42 41.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.902 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -58.32 159.85 10.73 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.589 0.709 . . . . 0.0 110.925 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.405 ' HA ' ' HB ' ' A' ' 20' ' ' THR . 54.3 Cg_endo -69.68 124.27 10.94 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.612 2.208 . . . . 0.0 112.339 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.871 HD11 HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -85.34 143.53 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.144 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -105.89 121.45 44.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.871 HG23 HD11 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -127.15 159.6 64.14 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.611 0.72 . . . . 0.0 111.124 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 153.72 68.77 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.675 2.25 . . . . 0.0 112.373 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.579 ' HB2' HG22 ' A' ' 38' ' ' VAL . 1.1 p -142.25 162.4 35.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.818 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -68.9 159.59 32.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -65.65 -26.41 67.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -68.93 -19.38 64.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 113.08 -16.13 22.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.48 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.6 HG22 ' HA ' ' A' ' 74' ' ' HIS . 38.7 p -82.23 -172.44 3.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.815 0.34 . . . . 0.0 111.162 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.624 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 67.9 t -139.39 119.08 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.119 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.43 148.54 27.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.744 HD12 ' CA ' ' A' ' 71' ' ' GLY . 1.7 tt -63.02 -23.08 67.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.922 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.8 p -65.22 -36.41 84.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.2 m -80.13 -27.93 39.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.119 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.914 HG21 HD23 ' A' ' 73' ' ' LEU . 41.2 t -67.89 -42.03 85.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.027 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.546 HG23 HD23 ' A' ' 40' ' ' LEU . 30.1 p -76.12 -14.62 60.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.567 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.16 -48.0 77.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.902 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -112.13 -17.4 12.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.335 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -127.88 75.49 78.17 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.564 0.697 . . . . 0.0 110.853 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.78 131.44 21.22 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.701 2.267 . . . . 0.0 112.33 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.48 6.27 89.39 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.531 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.638 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -88.17 107.01 18.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.826 0.346 . . . . 0.0 111.099 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.6 t -91.78 -53.07 4.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.874 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.583 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -119.34 130.74 8.67 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.514 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.638 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -115.28 139.74 49.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.082 0.468 . . . . 0.0 110.664 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.39 171.07 7.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.751 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -106.14 126.81 52.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.921 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -125.5 103.75 8.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.808 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.454 ' OD1' HD12 ' A' ' 83' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 121.597 0.713 . . . . 0.0 110.94 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.385 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.9 t -68.31 144.2 14.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 0.0 111.188 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -90.03 138.94 31.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.465 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.2 tm? -122.23 116.48 24.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.887 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.581 HG22 ' HG2' ' A' ' 70' ' ' GLU . 7.0 p -137.82 123.47 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.174 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.581 ' HG2' HG22 ' A' ' 69' ' ' VAL . 29.5 mm-40 58.6 22.75 10.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.817 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.744 ' CA ' HD12 ' A' ' 40' ' ' LEU . . . 92.47 -24.99 20.29 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.529 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.549 HG22 ' HB ' ' A' ' 37' ' ' THR . 3.8 mp -82.01 115.34 24.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.841 0.353 . . . . 0.0 111.146 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.914 HD23 HG21 ' A' ' 43' ' ' VAL . 4.1 mm? -74.23 108.75 7.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.948 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.6 ' HA ' HG22 ' A' ' 37' ' ' THR . 6.3 t60 -85.9 135.76 33.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.568 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -84.22 159.74 58.75 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.604 0.716 . . . . 0.0 111.054 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.556 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.8 Cg_endo -70.0 -172.88 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.677 2.251 . . . . 0.0 112.286 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -77.17 -2.0 32.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.301 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.38 -30.45 8.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.108 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.16 -169.21 16.24 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.505 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.624 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 77.4 m95 -81.24 -59.29 2.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.792 0.33 . . . . 0.0 110.895 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.71 -170.14 36.31 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.473 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -127.1 38.51 4.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.863 0.363 . . . . 0.0 110.901 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.699 ' H ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.25 -175.0 3.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.982 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.421 HG22 HG23 ' A' ' 20' ' ' THR . 20.6 t -94.61 145.2 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.129 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.556 ' CE2' HD12 ' A' ' 53' ' ' LEU . 5.9 p90 -116.14 146.05 42.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.988 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 99.0 t -101.44 120.91 51.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.103 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.2 m -67.48 148.98 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -145.01 107.07 4.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.93 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.895 -179.886 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 35.6 p90 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.885 0.374 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.73 HG23 HG13 ' A' ' 30' ' ' ILE . 5.5 tt -120.14 123.39 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.138 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.95 104.41 10.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.112 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.585 HG12 HD12 ' A' ' 83' ' ' LEU . 5.9 m -144.96 157.42 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.367 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . 1.083 HG23 HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -138.61 146.67 42.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.173 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.428 ' CG ' HG13 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -74.22 -50.12 20.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.842 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -102.42 137.52 40.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -69.49 -26.63 64.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -66.55 -26.33 67.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -91.74 -174.61 3.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.99 154.95 37.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.64 0.733 . . . . 0.0 110.907 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 110.84 2.66 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.738 2.292 . . . . 0.0 112.27 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.879 HD11 HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -72.18 144.2 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.189 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.21 122.26 46.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.862 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.879 HG23 HD11 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -127.32 159.98 62.5 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.624 0.725 . . . . 0.0 111.153 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.424 ' O ' HG21 ' A' ' 42' ' ' THR . 53.6 Cg_endo -69.74 147.95 64.11 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.717 2.278 . . . . 0.0 112.347 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.518 ' HB3' HG22 ' A' ' 38' ' ' VAL . 1.1 m -139.42 163.62 32.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -67.1 164.75 17.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.839 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -71.58 -28.07 63.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.897 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -68.44 -19.29 64.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.855 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.14 -14.43 21.24 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.452 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.41 ' HB ' HG22 ' A' ' 72' ' ' ILE . 18.0 p -82.93 -177.55 6.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.814 0.34 . . . . 0.0 111.111 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.602 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 57.5 t -138.09 125.81 29.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.124 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 tp -63.44 146.2 54.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.9 tp -61.52 -27.96 68.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.4 m -64.02 -30.13 71.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.795 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 31' ' ' PRO . 16.5 m -84.48 -24.71 29.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.51 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.669 HG21 HD23 ' A' ' 73' ' ' LEU . 38.7 t -72.54 -50.13 36.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.112 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.5 p -67.69 -13.78 62.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.183 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.49 -47.81 80.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.96 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -112.17 -8.8 13.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.233 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -138.35 75.9 38.5 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.621 0.724 . . . . 0.0 110.834 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.87 127.04 13.95 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.613 2.208 . . . . 0.0 112.345 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.18 -16.4 57.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.498 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.633 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -67.95 98.11 0.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.712 0.292 . . . . 0.0 111.13 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 t -84.41 -52.64 6.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.946 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.598 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -115.01 129.71 8.77 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.465 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.633 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -115.07 134.81 54.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.072 0.463 . . . . 0.0 110.683 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -108.88 167.68 9.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.709 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.645 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 9.9 m-85 -104.77 125.98 51.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.964 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.693 ' HB3' HG23 ' A' ' 84' ' ' VAL . 19.7 tpt180 -129.32 109.07 10.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.94 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 121.613 0.721 . . . . 0.0 110.912 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.645 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 41.5 t -61.65 135.53 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 111.192 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -81.22 138.77 35.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.861 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.5 HD22 ' N ' ' A' ' 69' ' ' VAL . 2.4 tm? -120.17 122.37 40.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.951 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.67 HG22 ' HG2' ' A' ' 70' ' ' GLU . 6.1 p -145.72 121.36 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.67 ' HG2' HG22 ' A' ' 69' ' ' VAL . 29.7 mm-40 58.01 22.86 9.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.19 -25.17 18.62 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.482 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.41 HG22 ' HB ' ' A' ' 37' ' ' THR . 3.3 mt -82.03 112.64 20.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.805 0.336 . . . . 0.0 111.212 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.669 HD23 HG21 ' A' ' 43' ' ' VAL . 4.2 mm? -73.88 120.0 18.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -92.32 135.59 33.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.558 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -87.65 159.74 48.86 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.487 0.66 . . . . 0.0 111.201 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.558 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.2 Cg_endo -69.98 -173.43 0.75 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.644 2.229 . . . . 0.0 112.332 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -77.07 -2.56 34.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.263 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.72 -28.4 9.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.118 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.56 -169.11 13.66 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.51 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.602 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 97.4 m95 -81.38 -58.98 2.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.835 0.35 . . . . 0.0 110.893 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.77 -159.89 30.81 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.453 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -127.83 37.86 4.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.864 0.364 . . . . 0.0 110.814 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.585 HD12 HG12 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -90.22 -176.27 4.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 1.083 HG12 HG23 ' A' ' 20' ' ' THR . 3.4 m -100.96 135.97 34.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.096 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.502 ' CD2' HD12 ' A' ' 53' ' ' LEU . 5.2 p90 -99.84 144.2 29.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.3 t -101.7 118.16 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.119 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.428 HG13 ' CG ' ' A' ' 21' ' ' GLU . 13.9 m -66.82 137.03 25.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.168 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -145.17 127.6 15.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.901 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.5 p90 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.932 -179.942 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 34.9 p90 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.857 0.36 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.731 HG23 HG13 ' A' ' 30' ' ' ILE . 5.3 tt -116.75 124.08 72.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.076 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.17 103.77 10.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.023 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.563 HG12 HD12 ' A' ' 83' ' ' LEU . 7.8 m -147.0 155.54 11.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.38 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.558 ' CG2' HG22 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -129.94 151.8 50.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.215 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.502 ' HG2' HG13 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -77.37 -50.07 13.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -107.01 143.11 35.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.51 -25.45 65.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.834 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -72.31 -26.45 61.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.85 -176.98 5.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.881 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -103.97 155.49 37.01 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.426 0.631 . . . . 0.0 111.218 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.87 106.82 1.75 Allowed 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.718 2.278 . . . . 0.0 112.309 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.862 HD11 HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -74.45 142.87 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.155 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -109.57 123.91 50.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.862 HG23 HD11 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -127.21 159.75 63.49 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.626 0.727 . . . . 0.0 111.092 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 134.36 27.86 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.743 2.295 . . . . 0.0 112.334 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.558 ' HB2' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -126.04 158.19 35.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.806 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -61.82 159.86 13.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.9 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -65.63 -27.39 68.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.803 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -67.62 -19.47 65.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.86 1.25 32.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.534 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.48 ' HB ' HG22 ' A' ' 72' ' ' ILE . 19.6 p -97.25 -176.07 3.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.855 0.359 . . . . 0.0 111.158 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.62 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 73.7 t -136.07 121.54 28.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.129 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.71 146.37 36.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.685 HD13 ' O ' ' A' ' 40' ' ' LEU . 3.3 tm? -60.69 -29.16 69.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.2 t -64.2 -39.89 94.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.4 m -73.29 -29.67 62.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.995 HG21 HD23 ' A' ' 73' ' ' LEU . 25.0 t -66.42 -37.8 80.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.013 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 67.2 p -78.09 -15.21 59.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.525 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.76 -47.9 81.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.965 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -112.59 -19.68 11.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.038 0.447 . . . . 0.0 111.294 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -126.75 75.34 75.37 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.651 0.739 . . . . 0.0 110.84 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.87 131.62 21.47 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.668 2.246 . . . . 0.0 112.28 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.21 6.79 89.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.49 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.681 ' HB1' HD21 ' A' ' 53' ' ' LEU . . . -88.17 107.95 19.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.735 0.302 . . . . 0.0 111.072 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.4 t -95.41 -53.24 3.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.936 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.56 ' O ' HD23 ' A' ' 53' ' ' LEU . . . -115.8 131.32 9.58 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.478 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.681 HD21 ' HB1' ' A' ' 50' ' ' ALA . 12.4 mt -120.88 140.83 51.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.017 0.437 . . . . 0.0 110.756 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.418 ' HB2' ' HB ' ' A' ' 86' ' ' VAL . 49.0 mtm180 -107.33 171.86 7.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.705 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.662 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 11.4 m-85 -111.06 126.9 55.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.1 tpm_? -127.91 103.61 7.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.878 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 121.567 0.699 . . . . 0.0 110.951 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.376 0 N-CA-C 112.584 -0.207 . . . . 0.0 112.584 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.662 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 21.9 t -69.1 142.72 15.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.78 0.324 . . . . 0.0 111.155 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -92.28 137.56 32.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.476 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.7 tm? -116.25 115.72 26.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.9 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.582 HG22 ' HG2' ' A' ' 70' ' ' GLU . 5.8 p -138.46 121.18 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.172 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.582 ' HG2' HG22 ' A' ' 69' ' ' VAL . 31.9 mm-40 58.65 22.71 10.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.871 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.67 -24.64 22.65 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.489 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.48 HG22 ' HB ' ' A' ' 37' ' ' THR . 4.4 mt -81.41 114.8 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.842 0.353 . . . . 0.0 111.198 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.995 HD23 HG21 ' A' ' 43' ' ' VAL . 4.2 mm? -73.77 101.82 3.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.903 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -75.16 143.21 43.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.83 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.564 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -93.57 159.98 33.83 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.573 0.702 . . . . 0.0 111.133 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.564 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.7 Cg_endo -70.06 -173.45 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.689 2.259 . . . . 0.0 112.294 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -77.12 -2.37 33.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.327 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.42 -31.23 8.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.086 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.9 -164.84 16.96 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.426 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.62 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 82.7 m95 -84.91 -59.58 2.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.749 0.309 . . . . 0.0 110.9 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.55 -162.79 36.52 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.488 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.22 37.93 4.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.912 0.387 . . . . 0.0 110.909 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.563 HD12 HG12 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -90.14 -175.8 4.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.914 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.558 HG22 ' CG2' ' A' ' 20' ' ' THR . 40.3 t -102.05 131.94 49.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.074 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.679 ' CD2' HD13 ' A' ' 53' ' ' LEU . 4.6 p90 -97.24 141.62 30.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.935 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 54' ' ' ARG . 15.5 t -99.64 115.31 40.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.118 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.502 HG13 ' HG2' ' A' ' 21' ' ' GLU . 17.3 m -61.8 145.14 13.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.064 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -145.05 110.78 5.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.96 -179.898 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.7 p90 . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.786 0.327 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.727 HG23 HG13 ' A' ' 30' ' ' ILE . 5.9 tt -122.85 123.38 68.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.169 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.58 103.44 9.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.066 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.499 HG12 ' CD2' ' A' ' 83' ' ' LEU . 6.4 m -147.31 155.66 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.308 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.558 ' CG2' HG22 ' A' ' 84' ' ' VAL . 0.7 OUTLIER -130.66 153.34 49.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.215 179.679 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.53 -49.64 14.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.839 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -100.78 147.49 26.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.26 -34.21 72.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -68.99 -25.4 64.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -85.11 164.5 18.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -89.93 155.13 47.68 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.619 0.724 . . . . 0.0 110.925 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 112.34 3.05 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.661 2.24 . . . . 0.0 112.343 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.51 HD12 ' H ' ' A' ' 29' ' ' GLU . 5.0 tp -76.67 140.01 17.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.51 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -102.92 116.57 32.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.704 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.727 HG13 HG23 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -123.52 160.13 52.14 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.61 0.719 . . . . 0.0 111.151 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 154.11 68.25 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.69 2.26 . . . . 0.0 112.341 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.642 ' HB2' HG22 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -140.15 163.98 31.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -64.16 165.78 8.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -66.17 -38.33 87.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.873 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.77 -19.29 64.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.61 -29.26 6.71 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.505 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.554 HG22 ' CG ' ' A' ' 74' ' ' HIS . 29.2 p -64.66 -176.24 0.24 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 0.0 111.137 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.642 HG22 ' HB2' ' A' ' 32' ' ' SER . 55.6 t -131.67 125.76 56.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.146 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.518 HD23 ' HB2' ' A' ' 41' ' ' SER . 13.8 tp -62.11 143.25 56.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.646 ' O ' HG23 ' A' ' 44' ' ' THR . 3.0 tm? -59.85 -23.97 63.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.88 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.518 ' HB2' HD23 ' A' ' 39' ' ' LEU . 19.0 m -67.72 -45.97 73.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.832 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.3 m -69.13 -30.32 68.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.138 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.878 HG21 HD23 ' A' ' 73' ' ' LEU . 23.3 t -65.82 -35.93 76.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.992 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.646 HG23 ' O ' ' A' ' 40' ' ' LEU . 22.4 p -79.04 -15.65 57.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.036 0.446 . . . . 0.0 111.629 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.26 -45.57 87.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.896 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -112.09 -24.16 10.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.092 0.472 . . . . 0.0 111.243 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -126.56 76.95 73.83 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 121.659 0.742 . . . . 0.0 110.87 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 134.5 28.05 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.696 2.264 . . . . 0.0 112.322 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.92 6.75 86.03 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.542 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.578 ' HB1' HD21 ' A' ' 53' ' ' LEU . . . -86.19 112.54 21.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.847 0.356 . . . . 0.0 111.094 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.9 t -99.13 -53.31 3.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.888 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.67 ' O ' HD23 ' A' ' 53' ' ' LEU . . . -116.9 134.72 11.47 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.52 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.67 HD23 ' O ' ' A' ' 52' ' ' GLY . 12.4 mt -124.06 141.2 52.25 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.048 0.452 . . . . 0.0 110.672 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -107.52 171.29 7.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.722 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.447 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 9.0 m-85 -108.83 125.53 52.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.962 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -129.3 99.62 5.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.869 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.3 t30 . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 121.634 0.731 . . . . 0.0 110.869 179.969 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.447 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 95.8 t -62.2 144.43 14.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.817 0.342 . . . . 0.0 111.155 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -95.27 138.64 32.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.877 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 69' ' ' VAL . 2.3 tm? -114.83 121.44 43.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.509 ' N ' HD22 ' A' ' 68' ' ' LEU . 6.0 p -139.12 120.22 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.119 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.475 ' HG2' HG22 ' A' ' 69' ' ' VAL . 57.1 mm-40 55.42 25.9 8.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.907 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.433 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . 93.21 -23.24 30.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.475 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.503 HG22 ' HB ' ' A' ' 37' ' ' THR . 5.3 mp -82.15 116.74 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.877 0.37 . . . . 0.0 111.103 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.878 HD23 HG21 ' A' ' 43' ' ' VAL . 4.1 mm? -79.24 101.58 8.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.554 ' CG ' HG22 ' A' ' 37' ' ' THR . 5.7 t-80 -76.37 141.94 41.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.83 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.536 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -91.6 159.37 38.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.553 0.692 . . . . 0.0 111.102 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.536 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.7 Cg_endo -70.03 -173.46 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.635 2.223 . . . . 0.0 112.32 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -77.27 -1.99 32.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.242 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.23 -30.13 8.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.094 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.48 -165.35 15.23 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.487 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.605 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 90.5 m95 -85.67 -59.79 2.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.851 0.358 . . . . 0.0 110.917 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.82 -163.88 32.35 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.487 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -128.09 38.55 3.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.827 0.346 . . . . 0.0 110.876 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.707 ' H ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -95.31 -175.76 3.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.963 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.558 HG22 ' CG2' ' A' ' 20' ' ' THR . 41.5 t -98.15 136.23 29.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.665 ' CD2' HD13 ' A' ' 53' ' ' LEU . 5.6 p90 -101.53 141.35 34.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.96 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.0 t -96.34 114.39 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.4 m -60.77 142.25 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.09 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -144.97 109.9 5.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.851 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.931 -179.986 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.3 p90 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.849 0.357 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.724 HG23 HG13 ' A' ' 30' ' ' ILE . 5.4 tt -119.43 122.92 70.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.089 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.02 103.57 9.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.043 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.52 HG12 ' CD2' ' A' ' 83' ' ' LEU . 11.8 m -146.87 154.28 12.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.327 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.56 155.81 41.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.187 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.51 -50.04 19.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -114.45 146.7 40.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -64.63 -26.82 68.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.848 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -68.99 -25.15 64.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -95.4 159.64 14.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.869 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -81.73 154.9 70.98 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.639 0.733 . . . . 0.0 110.887 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 114.99 3.9 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.687 2.258 . . . . 0.0 112.283 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 19' ' ' VAL . 5.3 tp -80.33 136.65 22.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.32 120.18 39.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.745 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.724 HG13 HG23 ' A' ' 17' ' ' ILE . 0.6 OUTLIER -126.61 159.63 62.63 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.616 0.722 . . . . 0.0 111.093 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.8 147.64 63.09 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.65 2.233 . . . . 0.0 112.351 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.544 ' CB ' HG22 ' A' ' 38' ' ' VAL . 53.8 p -133.18 179.05 6.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.829 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -80.53 166.11 21.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -71.82 -33.53 68.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -66.21 -18.79 65.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.853 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.66 -20.93 11.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.46 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 74' ' ' HIS . 20.2 p -78.51 -175.45 4.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.855 0.36 . . . . 0.0 111.139 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.582 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 55.4 t -138.61 120.51 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.104 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.8 147.96 21.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.905 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.562 ' O ' HG23 ' A' ' 44' ' ' THR . 21.8 tp -62.57 -20.22 64.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.9 m -66.06 -36.58 83.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.7 m -80.01 -34.04 38.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.183 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.903 HG21 HD23 ' A' ' 73' ' ' LEU . 31.1 t -64.31 -36.31 76.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.984 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 40' ' ' LEU . 34.5 p -80.25 -15.52 56.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.579 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.5 -44.98 85.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.947 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -111.86 -23.58 10.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.069 0.462 . . . . 0.0 111.245 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -124.73 75.1 64.57 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 121.66 0.743 . . . . 0.0 110.903 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 133.23 25.04 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.645 2.23 . . . . 0.0 112.324 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.34 4.07 89.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.508 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.648 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -82.6 118.22 23.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.322 . . . . 0.0 111.103 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.8 m -102.19 -52.81 3.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.562 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -120.03 129.15 7.83 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.532 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.669 HD12 ' CE1' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -115.97 138.26 51.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.038 0.447 . . . . 0.0 110.663 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -107.32 170.8 7.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.665 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.562 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 12.4 m-85 -110.47 126.06 53.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.976 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.727 ' HB3' HG13 ' A' ' 84' ' ' VAL . 15.8 tpt180 -129.14 103.78 7.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.864 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.6 t30 . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 121.567 0.699 . . . . 0.0 110.991 -179.946 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.562 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 92.4 t -69.86 144.58 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.839 0.352 . . . . 0.0 111.086 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -92.27 138.29 31.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.873 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.505 HD22 ' N ' ' A' ' 69' ' ' VAL . 2.3 tm? -118.01 121.7 41.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.614 HG22 ' HG3' ' A' ' 70' ' ' GLU . 6.0 p -142.67 121.36 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.614 ' HG3' HG22 ' A' ' 69' ' ' VAL . 10.2 mt-10 57.06 23.9 8.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.03 -24.93 22.39 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.529 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.452 HG22 ' HB ' ' A' ' 37' ' ' THR . 3.5 mp -81.05 117.49 27.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.912 0.387 . . . . 0.0 111.079 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.903 HD23 HG21 ' A' ' 43' ' ' VAL . 4.1 mm? -79.63 111.73 16.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.934 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.478 ' HA ' HG22 ' A' ' 37' ' ' THR . 5.8 t60 -84.66 135.84 34.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.946 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.56 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -87.86 159.75 48.24 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.572 0.701 . . . . 0.0 111.151 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.56 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.6 Cg_endo -69.94 -173.82 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.72 2.28 . . . . 0.0 112.325 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -77.32 -2.42 34.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.264 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -108.37 -27.6 9.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.053 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 118.15 -172.49 14.45 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.479 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.582 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 97.2 m95 -77.77 -59.3 2.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.775 0.322 . . . . 0.0 110.922 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.55 -162.76 30.7 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.498 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.91 38.1 4.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.877 0.37 . . . . 0.0 110.876 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.702 ' H ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -94.64 -175.72 3.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.727 HG13 ' HB3' ' A' ' 56' ' ' ARG . 4.0 p -100.57 132.31 46.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.15 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.669 ' CE1' HD12 ' A' ' 53' ' ' LEU . 2.9 p90 -99.86 145.64 27.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.947 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.2 t -102.04 120.08 51.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.103 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.9 m -64.94 145.79 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.123 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -145.02 99.89 3.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 45.9 p90 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 -179.894 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 27.6 p90 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.826 0.346 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.751 HG23 HG13 ' A' ' 30' ' ' ILE . 4.7 tt -117.1 123.58 72.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.138 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -119.9 104.03 9.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.063 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.543 HG12 HD23 ' A' ' 83' ' ' LEU . 25.2 m -147.6 152.23 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.37 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.12 152.95 42.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.151 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.8 -48.06 60.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -128.89 155.95 44.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.815 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -63.32 -26.19 68.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -66.59 -26.39 67.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.849 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -104.01 139.54 38.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -65.42 160.17 61.23 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.68 0.752 . . . . 0.0 110.841 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 114.76 3.82 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.687 2.258 . . . . 0.0 112.345 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.465 HD12 ' H ' ' A' ' 29' ' ' GLU . 4.5 tp -81.5 136.51 22.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.85 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.465 ' H ' HD12 ' A' ' 28' ' ' ILE . 11.3 pt-20 -101.7 120.39 40.27 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.735 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.751 HG13 HG23 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -126.71 159.22 65.06 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.662 0.744 . . . . 0.0 111.084 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.428 ' O ' HG21 ' A' ' 42' ' ' THR . 53.6 Cg_endo -69.72 147.72 63.75 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.649 2.233 . . . . 0.0 112.367 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.552 ' HB2' HG22 ' A' ' 38' ' ' VAL . 4.5 p -137.58 163.93 30.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.855 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -64.09 159.31 20.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.954 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.13 -29.23 69.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.877 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.84 -19.37 65.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.895 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.7 -8.37 27.95 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.499 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.505 HG22 ' HA ' ' A' ' 74' ' ' HIS . 32.7 p -90.01 179.9 5.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.825 0.345 . . . . 0.0 111.12 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.577 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 68.9 t -133.58 118.18 29.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.121 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.503 HD13 HG12 ' A' ' 72' ' ' ILE . 4.5 mm? -62.14 149.54 41.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.793 HD12 ' HA3' ' A' ' 71' ' ' GLY . 0.9 OUTLIER -60.3 -19.42 55.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.936 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 t -66.47 -39.22 88.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.989 0.423 . . . . 0.0 110.924 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.428 HG21 ' O ' ' A' ' 31' ' ' PRO . 10.0 m -78.63 -32.34 47.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.124 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.921 HG21 HD23 ' A' ' 73' ' ' LEU . 34.3 t -64.69 -36.68 78.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.981 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 40' ' ' LEU . 43.2 p -79.99 -15.32 57.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.55 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.92 -45.92 83.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.939 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -111.94 -24.51 9.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.979 0.418 . . . . 0.0 111.198 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -122.89 74.39 47.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.631 0.729 . . . . 0.0 110.933 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 129.07 16.93 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.663 2.242 . . . . 0.0 112.345 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.79 6.37 82.79 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.491 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.39 113.79 22.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 111.165 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.6 t -95.78 -53.32 3.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.705 ' C ' HD12 ' A' ' 53' ' ' LEU . . . -120.69 140.09 14.01 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.512 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.705 HD12 ' C ' ' A' ' 52' ' ' GLY . 8.4 mp -127.8 138.25 52.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.06 0.457 . . . . 0.0 110.682 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -106.73 170.39 7.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.702 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.694 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 13.6 m-85 -110.38 124.69 52.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.897 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.675 ' HB3' HG13 ' A' ' 84' ' ' VAL . 3.4 tmt_? -130.45 109.01 10.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.897 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 t30 . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 121.666 0.746 . . . . 0.0 110.885 -179.981 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.694 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 15.9 t -67.74 151.15 10.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.79 0.329 . . . . 0.0 111.15 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.539 ' HE ' HG23 ' A' ' 69' ' ' VAL . 1.7 tpt180 -97.96 119.32 36.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.49 ' C ' HD13 ' A' ' 68' ' ' LEU . 3.4 tm? -94.25 106.47 18.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.943 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.539 HG23 ' HE ' ' A' ' 67' ' ' ARG . 4.3 t -119.17 106.94 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.141 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 51.62 34.96 13.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.935 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.793 ' HA3' HD12 ' A' ' 40' ' ' LEU . . . 92.13 -24.99 19.15 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.516 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.503 HG12 HD13 ' A' ' 39' ' ' LEU . 3.1 mp -81.34 108.32 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.822 0.344 . . . . 0.0 111.083 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.921 HD23 HG21 ' A' ' 43' ' ' VAL . 3.9 mm? -73.69 102.45 3.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.505 ' HA ' HG22 ' A' ' 37' ' ' THR . 5.6 t60 -78.72 135.55 37.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.577 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -82.52 160.39 61.98 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.641 0.734 . . . . 0.0 111.046 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.577 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.3 Cg_endo -70.0 -173.55 0.78 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.722 2.281 . . . . 0.0 112.297 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -77.32 -1.99 32.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.322 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.67 -29.48 9.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.073 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.25 -170.36 15.09 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.441 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.577 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 93.0 m95 -81.45 -59.18 2.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.775 0.322 . . . . 0.0 110.941 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.36 -161.94 36.05 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.488 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -126.44 37.01 4.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.84 0.353 . . . . 0.0 110.854 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.558 HD11 ' HD1' ' A' ' 55' ' ' TYR . 1.1 pt? -88.2 -174.75 4.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.675 HG13 ' HB3' ' A' ' 56' ' ' ARG . 4.6 p -104.03 131.11 53.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.151 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.61 ' HE1' HG22 ' A' ' 87' ' ' VAL . 7.5 p90 -95.77 146.62 24.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.922 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 68.9 t -106.34 114.67 46.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.192 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.61 HG22 ' HE1' ' A' ' 85' ' ' TYR . 13.2 t -57.87 154.75 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.095 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -145.41 88.14 1.84 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.91 -179.9 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.3 p90 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.831 0.348 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.748 HG23 HG13 ' A' ' 30' ' ' ILE . 6.8 tt -106.16 123.17 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.099 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -121.25 103.73 9.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.049 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.602 HG12 HD23 ' A' ' 83' ' ' LEU . 13.1 m -148.03 151.74 13.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.281 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.749 HG23 HG13 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -118.35 154.75 31.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.175 179.779 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.25 -41.2 94.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.855 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -139.36 167.37 22.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -75.95 -24.15 55.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.108 0.48 . . . . 0.0 111.318 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -66.4 -26.51 67.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.85 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -98.66 -175.5 3.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.823 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.6 mp0 -103.83 157.07 34.69 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.611 0.72 . . . . 0.0 110.918 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 126.95 13.92 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.655 2.237 . . . . 0.0 112.416 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.5 tp -100.36 131.64 47.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.795 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -97.07 122.46 40.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.722 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.748 HG13 HG23 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -127.23 159.74 63.56 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.643 0.735 . . . . 0.0 111.14 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.68 145.89 59.02 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.714 2.276 . . . . 0.0 112.345 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.536 ' HB2' HG22 ' A' ' 38' ' ' VAL . 1.2 p -130.12 176.82 7.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -77.84 166.41 22.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.938 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -72.19 -27.44 62.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.873 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.86 -19.19 60.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.921 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.21 -15.03 13.42 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.484 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.622 HG22 ' CG ' ' A' ' 74' ' ' HIS . 16.1 p -80.62 -171.09 2.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.923 0.392 . . . . 0.0 111.092 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.595 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 53.4 t -140.12 118.99 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.139 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.8 mt -56.47 139.43 49.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.484 ' O ' HG23 ' A' ' 44' ' ' THR . 28.4 tp -57.98 -22.1 47.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.952 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -66.72 -34.64 78.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.2 m -81.6 -32.88 31.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.127 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.768 HG21 HD23 ' A' ' 73' ' ' LEU . 24.4 t -63.94 -36.0 75.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.032 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 40' ' ' LEU . 38.5 p -79.4 -15.46 57.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.501 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.09 -46.63 83.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.933 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -112.02 -22.62 10.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.25 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -126.37 75.85 73.4 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.626 0.727 . . . . 0.0 110.914 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 131.19 20.67 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.656 2.238 . . . . 0.0 112.302 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.81 6.47 88.98 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.416 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.621 ' HB1' HD21 ' A' ' 53' ' ' LEU . . . -87.32 111.93 21.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.726 0.298 . . . . 0.0 111.108 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.1 t -99.3 -53.41 3.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.644 ' O ' HD23 ' A' ' 53' ' ' LEU . . . -115.8 132.76 10.44 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.539 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.672 HD22 ' CE2' ' A' ' 85' ' ' TYR . 12.8 mt -123.81 141.1 52.34 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.979 0.419 . . . . 0.0 110.734 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.4 ' HB2' ' HB ' ' A' ' 86' ' ' VAL . 45.5 mtt-85 -108.73 171.84 7.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.673 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.532 ' CD1' HD11 ' A' ' 83' ' ' LEU . 6.2 m-85 -107.66 125.36 51.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.63 110.16 11.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.0 t30 . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 121.596 0.712 . . . . 0.0 110.878 -179.958 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.527 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 92.9 t -59.0 144.97 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.845 0.355 . . . . 0.0 111.12 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -96.64 138.58 34.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 69' ' ' VAL . 1.4 tm? -111.9 114.24 27.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.534 ' N ' HD22 ' A' ' 68' ' ' LEU . 5.4 p -127.13 127.35 69.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.153 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 69' ' ' VAL . 7.2 pt-20 45.92 32.0 1.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.515 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . 89.36 -29.18 6.27 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.517 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.4 mp -79.5 112.91 18.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.821 0.343 . . . . 0.0 111.113 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.768 HD23 HG21 ' A' ' 43' ' ' VAL . 4.2 mm? -72.62 106.58 4.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.622 ' CG ' HG22 ' A' ' 37' ' ' THR . 5.4 t-80 -82.42 137.44 34.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.613 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -87.86 160.21 47.28 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.591 0.71 . . . . 0.0 111.064 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.564 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.4 Cg_endo -69.96 -173.33 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.667 2.245 . . . . 0.0 112.343 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -77.31 -2.02 32.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.222 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.17 -30.22 8.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.115 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.77 -165.25 15.47 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.473 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.613 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 98.1 m95 -87.23 -59.89 2.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.799 0.333 . . . . 0.0 110.869 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.0 -166.74 30.07 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.443 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -124.36 36.99 4.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.89 0.376 . . . . 0.0 110.922 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.602 HD23 HG12 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -94.42 -173.08 2.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.749 HG13 HG23 ' A' ' 20' ' ' THR . 25.7 t -102.26 131.95 49.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.134 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.672 ' CE2' HD22 ' A' ' 53' ' ' LEU . 5.2 p90 -96.23 142.49 28.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.95 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 54' ' ' ARG . 15.1 t -95.54 114.88 33.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.093 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.8 m -61.59 135.55 26.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.153 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -144.98 103.21 3.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 -179.847 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 14.7 p90 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.925 0.393 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.752 HG23 HG13 ' A' ' 30' ' ' ILE . 6.2 tt -95.21 122.71 46.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.131 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.403 ' HB3' ' HA ' ' A' ' 82' ' ' ASN . 1.8 mtp180 -116.33 103.44 10.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.143 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.488 HG12 ' CD2' ' A' ' 83' ' ' LEU . 11.8 m -147.15 147.7 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.38 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.4 t -122.94 158.8 29.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.807 0.337 . . . . 0.0 111.153 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.81 -47.37 19.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.879 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.86 163.24 13.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -79.96 -30.31 39.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.223 0.535 . . . . 0.0 111.292 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.8 m-20 -66.49 -24.43 66.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.91 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -101.54 141.09 34.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.866 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.53 160.91 77.45 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.598 0.714 . . . . 0.0 110.893 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 133.68 26.02 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.639 2.226 . . . . 0.0 112.333 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.413 HD12 ' H ' ' A' ' 29' ' ' GLU . 4.3 tp -97.13 133.72 37.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.868 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.413 ' H ' HD12 ' A' ' 28' ' ' ILE . 2.1 tm-20 -93.54 122.62 36.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.735 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.752 HG13 HG23 ' A' ' 17' ' ' ILE . 0.2 OUTLIER -126.87 159.95 61.65 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.649 0.737 . . . . 0.0 111.086 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.595 ' O ' HG21 ' A' ' 42' ' ' THR . 53.5 Cg_endo -69.76 133.34 25.33 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.627 2.218 . . . . 0.0 112.345 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.589 ' HB2' HG22 ' A' ' 38' ' ' VAL . 17.2 p -122.05 -175.53 3.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -85.22 174.29 9.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -79.16 -33.39 44.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.83 -19.3 65.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.44 -11.18 19.28 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.489 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.62 HG22 ' HA ' ' A' ' 74' ' ' HIS . 30.2 p -86.21 -176.1 5.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.799 0.333 . . . . 0.0 111.138 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.63 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 66.9 t -138.46 121.37 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.4 mt -59.25 149.7 27.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.689 HD12 ' HA3' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -62.31 -21.98 65.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.911 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.1 p -66.55 -37.6 85.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.812 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.595 HG21 ' O ' ' A' ' 31' ' ' PRO . 10.5 m -76.56 -35.02 58.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.154 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.82 HG21 HD23 ' A' ' 73' ' ' LEU . 25.4 t -64.88 -37.89 81.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.043 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 40' ' ' LEU . 32.8 p -77.96 -15.55 58.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.57 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.97 -46.69 83.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.974 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -112.05 -15.96 13.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.313 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -132.88 76.69 70.16 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.622 0.725 . . . . 0.0 110.822 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 128.14 15.58 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.686 2.257 . . . . 0.0 112.332 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.83 -15.96 57.91 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.462 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.658 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -64.04 108.89 1.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.766 0.317 . . . . 0.0 111.1 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.4 t -94.5 -52.79 4.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.592 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -117.83 128.53 7.83 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.522 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.702 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -114.99 137.97 51.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.022 0.439 . . . . 0.0 110.679 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -107.3 170.43 7.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.759 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.579 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 9.5 m-85 -109.64 125.62 52.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.736 ' HB3' HG13 ' A' ' 84' ' ' VAL . 8.9 tpm_? -129.38 108.72 10.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.893 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.509 ' N ' ' HE ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 121.635 0.731 . . . . 0.0 110.907 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.579 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 22.3 t -56.6 139.18 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 111.129 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -88.63 136.88 32.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.496 ' C ' HD13 ' A' ' 68' ' ' LEU . 3.2 tm? -114.56 122.48 46.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.741 HG22 ' HG3' ' A' ' 70' ' ' GLU . 6.5 p -146.4 122.42 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.164 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.741 ' HG3' HG22 ' A' ' 69' ' ' VAL . 9.5 mt-10 58.0 22.62 9.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.864 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.689 ' HA3' HD12 ' A' ' 40' ' ' LEU . . . 92.46 -25.03 20.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.453 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.561 HG22 ' HB ' ' A' ' 37' ' ' THR . 3.1 mp -83.07 123.39 38.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.349 . . . . 0.0 111.195 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.82 HD23 HG21 ' A' ' 43' ' ' VAL . 4.0 mm? -81.33 115.57 20.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.946 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.62 ' HA ' HG22 ' A' ' 37' ' ' THR . 6.2 t60 -88.41 135.84 33.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.881 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.564 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -86.46 159.84 52.18 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.58 0.705 . . . . 0.0 111.132 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.564 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.3 Cg_endo -70.07 -172.64 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.68 2.253 . . . . 0.0 112.28 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -77.06 -2.6 34.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.299 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.18 -29.53 9.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.11 -167.39 14.69 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.461 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.63 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 85.0 m95 -81.77 -59.39 2.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.854 0.359 . . . . 0.0 110.913 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.75 -167.66 38.76 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.538 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 18' ' ' ARG . 4.8 m-20 -125.0 38.31 4.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.918 0.389 . . . . 0.0 110.916 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.721 ' H ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -93.44 -175.48 3.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.935 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.736 HG13 ' HB3' ' A' ' 56' ' ' ARG . 4.0 p -99.6 138.56 23.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.157 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.702 ' CE2' HD12 ' A' ' 53' ' ' LEU . 3.2 p90 -108.36 146.28 33.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.954 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 68.3 t -99.53 125.03 53.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.111 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.3 m -74.84 135.85 26.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -145.62 139.49 26.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.913 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 35.7 p90 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.816 0.341 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.748 HG23 HG13 ' A' ' 30' ' ' ILE . 5.5 tt -120.13 122.87 69.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.092 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.14 103.65 9.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.039 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.478 HG12 ' CD2' ' A' ' 83' ' ' LEU . 13.4 m -147.29 153.5 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.344 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.83 153.55 40.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.199 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.407 ' HG2' HG13 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -65.72 -39.14 90.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -139.23 -177.42 4.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -83.66 -29.43 27.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.194 0.521 . . . . 0.0 111.333 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -66.43 -24.16 66.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.887 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -105.4 128.81 53.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.789 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -57.91 159.69 9.87 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.554 0.693 . . . . 0.0 110.846 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 122.85 9.51 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.645 2.23 . . . . 0.0 112.349 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.472 HD12 ' H ' ' A' ' 29' ' ' GLU . 4.7 tp -91.46 137.11 22.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.931 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.472 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -101.54 121.77 42.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.812 179.948 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.748 HG13 HG23 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -127.16 159.44 65.01 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.594 0.712 . . . . 0.0 111.179 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.436 ' O ' HG21 ' A' ' 42' ' ' THR . 53.3 Cg_endo -69.8 141.65 45.62 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.638 2.225 . . . . 0.0 112.345 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.544 ' HB2' HG22 ' A' ' 38' ' ' VAL . 14.2 p -129.77 -179.64 5.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.82 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -82.86 159.94 22.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -67.72 -29.83 69.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -68.62 -19.5 64.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.57 -12.1 21.12 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.443 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.472 ' HB ' HG22 ' A' ' 72' ' ' ILE . 19.4 p -86.19 -175.41 5.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.863 0.363 . . . . 0.0 111.135 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.602 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 55.8 t -139.78 120.26 14.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.109 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.576 HD23 HG12 ' A' ' 72' ' ' ILE . 12.7 mt -60.31 146.6 43.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.514 ' O ' HG23 ' A' ' 44' ' ' THR . 22.2 tp -60.84 -20.8 62.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.6 t -65.62 -35.49 80.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.804 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.436 HG21 ' O ' ' A' ' 31' ' ' PRO . 12.4 m -82.23 -32.31 29.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.148 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.713 HG21 HD23 ' A' ' 73' ' ' LEU . 25.6 t -64.12 -35.53 74.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.004 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 40' ' ' LEU . 33.3 p -80.45 -15.36 56.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.006 0.431 . . . . 0.0 111.612 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.59 -45.25 83.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.909 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -112.0 -22.75 10.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.094 0.473 . . . . 0.0 111.282 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -127.04 75.17 76.75 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 121.608 0.718 . . . . 0.0 110.854 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 130.46 19.29 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.652 2.235 . . . . 0.0 112.363 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.49 6.07 87.89 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.448 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.66 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -85.61 115.69 23.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.348 . . . . 0.0 111.122 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 2.0 m -98.98 -52.9 3.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.569 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -121.25 130.74 8.31 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.501 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.66 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -116.46 142.08 47.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.824 0.345 . . . . 0.0 110.856 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -108.27 170.71 7.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.846 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -110.11 126.03 53.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.942 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.731 ' HB3' HG13 ' A' ' 84' ' ' VAL . 17.0 tpt180 -129.27 105.58 8.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.542 ' OD1' HD12 ' A' ' 83' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 121.552 0.691 . . . . 0.0 110.941 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.668 HG12 HD12 ' A' ' 73' ' ' LEU . 34.8 t -52.2 147.4 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 0.0 111.164 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -101.06 124.08 46.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.904 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.558 ' HA ' HD13 ' A' ' 73' ' ' LEU . 2.5 tm? -97.46 114.88 26.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.426 ' O ' ' CG ' ' A' ' 70' ' ' GLU . 6.3 p -135.15 128.78 49.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.12 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.591 ' CD ' HD12 ' A' ' 72' ' ' ILE . 7.6 pt-20 45.9 29.95 0.81 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.24 -28.04 6.48 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.543 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.591 HD12 ' CD ' ' A' ' 70' ' ' GLU . 6.0 mt -83.99 118.64 31.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.916 0.389 . . . . 0.0 111.177 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.713 HD23 HG21 ' A' ' 43' ' ' VAL . 4.3 mm? -76.49 118.89 19.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -90.61 135.56 33.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.884 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.599 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -86.36 160.66 50.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.63 0.728 . . . . 0.0 111.039 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.591 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.1 Cg_endo -69.98 -173.67 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.662 2.241 . . . . 0.0 112.311 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.09 -2.07 32.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.332 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -108.68 -27.55 9.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.103 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 118.53 -172.44 14.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.523 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.602 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 97.2 m95 -78.49 -59.71 2.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.812 0.339 . . . . 0.0 110.905 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.86 -162.94 30.44 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.464 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -127.78 38.16 4.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.867 0.365 . . . . 0.0 110.893 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.708 ' H ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -95.95 -175.25 3.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.731 HG13 ' HB3' ' A' ' 56' ' ' ARG . 3.2 p -98.37 140.46 18.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.187 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.657 ' CE1' HD12 ' A' ' 53' ' ' LEU . 3.0 p90 -110.05 145.79 36.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 53.7 t -98.05 121.08 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.137 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.407 HG13 ' HG2' ' A' ' 21' ' ' GLU . 14.6 m -68.78 141.93 16.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.126 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -144.02 119.5 10.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.938 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.866 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 mtp . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.786 0.327 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.57 41.43 7.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.103 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -157.51 122.87 1.21 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.467 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.9 m -140.66 145.67 36.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.893 0.378 . . . . 0.0 110.863 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.0 m170 -67.9 -26.39 65.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -57.07 -27.53 61.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -62.17 107.33 0.87 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.029 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -146.55 133.96 20.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -126.62 166.33 17.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.719 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -74.08 142.35 45.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.843 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.1 20.98 16.56 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.448 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.8 t -56.9 144.51 33.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.862 0.363 . . . . 0.0 110.843 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.5 ptm -111.36 164.47 12.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m -133.7 124.8 27.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.875 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.49 -171.91 2.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.859 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -122.0 161.88 22.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.91 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.752 HG23 HG13 ' A' ' 30' ' ' ILE . 6.1 tt -108.49 123.48 64.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.153 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.68 104.16 11.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.054 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.672 HG12 HD12 ' A' ' 83' ' ' LEU . 6.3 m -145.43 154.33 13.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.344 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.522 ' CG2' HG22 ' A' ' 84' ' ' VAL . 0.6 OUTLIER -128.9 152.23 48.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.128 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.86 -49.46 15.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.848 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -100.42 158.46 15.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -82.21 -31.89 30.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.223 0.535 . . . . 0.0 111.314 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -69.64 -26.56 64.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.874 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.65 -178.93 7.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.847 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -105.14 158.52 31.93 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.398 0.618 . . . . 0.0 111.266 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.9 114.66 3.8 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.38 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 19' ' ' VAL . 5.4 tp -79.51 141.36 15.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.919 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.443 ' H ' HD12 ' A' ' 28' ' ' ILE . 2.6 mt-10 -99.17 119.59 38.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.738 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.752 HG13 HG23 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -126.96 160.21 60.5 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.632 0.73 . . . . 0.0 111.122 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 155.35 66.06 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.699 2.266 . . . . 0.0 112.32 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.554 ' HB3' HG22 ' A' ' 38' ' ' VAL . 1.5 m -143.88 -175.99 4.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.839 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -88.63 172.96 8.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.945 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -78.49 -35.31 46.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.827 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -64.61 -19.03 65.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.853 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.69 -13.66 14.98 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.499 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.643 HG22 ' HA ' ' A' ' 74' ' ' HIS . 28.8 p -82.62 -174.08 5.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.851 0.357 . . . . 0.0 111.142 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.596 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 54.3 t -139.46 125.24 22.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.143 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.22 141.94 58.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.767 HD12 ' CA ' ' A' ' 71' ' ' GLY . 1.7 tt -60.56 -22.76 64.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.6 p -64.43 -29.72 70.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.788 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 58.0 m -87.1 -30.55 21.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.538 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.494 HG21 HD23 ' A' ' 73' ' ' LEU . 38.5 t -65.14 -39.91 87.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.992 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.582 HG23 HD23 ' A' ' 40' ' ' LEU . 42.9 p -77.41 -14.86 59.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.011 0.434 . . . . 0.0 111.569 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.04 -47.02 81.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.959 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 63.2 mm-40 -111.88 -21.71 11.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.116 0.484 . . . . 0.0 111.367 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -123.84 74.67 56.24 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 121.662 0.744 . . . . 0.0 110.878 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 129.99 18.61 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.66 2.24 . . . . 0.0 112.386 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.56 -9.68 70.07 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.51 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.688 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -67.73 99.27 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.744 0.307 . . . . 0.0 111.075 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.9 t -82.5 -43.77 16.78 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.093 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.575 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -130.27 134.82 8.0 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.399 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.688 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -115.68 130.02 56.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.074 0.464 . . . . 0.0 110.623 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -107.13 170.35 8.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.705 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.519 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 7.4 m-85 -106.16 126.09 51.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -129.27 121.53 27.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.907 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -138.63 118.49 9.68 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.609 0.718 . . . . 0.0 110.897 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -27.88 25.85 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.644 2.23 . . . . 0.0 112.328 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.5 m -86.58 -29.23 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.125 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.3 m -88.11 -27.24 22.04 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.061 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 59.75 22.42 11.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.046 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 6.7 m -90.69 -179.25 5.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.866 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.3 ptm -142.28 27.28 1.76 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.005 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -56.07 177.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.735 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.99 143.09 9.7 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.484 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.519 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 21.2 t -67.61 134.39 30.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.818 0.342 . . . . 0.0 111.143 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -77.43 138.46 39.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.478 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.7 tm? -121.33 124.43 44.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.948 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.459 ' N ' HD22 ' A' ' 68' ' ' LEU . 7.6 p -149.47 124.41 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.114 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.446 ' HG3' HG22 ' A' ' 69' ' ' VAL . 11.0 mt-10 57.92 22.62 8.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.767 ' CA ' HD12 ' A' ' 40' ' ' LEU . . . 92.23 -24.88 20.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.496 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.512 HG22 ' HB ' ' A' ' 37' ' ' THR . 3.2 mt -82.8 122.79 37.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 0.0 111.139 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.673 ' HG ' HD23 ' A' ' 53' ' ' LEU . 4.3 mm? -82.22 119.56 24.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.936 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.643 ' HA ' HG22 ' A' ' 37' ' ' THR . 41.9 t60 -91.88 135.76 33.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.568 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -87.68 160.05 48.15 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.55 0.69 . . . . 0.0 111.107 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.568 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.5 Cg_endo -69.99 -172.59 0.62 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.678 2.252 . . . . 0.0 112.306 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -77.16 -2.28 33.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.224 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.23 -31.52 8.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.95 -164.38 15.93 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.499 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.596 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 86.2 m95 -85.28 -59.24 2.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.758 0.313 . . . . 0.0 110.933 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.55 -161.77 37.27 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.456 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -125.91 37.75 4.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.906 0.384 . . . . 0.0 110.919 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.672 HD12 HG12 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -87.75 -175.85 5.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.522 HG22 ' CG2' ' A' ' 20' ' ' THR . 40.5 t -102.46 136.07 36.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.155 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.576 ' CD2' HD12 ' A' ' 53' ' ' LEU . 3.7 p90 -102.56 146.28 28.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.986 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 84.6 t -106.89 131.0 57.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.061 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.475 HG22 ' CE2' ' A' ' 85' ' ' TYR . 2.4 t -81.51 132.48 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.129 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -145.85 140.81 27.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.973 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 ptm . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.768 0.318 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.4 109.1 20.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.148 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.47 58.57 1.62 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.53 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.8 p -106.45 -35.76 7.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.867 0.365 . . . . 0.0 110.852 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -104.86 33.92 3.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -105.31 -35.11 7.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.871 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -156.47 167.45 30.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.895 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -106.62 158.83 16.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.721 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 -101.02 -30.68 11.48 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.604 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -69.31 -27.75 65.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.834 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.91 159.39 22.89 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.508 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -99.33 141.46 32.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.807 0.337 . . . . 0.0 110.818 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.4 ptt? -57.93 171.4 0.51 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.864 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.0 p -98.32 143.36 28.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -96.07 -177.79 4.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.893 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -128.99 168.42 16.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.932 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.77 HG23 HG13 ' A' ' 30' ' ' ILE . 6.1 tt -120.44 123.48 70.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.086 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -120.29 104.1 9.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.042 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.476 ' O ' HG22 ' A' ' 28' ' ' ILE . 6.1 m -145.0 152.29 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.351 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.528 HG23 HG22 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -127.31 157.47 39.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.138 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.42 -49.95 10.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.838 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -101.27 163.11 12.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -84.39 -29.71 25.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.211 0.529 . . . . 0.0 111.265 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -67.53 -26.6 66.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.868 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -94.41 163.43 13.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.871 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -89.16 159.92 44.01 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.677 0.751 . . . . 0.0 110.888 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.86 116.77 4.72 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.63 2.22 . . . . 0.0 112.367 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.476 HG22 ' O ' ' A' ' 19' ' ' VAL . 5.3 tp -76.68 137.98 21.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.867 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.05 119.77 37.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.802 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.77 HG13 HG23 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -126.43 159.89 60.77 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.627 0.727 . . . . 0.0 111.159 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.406 ' O ' HG21 ' A' ' 42' ' ' THR . 54.2 Cg_endo -69.73 148.82 66.08 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.643 2.229 . . . . 0.0 112.307 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.534 ' HB2' HG22 ' A' ' 38' ' ' VAL . 19.8 p -133.29 -175.69 3.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -84.66 169.94 13.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -75.57 -30.55 59.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -72.34 -17.5 61.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.787 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.13 -20.84 11.24 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.451 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.524 ' HB ' HG22 ' A' ' 72' ' ' ILE . 22.7 p -75.57 -174.24 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.796 0.331 . . . . 0.0 111.181 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.586 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 50.5 t -141.0 119.53 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.141 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.2 tp -56.94 145.34 30.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.874 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.737 HD12 ' CA ' ' A' ' 71' ' ' GLY . 1.3 tt -61.44 -19.61 62.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.9 t -66.29 -37.72 86.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.406 HG21 ' O ' ' A' ' 31' ' ' PRO . 8.9 m -77.06 -34.87 57.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.136 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.598 HG21 HD23 ' A' ' 73' ' ' LEU . 22.4 t -64.3 -34.94 72.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.027 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.579 HG23 ' O ' ' A' ' 40' ' ' LEU . 39.0 p -80.06 -15.78 56.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.559 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.65 -43.65 88.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.995 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -111.92 -23.95 10.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.305 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -129.69 75.66 79.47 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.647 0.736 . . . . 0.0 110.918 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 125.28 11.95 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.675 2.25 . . . . 0.0 112.382 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.46 6.5 64.26 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.517 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.718 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -82.13 116.11 21.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.774 0.321 . . . . 0.0 111.135 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.8 t -100.45 -52.92 3.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.633 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -122.08 127.04 6.66 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.545 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.778 HD12 ' CE1' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -115.31 139.73 49.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.953 0.406 . . . . 0.0 110.759 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -112.21 171.0 7.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.692 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -104.13 126.04 50.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.946 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.1 tpt180 -128.94 103.32 6.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -139.17 119.15 9.41 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.635 0.731 . . . . 0.0 110.935 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 -23.73 30.45 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.727 2.285 . . . . 0.0 112.295 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.7 m -84.31 -27.68 7.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.178 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.2 m -84.28 -27.0 28.17 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.013 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 59.16 23.55 11.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.058 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 21.9 p -108.85 165.38 11.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.8 ptt? -125.18 26.15 7.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.651 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -59.34 176.5 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.706 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.71 145.63 12.71 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.528 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.7 t -62.79 143.33 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.786 0.326 . . . . 0.0 111.151 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -91.97 138.55 31.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.885 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.482 HD22 ' N ' ' A' ' 69' ' ' VAL . 2.2 tm? -118.03 117.98 30.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.682 HG22 ' HG2' ' A' ' 70' ' ' GLU . 6.7 p -138.93 122.8 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.138 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.682 ' HG2' HG22 ' A' ' 69' ' ' VAL . 36.3 mm-40 58.12 22.58 9.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.737 ' CA ' HD12 ' A' ' 40' ' ' LEU . . . 92.33 -25.08 19.44 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.516 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.524 HG22 ' HB ' ' A' ' 37' ' ' THR . 4.3 mp -83.32 114.13 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.889 0.376 . . . . 0.0 111.076 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.598 HD23 HG21 ' A' ' 43' ' ' VAL . 4.1 mm? -73.78 116.09 13.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.956 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.46 ' HA ' HG22 ' A' ' 37' ' ' THR . 5.5 t60 -91.33 135.7 33.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.607 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -86.08 158.85 55.18 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.554 0.692 . . . . 0.0 111.124 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.525 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.9 Cg_endo -69.89 -172.94 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.689 2.26 . . . . 0.0 112.325 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -77.32 -2.15 33.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.266 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.74 -29.45 9.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.114 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.94 -168.86 14.65 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.514 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.607 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 98.0 m95 -82.49 -59.47 2.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.774 0.321 . . . . 0.0 110.866 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.11 -167.54 29.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.525 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -128.03 38.48 4.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.844 0.354 . . . . 0.0 110.895 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.677 ' H ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.61 -175.55 3.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.528 HG22 HG23 ' A' ' 20' ' ' THR . 21.9 t -93.58 144.28 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.106 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.778 ' CE1' HD12 ' A' ' 53' ' ' LEU . 1.7 p90 -111.31 146.35 37.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.959 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.5 t -95.48 125.55 48.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.139 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 t -74.48 135.98 26.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.108 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -145.11 106.48 4.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.884 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.976 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 mtt . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.783 0.325 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.97 -63.11 1.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.155 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -169.15 -103.95 0.17 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.509 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.5 m -117.52 132.56 56.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.937 0.398 . . . . 0.0 110.81 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 -86.23 -55.87 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.811 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -88.58 165.77 14.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -56.65 -27.56 58.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.757 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -148.5 165.05 32.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.989 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -67.37 105.45 1.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.693 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -85.88 -42.7 13.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -162.51 167.29 36.97 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.503 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -116.43 135.81 53.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.884 0.373 . . . . 0.0 110.911 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -64.59 -24.96 67.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.895 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.7 p -60.89 153.56 24.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.774 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -108.82 -176.62 3.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.942 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -129.75 166.9 18.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.932 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.75 HG23 HG13 ' A' ' 30' ' ' ILE . 6.0 tt -120.78 123.3 69.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.138 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -120.65 104.44 9.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.058 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.456 ' O ' HG22 ' A' ' 28' ' ' ILE . 10.2 m -146.3 153.31 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.371 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.561 HG23 HG22 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -126.91 156.63 41.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.176 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.15 -50.18 13.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -102.54 166.44 10.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.912 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -79.53 -32.85 42.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.152 0.501 . . . . 0.0 111.279 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -74.75 -25.79 59.33 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.855 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -86.28 129.01 35.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.921 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -60.46 155.0 51.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.638 0.732 . . . . 0.0 110.884 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 114.91 3.85 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.717 2.278 . . . . 0.0 112.317 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.474 HD12 ' H ' ' A' ' 29' ' ' GLU . 4.9 tp -76.75 139.43 18.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.474 ' H ' HD12 ' A' ' 28' ' ' ILE . 1.7 pm0 -102.04 120.06 39.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.712 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.75 HG13 HG23 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -125.91 159.7 60.33 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.692 0.758 . . . . 0.0 111.051 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.409 ' O ' HG21 ' A' ' 42' ' ' THR . 53.7 Cg_endo -69.71 142.77 49.05 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.652 2.235 . . . . 0.0 112.349 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.565 ' CB ' HG22 ' A' ' 38' ' ' VAL . 53.5 p -132.94 161.63 33.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.831 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -61.11 162.74 6.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.82 -31.85 65.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.849 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -65.2 -18.4 65.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.36 -19.37 11.68 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.461 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.457 ' HB ' HG22 ' A' ' 72' ' ' ILE . 20.5 p -81.05 -174.38 4.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.348 . . . . 0.0 111.145 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.608 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 53.5 t -137.76 124.56 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.154 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.8 tp -59.49 146.88 38.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.623 HD13 ' O ' ' A' ' 40' ' ' LEU . 3.1 tm? -63.06 -25.19 68.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.7 t -64.44 -39.13 93.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.409 HG21 ' O ' ' A' ' 31' ' ' PRO . 10.7 m -74.13 -31.02 62.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.176 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.909 HG21 HD23 ' A' ' 73' ' ' LEU . 17.7 t -66.16 -37.22 79.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.011 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.1 p -79.09 -15.84 57.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.578 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.13 -44.81 87.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.983 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -112.14 -20.86 11.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.118 0.485 . . . . 0.0 111.352 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -131.38 75.45 77.3 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 121.643 0.735 . . . . 0.0 110.849 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 131.87 22.19 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.619 2.213 . . . . 0.0 112.415 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.36 -8.87 72.57 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.518 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.593 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -71.06 119.73 15.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.807 0.337 . . . . 0.0 111.139 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.4 t -102.05 -53.01 3.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.584 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -121.07 130.25 8.14 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.494 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.709 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -115.69 137.81 51.71 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.992 0.425 . . . . 0.0 110.678 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -108.64 170.71 7.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.735 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -105.29 125.69 51.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -129.56 105.28 7.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -138.67 118.65 9.69 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.551 0.691 . . . . 0.0 110.909 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -24.67 29.3 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.687 2.258 . . . . 0.0 112.323 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.1 m -85.03 -29.49 6.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.045 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.1 t -87.83 -27.29 22.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.047 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 58.0 22.35 8.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.022 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 2.1 t -93.55 160.31 14.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.894 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 58.7 mmm -125.19 26.89 6.79 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.745 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.98 174.56 3.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.668 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.18 136.06 5.26 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.511 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 64.5 t -54.77 138.62 14.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.748 0.309 . . . . 0.0 111.181 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -88.15 138.49 31.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.517 HD21 ' HA2' ' A' ' 71' ' ' GLY . 2.2 tm? -117.3 115.05 24.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.555 HG22 ' HG2' ' A' ' 70' ' ' GLU . 5.6 p -134.32 120.28 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.141 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.555 ' HG2' HG22 ' A' ' 69' ' ' VAL . 17.4 mm-40 57.51 23.53 9.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.9 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.517 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . 93.39 -24.93 23.13 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.467 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.457 HG22 ' HB ' ' A' ' 37' ' ' THR . 4.2 mp -80.83 112.72 19.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.973 0.416 . . . . 0.0 111.089 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.909 HD23 HG21 ' A' ' 43' ' ' VAL . 4.1 mm? -74.72 111.24 9.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.911 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -86.65 135.41 33.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.649 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -87.98 159.87 47.64 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.467 0.651 . . . . 0.0 111.209 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.557 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.2 Cg_endo -69.94 -173.09 0.67 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.698 2.265 . . . . 0.0 112.285 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -77.2 -2.25 33.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.244 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.27 -29.81 9.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.99 -165.35 14.85 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.469 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.649 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 97.5 m95 -86.71 -59.6 2.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.82 0.343 . . . . 0.0 110.849 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.72 -165.8 29.83 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.466 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -128.16 38.24 4.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 0.0 110.861 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.693 ' H ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.29 -175.81 3.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.912 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.561 HG22 HG23 ' A' ' 20' ' ' THR . 38.3 t -93.85 144.44 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.191 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.709 ' CE2' HD12 ' A' ' 53' ' ' LEU . 3.6 p90 -114.61 145.9 41.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.939 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.4 t -99.65 126.74 52.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.121 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.8 t -72.58 145.35 12.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.17 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -145.08 87.75 1.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.963 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.4 p90 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 -179.883 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttp . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.776 0.322 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.48 -35.23 3.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.095 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 152.04 -150.13 21.94 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.517 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.6 t -99.2 109.0 21.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.844 0.354 . . . . 0.0 110.878 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -55.18 -63.79 1.04 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.809 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.39 165.46 23.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.806 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -94.34 145.71 24.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.3 t60 -81.91 -35.42 29.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.936 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -64.45 152.19 42.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -76.22 139.21 41.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.834 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.16 107.91 2.16 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.537 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -83.74 -27.51 28.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.908 0.385 . . . . 0.0 110.866 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.3 tpt -80.2 112.92 17.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.83 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.3 m -63.74 144.35 57.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.881 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -89.85 140.53 29.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -91.27 167.76 12.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.881 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.707 HG23 HG13 ' A' ' 30' ' ' ILE . 6.1 tt -119.35 123.47 71.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.098 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.4 mtm180 -119.48 104.69 10.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.109 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.543 HG12 HD23 ' A' ' 83' ' ' LEU . 6.5 m -145.71 153.44 13.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.3 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.716 ' CG2' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -124.76 155.33 39.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.167 179.701 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.06 -49.73 22.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.928 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -105.31 173.43 6.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.861 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -79.21 -46.6 17.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.283 0.564 . . . . 0.0 111.283 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -68.84 -26.8 65.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.878 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -72.79 126.98 31.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.93 149.89 63.27 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.695 0.759 . . . . 0.0 110.856 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.78 120.2 7.02 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.763 2.308 . . . . 0.0 112.311 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 19' ' ' VAL . 6.1 tp -87.54 143.4 11.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.99 123.15 48.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.707 HG13 HG23 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -127.39 160.57 59.5 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.656 0.741 . . . . 0.0 111.151 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.67 144.65 55.19 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.704 2.269 . . . . 0.0 112.426 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.571 ' HB3' HG22 ' A' ' 38' ' ' VAL . 1.5 m -133.18 -175.88 3.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.859 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -86.06 174.25 9.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.836 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -80.68 -35.39 33.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.806 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -63.36 -19.83 64.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.827 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.43 -12.55 13.87 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.441 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.439 ' HB ' HG22 ' A' ' 72' ' ' ILE . 20.6 p -85.38 -174.72 5.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.829 0.347 . . . . 0.0 111.182 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.606 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 53.7 t -136.7 135.08 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.208 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 tp -70.81 141.39 51.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.696 HD13 ' O ' ' A' ' 40' ' ' LEU . 2.6 tm? -59.48 -31.95 69.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.965 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -58.85 -29.23 66.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.792 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.4 m -83.97 -30.86 25.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.156 0.503 . . . . 0.0 111.619 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.618 HG21 HD23 ' A' ' 73' ' ' LEU . 20.1 t -65.16 -35.29 75.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.025 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.3 p -79.7 -15.39 57.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.465 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.26 -45.33 84.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.982 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -111.97 -18.28 12.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.016 0.436 . . . . 0.0 111.287 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -134.11 74.55 67.78 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.633 0.73 . . . . 0.0 110.864 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 129.5 17.75 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.698 2.265 . . . . 0.0 112.39 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.26 6.03 78.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.522 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.657 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -81.78 114.96 20.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.758 0.314 . . . . 0.0 111.129 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.2 t -95.79 -53.05 3.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.598 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -124.81 132.06 8.02 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.559 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.684 HD12 ' CE1' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -115.41 138.86 50.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.986 0.422 . . . . 0.0 110.745 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.17 170.78 7.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.715 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.696 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 10.3 m-85 -111.07 125.75 54.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.974 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -129.41 104.01 7.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.934 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -139.18 118.6 9.25 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.632 0.73 . . . . 0.0 110.902 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 -34.97 13.35 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.681 2.254 . . . . 0.0 112.355 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.0 m -74.08 -34.05 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.14 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.2 t -80.79 -27.09 36.78 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.026 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 60.07 20.11 9.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.092 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 22.7 m -83.84 162.94 20.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.924 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.5 28.24 3.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.043 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.06 -177.52 4.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.676 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.5 155.47 26.36 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.462 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.696 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 21.6 t -58.29 135.7 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.828 0.347 . . . . 0.0 111.069 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -83.26 138.54 33.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.867 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.49 ' C ' HD13 ' A' ' 68' ' ' LEU . 3.2 tm? -118.62 120.8 38.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.666 HG22 ' HG2' ' A' ' 70' ' ' GLU . 6.1 p -145.21 121.56 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.173 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.666 ' HG2' HG22 ' A' ' 69' ' ' VAL . 10.7 mm-40 58.16 22.53 9.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.858 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.96 -25.23 17.64 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.466 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.439 HG22 ' HB ' ' A' ' 37' ' ' THR . 2.1 mp -82.29 114.57 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.847 0.356 . . . . 0.0 111.144 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.618 HD23 HG21 ' A' ' 43' ' ' VAL . 4.1 mm? -73.86 120.54 19.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.428 ' HA ' HG22 ' A' ' 37' ' ' THR . 47.8 t60 -91.4 139.48 30.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.582 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -91.55 160.22 37.14 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.575 0.702 . . . . 0.0 111.092 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.582 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.2 Cg_endo -69.88 -172.79 0.63 Allowed 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.687 2.258 . . . . 0.0 112.304 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -77.02 -2.56 34.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.269 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.44 -29.43 9.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.78 -164.72 14.06 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.526 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.606 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 94.7 m95 -85.59 -59.42 2.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.775 0.322 . . . . 0.0 110.861 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.92 -162.17 38.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.493 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.49 36.99 4.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.851 0.358 . . . . 0.0 110.883 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.543 HD23 HG12 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -88.91 -173.85 4.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.891 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.716 HG22 ' CG2' ' A' ' 20' ' ' THR . 61.3 t -104.07 138.31 29.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.079 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.684 ' CE1' HD12 ' A' ' 53' ' ' LEU . 2.7 p90 -108.31 146.05 33.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.6 t -100.8 127.22 54.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.14 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.3 t -71.1 146.24 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.145 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -145.11 104.01 3.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.953 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.959 -179.888 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ptt? . . . . . 0 CA--C 1.526 0.032 0 CA-C-O 120.777 0.322 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.31 106.14 0.18 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.109 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 96.04 69.01 1.01 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.448 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.9 m -63.35 -55.19 26.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.893 0.377 . . . . 0.0 110.838 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -81.87 -66.05 0.94 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.61 176.53 11.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -61.94 135.07 57.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.983 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -149.27 116.22 5.99 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -157.15 153.96 28.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.761 0.315 . . . . 0.0 110.881 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -124.5 176.56 6.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.844 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.66 47.62 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.499 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.8 m -147.7 166.81 26.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.858 0.361 . . . . 0.0 110.854 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.0 tpt -113.71 117.47 31.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.93 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.5 m -56.76 139.41 50.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.799 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -96.42 -178.38 4.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -129.31 153.9 47.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.869 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.738 HG23 HG13 ' A' ' 30' ' ' ILE . 6.5 tt -109.1 123.16 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.095 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -118.45 104.51 10.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.005 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.57 HG12 HD12 ' A' ' 83' ' ' LEU . 7.4 m -147.35 153.17 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.336 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.579 ' CG2' HG22 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -127.1 151.18 48.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.082 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.07 -49.11 30.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -106.65 167.32 9.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.942 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -78.9 -38.05 38.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.202 0.525 . . . . 0.0 111.34 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -69.25 -26.57 64.84 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.936 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.85 130.47 34.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -62.15 156.26 60.28 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.603 0.715 . . . . 0.0 110.918 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 119.14 6.14 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.656 2.237 . . . . 0.0 112.388 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.843 HD11 HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -83.49 142.72 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.156 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -106.82 122.71 46.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.82 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.843 HG23 HD11 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -127.2 159.56 64.47 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.641 0.734 . . . . 0.0 111.092 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.86 145.59 57.03 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.667 2.245 . . . . 0.0 112.31 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.579 ' HB2' HG22 ' A' ' 38' ' ' VAL . 1.1 p -135.73 171.7 14.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.403 ' HG2' HD23 ' A' ' 39' ' ' LEU . 7.7 mm-40 -74.2 167.09 22.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -73.41 -27.34 61.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.847 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -71.03 -19.58 62.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.857 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.84 -8.28 21.67 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.448 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.488 ' HB ' HG22 ' A' ' 72' ' ' ILE . 20.0 p -86.18 -178.04 6.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.9 0.381 . . . . 0.0 111.125 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.608 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 55.4 t -135.35 127.68 47.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.186 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.403 HD23 ' HG2' ' A' ' 33' ' ' GLU . 3.6 mm? -63.0 143.78 57.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.693 HD13 ' O ' ' A' ' 40' ' ' LEU . 3.3 tm? -61.67 -30.44 70.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.0 t -62.8 -37.24 85.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.863 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 17.9 m -76.24 -23.51 54.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.094 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.828 HG21 HD23 ' A' ' 73' ' ' LEU . 25.6 t -72.25 -38.68 62.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.188 0.518 . . . . 0.0 111.341 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.9 p -77.82 -15.2 59.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.575 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.12 -46.69 86.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.941 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -112.18 -21.13 11.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.094 0.473 . . . . 0.0 111.265 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -124.98 75.01 66.83 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 121.647 0.737 . . . . 0.0 110.896 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.77 131.12 20.55 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.647 2.231 . . . . 0.0 112.379 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.76 5.91 89.46 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.488 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.572 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -86.98 114.3 23.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 0.0 111.093 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 m -98.86 -53.03 3.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.547 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -119.14 130.92 8.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.49 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.584 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -115.79 139.96 49.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.026 0.441 . . . . 0.0 110.705 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -109.04 170.74 7.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.751 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.45 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 7.8 m-85 -107.48 126.7 52.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.86 103.04 7.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -139.22 121.89 10.45 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.654 0.74 . . . . 0.0 110.926 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -49.09 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.678 2.252 . . . . 0.0 112.333 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.1 m -61.58 -37.01 76.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.111 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.5 t -67.89 -26.68 66.12 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.01 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 58.28 23.76 10.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.08 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 64.5 m -116.12 -179.15 3.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 28.0 ttp -145.17 38.41 1.17 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -178.97 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.746 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.02 134.43 4.44 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.488 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.45 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 59.6 t -58.12 136.94 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.878 0.371 . . . . 0.0 111.104 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -86.32 138.41 31.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.481 HD21 ' HA2' ' A' ' 71' ' ' GLY . 2.2 tm? -119.16 114.29 22.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.884 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.662 HG22 ' HG3' ' A' ' 70' ' ' GLU . 5.9 p -135.46 121.05 30.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.181 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.662 ' HG3' HG22 ' A' ' 69' ' ' VAL . 4.1 mt-10 57.77 23.05 9.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.481 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . 92.94 -24.84 22.56 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.509 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.488 HG22 ' HB ' ' A' ' 37' ' ' THR . 4.2 mp -80.22 111.52 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 111.173 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.828 HD23 HG21 ' A' ' 43' ' ' VAL . 4.1 mm? -73.12 109.06 6.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.924 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -84.24 137.22 33.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.625 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -89.29 160.32 42.81 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.552 0.691 . . . . 0.0 111.104 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.572 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.0 Cg_endo -69.92 -172.92 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.724 2.283 . . . . 0.0 112.292 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -76.98 -2.45 33.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.317 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.33 -29.64 9.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.097 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.38 -164.87 14.46 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.496 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.625 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 94.5 m95 -86.75 -59.42 2.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.758 0.313 . . . . 0.0 110.898 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.08 -163.19 32.98 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.484 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.34 37.69 4.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.806 0.336 . . . . 0.0 110.9 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.57 HD12 HG12 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -92.42 -175.8 4.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.579 HG22 ' CG2' ' A' ' 20' ' ' THR . 43.8 t -99.47 136.2 31.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.099 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.584 ' CE2' HD12 ' A' ' 53' ' ' LEU . 6.4 p90 -104.16 145.86 29.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.969 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.7 t -101.8 116.59 45.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.087 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.7 m -63.21 143.23 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.156 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -144.96 106.08 4.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.938 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 -179.909 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.793 0.33 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.18 148.17 22.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.111 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 73.0 62.42 3.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.442 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.4 m -85.78 -51.05 6.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.904 0.383 . . . . 0.0 110.841 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -130.65 125.54 34.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.86 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -72.36 -36.57 68.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -107.52 150.97 26.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.811 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -92.33 123.3 35.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -90.43 -26.75 19.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -69.2 145.07 53.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.64 35.12 3.36 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.472 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.8 t -126.24 145.3 50.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.91 0.386 . . . . 0.0 110.846 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.4 171.89 4.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.925 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.7 p -160.62 152.05 19.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -119.84 179.45 4.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.931 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -120.52 163.36 18.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.934 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.754 HG23 HG13 ' A' ' 30' ' ' ILE . 5.7 tt -109.91 123.83 66.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.103 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.66 103.64 10.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.042 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.528 HG12 HD23 ' A' ' 83' ' ' LEU . 8.3 m -147.91 155.32 10.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.38 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.601 ' CG2' HG22 ' A' ' 84' ' ' VAL . 0.8 OUTLIER -129.41 153.57 47.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.11 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.568 ' HG2' HG13 ' A' ' 87' ' ' VAL . 0.5 OUTLIER -79.79 -49.88 11.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.41 143.61 32.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -67.9 -30.8 70.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.929 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -67.04 -26.55 66.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.876 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -90.14 170.23 10.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.832 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -94.37 159.61 33.54 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.662 0.744 . . . . 0.0 110.853 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 112.85 3.2 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.675 2.25 . . . . 0.0 112.367 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.512 HD12 ' H ' ' A' ' 29' ' ' GLU . 5.0 tp -77.72 140.13 17.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.898 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.512 ' H ' HD12 ' A' ' 28' ' ' ILE . 3.0 mp0 -101.77 117.52 35.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.762 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.754 HG13 HG23 ' A' ' 17' ' ' ILE . 0.6 OUTLIER -123.94 159.58 55.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.645 0.736 . . . . 0.0 111.148 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 152.13 68.82 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.659 2.239 . . . . 0.0 112.357 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.653 ' HB2' HG22 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -142.3 155.91 45.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.863 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.597 ' HG2' HD23 ' A' ' 39' ' ' LEU . 4.0 mm-40 -57.51 166.4 1.28 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -70.18 -33.19 71.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -63.68 -20.25 65.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 113.57 -12.94 23.09 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.451 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.577 HG22 ' HA ' ' A' ' 74' ' ' HIS . 33.2 p -82.48 -177.16 6.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.833 0.349 . . . . 0.0 111.128 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.653 HG22 ' HB2' ' A' ' 32' ' ' SER . 53.3 t -130.9 123.3 53.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.179 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.597 HD23 ' HG2' ' A' ' 33' ' ' GLU . 1.9 mm? -61.89 145.57 52.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.64 ' O ' HG23 ' A' ' 44' ' ' THR . 3.0 tm? -61.04 -24.24 66.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.901 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.8 p -67.52 -44.16 79.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.5 m -71.16 -30.42 66.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.156 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.859 HG21 HD23 ' A' ' 73' ' ' LEU . 21.3 t -65.47 -35.2 74.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.989 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.64 HG23 ' O ' ' A' ' 40' ' ' LEU . 21.7 p -79.6 -15.74 57.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.581 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.12 90.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -112.11 -25.57 9.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.091 0.472 . . . . 0.0 111.342 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -125.35 75.63 68.68 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.609 0.719 . . . . 0.0 110.89 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 133.03 24.62 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.694 2.263 . . . . 0.0 112.311 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.33 6.02 89.46 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.511 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.578 ' HB1' HD21 ' A' ' 53' ' ' LEU . . . -84.02 117.22 23.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.8 0.333 . . . . 0.0 111.083 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 2.4 m -101.22 -53.22 3.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.846 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.611 ' O ' HD23 ' A' ' 53' ' ' LEU . . . -121.23 135.0 10.39 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.427 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.665 HD13 ' CD2' ' A' ' 85' ' ' TYR . 12.9 mt -122.93 146.27 47.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.781 0.324 . . . . 0.0 110.919 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.404 ' HB2' ' HB ' ' A' ' 86' ' ' VAL . 24.5 mtt180 -116.59 171.71 7.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.648 ' CD1' HD11 ' A' ' 83' ' ' LEU . 5.6 m-85 -106.06 126.65 52.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.95 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -128.3 107.23 9.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.842 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -140.1 148.74 55.85 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.684 0.754 . . . . 0.0 110.866 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.67 -40.54 5.35 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.711 2.274 . . . . 0.0 112.396 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.4 m -85.73 -22.71 7.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.057 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.0 m -87.97 -20.98 25.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.87 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.459 ' O ' ' C ' ' A' ' 62' ' ' CYS . 10.1 mm100 62.04 35.54 15.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.934 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 61' ' ' GLN . 26.9 p 32.87 49.77 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.921 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 5.4 tpt -92.39 -16.31 26.1 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.999 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.32 -175.11 2.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.731 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.78 168.45 39.64 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.492 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.533 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 91.3 t -85.11 143.05 12.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.784 0.326 . . . . 0.0 111.133 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -99.62 138.56 36.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.836 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.522 HD21 ' HA2' ' A' ' 71' ' ' GLY . 1.9 tm? -116.28 115.97 26.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.669 HG22 ' HG3' ' A' ' 70' ' ' GLU . 6.0 p -134.03 121.12 37.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.147 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.669 ' HG3' HG22 ' A' ' 69' ' ' VAL . 4.1 mt-10 58.92 23.65 11.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.522 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . 93.19 -24.56 24.43 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.509 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.575 HG22 ' HB ' ' A' ' 37' ' ' THR . 4.6 mp -82.73 114.62 23.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.857 0.36 . . . . 0.0 111.151 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.859 HD23 HG21 ' A' ' 43' ' ' VAL . 4.0 mm? -74.64 100.29 3.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.969 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.577 ' HA ' HG22 ' A' ' 37' ' ' THR . 6.4 t60 -76.96 136.48 38.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.845 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.553 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -85.36 159.67 55.68 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.582 0.706 . . . . 0.0 111.092 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.553 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.8 Cg_endo -70.02 -173.22 0.71 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.618 2.212 . . . . 0.0 112.317 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -77.32 -1.98 32.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.182 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.91 -32.95 8.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.108 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.17 -165.18 19.47 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.51 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.621 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 83.8 m95 -86.64 -59.55 2.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.868 0.366 . . . . 0.0 110.844 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.71 -164.37 32.81 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.491 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.68 36.73 4.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.851 0.358 . . . . 0.0 110.858 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.648 HD11 ' CD1' ' A' ' 55' ' ' TYR . 0.8 OUTLIER -91.87 -173.71 3.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.907 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.601 HG22 ' CG2' ' A' ' 20' ' ' THR . 42.9 t -101.12 136.69 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.121 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.665 ' CD2' HD13 ' A' ' 53' ' ' LEU . 4.4 p90 -101.33 139.59 36.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.943 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 54' ' ' ARG . 20.5 t -97.49 114.76 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.149 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.568 HG13 ' HG2' ' A' ' 21' ' ' GLU . 23.3 m -61.29 147.82 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.108 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -145.36 96.8 2.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.916 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 45.6 p90 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.933 -179.922 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.6 mmt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.747 0.308 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.71 153.05 37.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.092 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -137.87 -164.47 10.01 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.499 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.2 p -134.66 170.02 16.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.883 0.373 . . . . 0.0 110.836 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -158.25 158.17 33.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.913 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.33 162.6 37.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -129.34 174.7 9.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.95 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -137.15 132.5 34.07 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.859 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -151.49 117.67 5.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.784 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 23.3 m170 -74.8 166.07 24.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -163.66 -49.91 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.407 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.2 m -115.94 176.25 5.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.355 . . . . 0.0 110.845 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 18.4 ttt -85.42 128.62 34.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.7 t -61.01 135.01 57.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.791 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -103.38 147.45 27.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.856 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -102.31 160.7 14.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.991 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.763 HG23 HG13 ' A' ' 30' ' ' ILE . 5.1 tt -121.46 123.32 69.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.098 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -121.97 103.76 9.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.095 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.732 HG12 HD12 ' A' ' 83' ' ' LEU . 16.3 m -143.53 149.64 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.355 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.558 HG23 HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -121.18 151.13 40.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.145 179.746 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.411 ' CG ' HG13 ' A' ' 87' ' ' VAL . 0.5 OUTLIER -79.59 -49.97 11.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.951 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.28 139.49 37.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -65.67 -33.34 75.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.829 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -71.78 -26.51 62.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -78.31 -171.01 2.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.79 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.4 154.92 43.55 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.382 0.611 . . . . 0.0 111.273 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.87 126.15 12.9 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.806 2.338 . . . . 0.0 112.362 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.413 HD12 ' H ' ' A' ' 29' ' ' GLU . 3.7 tp -98.69 131.92 44.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.413 ' H ' HD12 ' A' ' 28' ' ' ILE . 16.1 pt-20 -99.03 123.12 43.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.724 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.763 HG13 HG23 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -127.02 159.67 63.5 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.614 0.721 . . . . 0.0 111.093 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 152.32 69.43 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.663 2.242 . . . . 0.0 112.374 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.658 ' HB2' HG22 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -141.98 163.37 33.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -68.34 161.56 27.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -67.09 -27.17 67.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.803 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.63 -18.9 65.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.799 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.04 -12.81 34.32 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.481 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.517 HG22 ' HA ' ' A' ' 74' ' ' HIS . 43.2 p -83.65 -172.42 4.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.853 0.359 . . . . 0.0 111.102 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.658 HG22 ' HB2' ' A' ' 32' ' ' SER . 45.0 t -137.66 119.23 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.089 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.3 tp -59.71 142.4 53.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.937 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 44' ' ' THR . 23.0 tp -59.0 -21.12 58.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.953 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.4 t -68.39 -34.69 76.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.947 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.8 m -80.57 -30.65 36.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.179 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.959 HG21 HD23 ' A' ' 73' ' ' LEU . 25.5 t -64.84 -36.43 77.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.032 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 40' ' ' LEU . 32.1 p -79.95 -15.46 57.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.537 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.74 -44.64 85.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.956 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -111.35 -23.59 10.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.003 0.43 . . . . 0.0 111.261 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -124.82 74.9 65.33 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.669 0.747 . . . . 0.0 110.896 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 131.52 21.41 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.627 2.218 . . . . 0.0 112.326 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.9 5.52 89.71 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.431 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.56 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -84.69 114.86 22.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.724 0.297 . . . . 0.0 111.059 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 2.5 t -91.64 -52.87 4.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.881 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.533 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -127.18 136.17 9.19 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.543 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.576 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.8 OUTLIER -115.65 137.56 51.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.052 0.453 . . . . 0.0 110.652 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -107.47 170.41 7.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.682 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.593 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 9.8 m-85 -108.0 126.37 52.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.957 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -128.68 122.22 30.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -138.99 118.8 9.44 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.544 0.687 . . . . 0.0 110.877 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.74 -28.51 25.26 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.657 2.238 . . . . 0.0 112.366 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.6 m -86.37 -29.4 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.176 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.8 m -87.69 -27.75 22.23 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.991 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 59.82 24.87 13.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.023 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -98.37 168.7 10.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.958 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 13.3 mtt -129.85 33.6 4.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.669 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.8 ttt85 -57.32 179.51 0.05 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.698 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.83 147.35 16.58 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.613 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.593 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 50.5 t -72.36 134.95 28.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.849 0.357 . . . . 0.0 111.11 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.458 ' HE ' HG23 ' A' ' 69' ' ' VAL . 4.4 tpt180 -77.2 138.77 39.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.867 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.504 ' C ' HD13 ' A' ' 68' ' ' LEU . 3.3 tm? -116.38 107.56 14.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.458 HG23 ' HE ' ' A' ' 67' ' ' ARG . 15.1 t -115.77 105.96 19.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.19 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 50.52 40.19 22.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.436 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . 90.31 -25.9 11.55 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.537 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.461 HG22 ' HB ' ' A' ' 37' ' ' THR . 2.7 mp -78.18 110.38 13.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.842 0.353 . . . . 0.0 111.116 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.959 HD23 HG21 ' A' ' 43' ' ' VAL . 4.1 mm? -73.93 102.97 4.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.517 ' HA ' HG22 ' A' ' 37' ' ' THR . 6.6 t60 -83.61 136.25 34.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.809 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.649 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -84.4 160.15 57.4 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.594 0.711 . . . . 0.0 111.108 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.569 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.2 Cg_endo -69.95 -171.85 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.711 2.274 . . . . 0.0 112.302 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.12 -2.32 33.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.294 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.86 -30.95 8.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.125 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.86 -165.73 14.7 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.441 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.649 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 95.4 m95 -86.59 -59.18 2.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.807 0.337 . . . . 0.0 110.936 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.2 -167.13 48.96 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.456 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -117.88 38.81 3.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.896 0.379 . . . . 0.0 110.862 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.732 HD12 HG12 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -87.22 -175.33 5.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.993 179.884 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.558 HG22 HG23 ' A' ' 20' ' ' THR . 39.6 t -106.71 134.33 48.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.102 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.576 ' CE2' HD12 ' A' ' 53' ' ' LEU . 3.7 p90 -100.75 146.03 27.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 63.4 t -106.47 112.77 40.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.089 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.411 HG13 ' CG ' ' A' ' 21' ' ' GLU . 4.7 m -53.87 143.73 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.135 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -145.13 105.68 4.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.915 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.817 0.341 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.13 126.8 3.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.155 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -172.96 66.29 0.12 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.453 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.4 p -158.64 -48.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.959 0.409 . . . . 0.0 110.84 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.5 m80 -71.04 146.92 49.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 57.28 93.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -60.04 148.8 34.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -119.27 112.55 19.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -151.95 155.08 37.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -129.28 141.87 50.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.857 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.56 112.77 0.46 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.481 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 93.7 p -174.8 121.69 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.816 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.4 ptt? -139.95 147.53 40.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.891 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.4 p -175.59 158.93 2.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.818 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -84.75 156.99 21.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -116.18 163.7 15.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.86 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.735 HG23 HG13 ' A' ' 30' ' ' ILE . 7.0 tt -126.95 121.28 57.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.024 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -119.32 101.53 8.04 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.231 0.539 . . . . 0.0 110.442 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.595 HG12 ' CD2' ' A' ' 83' ' ' LEU . 6.7 m -139.77 159.84 27.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.062 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.19 156.95 47.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.155 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.429 ' OE2' HG22 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -83.7 -57.87 3.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.28 164.26 14.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -85.35 -28.5 25.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.099 0.476 . . . . 0.0 111.287 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -70.05 -44.42 69.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.839 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -65.02 -170.57 0.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.841 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -116.96 160.53 36.61 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.383 0.611 . . . . 0.0 111.297 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.94 106.45 1.7 Allowed 'Trans proline' 0 C--O 1.23 0.109 0 C-N-CA 122.664 2.243 . . . . 0.0 112.255 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.477 HD12 ' H ' ' A' ' 29' ' ' GLU . 5.0 tp -74.65 138.5 20.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.929 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.477 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -101.02 118.62 37.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.732 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.735 HG13 HG23 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -123.44 159.22 56.02 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.594 0.711 . . . . 0.0 111.174 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.42 ' O ' HG21 ' A' ' 42' ' ' THR . 54.2 Cg_endo -69.79 162.46 42.0 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.727 2.285 . . . . 0.0 112.338 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.593 ' HB2' HG22 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -149.55 175.4 11.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -75.11 178.83 5.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.843 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -81.47 -34.5 31.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.047 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.5 -29.94 70.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.105 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 121.47 16.67 4.15 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.601 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.651 HG22 ' HA ' ' A' ' 74' ' ' HIS . 52.4 p -111.18 178.84 4.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.851 0.358 . . . . 0.0 111.166 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.649 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 73.3 t -133.75 106.04 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.086 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.63 144.18 22.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.001 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.542 HD12 ' HA3' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -50.23 -31.25 13.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.946 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.0 p -52.81 -45.13 67.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.913 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.42 HG21 ' O ' ' A' ' 31' ' ' PRO . 14.4 m -75.39 -30.92 60.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.123 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.962 HG21 HD23 ' A' ' 73' ' ' LEU . 40.3 t -66.92 -43.14 89.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.986 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.2 p -74.42 -6.34 47.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.501 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.53 -46.62 63.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.949 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -114.85 -23.34 9.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.314 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -119.2 74.93 15.03 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.601 0.715 . . . . 0.0 110.852 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 130.25 19.06 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.706 2.271 . . . . 0.0 112.307 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.34 3.76 89.85 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.446 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.605 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -83.9 118.91 24.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.782 0.325 . . . . 0.0 111.077 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.3 m -100.51 -58.14 1.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.91 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.564 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -117.75 130.17 8.65 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.514 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.666 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.5 OUTLIER -114.5 140.96 48.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.93 0.395 . . . . 0.0 110.738 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.42 176.09 5.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.83 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.427 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 10.4 m-85 -111.73 134.69 53.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.932 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -144.31 117.93 9.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -177.99 148.51 0.66 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.734 0.778 . . . . 0.0 110.887 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -46.84 1.09 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.642 2.228 . . . . 0.0 112.362 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.1 m -64.65 -18.26 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.181 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.1 t -68.73 -40.42 79.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.105 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 62.18 25.35 15.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.097 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.72 164.46 33.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 14.8 ttt -115.77 36.33 4.05 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.076 0.465 . . . . 0.0 110.801 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.01 173.42 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.723 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -145.64 131.52 4.2 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.414 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.456 HG12 HD12 ' A' ' 73' ' ' LEU . 27.3 t -54.5 128.77 14.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.819 0.343 . . . . 0.0 111.152 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -77.91 149.77 34.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 69' ' ' VAL . 2.7 tm? -127.61 126.37 41.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.936 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.507 HG22 ' HG2' ' A' ' 70' ' ' GLU . 6.9 p -149.01 123.42 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.172 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.507 ' HG2' HG22 ' A' ' 69' ' ' VAL . 72.8 mm-40 58.11 22.81 9.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.877 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.542 ' HA3' HD12 ' A' ' 40' ' ' LEU . . . 88.91 -14.63 59.87 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.526 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.524 HG22 ' HB ' ' A' ' 37' ' ' THR . 2.0 mp -92.94 110.37 22.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.808 0.337 . . . . 0.0 111.131 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.962 HD23 HG21 ' A' ' 43' ' ' VAL . 4.2 mm? -66.18 121.67 15.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.998 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.651 ' HA ' HG22 ' A' ' 37' ' ' THR . 2.8 t60 -93.42 126.56 38.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.597 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -67.81 160.48 73.28 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.587 0.708 . . . . 0.0 111.195 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.597 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.1 Cg_endo -69.94 -170.92 0.44 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.69 2.26 . . . . 0.0 112.331 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.12 53.48 2.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.278 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -173.79 -40.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.837 0.351 . . . . 0.0 111.136 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.68 -176.03 21.73 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.439 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.649 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 90.9 m95 -76.09 -74.96 0.2 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.743 0.306 . . . . 0.0 110.91 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.27 -161.78 24.44 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.476 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.573 ' C ' HD13 ' A' ' 83' ' ' LEU . 2.2 m-20 -127.0 95.81 4.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 110.96 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.629 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -151.26 -176.23 5.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.986 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.8 p -101.65 127.83 54.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.128 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.666 ' CE2' HD12 ' A' ' 53' ' ' LEU . 3.4 p90 -98.62 156.25 16.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.921 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.8 t -113.14 122.37 67.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.203 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.429 HG22 ' OE2' ' A' ' 21' ' ' GLU . 27.9 m -66.54 150.81 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.161 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -144.51 92.14 2.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 44.4 p90 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.954 -179.885 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.769 0.319 . . . . 0.0 110.815 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.74 -178.88 6.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.6 160.59 19.42 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.553 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.2 t -69.88 108.98 4.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.919 0.39 . . . . 0.0 110.816 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -86.42 -26.49 24.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.07 173.97 6.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.807 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -122.79 165.9 15.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.96 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 26.3 p-80 -127.26 136.9 52.63 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.969 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -102.95 163.25 12.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.685 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -84.07 -41.5 17.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.59 113.89 0.51 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.518 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.7 p -145.61 140.49 27.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.819 0.342 . . . . 0.0 110.863 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.59 161.4 12.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.805 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.7 p -145.51 142.09 28.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.842 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -85.91 -174.54 5.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -134.35 160.95 36.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.956 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.753 HG23 HG13 ' A' ' 30' ' ' ILE . 6.1 tt -118.14 123.28 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.105 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.43 103.82 10.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.09 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.416 ' O ' HG22 ' A' ' 28' ' ' ILE . 12.4 m -147.49 150.79 14.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.409 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.698 ' CG2' HG22 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -121.06 155.83 33.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.195 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -71.28 -48.32 51.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.1 170.85 8.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.923 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -87.18 -24.52 24.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.207 0.527 . . . . 0.0 111.447 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -66.15 -26.29 67.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.836 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -96.68 -171.42 2.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.809 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -108.72 159.36 31.23 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.343 0.592 . . . . 0.0 111.309 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.96 124.63 11.18 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.671 2.247 . . . . 0.0 112.367 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.484 HD12 ' H ' ' A' ' 29' ' ' GLU . 4.6 tp -92.83 137.41 22.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.897 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.484 ' H ' HD12 ' A' ' 28' ' ' ILE . 1.4 pp20? -99.31 122.02 41.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.731 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.753 HG13 HG23 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -126.82 159.9 61.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.616 0.722 . . . . 0.0 111.11 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 142.55 48.39 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.731 2.287 . . . . 0.0 112.361 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.543 ' HB2' HG22 ' A' ' 38' ' ' VAL . 6.3 p -131.63 168.45 17.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.835 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -72.31 156.7 38.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -64.87 -30.49 71.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -67.01 -19.46 65.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.63 -16.35 16.64 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.469 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.578 ' HB ' HG22 ' A' ' 72' ' ' ILE . 30.6 p -81.54 -172.84 4.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.362 . . . . 0.0 111.134 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.6 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 55.9 t -140.74 120.45 12.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.1 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.8 mt -58.7 144.0 44.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.762 HD12 ' CA ' ' A' ' 71' ' ' GLY . 1.6 tt -61.23 -21.99 64.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.944 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.8 m -65.61 -37.65 87.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.7 m -77.51 -30.43 52.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.15 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.728 HG21 HD23 ' A' ' 73' ' ' LEU . 25.6 t -65.58 -37.71 80.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.048 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 40' ' ' LEU . 33.8 p -78.19 -15.32 58.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.614 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.02 -45.98 83.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.887 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -111.94 -16.96 13.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.969 0.414 . . . . 0.0 111.223 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -132.39 75.22 74.48 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.62 0.724 . . . . 0.0 110.887 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 127.54 14.73 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.737 2.291 . . . . 0.0 112.323 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.7 -15.89 59.39 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.538 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.517 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -62.35 110.18 1.57 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.697 0.284 . . . . 0.0 111.096 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.7 t -92.87 -42.86 9.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.187 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.686 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -129.43 137.29 9.47 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.406 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.792 HD12 ' CE1' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -120.27 133.34 55.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.988 0.423 . . . . 0.0 110.707 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -107.02 171.91 7.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.71 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -107.99 125.75 51.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.918 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -129.22 104.22 7.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.499 ' OD1' HD12 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -122.36 117.41 29.23 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.615 0.721 . . . . 0.0 110.88 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 -27.09 27.24 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.695 2.263 . . . . 0.0 112.371 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.7 m -86.17 -29.4 6.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.131 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.1 m -88.88 -27.31 21.1 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.009 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 59.39 25.85 14.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.039 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.8 m -94.1 176.15 6.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 23.7 mtp -135.2 29.37 3.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.923 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -60.4 -174.61 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.755 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.3 143.18 8.25 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.526 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.78 143.14 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.839 0.352 . . . . 0.0 111.087 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -90.63 130.72 36.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.497 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.8 tm? -110.93 114.54 27.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.69 HG22 ' HG2' ' A' ' 70' ' ' GLU . 7.7 p -137.82 124.68 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.125 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.69 ' HG2' HG22 ' A' ' 69' ' ' VAL . 5.3 mm-40 57.17 22.77 7.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.762 ' CA ' HD12 ' A' ' 40' ' ' LEU . . . 91.97 -24.94 18.87 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.501 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.578 HG22 ' HB ' ' A' ' 37' ' ' THR . 3.3 mp -83.05 121.05 35.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.816 0.341 . . . . 0.0 111.176 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.728 HD23 HG21 ' A' ' 43' ' ' VAL . 3.9 mm? -80.13 109.85 14.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.913 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.55 ' HA ' HG22 ' A' ' 37' ' ' THR . 6.0 t60 -86.76 135.54 33.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.596 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -84.09 159.85 58.87 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.543 0.687 . . . . 0.0 111.199 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.562 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.6 Cg_endo -69.84 -172.26 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.72 2.28 . . . . 0.0 112.376 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -76.98 -2.49 34.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.253 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.92 -29.09 9.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.21 -168.07 14.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.527 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.6 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 93.8 m95 -82.78 -59.23 2.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.809 0.338 . . . . 0.0 110.875 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.35 -166.61 32.06 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.492 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -127.91 38.28 4.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 0.0 110.9 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.692 ' H ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.55 -175.73 3.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.698 HG22 ' CG2' ' A' ' 20' ' ' THR . 48.2 t -94.64 146.92 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.792 ' CE1' HD12 ' A' ' 53' ' ' LEU . 3.4 p90 -116.9 146.15 43.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.976 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 88.8 t -96.41 130.18 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.113 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.51 HG22 ' CE1' ' A' ' 85' ' ' TYR . 2.1 t -85.16 133.08 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.084 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -145.39 136.17 24.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.883 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.975 -179.943 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.841 0.353 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.54 123.56 25.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.108 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 157.12 -84.96 0.13 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.511 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.3 p -80.44 121.18 25.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.866 0.365 . . . . 0.0 110.892 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -113.77 118.0 33.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -85.55 136.81 33.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.841 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -123.85 115.56 21.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.907 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -92.45 -27.04 17.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 59.1 42.08 19.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.85 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -149.49 164.52 34.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.6 140.34 45.8 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.451 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -136.47 162.51 32.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.9 0.381 . . . . 0.0 110.858 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 mpp? -112.45 26.07 10.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.838 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.6 t -66.99 -69.71 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -148.24 130.07 15.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.88 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -86.22 162.61 18.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.4 ' CG2' HG13 ' A' ' 30' ' ' ILE . 2.6 tt -115.54 125.51 72.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.153 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -120.64 104.99 10.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.01 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.543 HG12 HD23 ' A' ' 83' ' ' LEU . 16.1 m -148.74 148.01 16.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.325 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.59 HG23 HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -122.46 153.81 38.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.11 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.9 -49.73 23.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -115.4 144.17 44.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -63.89 -25.27 68.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -72.5 -26.71 61.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -88.93 172.3 9.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.825 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -89.92 153.34 47.24 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.658 0.742 . . . . 0.0 110.864 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.425 ' HA ' ' HB ' ' A' ' 20' ' ' THR . 53.3 Cg_endo -69.79 116.44 4.57 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.697 2.264 . . . . 0.0 112.284 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.537 HD13 ' HG3' ' A' ' 46' ' ' GLN . 1.0 OUTLIER -72.12 162.48 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.119 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.431 ' N ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -136.77 111.66 8.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.437 HD12 HG22 ' A' ' 42' ' ' THR . 6.7 pt -126.79 155.6 75.02 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.648 0.737 . . . . 0.0 111.076 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 145.6 57.51 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.631 2.221 . . . . 0.0 112.319 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.477 ' HB2' HG22 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -119.68 171.45 8.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -67.62 -179.32 1.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -73.24 -43.56 60.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.986 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -65.33 -17.04 64.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.855 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.17 -24.57 9.23 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.536 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.609 HG22 ' HA ' ' A' ' 74' ' ' HIS . 43.6 p -61.78 -173.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.801 0.334 . . . . 0.0 111.166 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.601 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 47.1 t -137.21 122.13 24.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.5 tp -61.12 146.57 46.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.682 HD13 ' O ' ' A' ' 40' ' ' LEU . 2.6 tm? -62.34 -34.24 76.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.851 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.5 t -60.91 -27.89 68.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.796 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.437 HG22 HD12 ' A' ' 30' ' ' ILE . 8.8 m -87.35 -26.65 23.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.101 0.477 . . . . 0.0 111.549 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.848 HG21 HD23 ' A' ' 73' ' ' LEU . 12.2 t -66.87 -40.06 84.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.061 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.2 p -71.91 -13.58 61.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.169 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.98 -48.49 81.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.537 ' HG3' HD13 ' A' ' 28' ' ' ILE . 66.7 mm-40 -112.36 -19.14 12.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.298 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -125.44 74.96 69.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.623 0.725 . . . . 0.0 110.901 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 136.28 32.8 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.703 2.269 . . . . 0.0 112.343 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.71 6.44 66.89 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.487 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.52 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -83.52 123.01 29.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.722 0.296 . . . . 0.0 111.134 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.1 m -101.07 -52.88 3.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.893 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.577 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -122.35 132.69 8.91 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.458 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.631 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -115.24 138.25 51.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.948 0.404 . . . . 0.0 110.759 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -107.51 171.28 7.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.648 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.639 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 10.9 m-85 -110.34 126.39 54.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -128.78 108.74 10.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.7 114.79 26.84 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.607 0.717 . . . . 0.0 110.859 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -26.12 27.79 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.659 2.24 . . . . 0.0 112.326 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.2 m -86.34 -30.4 6.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.2 t -86.18 -27.11 24.75 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.031 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 61.64 26.04 15.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.061 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 63.0 m -101.04 176.27 5.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.8 ptt? -135.75 40.41 2.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -174.33 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.701 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.79 134.78 3.63 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.464 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.639 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 21.3 t -59.11 136.1 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.811 0.339 . . . . 0.0 111.166 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -84.07 138.41 33.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.931 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.487 HD22 ' N ' ' A' ' 69' ' ' VAL . 2.6 tm? -119.98 124.21 45.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.954 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.613 HG22 ' HG2' ' A' ' 70' ' ' GLU . 6.2 p -147.32 121.84 2.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.165 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.613 ' HG2' HG22 ' A' ' 69' ' ' VAL . 8.5 mm-40 58.36 22.52 9.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.872 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.72 -24.78 22.16 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.491 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.528 HG22 ' HB ' ' A' ' 37' ' ' THR . 3.9 mt -82.54 115.69 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.794 0.331 . . . . 0.0 111.134 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.848 HD23 HG21 ' A' ' 43' ' ' VAL . 4.2 mm? -75.69 111.62 11.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.966 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.609 ' HA ' HG22 ' A' ' 37' ' ' THR . 6.7 t60 -86.45 135.97 33.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.614 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -84.84 160.07 56.38 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.589 0.709 . . . . 0.0 111.135 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.559 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.6 Cg_endo -70.0 -173.37 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.702 2.268 . . . . 0.0 112.35 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.3 -2.41 34.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.3 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.78 -28.69 9.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.136 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.78 -169.23 13.78 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.444 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.614 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 98.0 m95 -82.87 -58.79 2.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.851 0.358 . . . . 0.0 110.935 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.04 -160.91 34.1 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.43 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -127.36 37.19 4.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.821 0.343 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.543 HD23 HG12 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -91.57 -175.71 4.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.914 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.59 HG22 HG23 ' A' ' 20' ' ' THR . 47.0 t -100.04 140.07 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.631 ' CE2' HD12 ' A' ' 53' ' ' LEU . 2.9 p90 -105.62 146.12 30.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.011 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 87.4 t -103.92 124.91 58.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.107 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.0 t -69.83 147.39 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.147 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -145.21 96.71 2.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.95 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.913 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.5 ttp . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.723 0.297 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.75 -67.9 0.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 132.53 -140.28 11.68 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.521 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.3 t -61.35 161.14 9.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.932 0.396 . . . . 0.0 110.866 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -85.98 -26.69 25.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.865 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -52.15 161.05 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.829 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -62.17 149.39 41.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.838 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -91.02 -25.93 19.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -58.15 114.97 2.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.831 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -115.19 26.05 10.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.836 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.16 141.37 37.49 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.503 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.2 p -132.82 171.05 14.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 0.0 110.85 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 10.8 ptm -52.63 137.57 30.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.807 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.8 p -151.5 153.39 34.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -96.76 132.71 42.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -86.53 172.42 10.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.752 HG23 HG13 ' A' ' 30' ' ' ILE . 6.1 tt -119.48 122.95 70.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.222 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.2 103.84 10.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.107 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.462 ' O ' HG22 ' A' ' 28' ' ' ILE . 6.7 m -147.61 153.18 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.33 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.581 ' CG2' HG22 ' A' ' 84' ' ' VAL . 0.6 OUTLIER -126.77 149.78 49.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.067 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.51 -50.0 15.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -101.88 149.66 23.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -75.32 -31.5 60.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.139 0.495 . . . . 0.0 111.215 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -66.93 -26.69 66.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.89 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -87.46 -175.92 5.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.88 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -107.27 159.69 29.2 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.374 0.606 . . . . 0.0 111.304 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.92 118.98 6.0 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.686 2.257 . . . . 0.0 112.386 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.859 HD11 HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -85.27 143.52 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.156 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.69 121.28 43.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.89 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.859 HG23 HD11 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -127.1 159.95 62.19 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.71 . . . . 0.0 111.213 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 148.84 65.79 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.658 2.239 . . . . 0.0 112.326 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.548 ' HB3' HG22 ' A' ' 38' ' ' VAL . 1.3 m -140.35 168.41 19.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.889 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -75.71 158.34 32.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -65.82 -29.61 70.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.856 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -65.28 -19.42 65.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.885 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 113.4 -14.26 23.0 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.466 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.489 ' HB ' HG22 ' A' ' 72' ' ' ILE . 22.3 p -85.24 -176.77 6.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.761 0.315 . . . . 0.0 111.222 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.622 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 70.0 t -138.23 122.57 21.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.176 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 30.3 mt -58.88 146.77 36.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.4 ' O ' HG23 ' A' ' 44' ' ' THR . 22.6 tp -62.76 -23.25 67.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.952 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.8 t -65.1 -33.51 76.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.934 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.2 m -82.9 -29.64 29.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.199 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.839 HG21 HD23 ' A' ' 73' ' ' LEU . 40.0 t -66.99 -40.96 86.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.985 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 40' ' ' LEU . 30.8 p -76.88 -14.81 59.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.533 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.79 -47.77 79.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.915 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -112.12 -20.34 11.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.998 0.428 . . . . 0.0 111.325 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -124.38 75.4 61.53 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.639 0.733 . . . . 0.0 110.857 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 131.91 22.22 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.72 2.28 . . . . 0.0 112.339 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.17 6.33 89.25 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.524 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.708 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -86.81 107.76 18.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.78 0.324 . . . . 0.0 111.094 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.5 t -93.72 -52.93 4.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.554 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -118.9 129.12 7.97 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.477 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.708 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -115.69 136.85 52.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.02 0.438 . . . . 0.0 110.65 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.7 ttm-85 -107.39 171.17 7.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.779 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -105.96 126.34 52.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.91 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -128.43 103.62 7.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.478 ' OD1' HD12 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -125.8 115.29 24.58 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.703 0.764 . . . . 0.0 110.863 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -25.78 28.2 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.623 2.215 . . . . 0.0 112.365 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.4 m -86.4 -29.75 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.18 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.0 m -88.15 -27.16 22.05 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.107 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 60.36 26.22 15.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.097 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.4 t -96.86 167.14 11.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.875 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -126.93 25.57 6.27 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.704 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.5 ttt-85 -58.06 179.28 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.785 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.09 142.48 8.12 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.524 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.23 142.57 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.889 0.376 . . . . 0.0 111.132 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -91.21 138.54 31.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.775 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.476 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.4 tm? -116.15 117.13 29.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.641 HG22 ' HG3' ' A' ' 70' ' ' GLU . 6.2 p -138.07 122.18 21.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.123 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.641 ' HG3' HG22 ' A' ' 69' ' ' VAL . 5.2 mt-10 57.65 22.64 8.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.424 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . 92.65 -24.8 21.83 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.538 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.489 HG22 ' HB ' ' A' ' 37' ' ' THR . 3.4 mt -82.53 112.79 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.822 0.344 . . . . 0.0 111.127 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.839 HD23 HG21 ' A' ' 43' ' ' VAL . 4.2 mm? -73.18 111.22 8.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.473 ' HA ' HG22 ' A' ' 37' ' ' THR . 5.6 t60 -84.65 135.58 34.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.557 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -88.83 159.74 45.33 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.516 0.674 . . . . 0.0 111.174 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.557 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.5 Cg_endo -69.92 -173.12 0.68 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.698 2.266 . . . . 0.0 112.387 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -77.28 -2.12 33.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.272 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.13 -30.27 8.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.101 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.55 -164.69 15.47 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.521 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.622 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 95.1 m95 -85.64 -59.54 2.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.807 0.337 . . . . 0.0 110.918 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.16 -165.63 30.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.585 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -128.44 38.5 3.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.873 0.368 . . . . 0.0 110.908 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.704 ' H ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.42 -175.66 3.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.919 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.581 HG22 ' CG2' ' A' ' 20' ' ' THR . 45.6 t -95.43 140.39 17.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.162 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.618 ' CE2' HD12 ' A' ' 53' ' ' LEU . 7.2 p90 -109.9 145.46 36.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.979 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.3 t -101.28 119.77 49.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.051 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.2 m -66.63 150.98 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.092 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -145.06 102.5 3.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 -179.915 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 tpt . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.723 0.297 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.79 176.74 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.097 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -156.03 -150.39 5.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.528 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 t -137.35 152.05 49.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.905 0.384 . . . . 0.0 110.869 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -115.6 156.57 25.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.869 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -112.34 152.29 28.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.821 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -138.16 148.18 44.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.905 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -110.86 156.55 20.99 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.697 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -81.39 159.87 24.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.673 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 26.7 p80 -104.71 -30.0 10.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.856 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -53.66 166.7 1.75 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.455 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.1 t -76.14 158.27 31.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 110.919 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.8 ptp -85.91 154.27 21.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 94.3 p -103.48 159.86 15.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.85 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -93.09 -176.15 4.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -134.1 165.17 25.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.984 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.716 HG23 HG13 ' A' ' 30' ' ' ILE . 6.3 tt -121.2 123.29 69.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.149 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.21 103.89 10.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.45 ' O ' HG22 ' A' ' 28' ' ' ILE . 9.6 m -147.49 150.17 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.262 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.421 HG23 HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -124.12 148.92 46.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.197 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -72.56 -49.56 31.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -114.49 139.55 49.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.858 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.69 -18.27 58.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -73.87 -26.57 60.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.67 137.42 41.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.902 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -58.32 159.85 10.73 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.589 0.709 . . . . 0.0 110.925 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.405 ' HA ' ' HB ' ' A' ' 20' ' ' THR . 54.3 Cg_endo -69.68 124.27 10.94 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.612 2.208 . . . . 0.0 112.339 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.871 HD11 HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -85.34 143.53 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.144 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -105.89 121.45 44.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.871 HG23 HD11 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -127.15 159.6 64.14 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.611 0.72 . . . . 0.0 111.124 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 153.72 68.77 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.675 2.25 . . . . 0.0 112.373 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.579 ' HB2' HG22 ' A' ' 38' ' ' VAL . 1.1 p -142.25 162.4 35.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.818 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -68.9 159.59 32.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -65.65 -26.41 67.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -68.93 -19.38 64.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 113.08 -16.13 22.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.48 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.6 HG22 ' HA ' ' A' ' 74' ' ' HIS . 38.7 p -82.23 -172.44 3.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.815 0.34 . . . . 0.0 111.162 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.624 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 67.9 t -139.39 119.08 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.119 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.43 148.54 27.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.744 HD12 ' CA ' ' A' ' 71' ' ' GLY . 1.7 tt -63.02 -23.08 67.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.922 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.8 p -65.22 -36.41 84.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.2 m -80.13 -27.93 39.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.119 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.914 HG21 HD23 ' A' ' 73' ' ' LEU . 41.2 t -67.89 -42.03 85.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.027 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.546 HG23 HD23 ' A' ' 40' ' ' LEU . 30.1 p -76.12 -14.62 60.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.567 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.16 -48.0 77.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.902 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -112.13 -17.4 12.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.335 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -127.88 75.49 78.17 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.564 0.697 . . . . 0.0 110.853 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.78 131.44 21.22 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.701 2.267 . . . . 0.0 112.33 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.48 6.27 89.39 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.531 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.638 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -88.17 107.01 18.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.826 0.346 . . . . 0.0 111.099 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.6 t -91.78 -53.07 4.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.874 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.583 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -119.34 130.74 8.67 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.514 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.638 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -115.28 139.74 49.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.082 0.468 . . . . 0.0 110.664 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.39 171.07 7.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.751 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -106.14 126.81 52.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.921 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -125.5 103.75 8.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.808 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.454 ' OD1' HD12 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -132.44 105.32 13.26 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.597 0.713 . . . . 0.0 110.94 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 57' ' ' ASN . 53.7 Cg_endo -69.66 -21.31 34.13 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.696 2.264 . . . . 0.0 112.405 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.6 m -86.64 -16.65 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.128 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 62.0 m -89.64 -27.06 20.42 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.041 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 62.17 32.78 17.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.114 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 37.5 m -131.42 -177.14 4.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.861 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -139.44 98.57 3.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.197 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.59 -174.2 2.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.817 0.341 . . . . 0.0 110.901 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.26 142.84 8.15 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.499 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.9 t -68.31 144.2 14.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 0.0 111.188 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -90.03 138.94 31.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.465 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.2 tm? -122.23 116.48 24.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.887 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.581 HG22 ' HG2' ' A' ' 70' ' ' GLU . 7.0 p -137.82 123.47 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.174 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.581 ' HG2' HG22 ' A' ' 69' ' ' VAL . 29.5 mm-40 58.6 22.75 10.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.817 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.744 ' CA ' HD12 ' A' ' 40' ' ' LEU . . . 92.47 -24.99 20.29 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.529 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.549 HG22 ' HB ' ' A' ' 37' ' ' THR . 3.8 mp -82.01 115.34 24.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.841 0.353 . . . . 0.0 111.146 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.914 HD23 HG21 ' A' ' 43' ' ' VAL . 4.1 mm? -74.23 108.75 7.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.948 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.6 ' HA ' HG22 ' A' ' 37' ' ' THR . 6.3 t60 -85.9 135.76 33.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.568 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -84.22 159.74 58.75 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.604 0.716 . . . . 0.0 111.054 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.556 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.8 Cg_endo -70.0 -172.88 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.677 2.251 . . . . 0.0 112.286 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -77.17 -2.0 32.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.301 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.38 -30.45 8.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.108 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.16 -169.21 16.24 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.505 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.624 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 77.4 m95 -81.24 -59.29 2.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.792 0.33 . . . . 0.0 110.895 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.71 -170.14 36.31 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.473 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -127.1 38.51 4.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.863 0.363 . . . . 0.0 110.901 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.699 ' H ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.25 -175.0 3.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.982 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.421 HG22 HG23 ' A' ' 20' ' ' THR . 20.6 t -94.61 145.2 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.129 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.556 ' CE2' HD12 ' A' ' 53' ' ' LEU . 5.9 p90 -116.14 146.05 42.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.988 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 99.0 t -101.44 120.91 51.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.103 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.2 m -67.48 148.98 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -145.01 107.07 4.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.93 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.895 -179.886 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 mtt . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.797 0.332 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.3 160.27 11.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.104 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.83 -72.16 1.24 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.479 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 p -82.72 172.73 12.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.886 0.374 . . . . 0.0 110.874 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -83.14 110.92 18.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.819 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.9 m170 -79.37 120.47 23.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.851 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -88.76 -53.87 4.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.739 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -154.93 139.09 16.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.756 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -141.5 155.44 45.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.744 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -61.66 -37.08 82.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -54.62 149.12 20.47 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.543 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.0 t -116.29 120.44 38.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.892 0.377 . . . . 0.0 110.88 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.3 ptm -92.81 -29.01 16.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.901 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 87.6 p -63.01 117.09 5.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.839 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -92.15 145.83 24.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.919 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -89.8 174.1 7.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.959 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.73 HG23 HG13 ' A' ' 30' ' ' ILE . 5.5 tt -120.14 123.39 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.138 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.95 104.41 10.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.112 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.585 HG12 HD12 ' A' ' 83' ' ' LEU . 5.9 m -144.96 157.42 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.367 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . 1.083 HG23 HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -138.61 146.67 42.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.173 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.428 ' CG ' HG13 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -74.22 -50.12 20.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.842 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -102.42 137.52 40.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -69.49 -26.63 64.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -66.55 -26.33 67.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -91.74 -174.61 3.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.99 154.95 37.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.64 0.733 . . . . 0.0 110.907 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 110.84 2.66 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.738 2.292 . . . . 0.0 112.27 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.879 HD11 HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -72.18 144.2 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.189 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.21 122.26 46.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.862 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.879 HG23 HD11 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -127.32 159.98 62.5 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.624 0.725 . . . . 0.0 111.153 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.424 ' O ' HG21 ' A' ' 42' ' ' THR . 53.6 Cg_endo -69.74 147.95 64.11 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.717 2.278 . . . . 0.0 112.347 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.518 ' HB3' HG22 ' A' ' 38' ' ' VAL . 1.1 m -139.42 163.62 32.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -67.1 164.75 17.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.839 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -71.58 -28.07 63.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.897 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -68.44 -19.29 64.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.855 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.14 -14.43 21.24 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.452 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.41 ' HB ' HG22 ' A' ' 72' ' ' ILE . 18.0 p -82.93 -177.55 6.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.814 0.34 . . . . 0.0 111.111 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.602 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 57.5 t -138.09 125.81 29.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.124 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 tp -63.44 146.2 54.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.9 tp -61.52 -27.96 68.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.4 m -64.02 -30.13 71.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.795 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 31' ' ' PRO . 16.5 m -84.48 -24.71 29.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.51 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.669 HG21 HD23 ' A' ' 73' ' ' LEU . 38.7 t -72.54 -50.13 36.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.112 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.5 p -67.69 -13.78 62.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.183 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.49 -47.81 80.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.96 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -112.17 -8.8 13.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.233 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -138.35 75.9 38.5 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.621 0.724 . . . . 0.0 110.834 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.87 127.04 13.95 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.613 2.208 . . . . 0.0 112.345 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.18 -16.4 57.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.498 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.633 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -67.95 98.11 0.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.712 0.292 . . . . 0.0 111.13 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 t -84.41 -52.64 6.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.946 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.598 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -115.01 129.71 8.77 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.465 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.633 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -115.07 134.81 54.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.072 0.463 . . . . 0.0 110.683 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -108.88 167.68 9.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.709 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.645 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 9.9 m-85 -104.77 125.98 51.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.964 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.693 ' HB3' HG23 ' A' ' 84' ' ' VAL . 19.7 tpt180 -129.32 109.07 10.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.94 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.489 ' ND2' HG22 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -132.46 109.32 13.51 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.613 0.721 . . . . 0.0 110.912 -179.885 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 57' ' ' ASN . 53.7 Cg_endo -69.78 -22.5 31.9 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.699 2.266 . . . . 0.0 112.29 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.489 HG22 ' ND2' ' A' ' 57' ' ' ASN . 18.6 m -86.31 -18.78 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.6 m -92.52 -24.99 18.59 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.991 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 60.62 22.14 11.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.007 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -111.83 -177.41 3.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.84 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -144.3 94.55 2.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.087 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.14 -175.02 2.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.897 0.379 . . . . 0.0 110.834 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.34 133.62 3.43 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.504 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.645 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 41.5 t -61.65 135.53 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 111.192 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -81.22 138.77 35.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.861 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.5 HD22 ' N ' ' A' ' 69' ' ' VAL . 2.4 tm? -120.17 122.37 40.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.951 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.67 HG22 ' HG2' ' A' ' 70' ' ' GLU . 6.1 p -145.72 121.36 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.67 ' HG2' HG22 ' A' ' 69' ' ' VAL . 29.7 mm-40 58.01 22.86 9.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.19 -25.17 18.62 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.482 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.41 HG22 ' HB ' ' A' ' 37' ' ' THR . 3.3 mt -82.03 112.64 20.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.805 0.336 . . . . 0.0 111.212 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.669 HD23 HG21 ' A' ' 43' ' ' VAL . 4.2 mm? -73.88 120.0 18.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -92.32 135.59 33.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.558 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -87.65 159.74 48.86 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.487 0.66 . . . . 0.0 111.201 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.558 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.2 Cg_endo -69.98 -173.43 0.75 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.644 2.229 . . . . 0.0 112.332 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -77.07 -2.56 34.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.263 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.72 -28.4 9.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.118 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.56 -169.11 13.66 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.51 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.602 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 97.4 m95 -81.38 -58.98 2.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.835 0.35 . . . . 0.0 110.893 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.77 -159.89 30.81 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.453 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -127.83 37.86 4.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.864 0.364 . . . . 0.0 110.814 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.585 HD12 HG12 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -90.22 -176.27 4.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 1.083 HG12 HG23 ' A' ' 20' ' ' THR . 3.4 m -100.96 135.97 34.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.096 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.502 ' CD2' HD12 ' A' ' 53' ' ' LEU . 5.2 p90 -99.84 144.2 29.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.3 t -101.7 118.16 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.119 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.428 HG13 ' CG ' ' A' ' 21' ' ' GLU . 13.9 m -66.82 137.03 25.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.168 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -145.17 127.6 15.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.901 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.5 p90 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.932 -179.942 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 ptm . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.745 0.307 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.52 -36.31 9.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.57 -115.04 4.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.447 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.0 m -148.9 125.63 11.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.969 0.414 . . . . 0.0 110.81 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -111.59 -26.43 9.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.881 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -56.44 163.91 1.57 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.79 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -89.65 -33.77 16.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 50.0 m170 -60.43 159.16 10.69 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.712 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -136.0 158.03 45.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.794 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -80.55 -41.56 23.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.83 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.28 164.31 24.25 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.553 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 t -90.01 112.26 23.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.832 0.349 . . . . 0.0 110.843 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 34.4 tpp -113.81 -26.54 8.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.896 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.9 p -73.56 152.75 40.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -93.55 173.54 7.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -122.83 159.89 27.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.912 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.731 HG23 HG13 ' A' ' 30' ' ' ILE . 5.3 tt -116.75 124.08 72.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.076 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.17 103.77 10.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.023 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.563 HG12 HD12 ' A' ' 83' ' ' LEU . 7.8 m -147.0 155.54 11.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.38 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.558 ' CG2' HG22 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -129.94 151.8 50.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.215 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.502 ' HG2' HG13 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -77.37 -50.07 13.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -107.01 143.11 35.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.51 -25.45 65.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.834 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -72.31 -26.45 61.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.85 -176.98 5.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.881 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -103.97 155.49 37.01 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.426 0.631 . . . . 0.0 111.218 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.87 106.82 1.75 Allowed 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.718 2.278 . . . . 0.0 112.309 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.862 HD11 HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -74.45 142.87 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.155 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -109.57 123.91 50.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.862 HG23 HD11 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -127.21 159.75 63.49 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.626 0.727 . . . . 0.0 111.092 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 134.36 27.86 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.743 2.295 . . . . 0.0 112.334 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.558 ' HB2' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -126.04 158.19 35.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.806 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -61.82 159.86 13.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.9 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -65.63 -27.39 68.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.803 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -67.62 -19.47 65.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.86 1.25 32.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.534 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.48 ' HB ' HG22 ' A' ' 72' ' ' ILE . 19.6 p -97.25 -176.07 3.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.855 0.359 . . . . 0.0 111.158 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.62 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 73.7 t -136.07 121.54 28.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.129 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.71 146.37 36.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.685 HD13 ' O ' ' A' ' 40' ' ' LEU . 3.3 tm? -60.69 -29.16 69.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.2 t -64.2 -39.89 94.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.4 m -73.29 -29.67 62.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.995 HG21 HD23 ' A' ' 73' ' ' LEU . 25.0 t -66.42 -37.8 80.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.013 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 67.2 p -78.09 -15.21 59.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.525 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.76 -47.9 81.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.965 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -112.59 -19.68 11.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.038 0.447 . . . . 0.0 111.294 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -126.75 75.34 75.37 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.651 0.739 . . . . 0.0 110.84 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.87 131.62 21.47 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.668 2.246 . . . . 0.0 112.28 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.21 6.79 89.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.49 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.681 ' HB1' HD21 ' A' ' 53' ' ' LEU . . . -88.17 107.95 19.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.735 0.302 . . . . 0.0 111.072 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.4 t -95.41 -53.24 3.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.936 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.56 ' O ' HD23 ' A' ' 53' ' ' LEU . . . -115.8 131.32 9.58 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.478 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.681 HD21 ' HB1' ' A' ' 50' ' ' ALA . 12.4 mt -120.88 140.83 51.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.017 0.437 . . . . 0.0 110.756 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.418 ' HB2' ' HB ' ' A' ' 86' ' ' VAL . 49.0 mtm180 -107.33 171.86 7.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.705 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.662 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 11.4 m-85 -111.06 126.9 55.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.1 tpm_? -127.91 103.61 7.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.878 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.551 ' ND2' HG22 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -130.79 110.58 15.89 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.567 0.699 . . . . 0.0 110.951 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 57' ' ' ASN . 54.0 Cg_endo -69.74 -22.81 31.66 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.665 2.243 . . . . 0.0 112.348 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.551 HG22 ' ND2' ' A' ' 57' ' ' ASN . 30.6 m -86.96 -20.75 7.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.163 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.1 m -93.87 -27.47 16.39 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.078 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 61.21 25.76 15.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.132 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 2.2 m -93.89 179.1 5.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 7.3 ttm -144.91 37.27 1.16 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.989 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.3 ptp85 -88.81 -177.14 5.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.752 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.82 160.26 28.93 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.584 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.662 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 21.9 t -69.1 142.72 15.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.78 0.324 . . . . 0.0 111.155 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -92.28 137.56 32.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.476 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.7 tm? -116.25 115.72 26.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.9 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.582 HG22 ' HG2' ' A' ' 70' ' ' GLU . 5.8 p -138.46 121.18 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.172 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.582 ' HG2' HG22 ' A' ' 69' ' ' VAL . 31.9 mm-40 58.65 22.71 10.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.871 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.67 -24.64 22.65 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.489 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.48 HG22 ' HB ' ' A' ' 37' ' ' THR . 4.4 mt -81.41 114.8 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.842 0.353 . . . . 0.0 111.198 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.995 HD23 HG21 ' A' ' 43' ' ' VAL . 4.2 mm? -73.77 101.82 3.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.903 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -75.16 143.21 43.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.83 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.564 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -93.57 159.98 33.83 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.573 0.702 . . . . 0.0 111.133 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.564 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.7 Cg_endo -70.06 -173.45 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.689 2.259 . . . . 0.0 112.294 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -77.12 -2.37 33.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.327 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.42 -31.23 8.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.086 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.9 -164.84 16.96 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.426 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.62 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 82.7 m95 -84.91 -59.58 2.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.749 0.309 . . . . 0.0 110.9 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.55 -162.79 36.52 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.488 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.22 37.93 4.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.912 0.387 . . . . 0.0 110.909 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.563 HD12 HG12 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -90.14 -175.8 4.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.914 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.558 HG22 ' CG2' ' A' ' 20' ' ' THR . 40.3 t -102.05 131.94 49.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.074 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.679 ' CD2' HD13 ' A' ' 53' ' ' LEU . 4.6 p90 -97.24 141.62 30.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.935 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 54' ' ' ARG . 15.5 t -99.64 115.31 40.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.118 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.502 HG13 ' HG2' ' A' ' 21' ' ' GLU . 17.3 m -61.8 145.14 13.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.064 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -145.05 110.78 5.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.96 -179.898 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.9 mmt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.802 0.334 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.35 37.26 24.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.167 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -113.53 120.77 5.26 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.536 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m -81.0 145.67 31.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.366 . . . . 0.0 110.817 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -100.91 -32.8 10.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.822 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -62.05 161.41 10.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.853 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -136.19 149.9 48.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.853 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 -82.89 151.88 25.79 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.687 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -60.85 130.81 48.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.712 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -86.51 119.06 26.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.861 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 166.92 73.73 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.487 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.2 t -161.38 159.78 28.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 0.0 110.874 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 14.8 tpt -110.51 141.25 43.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.843 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.3 t -84.67 137.64 33.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -92.59 150.95 20.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.823 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -103.08 165.31 11.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.934 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.727 HG23 HG13 ' A' ' 30' ' ' ILE . 5.9 tt -122.85 123.38 68.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.169 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.58 103.44 9.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.066 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.499 HG12 ' CD2' ' A' ' 83' ' ' LEU . 6.4 m -147.31 155.66 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.308 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.558 ' CG2' HG22 ' A' ' 84' ' ' VAL . 0.7 OUTLIER -130.66 153.34 49.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.215 179.679 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.53 -49.64 14.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.839 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -100.78 147.49 26.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.26 -34.21 72.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -68.99 -25.4 64.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -85.11 164.5 18.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -89.93 155.13 47.68 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.619 0.724 . . . . 0.0 110.925 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 112.34 3.05 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.661 2.24 . . . . 0.0 112.343 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.51 HD12 ' H ' ' A' ' 29' ' ' GLU . 5.0 tp -76.67 140.01 17.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.51 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -102.92 116.57 32.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.704 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.727 HG13 HG23 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -123.52 160.13 52.14 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.61 0.719 . . . . 0.0 111.151 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 154.11 68.25 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.69 2.26 . . . . 0.0 112.341 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.642 ' HB2' HG22 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -140.15 163.98 31.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -64.16 165.78 8.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -66.17 -38.33 87.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.873 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.77 -19.29 64.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.61 -29.26 6.71 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.505 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.554 HG22 ' CG ' ' A' ' 74' ' ' HIS . 29.2 p -64.66 -176.24 0.24 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 0.0 111.137 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.642 HG22 ' HB2' ' A' ' 32' ' ' SER . 55.6 t -131.67 125.76 56.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.146 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.518 HD23 ' HB2' ' A' ' 41' ' ' SER . 13.8 tp -62.11 143.25 56.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.646 ' O ' HG23 ' A' ' 44' ' ' THR . 3.0 tm? -59.85 -23.97 63.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.88 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.518 ' HB2' HD23 ' A' ' 39' ' ' LEU . 19.0 m -67.72 -45.97 73.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.832 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.3 m -69.13 -30.32 68.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.138 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.878 HG21 HD23 ' A' ' 73' ' ' LEU . 23.3 t -65.82 -35.93 76.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.992 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.646 HG23 ' O ' ' A' ' 40' ' ' LEU . 22.4 p -79.04 -15.65 57.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.036 0.446 . . . . 0.0 111.629 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.26 -45.57 87.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.896 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -112.09 -24.16 10.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.092 0.472 . . . . 0.0 111.243 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -126.56 76.95 73.83 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 121.659 0.742 . . . . 0.0 110.87 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 134.5 28.05 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.696 2.264 . . . . 0.0 112.322 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.92 6.75 86.03 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.542 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.578 ' HB1' HD21 ' A' ' 53' ' ' LEU . . . -86.19 112.54 21.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.847 0.356 . . . . 0.0 111.094 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.9 t -99.13 -53.31 3.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.888 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.67 ' O ' HD23 ' A' ' 53' ' ' LEU . . . -116.9 134.72 11.47 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.52 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.67 HD23 ' O ' ' A' ' 52' ' ' GLY . 12.4 mt -124.06 141.2 52.25 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.048 0.452 . . . . 0.0 110.672 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -107.52 171.29 7.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.722 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.447 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 9.0 m-85 -108.83 125.53 52.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.962 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -129.3 99.62 5.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.869 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -139.43 119.45 9.32 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.634 0.731 . . . . 0.0 110.869 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.87 -22.61 31.36 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.651 2.234 . . . . 0.0 112.331 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.9 m -85.56 -31.9 6.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.136 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.2 m -77.15 -27.28 53.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.01 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 58.92 21.69 9.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.069 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 97.6 m -102.2 162.5 12.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.916 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 36.5 mtm -129.14 26.5 5.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.765 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -78.94 -176.56 5.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.712 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.82 154.92 25.84 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.52 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.447 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 95.8 t -62.2 144.43 14.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.817 0.342 . . . . 0.0 111.155 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -95.27 138.64 32.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.877 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 69' ' ' VAL . 2.3 tm? -114.83 121.44 43.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.509 ' N ' HD22 ' A' ' 68' ' ' LEU . 6.0 p -139.12 120.22 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.119 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.475 ' HG2' HG22 ' A' ' 69' ' ' VAL . 57.1 mm-40 55.42 25.9 8.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.907 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.433 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . 93.21 -23.24 30.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.475 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.503 HG22 ' HB ' ' A' ' 37' ' ' THR . 5.3 mp -82.15 116.74 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.877 0.37 . . . . 0.0 111.103 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.878 HD23 HG21 ' A' ' 43' ' ' VAL . 4.1 mm? -79.24 101.58 8.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.554 ' CG ' HG22 ' A' ' 37' ' ' THR . 5.7 t-80 -76.37 141.94 41.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.83 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.536 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -91.6 159.37 38.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.553 0.692 . . . . 0.0 111.102 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.536 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.7 Cg_endo -70.03 -173.46 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.635 2.223 . . . . 0.0 112.32 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -77.27 -1.99 32.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.242 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.23 -30.13 8.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.094 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.48 -165.35 15.23 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.487 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.605 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 90.5 m95 -85.67 -59.79 2.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.851 0.358 . . . . 0.0 110.917 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.82 -163.88 32.35 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.487 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -128.09 38.55 3.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.827 0.346 . . . . 0.0 110.876 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.707 ' H ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -95.31 -175.76 3.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.963 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.558 HG22 ' CG2' ' A' ' 20' ' ' THR . 41.5 t -98.15 136.23 29.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.665 ' CD2' HD13 ' A' ' 53' ' ' LEU . 5.6 p90 -101.53 141.35 34.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.96 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.0 t -96.34 114.39 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.4 m -60.77 142.25 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.09 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -144.97 109.9 5.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.851 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.931 -179.986 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.0 mtm . . . . . 0 N--CA 1.46 0.051 0 CA-C-O 120.841 0.353 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.7 -64.23 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.139 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.72 -24.76 3.3 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.519 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.6 p -142.56 152.23 42.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.988 0.423 . . . . 0.0 110.838 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -117.27 140.45 49.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -82.35 161.63 22.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -85.04 136.6 33.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.869 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.1 m170 -64.72 -66.06 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.77 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -69.95 170.71 10.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -68.02 -38.74 82.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 74.77 171.82 28.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.481 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.59 156.82 1.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.829 0.347 . . . . 0.0 110.908 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.9 ttt -128.77 117.94 21.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.0 m -142.88 123.6 14.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.837 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -109.56 -172.32 2.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -129.8 165.66 21.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.867 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.724 HG23 HG13 ' A' ' 30' ' ' ILE . 5.4 tt -119.43 122.92 70.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.089 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.02 103.57 9.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.043 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.52 HG12 ' CD2' ' A' ' 83' ' ' LEU . 11.8 m -146.87 154.28 12.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.327 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.56 155.81 41.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.187 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.51 -50.04 19.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -114.45 146.7 40.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -64.63 -26.82 68.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.848 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -68.99 -25.15 64.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -95.4 159.64 14.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.869 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -81.73 154.9 70.98 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.639 0.733 . . . . 0.0 110.887 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 114.99 3.9 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.687 2.258 . . . . 0.0 112.283 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 19' ' ' VAL . 5.3 tp -80.33 136.65 22.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.32 120.18 39.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.745 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.724 HG13 HG23 ' A' ' 17' ' ' ILE . 0.6 OUTLIER -126.61 159.63 62.63 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.616 0.722 . . . . 0.0 111.093 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.8 147.64 63.09 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.65 2.233 . . . . 0.0 112.351 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.544 ' CB ' HG22 ' A' ' 38' ' ' VAL . 53.8 p -133.18 179.05 6.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.829 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -80.53 166.11 21.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -71.82 -33.53 68.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -66.21 -18.79 65.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.853 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.66 -20.93 11.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.46 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 74' ' ' HIS . 20.2 p -78.51 -175.45 4.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.855 0.36 . . . . 0.0 111.139 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.582 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 55.4 t -138.61 120.51 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.104 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.8 147.96 21.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.905 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.562 ' O ' HG23 ' A' ' 44' ' ' THR . 21.8 tp -62.57 -20.22 64.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.9 m -66.06 -36.58 83.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.7 m -80.01 -34.04 38.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.183 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.903 HG21 HD23 ' A' ' 73' ' ' LEU . 31.1 t -64.31 -36.31 76.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.984 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 40' ' ' LEU . 34.5 p -80.25 -15.52 56.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.579 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.5 -44.98 85.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.947 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -111.86 -23.58 10.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.069 0.462 . . . . 0.0 111.245 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -124.73 75.1 64.57 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 121.66 0.743 . . . . 0.0 110.903 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 133.23 25.04 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.645 2.23 . . . . 0.0 112.324 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.34 4.07 89.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.508 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.648 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -82.6 118.22 23.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.322 . . . . 0.0 111.103 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.8 m -102.19 -52.81 3.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.562 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -120.03 129.15 7.83 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.532 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.669 HD12 ' CE1' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -115.97 138.26 51.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.038 0.447 . . . . 0.0 110.663 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -107.32 170.8 7.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.665 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.562 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 12.4 m-85 -110.47 126.06 53.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.976 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.727 ' HB3' HG13 ' A' ' 84' ' ' VAL . 15.8 tpt180 -129.14 103.78 7.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.864 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.407 ' HB3' ' HB3' ' A' ' 60' ' ' SER . 3.8 t-20 -140.26 121.63 9.43 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.567 0.699 . . . . 0.0 110.991 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -49.11 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.673 2.248 . . . . 0.0 112.332 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.0 m -61.4 -36.81 75.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.122 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.407 ' HB3' ' HB3' ' A' ' 57' ' ' ASN . 7.5 t -68.42 -27.11 65.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.053 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 60.28 24.46 13.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.066 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 28.8 p -110.06 178.25 4.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.887 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.82 38.66 0.68 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -81.71 -174.3 4.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.763 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -149.78 154.78 25.92 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.52 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.562 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 92.4 t -69.86 144.58 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.839 0.352 . . . . 0.0 111.086 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -92.27 138.29 31.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.873 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.505 HD22 ' N ' ' A' ' 69' ' ' VAL . 2.3 tm? -118.01 121.7 41.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.614 HG22 ' HG3' ' A' ' 70' ' ' GLU . 6.0 p -142.67 121.36 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.614 ' HG3' HG22 ' A' ' 69' ' ' VAL . 10.2 mt-10 57.06 23.9 8.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.03 -24.93 22.39 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.529 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.452 HG22 ' HB ' ' A' ' 37' ' ' THR . 3.5 mp -81.05 117.49 27.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.912 0.387 . . . . 0.0 111.079 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.903 HD23 HG21 ' A' ' 43' ' ' VAL . 4.1 mm? -79.63 111.73 16.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.934 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.478 ' HA ' HG22 ' A' ' 37' ' ' THR . 5.8 t60 -84.66 135.84 34.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.946 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.56 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -87.86 159.75 48.24 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.572 0.701 . . . . 0.0 111.151 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.56 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.6 Cg_endo -69.94 -173.82 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.72 2.28 . . . . 0.0 112.325 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -77.32 -2.42 34.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.264 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -108.37 -27.6 9.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.053 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 118.15 -172.49 14.45 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.479 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.582 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 97.2 m95 -77.77 -59.3 2.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.775 0.322 . . . . 0.0 110.922 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.55 -162.76 30.7 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.498 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.91 38.1 4.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.877 0.37 . . . . 0.0 110.876 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.702 ' H ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -94.64 -175.72 3.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.727 HG13 ' HB3' ' A' ' 56' ' ' ARG . 4.0 p -100.57 132.31 46.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.15 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.669 ' CE1' HD12 ' A' ' 53' ' ' LEU . 2.9 p90 -99.86 145.64 27.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.947 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.2 t -102.04 120.08 51.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.103 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.9 m -64.94 145.79 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.123 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -145.02 99.89 3.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 45.9 p90 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 -179.894 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.743 0.306 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.26 102.03 9.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.153 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.77 -75.26 0.96 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.478 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.2 m -66.56 129.27 39.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.86 0.362 . . . . 0.0 110.84 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -119.98 116.4 25.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -61.64 120.31 10.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -154.1 166.51 32.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.911 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -67.28 -38.2 84.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.822 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -55.83 -26.21 45.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.846 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -52.5 -44.74 65.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.862 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.2 82.72 0.32 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.522 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.8 t -156.61 161.22 39.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.859 0.361 . . . . 0.0 110.822 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 15.8 ptt? -63.57 168.17 4.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.902 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.5 m -64.72 133.2 51.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.847 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -86.22 179.75 6.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -124.74 163.26 22.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.944 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.751 HG23 HG13 ' A' ' 30' ' ' ILE . 4.7 tt -117.1 123.58 72.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.138 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -119.9 104.03 9.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.063 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.543 HG12 HD23 ' A' ' 83' ' ' LEU . 25.2 m -147.6 152.23 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.37 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.12 152.95 42.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.151 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.8 -48.06 60.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -128.89 155.95 44.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.815 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -63.32 -26.19 68.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -66.59 -26.39 67.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.849 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -104.01 139.54 38.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -65.42 160.17 61.23 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.68 0.752 . . . . 0.0 110.841 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 114.76 3.82 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.687 2.258 . . . . 0.0 112.345 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.465 HD12 ' H ' ' A' ' 29' ' ' GLU . 4.5 tp -81.5 136.51 22.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.85 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.465 ' H ' HD12 ' A' ' 28' ' ' ILE . 11.3 pt-20 -101.7 120.39 40.27 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.735 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.751 HG13 HG23 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -126.71 159.22 65.06 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.662 0.744 . . . . 0.0 111.084 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.428 ' O ' HG21 ' A' ' 42' ' ' THR . 53.6 Cg_endo -69.72 147.72 63.75 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.649 2.233 . . . . 0.0 112.367 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.552 ' HB2' HG22 ' A' ' 38' ' ' VAL . 4.5 p -137.58 163.93 30.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.855 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -64.09 159.31 20.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.954 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.13 -29.23 69.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.877 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.84 -19.37 65.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.895 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.7 -8.37 27.95 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.499 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.505 HG22 ' HA ' ' A' ' 74' ' ' HIS . 32.7 p -90.01 179.9 5.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.825 0.345 . . . . 0.0 111.12 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.577 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 68.9 t -133.58 118.18 29.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.121 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.503 HD13 HG12 ' A' ' 72' ' ' ILE . 4.5 mm? -62.14 149.54 41.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.793 HD12 ' HA3' ' A' ' 71' ' ' GLY . 0.9 OUTLIER -60.3 -19.42 55.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.936 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 t -66.47 -39.22 88.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.989 0.423 . . . . 0.0 110.924 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.428 HG21 ' O ' ' A' ' 31' ' ' PRO . 10.0 m -78.63 -32.34 47.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.124 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.921 HG21 HD23 ' A' ' 73' ' ' LEU . 34.3 t -64.69 -36.68 78.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.981 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 40' ' ' LEU . 43.2 p -79.99 -15.32 57.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.55 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.92 -45.92 83.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.939 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -111.94 -24.51 9.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.979 0.418 . . . . 0.0 111.198 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -122.89 74.39 47.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.631 0.729 . . . . 0.0 110.933 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 129.07 16.93 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.663 2.242 . . . . 0.0 112.345 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.79 6.37 82.79 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.491 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.39 113.79 22.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 111.165 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.6 t -95.78 -53.32 3.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.705 ' C ' HD12 ' A' ' 53' ' ' LEU . . . -120.69 140.09 14.01 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.512 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.705 HD12 ' C ' ' A' ' 52' ' ' GLY . 8.4 mp -127.8 138.25 52.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.06 0.457 . . . . 0.0 110.682 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -106.73 170.39 7.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.702 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.694 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 13.6 m-85 -110.38 124.69 52.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.897 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.675 ' HB3' HG13 ' A' ' 84' ' ' VAL . 3.4 tmt_? -130.45 109.01 10.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.897 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -139.35 118.82 9.18 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.666 0.746 . . . . 0.0 110.885 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -24.38 30.01 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.689 2.259 . . . . 0.0 112.375 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.2 m -85.04 -32.02 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.116 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.1 t -79.7 -26.82 40.78 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.069 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 61.96 23.73 14.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.047 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.9 t -106.53 159.91 15.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -128.2 27.63 5.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.68 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.78 -179.94 2.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.656 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -145.41 160.54 28.1 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.507 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.694 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 15.9 t -67.74 151.15 10.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.79 0.329 . . . . 0.0 111.15 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.539 ' HE ' HG23 ' A' ' 69' ' ' VAL . 1.7 tpt180 -97.96 119.32 36.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.49 ' C ' HD13 ' A' ' 68' ' ' LEU . 3.4 tm? -94.25 106.47 18.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.943 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.539 HG23 ' HE ' ' A' ' 67' ' ' ARG . 4.3 t -119.17 106.94 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.141 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 51.62 34.96 13.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.935 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.793 ' HA3' HD12 ' A' ' 40' ' ' LEU . . . 92.13 -24.99 19.15 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.516 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.503 HG12 HD13 ' A' ' 39' ' ' LEU . 3.1 mp -81.34 108.32 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.822 0.344 . . . . 0.0 111.083 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.921 HD23 HG21 ' A' ' 43' ' ' VAL . 3.9 mm? -73.69 102.45 3.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.505 ' HA ' HG22 ' A' ' 37' ' ' THR . 5.6 t60 -78.72 135.55 37.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.577 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -82.52 160.39 61.98 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.641 0.734 . . . . 0.0 111.046 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.577 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.3 Cg_endo -70.0 -173.55 0.78 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.722 2.281 . . . . 0.0 112.297 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -77.32 -1.99 32.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.322 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.67 -29.48 9.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.073 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.25 -170.36 15.09 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.441 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.577 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 93.0 m95 -81.45 -59.18 2.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.775 0.322 . . . . 0.0 110.941 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.36 -161.94 36.05 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.488 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -126.44 37.01 4.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.84 0.353 . . . . 0.0 110.854 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.558 HD11 ' HD1' ' A' ' 55' ' ' TYR . 1.1 pt? -88.2 -174.75 4.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.675 HG13 ' HB3' ' A' ' 56' ' ' ARG . 4.6 p -104.03 131.11 53.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.151 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.61 ' HE1' HG22 ' A' ' 87' ' ' VAL . 7.5 p90 -95.77 146.62 24.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.922 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 68.9 t -106.34 114.67 46.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.192 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.61 HG22 ' HE1' ' A' ' 85' ' ' TYR . 13.2 t -57.87 154.75 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.095 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -145.41 88.14 1.84 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.91 -179.9 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 mmt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.806 0.336 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.53 120.02 28.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.103 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.03 -69.89 1.28 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.472 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.4 m -83.09 118.98 23.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.955 0.407 . . . . 0.0 110.821 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -129.37 166.27 19.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.849 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 52.1 47.34 24.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -83.36 -57.2 3.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.832 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -63.44 178.5 0.55 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.828 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -155.01 162.95 40.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -155.66 142.94 19.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.849 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -112.08 85.9 0.41 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.5 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.0 m -66.32 -52.39 47.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 0.0 110.81 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.9 mtp -72.59 -34.96 67.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.2 m -69.42 132.7 46.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -121.35 149.96 42.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -85.93 160.34 19.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.947 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.748 HG23 HG13 ' A' ' 30' ' ' ILE . 6.8 tt -106.16 123.17 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.099 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -121.25 103.73 9.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.049 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.602 HG12 HD23 ' A' ' 83' ' ' LEU . 13.1 m -148.03 151.74 13.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.281 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.749 HG23 HG13 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -118.35 154.75 31.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.175 179.779 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.25 -41.2 94.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.855 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -139.36 167.37 22.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -75.95 -24.15 55.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.108 0.48 . . . . 0.0 111.318 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -66.4 -26.51 67.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.85 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -98.66 -175.5 3.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.823 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.6 mp0 -103.83 157.07 34.69 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.611 0.72 . . . . 0.0 110.918 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 126.95 13.92 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.655 2.237 . . . . 0.0 112.416 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.5 tp -100.36 131.64 47.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.795 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -97.07 122.46 40.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.722 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.748 HG13 HG23 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -127.23 159.74 63.56 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.643 0.735 . . . . 0.0 111.14 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.68 145.89 59.02 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.714 2.276 . . . . 0.0 112.345 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.536 ' HB2' HG22 ' A' ' 38' ' ' VAL . 1.2 p -130.12 176.82 7.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -77.84 166.41 22.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.938 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -72.19 -27.44 62.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.873 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.86 -19.19 60.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.921 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.21 -15.03 13.42 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.484 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.622 HG22 ' CG ' ' A' ' 74' ' ' HIS . 16.1 p -80.62 -171.09 2.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.923 0.392 . . . . 0.0 111.092 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.595 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 53.4 t -140.12 118.99 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.139 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.8 mt -56.47 139.43 49.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.484 ' O ' HG23 ' A' ' 44' ' ' THR . 28.4 tp -57.98 -22.1 47.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.952 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -66.72 -34.64 78.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.2 m -81.6 -32.88 31.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.127 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.768 HG21 HD23 ' A' ' 73' ' ' LEU . 24.4 t -63.94 -36.0 75.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.032 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 40' ' ' LEU . 38.5 p -79.4 -15.46 57.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.501 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.09 -46.63 83.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.933 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -112.02 -22.62 10.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.25 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -126.37 75.85 73.4 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.626 0.727 . . . . 0.0 110.914 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 131.19 20.67 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.656 2.238 . . . . 0.0 112.302 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.81 6.47 88.98 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.416 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.621 ' HB1' HD21 ' A' ' 53' ' ' LEU . . . -87.32 111.93 21.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.726 0.298 . . . . 0.0 111.108 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.1 t -99.3 -53.41 3.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.644 ' O ' HD23 ' A' ' 53' ' ' LEU . . . -115.8 132.76 10.44 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.539 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.672 HD22 ' CE2' ' A' ' 85' ' ' TYR . 12.8 mt -123.81 141.1 52.34 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.979 0.419 . . . . 0.0 110.734 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.4 ' HB2' ' HB ' ' A' ' 86' ' ' VAL . 45.5 mtt-85 -108.73 171.84 7.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.673 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.532 ' CD1' HD11 ' A' ' 83' ' ' LEU . 6.2 m-85 -107.66 125.36 51.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.63 110.16 11.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -139.19 119.3 9.45 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.596 0.712 . . . . 0.0 110.878 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -23.21 31.22 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.701 2.267 . . . . 0.0 112.371 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.0 m -85.79 -31.09 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.16 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.1 m -86.89 -27.29 23.49 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.983 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 58.61 22.77 10.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.028 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 32.8 m -95.24 164.31 12.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 4.7 tpt -124.84 25.46 7.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.793 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -178.78 0.14 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.722 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.68 138.29 5.28 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.495 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.527 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 92.9 t -59.0 144.97 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.845 0.355 . . . . 0.0 111.12 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -96.64 138.58 34.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 69' ' ' VAL . 1.4 tm? -111.9 114.24 27.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.534 ' N ' HD22 ' A' ' 68' ' ' LEU . 5.4 p -127.13 127.35 69.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.153 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 69' ' ' VAL . 7.2 pt-20 45.92 32.0 1.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.515 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . 89.36 -29.18 6.27 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.517 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.4 mp -79.5 112.91 18.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.821 0.343 . . . . 0.0 111.113 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.768 HD23 HG21 ' A' ' 43' ' ' VAL . 4.2 mm? -72.62 106.58 4.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.622 ' CG ' HG22 ' A' ' 37' ' ' THR . 5.4 t-80 -82.42 137.44 34.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.613 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -87.86 160.21 47.28 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.591 0.71 . . . . 0.0 111.064 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.564 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.4 Cg_endo -69.96 -173.33 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.667 2.245 . . . . 0.0 112.343 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -77.31 -2.02 32.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.222 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.17 -30.22 8.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.115 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.77 -165.25 15.47 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.473 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.613 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 98.1 m95 -87.23 -59.89 2.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.799 0.333 . . . . 0.0 110.869 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.0 -166.74 30.07 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.443 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -124.36 36.99 4.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.89 0.376 . . . . 0.0 110.922 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.602 HD23 HG12 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -94.42 -173.08 2.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.749 HG13 HG23 ' A' ' 20' ' ' THR . 25.7 t -102.26 131.95 49.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.134 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.672 ' CE2' HD22 ' A' ' 53' ' ' LEU . 5.2 p90 -96.23 142.49 28.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.95 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 54' ' ' ARG . 15.1 t -95.54 114.88 33.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.093 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.8 m -61.59 135.55 26.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.153 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -144.98 103.21 3.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 -179.847 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 tpp . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.73 0.3 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.04 178.55 6.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.145 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 73.76 23.96 75.43 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.503 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 p -64.62 -32.15 73.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.938 0.399 . . . . 0.0 110.869 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -79.39 158.5 27.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.2 m170 53.97 47.72 22.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.832 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -128.31 147.96 50.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.832 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -72.47 127.96 34.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -141.41 151.09 43.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.86 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -110.54 165.69 11.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.849 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.47 55.84 0.54 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.481 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 m -75.43 -34.99 61.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.84 0.352 . . . . 0.0 110.813 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.4 ptp -96.02 -25.9 15.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.875 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.9 m -53.62 148.24 9.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.831 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -94.95 179.78 5.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.891 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -120.68 140.13 52.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.752 HG23 HG13 ' A' ' 30' ' ' ILE . 6.2 tt -95.21 122.71 46.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.131 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.403 ' HB3' ' HA ' ' A' ' 82' ' ' ASN . 1.8 mtp180 -116.33 103.44 10.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.143 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.488 HG12 ' CD2' ' A' ' 83' ' ' LEU . 11.8 m -147.15 147.7 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.38 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.4 t -122.94 158.8 29.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.807 0.337 . . . . 0.0 111.153 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.81 -47.37 19.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.879 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.86 163.24 13.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -79.96 -30.31 39.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.223 0.535 . . . . 0.0 111.292 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.8 m-20 -66.49 -24.43 66.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.91 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -101.54 141.09 34.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.866 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.53 160.91 77.45 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.598 0.714 . . . . 0.0 110.893 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 133.68 26.02 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.639 2.226 . . . . 0.0 112.333 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.413 HD12 ' H ' ' A' ' 29' ' ' GLU . 4.3 tp -97.13 133.72 37.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.868 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.413 ' H ' HD12 ' A' ' 28' ' ' ILE . 2.1 tm-20 -93.54 122.62 36.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.735 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.752 HG13 HG23 ' A' ' 17' ' ' ILE . 0.2 OUTLIER -126.87 159.95 61.65 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.649 0.737 . . . . 0.0 111.086 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.595 ' O ' HG21 ' A' ' 42' ' ' THR . 53.5 Cg_endo -69.76 133.34 25.33 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.627 2.218 . . . . 0.0 112.345 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.589 ' HB2' HG22 ' A' ' 38' ' ' VAL . 17.2 p -122.05 -175.53 3.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -85.22 174.29 9.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -79.16 -33.39 44.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.83 -19.3 65.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.44 -11.18 19.28 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.489 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.62 HG22 ' HA ' ' A' ' 74' ' ' HIS . 30.2 p -86.21 -176.1 5.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.799 0.333 . . . . 0.0 111.138 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.63 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 66.9 t -138.46 121.37 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.4 mt -59.25 149.7 27.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.689 HD12 ' HA3' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -62.31 -21.98 65.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.911 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.1 p -66.55 -37.6 85.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.812 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.595 HG21 ' O ' ' A' ' 31' ' ' PRO . 10.5 m -76.56 -35.02 58.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.154 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.82 HG21 HD23 ' A' ' 73' ' ' LEU . 25.4 t -64.88 -37.89 81.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.043 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 40' ' ' LEU . 32.8 p -77.96 -15.55 58.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.57 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.97 -46.69 83.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.974 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -112.05 -15.96 13.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.313 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -132.88 76.69 70.16 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.622 0.725 . . . . 0.0 110.822 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 128.14 15.58 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.686 2.257 . . . . 0.0 112.332 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.83 -15.96 57.91 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.462 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.658 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -64.04 108.89 1.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.766 0.317 . . . . 0.0 111.1 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.4 t -94.5 -52.79 4.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.592 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -117.83 128.53 7.83 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.522 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.702 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -114.99 137.97 51.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.022 0.439 . . . . 0.0 110.679 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -107.3 170.43 7.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.759 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.579 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 9.5 m-85 -109.64 125.62 52.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.736 ' HB3' HG13 ' A' ' 84' ' ' VAL . 8.9 tpm_? -129.38 108.72 10.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.893 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.509 ' N ' ' HE ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -128.75 113.79 19.1 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.635 0.731 . . . . 0.0 110.907 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -23.55 30.53 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.695 2.264 . . . . 0.0 112.343 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.8 m -86.87 -27.36 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.199 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.5 t -90.28 -27.53 19.38 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.064 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 60.7 23.59 13.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.121 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 18.2 m -96.19 174.03 7.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.924 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.0 ttt -135.45 54.43 1.92 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.838 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.44 -174.8 5.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.679 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.52 135.59 3.87 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.492 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.579 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 22.3 t -56.6 139.18 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 111.129 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -88.63 136.88 32.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.496 ' C ' HD13 ' A' ' 68' ' ' LEU . 3.2 tm? -114.56 122.48 46.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.741 HG22 ' HG3' ' A' ' 70' ' ' GLU . 6.5 p -146.4 122.42 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.164 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.741 ' HG3' HG22 ' A' ' 69' ' ' VAL . 9.5 mt-10 58.0 22.62 9.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.864 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.689 ' HA3' HD12 ' A' ' 40' ' ' LEU . . . 92.46 -25.03 20.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.453 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.561 HG22 ' HB ' ' A' ' 37' ' ' THR . 3.1 mp -83.07 123.39 38.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.349 . . . . 0.0 111.195 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.82 HD23 HG21 ' A' ' 43' ' ' VAL . 4.0 mm? -81.33 115.57 20.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.946 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.62 ' HA ' HG22 ' A' ' 37' ' ' THR . 6.2 t60 -88.41 135.84 33.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.881 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.564 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -86.46 159.84 52.18 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.58 0.705 . . . . 0.0 111.132 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.564 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.3 Cg_endo -70.07 -172.64 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.68 2.253 . . . . 0.0 112.28 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -77.06 -2.6 34.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.299 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.18 -29.53 9.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.11 -167.39 14.69 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.461 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.63 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 85.0 m95 -81.77 -59.39 2.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.854 0.359 . . . . 0.0 110.913 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.75 -167.66 38.76 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.538 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 18' ' ' ARG . 4.8 m-20 -125.0 38.31 4.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.918 0.389 . . . . 0.0 110.916 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.721 ' H ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -93.44 -175.48 3.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.935 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.736 HG13 ' HB3' ' A' ' 56' ' ' ARG . 4.0 p -99.6 138.56 23.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.157 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.702 ' CE2' HD12 ' A' ' 53' ' ' LEU . 3.2 p90 -108.36 146.28 33.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.954 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 68.3 t -99.53 125.03 53.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.111 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.3 m -74.84 135.85 26.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -145.62 139.49 26.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.913 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.854 0.359 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.98 148.96 1.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.34 -145.46 12.14 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.462 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.0 m -110.15 113.29 25.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.927 0.394 . . . . 0.0 110.876 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -104.3 30.69 5.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.842 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -118.95 133.43 55.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 55.5 m80 -98.84 154.82 17.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.843 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -80.39 137.78 36.57 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.595 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -109.09 27.57 9.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.747 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -68.11 -33.93 75.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.847 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.7 -145.09 0.21 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.455 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.1 p -120.63 174.45 6.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.856 0.36 . . . . 0.0 110.869 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 14.8 mtt -93.14 133.18 36.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 93.8 p -62.54 126.15 26.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.91 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -97.48 -176.46 3.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.895 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -124.69 170.23 11.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.95 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.748 HG23 HG13 ' A' ' 30' ' ' ILE . 5.5 tt -120.13 122.87 69.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.092 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.14 103.65 9.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.039 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.478 HG12 ' CD2' ' A' ' 83' ' ' LEU . 13.4 m -147.29 153.5 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.344 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.83 153.55 40.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.199 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.407 ' HG2' HG13 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -65.72 -39.14 90.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -139.23 -177.42 4.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -83.66 -29.43 27.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.194 0.521 . . . . 0.0 111.333 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -66.43 -24.16 66.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.887 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -105.4 128.81 53.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.789 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -57.91 159.69 9.87 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.554 0.693 . . . . 0.0 110.846 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 122.85 9.51 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.645 2.23 . . . . 0.0 112.349 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.472 HD12 ' H ' ' A' ' 29' ' ' GLU . 4.7 tp -91.46 137.11 22.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.931 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.472 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -101.54 121.77 42.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.812 179.948 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.748 HG13 HG23 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -127.16 159.44 65.01 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.594 0.712 . . . . 0.0 111.179 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.436 ' O ' HG21 ' A' ' 42' ' ' THR . 53.3 Cg_endo -69.8 141.65 45.62 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.638 2.225 . . . . 0.0 112.345 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.544 ' HB2' HG22 ' A' ' 38' ' ' VAL . 14.2 p -129.77 -179.64 5.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.82 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -82.86 159.94 22.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -67.72 -29.83 69.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -68.62 -19.5 64.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.57 -12.1 21.12 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.443 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.472 ' HB ' HG22 ' A' ' 72' ' ' ILE . 19.4 p -86.19 -175.41 5.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.863 0.363 . . . . 0.0 111.135 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.602 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 55.8 t -139.78 120.26 14.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.109 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.576 HD23 HG12 ' A' ' 72' ' ' ILE . 12.7 mt -60.31 146.6 43.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.514 ' O ' HG23 ' A' ' 44' ' ' THR . 22.2 tp -60.84 -20.8 62.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.6 t -65.62 -35.49 80.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.804 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.436 HG21 ' O ' ' A' ' 31' ' ' PRO . 12.4 m -82.23 -32.31 29.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.148 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.713 HG21 HD23 ' A' ' 73' ' ' LEU . 25.6 t -64.12 -35.53 74.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.004 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 40' ' ' LEU . 33.3 p -80.45 -15.36 56.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.006 0.431 . . . . 0.0 111.612 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.59 -45.25 83.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.909 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -112.0 -22.75 10.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.094 0.473 . . . . 0.0 111.282 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -127.04 75.17 76.75 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 121.608 0.718 . . . . 0.0 110.854 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 130.46 19.29 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.652 2.235 . . . . 0.0 112.363 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.49 6.07 87.89 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.448 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.66 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -85.61 115.69 23.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.348 . . . . 0.0 111.122 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 2.0 m -98.98 -52.9 3.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.569 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -121.25 130.74 8.31 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.501 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.66 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -116.46 142.08 47.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.824 0.345 . . . . 0.0 110.856 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -108.27 170.71 7.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.846 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -110.11 126.03 53.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.942 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.731 ' HB3' HG13 ' A' ' 84' ' ' VAL . 17.0 tpt180 -129.27 105.58 8.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.542 ' OD1' HD12 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -126.75 115.75 22.52 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.552 0.691 . . . . 0.0 110.941 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 -24.94 28.95 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.607 2.205 . . . . 0.0 112.354 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.1 m -86.63 -30.79 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.119 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.7 m -85.56 -27.16 25.73 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.028 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 59.97 24.04 13.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.016 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 84.4 m -94.0 -176.79 4.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.88 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.9 ptt? -143.67 32.26 1.3 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.926 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -174.56 0.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.715 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.01 135.55 3.75 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.488 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.668 HG12 HD12 ' A' ' 73' ' ' LEU . 34.8 t -52.2 147.4 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 0.0 111.164 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -101.06 124.08 46.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.904 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.558 ' HA ' HD13 ' A' ' 73' ' ' LEU . 2.5 tm? -97.46 114.88 26.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.426 ' O ' ' CG ' ' A' ' 70' ' ' GLU . 6.3 p -135.15 128.78 49.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.12 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.591 ' CD ' HD12 ' A' ' 72' ' ' ILE . 7.6 pt-20 45.9 29.95 0.81 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.24 -28.04 6.48 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.543 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.591 HD12 ' CD ' ' A' ' 70' ' ' GLU . 6.0 mt -83.99 118.64 31.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.916 0.389 . . . . 0.0 111.177 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.713 HD23 HG21 ' A' ' 43' ' ' VAL . 4.3 mm? -76.49 118.89 19.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -90.61 135.56 33.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.884 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.599 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -86.36 160.66 50.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.63 0.728 . . . . 0.0 111.039 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.591 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.1 Cg_endo -69.98 -173.67 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.662 2.241 . . . . 0.0 112.311 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.09 -2.07 32.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.332 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -108.68 -27.55 9.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.103 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 118.53 -172.44 14.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.523 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.602 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 97.2 m95 -78.49 -59.71 2.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.812 0.339 . . . . 0.0 110.905 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.86 -162.94 30.44 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.464 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -127.78 38.16 4.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.867 0.365 . . . . 0.0 110.893 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.708 ' H ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -95.95 -175.25 3.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.731 HG13 ' HB3' ' A' ' 56' ' ' ARG . 3.2 p -98.37 140.46 18.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.187 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.657 ' CE1' HD12 ' A' ' 53' ' ' LEU . 3.0 p90 -110.05 145.79 36.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 53.7 t -98.05 121.08 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.137 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.407 HG13 ' HG2' ' A' ' 21' ' ' GLU . 14.6 m -68.78 141.93 16.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.126 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -144.02 119.5 10.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.938 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.866 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 23.2 p90 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.861 0.362 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.752 HG23 HG13 ' A' ' 30' ' ' ILE . 6.1 tt -108.49 123.48 64.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.153 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.68 104.16 11.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.054 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.672 HG12 HD12 ' A' ' 83' ' ' LEU . 6.3 m -145.43 154.33 13.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.344 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.522 ' CG2' HG22 ' A' ' 84' ' ' VAL . 0.6 OUTLIER -128.9 152.23 48.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.128 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.86 -49.46 15.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.848 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -100.42 158.46 15.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -82.21 -31.89 30.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.223 0.535 . . . . 0.0 111.314 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -69.64 -26.56 64.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.874 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.65 -178.93 7.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.847 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -105.14 158.52 31.93 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.398 0.618 . . . . 0.0 111.266 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.9 114.66 3.8 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.38 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 19' ' ' VAL . 5.4 tp -79.51 141.36 15.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.919 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.443 ' H ' HD12 ' A' ' 28' ' ' ILE . 2.6 mt-10 -99.17 119.59 38.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.738 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.752 HG13 HG23 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -126.96 160.21 60.5 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.632 0.73 . . . . 0.0 111.122 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 155.35 66.06 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.699 2.266 . . . . 0.0 112.32 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.554 ' HB3' HG22 ' A' ' 38' ' ' VAL . 1.5 m -143.88 -175.99 4.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.839 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -88.63 172.96 8.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.945 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -78.49 -35.31 46.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.827 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -64.61 -19.03 65.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.853 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.69 -13.66 14.98 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.499 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.643 HG22 ' HA ' ' A' ' 74' ' ' HIS . 28.8 p -82.62 -174.08 5.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.851 0.357 . . . . 0.0 111.142 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.596 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 54.3 t -139.46 125.24 22.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.143 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.22 141.94 58.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.767 HD12 ' CA ' ' A' ' 71' ' ' GLY . 1.7 tt -60.56 -22.76 64.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.6 p -64.43 -29.72 70.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.788 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 58.0 m -87.1 -30.55 21.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.538 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.494 HG21 HD23 ' A' ' 73' ' ' LEU . 38.5 t -65.14 -39.91 87.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.992 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.582 HG23 HD23 ' A' ' 40' ' ' LEU . 42.9 p -77.41 -14.86 59.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.011 0.434 . . . . 0.0 111.569 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.04 -47.02 81.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.959 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 63.2 mm-40 -111.88 -21.71 11.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.116 0.484 . . . . 0.0 111.367 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -123.84 74.67 56.24 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 121.662 0.744 . . . . 0.0 110.878 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 129.99 18.61 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.66 2.24 . . . . 0.0 112.386 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.56 -9.68 70.07 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.51 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.688 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -67.73 99.27 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.744 0.307 . . . . 0.0 111.075 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.9 t -82.5 -43.77 16.78 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.093 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.575 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -130.27 134.82 8.0 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.399 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.688 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -115.68 130.02 56.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.074 0.464 . . . . 0.0 110.623 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -107.13 170.35 8.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.705 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.519 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 7.4 m-85 -106.16 126.09 51.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -129.27 121.53 27.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.907 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 121.609 0.718 . . . . 0.0 110.897 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.484 -0.247 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.519 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 21.2 t -67.61 134.39 30.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.818 0.342 . . . . 0.0 111.143 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -77.43 138.46 39.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.478 HD13 ' C ' ' A' ' 68' ' ' LEU . 2.7 tm? -121.33 124.43 44.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.948 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.459 ' N ' HD22 ' A' ' 68' ' ' LEU . 7.6 p -149.47 124.41 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.114 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.446 ' HG3' HG22 ' A' ' 69' ' ' VAL . 11.0 mt-10 57.92 22.62 8.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.767 ' CA ' HD12 ' A' ' 40' ' ' LEU . . . 92.23 -24.88 20.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.496 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.512 HG22 ' HB ' ' A' ' 37' ' ' THR . 3.2 mt -82.8 122.79 37.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 0.0 111.139 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.673 ' HG ' HD23 ' A' ' 53' ' ' LEU . 4.3 mm? -82.22 119.56 24.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.936 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.643 ' HA ' HG22 ' A' ' 37' ' ' THR . 41.9 t60 -91.88 135.76 33.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.568 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -87.68 160.05 48.15 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.55 0.69 . . . . 0.0 111.107 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.568 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.5 Cg_endo -69.99 -172.59 0.62 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.678 2.252 . . . . 0.0 112.306 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -77.16 -2.28 33.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.224 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.23 -31.52 8.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.95 -164.38 15.93 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.499 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.596 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 86.2 m95 -85.28 -59.24 2.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.758 0.313 . . . . 0.0 110.933 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.55 -161.77 37.27 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.456 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -125.91 37.75 4.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.906 0.384 . . . . 0.0 110.919 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.672 HD12 HG12 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -87.75 -175.85 5.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.522 HG22 ' CG2' ' A' ' 20' ' ' THR . 40.5 t -102.46 136.07 36.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.155 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.576 ' CD2' HD12 ' A' ' 53' ' ' LEU . 3.7 p90 -102.56 146.28 28.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.986 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 84.6 t -106.89 131.0 57.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.061 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.475 HG22 ' CE2' ' A' ' 85' ' ' TYR . 2.4 t -81.51 132.48 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.129 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -145.85 140.81 27.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.973 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.1 p90 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.807 0.337 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.77 HG23 HG13 ' A' ' 30' ' ' ILE . 6.1 tt -120.44 123.48 70.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.086 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -120.29 104.1 9.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.042 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.476 ' O ' HG22 ' A' ' 28' ' ' ILE . 6.1 m -145.0 152.29 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.351 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.528 HG23 HG22 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -127.31 157.47 39.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.138 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.42 -49.95 10.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.838 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -101.27 163.11 12.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -84.39 -29.71 25.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.211 0.529 . . . . 0.0 111.265 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -67.53 -26.6 66.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.868 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -94.41 163.43 13.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.871 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -89.16 159.92 44.01 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.677 0.751 . . . . 0.0 110.888 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.86 116.77 4.72 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.63 2.22 . . . . 0.0 112.367 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.476 HG22 ' O ' ' A' ' 19' ' ' VAL . 5.3 tp -76.68 137.98 21.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.867 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.05 119.77 37.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.802 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.77 HG13 HG23 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -126.43 159.89 60.77 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.627 0.727 . . . . 0.0 111.159 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.406 ' O ' HG21 ' A' ' 42' ' ' THR . 54.2 Cg_endo -69.73 148.82 66.08 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.643 2.229 . . . . 0.0 112.307 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.534 ' HB2' HG22 ' A' ' 38' ' ' VAL . 19.8 p -133.29 -175.69 3.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -84.66 169.94 13.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -75.57 -30.55 59.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -72.34 -17.5 61.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.787 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.13 -20.84 11.24 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.451 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.524 ' HB ' HG22 ' A' ' 72' ' ' ILE . 22.7 p -75.57 -174.24 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.796 0.331 . . . . 0.0 111.181 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.586 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 50.5 t -141.0 119.53 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.141 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.2 tp -56.94 145.34 30.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.874 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.737 HD12 ' CA ' ' A' ' 71' ' ' GLY . 1.3 tt -61.44 -19.61 62.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.9 t -66.29 -37.72 86.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.406 HG21 ' O ' ' A' ' 31' ' ' PRO . 8.9 m -77.06 -34.87 57.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.136 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.598 HG21 HD23 ' A' ' 73' ' ' LEU . 22.4 t -64.3 -34.94 72.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.027 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.579 HG23 ' O ' ' A' ' 40' ' ' LEU . 39.0 p -80.06 -15.78 56.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.559 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.65 -43.65 88.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.995 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -111.92 -23.95 10.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.305 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -129.69 75.66 79.47 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.647 0.736 . . . . 0.0 110.918 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 125.28 11.95 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.675 2.25 . . . . 0.0 112.382 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.46 6.5 64.26 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.517 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.718 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -82.13 116.11 21.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.774 0.321 . . . . 0.0 111.135 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.8 t -100.45 -52.92 3.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.633 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -122.08 127.04 6.66 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.545 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.778 HD12 ' CE1' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -115.31 139.73 49.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.953 0.406 . . . . 0.0 110.759 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -112.21 171.0 7.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.692 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -104.13 126.04 50.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.946 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.1 tpt180 -128.94 103.32 6.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.9 t30 . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 121.635 0.731 . . . . 0.0 110.935 -179.986 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.7 t -62.79 143.33 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.786 0.326 . . . . 0.0 111.151 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -91.97 138.55 31.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.885 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.482 HD22 ' N ' ' A' ' 69' ' ' VAL . 2.2 tm? -118.03 117.98 30.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.682 HG22 ' HG2' ' A' ' 70' ' ' GLU . 6.7 p -138.93 122.8 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.138 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.682 ' HG2' HG22 ' A' ' 69' ' ' VAL . 36.3 mm-40 58.12 22.58 9.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.737 ' CA ' HD12 ' A' ' 40' ' ' LEU . . . 92.33 -25.08 19.44 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.516 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.524 HG22 ' HB ' ' A' ' 37' ' ' THR . 4.3 mp -83.32 114.13 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.889 0.376 . . . . 0.0 111.076 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.598 HD23 HG21 ' A' ' 43' ' ' VAL . 4.1 mm? -73.78 116.09 13.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.956 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.46 ' HA ' HG22 ' A' ' 37' ' ' THR . 5.5 t60 -91.33 135.7 33.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.607 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -86.08 158.85 55.18 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.554 0.692 . . . . 0.0 111.124 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.525 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.9 Cg_endo -69.89 -172.94 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.689 2.26 . . . . 0.0 112.325 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -77.32 -2.15 33.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.266 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.74 -29.45 9.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.114 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.94 -168.86 14.65 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.514 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.607 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 98.0 m95 -82.49 -59.47 2.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.774 0.321 . . . . 0.0 110.866 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.11 -167.54 29.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.525 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -128.03 38.48 4.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.844 0.354 . . . . 0.0 110.895 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.677 HD13 ' H ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.61 -175.55 3.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.528 HG22 HG23 ' A' ' 20' ' ' THR . 21.9 t -93.58 144.28 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.106 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.778 ' CE1' HD12 ' A' ' 53' ' ' LEU . 1.7 p90 -111.31 146.35 37.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.959 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.5 t -95.48 125.55 48.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.139 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 t -74.48 135.98 26.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.108 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -145.11 106.48 4.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.884 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.976 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 27.4 p90 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.812 0.339 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.75 HG23 HG13 ' A' ' 30' ' ' ILE . 6.0 tt -120.78 123.3 69.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.138 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -120.65 104.44 9.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.058 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.456 ' O ' HG22 ' A' ' 28' ' ' ILE . 10.2 m -146.3 153.31 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.371 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.561 HG23 HG22 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -126.91 156.63 41.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.176 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.15 -50.18 13.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -102.54 166.44 10.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.912 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -79.53 -32.85 42.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.152 0.501 . . . . 0.0 111.279 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -74.75 -25.79 59.33 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.855 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -86.28 129.01 35.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.921 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -60.46 155.0 51.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.638 0.732 . . . . 0.0 110.884 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 114.91 3.85 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.717 2.278 . . . . 0.0 112.317 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.474 HD12 ' H ' ' A' ' 29' ' ' GLU . 4.9 tp -76.75 139.43 18.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.474 ' H ' HD12 ' A' ' 28' ' ' ILE . 1.7 pm0 -102.04 120.06 39.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.712 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.75 HG13 HG23 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -125.91 159.7 60.33 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.692 0.758 . . . . 0.0 111.051 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.409 ' O ' HG21 ' A' ' 42' ' ' THR . 53.7 Cg_endo -69.71 142.77 49.05 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.652 2.235 . . . . 0.0 112.349 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.565 ' CB ' HG22 ' A' ' 38' ' ' VAL . 53.5 p -132.94 161.63 33.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.831 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -61.11 162.74 6.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.82 -31.85 65.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.849 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -65.2 -18.4 65.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.36 -19.37 11.68 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.461 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.457 ' HB ' HG22 ' A' ' 72' ' ' ILE . 20.5 p -81.05 -174.38 4.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.348 . . . . 0.0 111.145 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.608 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 53.5 t -137.76 124.56 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.154 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.8 tp -59.49 146.88 38.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.623 HD13 ' O ' ' A' ' 40' ' ' LEU . 3.1 tm? -63.06 -25.19 68.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.7 t -64.44 -39.13 93.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.409 HG21 ' O ' ' A' ' 31' ' ' PRO . 10.7 m -74.13 -31.02 62.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.176 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.909 HG21 HD23 ' A' ' 73' ' ' LEU . 17.7 t -66.16 -37.22 79.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.011 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.1 p -79.09 -15.84 57.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.578 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.13 -44.81 87.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.983 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -112.14 -20.86 11.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.118 0.485 . . . . 0.0 111.352 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -131.38 75.45 77.3 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 121.643 0.735 . . . . 0.0 110.849 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 131.87 22.19 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.619 2.213 . . . . 0.0 112.415 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.36 -8.87 72.57 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.518 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.593 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -71.06 119.73 15.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.807 0.337 . . . . 0.0 111.139 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.4 t -102.05 -53.01 3.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.584 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -121.07 130.25 8.14 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.494 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.709 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -115.69 137.81 51.71 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.992 0.425 . . . . 0.0 110.678 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -108.64 170.71 7.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.735 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -105.29 125.69 51.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -129.56 105.28 7.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.7 t30 . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 121.551 0.691 . . . . 0.0 110.909 -179.932 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 64.5 t -54.77 138.62 14.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.748 0.309 . . . . 0.0 111.181 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -88.15 138.49 31.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.517 HD21 ' HA2' ' A' ' 71' ' ' GLY . 2.2 tm? -117.3 115.05 24.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.555 HG22 ' HG2' ' A' ' 70' ' ' GLU . 5.6 p -134.32 120.28 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.141 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.555 ' HG2' HG22 ' A' ' 69' ' ' VAL . 17.4 mm-40 57.51 23.53 9.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.9 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.517 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . 93.39 -24.93 23.13 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.467 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.457 HG22 ' HB ' ' A' ' 37' ' ' THR . 4.2 mp -80.83 112.72 19.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.973 0.416 . . . . 0.0 111.089 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.909 HD23 HG21 ' A' ' 43' ' ' VAL . 4.1 mm? -74.72 111.24 9.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.911 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -86.65 135.41 33.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.649 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -87.98 159.87 47.64 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.467 0.651 . . . . 0.0 111.209 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.557 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.2 Cg_endo -69.94 -173.09 0.67 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.698 2.265 . . . . 0.0 112.285 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -77.2 -2.25 33.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.244 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.27 -29.81 9.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.99 -165.35 14.85 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.469 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.649 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 97.5 m95 -86.71 -59.6 2.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.82 0.343 . . . . 0.0 110.849 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.72 -165.8 29.83 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.466 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -128.16 38.24 4.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 0.0 110.861 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.693 HD13 ' H ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.29 -175.81 3.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.912 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.561 HG22 HG23 ' A' ' 20' ' ' THR . 38.3 t -93.85 144.44 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.191 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.709 ' CE2' HD12 ' A' ' 53' ' ' LEU . 3.6 p90 -114.61 145.9 41.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.939 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.4 t -99.65 126.74 52.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.121 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.8 t -72.58 145.35 12.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.17 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -145.08 87.75 1.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.963 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.4 p90 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 -179.883 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.4 p90 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.891 0.376 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.707 HG23 HG13 ' A' ' 30' ' ' ILE . 6.1 tt -119.35 123.47 71.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.098 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.4 mtm180 -119.48 104.69 10.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.109 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.543 HG12 HD23 ' A' ' 83' ' ' LEU . 6.5 m -145.71 153.44 13.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.3 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.716 ' CG2' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -124.76 155.33 39.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.167 179.701 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.06 -49.73 22.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.928 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -105.31 173.43 6.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.861 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -79.21 -46.6 17.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.283 0.564 . . . . 0.0 111.283 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -68.84 -26.8 65.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.878 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -72.79 126.98 31.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.93 149.89 63.27 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.695 0.759 . . . . 0.0 110.856 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.78 120.2 7.02 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.763 2.308 . . . . 0.0 112.311 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 19' ' ' VAL . 6.1 tp -87.54 143.4 11.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.99 123.15 48.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.707 HG13 HG23 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -127.39 160.57 59.5 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.656 0.741 . . . . 0.0 111.151 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.67 144.65 55.19 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.704 2.269 . . . . 0.0 112.426 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.571 ' HB3' HG22 ' A' ' 38' ' ' VAL . 1.5 m -133.18 -175.88 3.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.859 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -86.06 174.25 9.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.836 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -80.68 -35.39 33.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.806 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -63.36 -19.83 64.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.827 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.43 -12.55 13.87 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.441 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.439 ' HB ' HG22 ' A' ' 72' ' ' ILE . 20.6 p -85.38 -174.72 5.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.829 0.347 . . . . 0.0 111.182 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.606 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 53.7 t -136.7 135.08 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.208 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 tp -70.81 141.39 51.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.696 HD13 ' O ' ' A' ' 40' ' ' LEU . 2.6 tm? -59.48 -31.95 69.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.965 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -58.85 -29.23 66.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.792 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.4 m -83.97 -30.86 25.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.156 0.503 . . . . 0.0 111.619 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.618 HG21 HD23 ' A' ' 73' ' ' LEU . 20.1 t -65.16 -35.29 75.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.025 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.3 p -79.7 -15.39 57.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.465 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.26 -45.33 84.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.982 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -111.97 -18.28 12.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.016 0.436 . . . . 0.0 111.287 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -134.11 74.55 67.78 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.633 0.73 . . . . 0.0 110.864 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 129.5 17.75 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.698 2.265 . . . . 0.0 112.39 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.26 6.03 78.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.522 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.657 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -81.78 114.96 20.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.758 0.314 . . . . 0.0 111.129 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.2 t -95.79 -53.05 3.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.598 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -124.81 132.06 8.02 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.559 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.684 HD12 ' CE1' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -115.41 138.86 50.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.986 0.422 . . . . 0.0 110.745 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.17 170.78 7.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.715 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.696 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 10.3 m-85 -111.07 125.75 54.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.974 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -129.41 104.01 7.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.934 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t30 . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 121.632 0.73 . . . . 0.0 110.902 -179.908 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.696 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 21.6 t -58.29 135.7 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.828 0.347 . . . . 0.0 111.069 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -83.26 138.54 33.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.867 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.49 HD13 ' C ' ' A' ' 68' ' ' LEU . 3.2 tm? -118.62 120.8 38.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.666 HG22 ' HG2' ' A' ' 70' ' ' GLU . 6.1 p -145.21 121.56 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.173 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.666 ' HG2' HG22 ' A' ' 69' ' ' VAL . 10.7 mm-40 58.16 22.53 9.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.858 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.96 -25.23 17.64 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.466 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.439 HG22 ' HB ' ' A' ' 37' ' ' THR . 2.1 mp -82.29 114.57 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.847 0.356 . . . . 0.0 111.144 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.618 HD23 HG21 ' A' ' 43' ' ' VAL . 4.1 mm? -73.86 120.54 19.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.428 ' HA ' HG22 ' A' ' 37' ' ' THR . 47.8 t60 -91.4 139.48 30.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.582 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -91.55 160.22 37.14 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.575 0.702 . . . . 0.0 111.092 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.582 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.2 Cg_endo -69.88 -172.79 0.63 Allowed 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.687 2.258 . . . . 0.0 112.304 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -77.02 -2.56 34.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.269 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.44 -29.43 9.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.78 -164.72 14.06 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.526 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.606 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 94.7 m95 -85.59 -59.42 2.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.775 0.322 . . . . 0.0 110.861 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.92 -162.17 38.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.493 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.49 36.99 4.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.851 0.358 . . . . 0.0 110.883 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.543 HD23 HG12 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -88.91 -173.85 4.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.891 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.716 HG22 ' CG2' ' A' ' 20' ' ' THR . 61.3 t -104.07 138.31 29.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.079 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.684 ' CE1' HD12 ' A' ' 53' ' ' LEU . 2.7 p90 -108.31 146.05 33.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.6 t -100.8 127.22 54.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.14 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.3 t -71.1 146.24 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.145 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -145.11 104.01 3.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.953 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.959 -179.888 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.5 p90 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.866 0.365 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.738 HG23 HG13 ' A' ' 30' ' ' ILE . 6.5 tt -109.1 123.16 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.095 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -118.45 104.51 10.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.005 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.57 HG12 HD12 ' A' ' 83' ' ' LEU . 7.4 m -147.35 153.17 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.336 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.579 ' CG2' HG22 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -127.1 151.18 48.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.082 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.07 -49.11 30.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -106.65 167.32 9.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.942 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -78.9 -38.05 38.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.202 0.525 . . . . 0.0 111.34 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -69.25 -26.57 64.84 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.936 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.85 130.47 34.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -62.15 156.26 60.28 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.603 0.715 . . . . 0.0 110.918 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 119.14 6.14 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.656 2.237 . . . . 0.0 112.388 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.843 HD11 HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -83.49 142.72 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.156 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -106.82 122.71 46.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.82 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.843 HG23 HD11 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -127.2 159.56 64.47 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.641 0.734 . . . . 0.0 111.092 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.86 145.59 57.03 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.667 2.245 . . . . 0.0 112.31 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.579 ' HB2' HG22 ' A' ' 38' ' ' VAL . 1.1 p -135.73 171.7 14.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.403 ' HG2' HD23 ' A' ' 39' ' ' LEU . 7.7 mm-40 -74.2 167.09 22.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -73.41 -27.34 61.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.847 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -71.03 -19.58 62.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.857 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.84 -8.28 21.67 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.448 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.488 ' HB ' HG22 ' A' ' 72' ' ' ILE . 20.0 p -86.18 -178.04 6.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.9 0.381 . . . . 0.0 111.125 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.608 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 55.4 t -135.35 127.68 47.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.186 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.403 HD23 ' HG2' ' A' ' 33' ' ' GLU . 3.6 mm? -63.0 143.78 57.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.693 HD13 ' O ' ' A' ' 40' ' ' LEU . 3.3 tm? -61.67 -30.44 70.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.0 t -62.8 -37.24 85.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.863 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 17.9 m -76.24 -23.51 54.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.094 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.828 HG21 HD23 ' A' ' 73' ' ' LEU . 25.6 t -72.25 -38.68 62.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.188 0.518 . . . . 0.0 111.341 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.9 p -77.82 -15.2 59.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.575 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.12 -46.69 86.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.941 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -112.18 -21.13 11.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.094 0.473 . . . . 0.0 111.265 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -124.98 75.01 66.83 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 121.647 0.737 . . . . 0.0 110.896 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.77 131.12 20.55 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.647 2.231 . . . . 0.0 112.379 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.76 5.91 89.46 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.488 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.572 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -86.98 114.3 23.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 0.0 111.093 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 m -98.86 -53.03 3.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.547 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -119.14 130.92 8.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.49 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.584 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -115.79 139.96 49.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.026 0.441 . . . . 0.0 110.705 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -109.04 170.74 7.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.751 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.45 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 7.8 m-85 -107.48 126.7 52.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.86 103.04 7.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 121.654 0.74 . . . . 0.0 110.926 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.45 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 59.6 t -58.12 136.94 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.878 0.371 . . . . 0.0 111.104 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -86.32 138.41 31.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.481 HD21 ' HA2' ' A' ' 71' ' ' GLY . 2.2 tm? -119.16 114.29 22.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.884 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.662 HG22 ' HG3' ' A' ' 70' ' ' GLU . 5.9 p -135.46 121.05 30.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.181 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.662 ' HG3' HG22 ' A' ' 69' ' ' VAL . 4.1 mt-10 57.77 23.05 9.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.481 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . 92.94 -24.84 22.56 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.509 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.488 HG22 ' HB ' ' A' ' 37' ' ' THR . 4.2 mp -80.22 111.52 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 111.173 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.828 HD23 HG21 ' A' ' 43' ' ' VAL . 4.1 mm? -73.12 109.06 6.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.924 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -84.24 137.22 33.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.625 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -89.29 160.32 42.81 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.552 0.691 . . . . 0.0 111.104 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.572 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.0 Cg_endo -69.92 -172.92 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.724 2.283 . . . . 0.0 112.292 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -76.98 -2.45 33.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.317 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.33 -29.64 9.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.097 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.38 -164.87 14.46 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.496 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.625 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 94.5 m95 -86.75 -59.42 2.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.758 0.313 . . . . 0.0 110.898 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.08 -163.19 32.98 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.484 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.34 37.69 4.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.806 0.336 . . . . 0.0 110.9 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.57 HD12 HG12 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -92.42 -175.8 4.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.579 HG22 ' CG2' ' A' ' 20' ' ' THR . 43.8 t -99.47 136.2 31.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.099 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.584 ' CE2' HD12 ' A' ' 53' ' ' LEU . 6.4 p90 -104.16 145.86 29.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.969 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.7 t -101.8 116.59 45.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.087 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.7 m -63.21 143.23 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.156 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -144.96 106.08 4.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.938 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 -179.909 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 26.0 p90 . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.849 0.357 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.754 HG23 HG13 ' A' ' 30' ' ' ILE . 5.7 tt -109.91 123.83 66.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.103 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.66 103.64 10.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.042 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.528 HG12 HD23 ' A' ' 83' ' ' LEU . 8.3 m -147.91 155.32 10.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.38 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.601 ' CG2' HG22 ' A' ' 84' ' ' VAL . 0.8 OUTLIER -129.41 153.57 47.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.11 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.568 ' HG2' HG13 ' A' ' 87' ' ' VAL . 0.5 OUTLIER -79.79 -49.88 11.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.41 143.61 32.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -67.9 -30.8 70.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.929 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -67.04 -26.55 66.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.876 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -90.14 170.23 10.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.832 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -94.37 159.61 33.54 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.662 0.744 . . . . 0.0 110.853 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 112.85 3.2 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.675 2.25 . . . . 0.0 112.367 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.512 HD12 ' H ' ' A' ' 29' ' ' GLU . 5.0 tp -77.72 140.13 17.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.898 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.512 ' H ' HD12 ' A' ' 28' ' ' ILE . 3.0 mp0 -101.77 117.52 35.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.762 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.754 HG13 HG23 ' A' ' 17' ' ' ILE . 0.6 OUTLIER -123.94 159.58 55.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.645 0.736 . . . . 0.0 111.148 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 152.13 68.82 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.659 2.239 . . . . 0.0 112.357 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.653 ' HB2' HG22 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -142.3 155.91 45.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.863 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.597 ' HG2' HD23 ' A' ' 39' ' ' LEU . 4.0 mm-40 -57.51 166.4 1.28 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -70.18 -33.19 71.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -63.68 -20.25 65.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 113.57 -12.94 23.09 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.451 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.577 HG22 ' HA ' ' A' ' 74' ' ' HIS . 33.2 p -82.48 -177.16 6.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.833 0.349 . . . . 0.0 111.128 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.653 HG22 ' HB2' ' A' ' 32' ' ' SER . 53.3 t -130.9 123.3 53.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.179 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.597 HD23 ' HG2' ' A' ' 33' ' ' GLU . 1.9 mm? -61.89 145.57 52.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.64 ' O ' HG23 ' A' ' 44' ' ' THR . 3.0 tm? -61.04 -24.24 66.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.901 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.8 p -67.52 -44.16 79.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.5 m -71.16 -30.42 66.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.156 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.859 HG21 HD23 ' A' ' 73' ' ' LEU . 21.3 t -65.47 -35.2 74.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.989 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.64 HG23 ' O ' ' A' ' 40' ' ' LEU . 21.7 p -79.6 -15.74 57.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.581 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.12 90.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -112.11 -25.57 9.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.091 0.472 . . . . 0.0 111.342 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -125.35 75.63 68.68 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.609 0.719 . . . . 0.0 110.89 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 133.03 24.62 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.694 2.263 . . . . 0.0 112.311 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.33 6.02 89.46 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.511 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.578 ' HB1' HD21 ' A' ' 53' ' ' LEU . . . -84.02 117.22 23.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.8 0.333 . . . . 0.0 111.083 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 2.4 m -101.22 -53.22 3.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.846 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.611 ' O ' HD23 ' A' ' 53' ' ' LEU . . . -121.23 135.0 10.39 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.427 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.665 HD13 ' CD2' ' A' ' 85' ' ' TYR . 12.9 mt -122.93 146.27 47.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.781 0.324 . . . . 0.0 110.919 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.404 ' HB2' ' HB ' ' A' ' 86' ' ' VAL . 24.5 mtt180 -116.59 171.71 7.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.648 ' CD1' HD11 ' A' ' 83' ' ' LEU . 5.6 m-85 -106.06 126.65 52.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.95 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -128.3 107.23 9.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.842 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 121.684 0.754 . . . . 0.0 110.866 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.533 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 91.3 t -85.11 143.05 12.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.784 0.326 . . . . 0.0 111.133 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -99.62 138.56 36.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.836 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.522 HD21 ' HA2' ' A' ' 71' ' ' GLY . 1.9 tm? -116.28 115.97 26.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.669 HG22 ' HG3' ' A' ' 70' ' ' GLU . 6.0 p -134.03 121.12 37.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.147 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.669 ' HG3' HG22 ' A' ' 69' ' ' VAL . 4.1 mt-10 58.92 23.65 11.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.522 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . 93.19 -24.56 24.43 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.509 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.575 HG22 ' HB ' ' A' ' 37' ' ' THR . 4.6 mp -82.73 114.62 23.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.857 0.36 . . . . 0.0 111.151 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.859 HD23 HG21 ' A' ' 43' ' ' VAL . 4.0 mm? -74.64 100.29 3.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.969 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.577 ' HA ' HG22 ' A' ' 37' ' ' THR . 6.4 t60 -76.96 136.48 38.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.845 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.553 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -85.36 159.67 55.68 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.582 0.706 . . . . 0.0 111.092 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.553 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.8 Cg_endo -70.02 -173.22 0.71 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.618 2.212 . . . . 0.0 112.317 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -77.32 -1.98 32.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.182 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.91 -32.95 8.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.108 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.17 -165.18 19.47 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.51 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.621 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 83.8 m95 -86.64 -59.55 2.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.868 0.366 . . . . 0.0 110.844 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.71 -164.37 32.81 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.491 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -127.68 36.73 4.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.851 0.358 . . . . 0.0 110.858 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.648 HD11 ' CD1' ' A' ' 55' ' ' TYR . 0.8 OUTLIER -91.87 -173.71 3.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.907 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.601 HG22 ' CG2' ' A' ' 20' ' ' THR . 42.9 t -101.12 136.69 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.121 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.665 ' CD2' HD13 ' A' ' 53' ' ' LEU . 4.4 p90 -101.33 139.59 36.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.943 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 54' ' ' ARG . 20.5 t -97.49 114.76 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.149 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.568 HG13 ' HG2' ' A' ' 21' ' ' GLU . 23.3 m -61.29 147.82 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.108 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -145.36 96.8 2.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.916 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 45.6 p90 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.933 -179.922 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 34.1 p90 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.827 0.346 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.763 HG23 HG13 ' A' ' 30' ' ' ILE . 5.1 tt -121.46 123.32 69.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.098 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -121.97 103.76 9.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.095 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.732 HG12 HD12 ' A' ' 83' ' ' LEU . 16.3 m -143.53 149.64 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.355 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.558 HG23 HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -121.18 151.13 40.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.145 179.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.411 ' CG ' HG13 ' A' ' 87' ' ' VAL . 0.5 OUTLIER -79.59 -49.97 11.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.951 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.28 139.49 37.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -65.67 -33.34 75.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.829 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -71.78 -26.51 62.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -78.31 -171.01 2.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.79 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.4 154.92 43.55 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.382 0.611 . . . . 0.0 111.273 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.87 126.15 12.9 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.806 2.338 . . . . 0.0 112.362 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.413 HD12 ' H ' ' A' ' 29' ' ' GLU . 3.7 tp -98.69 131.92 44.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.413 ' H ' HD12 ' A' ' 28' ' ' ILE . 16.1 pt-20 -99.03 123.12 43.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.724 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.763 HG13 HG23 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -127.02 159.67 63.5 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.614 0.721 . . . . 0.0 111.093 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 152.32 69.43 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.663 2.242 . . . . 0.0 112.374 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.658 ' HB2' HG22 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -141.98 163.37 33.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -68.34 161.56 27.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -67.09 -27.17 67.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.803 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.63 -18.9 65.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.799 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.04 -12.81 34.32 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.481 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.517 HG22 ' HA ' ' A' ' 74' ' ' HIS . 43.2 p -83.65 -172.42 4.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.853 0.359 . . . . 0.0 111.102 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.658 HG22 ' HB2' ' A' ' 32' ' ' SER . 45.0 t -137.66 119.23 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.089 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.3 tp -59.71 142.4 53.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.937 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 44' ' ' THR . 23.0 tp -59.0 -21.12 58.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.953 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.4 t -68.39 -34.69 76.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.947 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.8 m -80.57 -30.65 36.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.179 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.959 HG21 HD23 ' A' ' 73' ' ' LEU . 25.5 t -64.84 -36.43 77.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.032 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 40' ' ' LEU . 32.1 p -79.95 -15.46 57.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.537 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.74 -44.64 85.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.956 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -111.35 -23.59 10.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.003 0.43 . . . . 0.0 111.261 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -124.82 74.9 65.33 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.669 0.747 . . . . 0.0 110.896 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 131.52 21.41 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.627 2.218 . . . . 0.0 112.326 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.9 5.52 89.71 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.431 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.56 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -84.69 114.86 22.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.724 0.297 . . . . 0.0 111.059 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 2.5 t -91.64 -52.87 4.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.881 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.533 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -127.18 136.17 9.19 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.543 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.576 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.8 OUTLIER -115.65 137.56 51.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.052 0.453 . . . . 0.0 110.652 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -107.47 170.41 7.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.682 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.593 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 9.8 m-85 -108.0 126.37 52.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.957 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -128.68 122.22 30.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 121.544 0.687 . . . . 0.0 110.877 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 112.613 -0.195 . . . . 0.0 112.613 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.593 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 50.5 t -72.36 134.95 28.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.849 0.357 . . . . 0.0 111.11 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.458 ' HE ' HG23 ' A' ' 69' ' ' VAL . 4.4 tpt180 -77.2 138.77 39.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.867 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.504 HD13 ' C ' ' A' ' 68' ' ' LEU . 3.3 tm? -116.38 107.56 14.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.458 HG23 ' HE ' ' A' ' 67' ' ' ARG . 15.1 t -115.77 105.96 19.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.19 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 50.52 40.19 22.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.436 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . 90.31 -25.9 11.55 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.537 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.461 HG22 ' HB ' ' A' ' 37' ' ' THR . 2.7 mp -78.18 110.38 13.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.842 0.353 . . . . 0.0 111.116 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.959 HD23 HG21 ' A' ' 43' ' ' VAL . 4.1 mm? -73.93 102.97 4.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.517 ' HA ' HG22 ' A' ' 37' ' ' THR . 6.6 t60 -83.61 136.25 34.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.809 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.649 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -84.4 160.15 57.4 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.594 0.711 . . . . 0.0 111.108 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.569 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.2 Cg_endo -69.95 -171.85 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.711 2.274 . . . . 0.0 112.302 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.12 -2.32 33.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.294 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.86 -30.95 8.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.125 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.86 -165.73 14.7 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.441 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.649 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 95.4 m95 -86.59 -59.18 2.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.807 0.337 . . . . 0.0 110.936 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.2 -167.13 48.96 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.456 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -117.88 38.81 3.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.896 0.379 . . . . 0.0 110.862 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.732 HD12 HG12 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -87.22 -175.33 5.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.993 179.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.558 HG22 HG23 ' A' ' 20' ' ' THR . 39.6 t -106.71 134.33 48.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.102 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.576 ' CE2' HD12 ' A' ' 53' ' ' LEU . 3.7 p90 -100.75 146.03 27.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 63.4 t -106.47 112.77 40.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.089 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.411 HG13 ' CG ' ' A' ' 21' ' ' GLU . 4.7 m -53.87 143.73 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.135 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -145.13 105.68 4.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.915 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.4 p90 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.884 0.373 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.735 HG23 HG13 ' A' ' 30' ' ' ILE . 7.0 tt -126.95 121.28 57.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.024 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -119.32 101.53 8.04 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.231 0.539 . . . . 0.0 110.442 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.595 HG12 ' CD2' ' A' ' 83' ' ' LEU . 6.7 m -139.77 159.84 27.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.062 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.19 156.95 47.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.155 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.429 ' OE2' HG22 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -83.7 -57.87 3.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.28 164.26 14.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -85.35 -28.5 25.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.099 0.476 . . . . 0.0 111.287 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -70.05 -44.42 69.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.839 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -65.02 -170.57 0.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.841 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -116.96 160.53 36.61 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.383 0.611 . . . . 0.0 111.297 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.94 106.45 1.7 Allowed 'Trans proline' 0 C--O 1.23 0.109 0 C-N-CA 122.664 2.243 . . . . 0.0 112.255 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.477 HD12 ' H ' ' A' ' 29' ' ' GLU . 5.0 tp -74.65 138.5 20.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.929 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.477 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -101.02 118.62 37.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.732 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.735 HG13 HG23 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -123.44 159.22 56.02 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.594 0.711 . . . . 0.0 111.174 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.42 ' O ' HG21 ' A' ' 42' ' ' THR . 54.2 Cg_endo -69.79 162.46 42.0 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.727 2.285 . . . . 0.0 112.338 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.593 ' HB2' HG22 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -149.55 175.4 11.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -75.11 178.83 5.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.843 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -81.47 -34.5 31.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.047 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.5 -29.94 70.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.105 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 121.47 16.67 4.15 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.601 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.651 HG22 ' HA ' ' A' ' 74' ' ' HIS . 52.4 p -111.18 178.84 4.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.851 0.358 . . . . 0.0 111.166 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.649 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 73.3 t -133.75 106.04 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.086 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.63 144.18 22.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.001 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.542 HD12 ' HA3' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -50.23 -31.25 13.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.946 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.0 p -52.81 -45.13 67.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.913 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.42 HG21 ' O ' ' A' ' 31' ' ' PRO . 14.4 m -75.39 -30.92 60.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.123 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.962 HG21 HD23 ' A' ' 73' ' ' LEU . 40.3 t -66.92 -43.14 89.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.986 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.2 p -74.42 -6.34 47.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.501 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.53 -46.62 63.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.949 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -114.85 -23.34 9.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.314 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -119.2 74.93 15.03 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.601 0.715 . . . . 0.0 110.852 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 130.25 19.06 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.706 2.271 . . . . 0.0 112.307 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.34 3.76 89.85 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.446 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.605 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -83.9 118.91 24.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.782 0.325 . . . . 0.0 111.077 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.3 m -100.51 -58.14 1.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.91 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.564 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -117.75 130.17 8.65 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.514 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.666 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.5 OUTLIER -114.5 140.96 48.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.93 0.395 . . . . 0.0 110.738 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.42 176.09 5.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.83 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.427 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 10.4 m-85 -111.73 134.69 53.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.932 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -144.31 117.93 9.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 121.734 0.778 . . . . 0.0 110.887 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.414 -0.274 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.456 HG12 HD12 ' A' ' 73' ' ' LEU . 27.3 t -54.5 128.77 14.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.819 0.343 . . . . 0.0 111.152 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -77.91 149.77 34.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 69' ' ' VAL . 2.7 tm? -127.61 126.37 41.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.936 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.507 HG22 ' HG2' ' A' ' 70' ' ' GLU . 6.9 p -149.01 123.42 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.172 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.507 ' HG2' HG22 ' A' ' 69' ' ' VAL . 72.8 mm-40 58.11 22.81 9.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.877 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.542 ' HA3' HD12 ' A' ' 40' ' ' LEU . . . 88.91 -14.63 59.87 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.526 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.524 HG22 ' HB ' ' A' ' 37' ' ' THR . 2.0 mp -92.94 110.37 22.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.808 0.337 . . . . 0.0 111.131 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.962 HD23 HG21 ' A' ' 43' ' ' VAL . 4.2 mm? -66.18 121.67 15.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.998 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.651 ' HA ' HG22 ' A' ' 37' ' ' THR . 2.8 t60 -93.42 126.56 38.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.597 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -67.81 160.48 73.28 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.587 0.708 . . . . 0.0 111.195 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.597 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.1 Cg_endo -69.94 -170.92 0.44 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.69 2.26 . . . . 0.0 112.331 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.12 53.48 2.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.278 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -173.79 -40.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.837 0.351 . . . . 0.0 111.136 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.68 -176.03 21.73 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.439 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.649 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 90.9 m95 -76.09 -74.96 0.2 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.743 0.306 . . . . 0.0 110.91 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.27 -161.78 24.44 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.476 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.573 ' C ' HD13 ' A' ' 83' ' ' LEU . 2.2 m-20 -127.0 95.81 4.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 110.96 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.629 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -151.26 -176.23 5.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.986 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.8 p -101.65 127.83 54.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.128 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.666 ' CE2' HD12 ' A' ' 53' ' ' LEU . 3.4 p90 -98.62 156.25 16.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.921 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.8 t -113.14 122.37 67.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.203 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.429 HG22 ' OE2' ' A' ' 21' ' ' GLU . 27.9 m -66.54 150.81 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.161 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -144.51 92.14 2.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 44.4 p90 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.954 -179.885 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.0 p90 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.939 0.4 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.753 HG23 HG13 ' A' ' 30' ' ' ILE . 6.1 tt -118.14 123.28 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.105 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.43 103.82 10.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.09 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.416 ' O ' HG22 ' A' ' 28' ' ' ILE . 12.4 m -147.49 150.79 14.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.409 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.698 ' CG2' HG22 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -121.06 155.83 33.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.195 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -71.28 -48.32 51.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.1 170.85 8.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.923 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -87.18 -24.52 24.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.207 0.527 . . . . 0.0 111.447 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -66.15 -26.29 67.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.836 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -96.68 -171.42 2.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.809 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -108.72 159.36 31.23 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.343 0.592 . . . . 0.0 111.309 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.96 124.63 11.18 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.671 2.247 . . . . 0.0 112.367 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.484 HD12 ' H ' ' A' ' 29' ' ' GLU . 4.6 tp -92.83 137.41 22.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.897 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.484 ' H ' HD12 ' A' ' 28' ' ' ILE . 1.4 pp20? -99.31 122.02 41.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.731 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.753 HG13 HG23 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -126.82 159.9 61.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.616 0.722 . . . . 0.0 111.11 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 142.55 48.39 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.731 2.287 . . . . 0.0 112.361 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.543 ' HB2' HG22 ' A' ' 38' ' ' VAL . 6.3 p -131.63 168.45 17.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.835 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -72.31 156.7 38.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -64.87 -30.49 71.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -67.01 -19.46 65.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.63 -16.35 16.64 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.469 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.578 ' HB ' HG22 ' A' ' 72' ' ' ILE . 30.6 p -81.54 -172.84 4.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.362 . . . . 0.0 111.134 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.6 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 55.9 t -140.74 120.45 12.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.1 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.8 mt -58.7 144.0 44.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.762 HD12 ' CA ' ' A' ' 71' ' ' GLY . 1.6 tt -61.23 -21.99 64.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.944 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.8 m -65.61 -37.65 87.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.7 m -77.51 -30.43 52.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.15 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.728 HG21 HD23 ' A' ' 73' ' ' LEU . 25.6 t -65.58 -37.71 80.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.048 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 40' ' ' LEU . 33.8 p -78.19 -15.32 58.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.614 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.02 -45.98 83.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.887 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -111.94 -16.96 13.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.969 0.414 . . . . 0.0 111.223 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -132.39 75.22 74.48 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.62 0.724 . . . . 0.0 110.887 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 127.54 14.73 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.737 2.291 . . . . 0.0 112.323 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.7 -15.89 59.39 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.538 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.517 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -62.35 110.18 1.57 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.697 0.284 . . . . 0.0 111.096 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.7 t -92.87 -42.86 9.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.187 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.686 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -129.43 137.29 9.47 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.406 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.792 HD12 ' CE1' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -120.27 133.34 55.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.988 0.423 . . . . 0.0 110.707 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -107.02 171.91 7.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.71 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -107.99 125.75 51.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.918 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -129.22 104.22 7.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.499 ' OD1' HD12 ' A' ' 83' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 121.615 0.721 . . . . 0.0 110.88 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.78 143.14 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.839 0.352 . . . . 0.0 111.087 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -90.63 130.72 36.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.497 HD13 ' C ' ' A' ' 68' ' ' LEU . 2.8 tm? -110.93 114.54 27.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.69 HG22 ' HG2' ' A' ' 70' ' ' GLU . 7.7 p -137.82 124.68 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.125 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.69 ' HG2' HG22 ' A' ' 69' ' ' VAL . 5.3 mm-40 57.17 22.77 7.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.762 ' CA ' HD12 ' A' ' 40' ' ' LEU . . . 91.97 -24.94 18.87 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.501 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.578 HG22 ' HB ' ' A' ' 37' ' ' THR . 3.3 mp -83.05 121.05 35.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.816 0.341 . . . . 0.0 111.176 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.728 HD23 HG21 ' A' ' 43' ' ' VAL . 3.9 mm? -80.13 109.85 14.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.913 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.55 ' HA ' HG22 ' A' ' 37' ' ' THR . 6.0 t60 -86.76 135.54 33.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.596 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -84.09 159.85 58.87 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.543 0.687 . . . . 0.0 111.199 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.562 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.6 Cg_endo -69.84 -172.26 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.72 2.28 . . . . 0.0 112.376 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -76.98 -2.49 34.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.253 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.92 -29.09 9.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.21 -168.07 14.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.527 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.6 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 93.8 m95 -82.78 -59.23 2.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.809 0.338 . . . . 0.0 110.875 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.35 -166.61 32.06 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.492 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -127.91 38.28 4.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 0.0 110.9 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.692 HD13 ' H ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.55 -175.73 3.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.698 HG22 ' CG2' ' A' ' 20' ' ' THR . 48.2 t -94.64 146.92 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.792 ' CE1' HD12 ' A' ' 53' ' ' LEU . 3.4 p90 -116.9 146.15 43.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.976 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 88.8 t -96.41 130.18 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.113 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.51 HG22 ' CE1' ' A' ' 85' ' ' TYR . 2.1 t -85.16 133.08 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.084 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -145.39 136.17 24.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.883 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.975 -179.943 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 42.5 p90 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.886 0.374 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.4 ' CG2' HG13 ' A' ' 30' ' ' ILE . 2.6 tt -115.54 125.51 72.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.153 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -120.64 104.99 10.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.01 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.543 HG12 HD23 ' A' ' 83' ' ' LEU . 16.1 m -148.74 148.01 16.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.325 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.59 HG23 HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -122.46 153.81 38.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.11 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.9 -49.73 23.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -115.4 144.17 44.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -63.89 -25.27 68.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -72.5 -26.71 61.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -88.93 172.3 9.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.825 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -89.92 153.34 47.24 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.658 0.742 . . . . 0.0 110.864 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.425 ' HA ' ' HB ' ' A' ' 20' ' ' THR . 53.3 Cg_endo -69.79 116.44 4.57 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.697 2.264 . . . . 0.0 112.284 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.537 HD13 ' HG3' ' A' ' 46' ' ' GLN . 1.0 OUTLIER -72.12 162.48 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.119 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.431 ' N ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -136.77 111.66 8.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.437 HD12 HG22 ' A' ' 42' ' ' THR . 6.7 pt -126.79 155.6 75.02 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.648 0.737 . . . . 0.0 111.076 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 145.6 57.51 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.631 2.221 . . . . 0.0 112.319 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.477 ' HB2' HG22 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -119.68 171.45 8.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -67.62 -179.32 1.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -73.24 -43.56 60.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.986 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -65.33 -17.04 64.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.855 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.17 -24.57 9.23 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.536 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.609 HG22 ' HA ' ' A' ' 74' ' ' HIS . 43.6 p -61.78 -173.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.801 0.334 . . . . 0.0 111.166 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.601 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 47.1 t -137.21 122.13 24.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.5 tp -61.12 146.57 46.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.682 HD13 ' O ' ' A' ' 40' ' ' LEU . 2.6 tm? -62.34 -34.24 76.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.851 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.5 t -60.91 -27.89 68.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.796 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.437 HG22 HD12 ' A' ' 30' ' ' ILE . 8.8 m -87.35 -26.65 23.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.101 0.477 . . . . 0.0 111.549 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.848 HG21 HD23 ' A' ' 73' ' ' LEU . 12.2 t -66.87 -40.06 84.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.061 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.2 p -71.91 -13.58 61.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.169 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.98 -48.49 81.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.537 ' HG3' HD13 ' A' ' 28' ' ' ILE . 66.7 mm-40 -112.36 -19.14 12.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.298 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -125.44 74.96 69.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.623 0.725 . . . . 0.0 110.901 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 136.28 32.8 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.703 2.269 . . . . 0.0 112.343 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.71 6.44 66.89 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.487 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.52 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -83.52 123.01 29.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.722 0.296 . . . . 0.0 111.134 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.1 m -101.07 -52.88 3.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.893 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.577 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -122.35 132.69 8.91 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.458 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.631 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -115.24 138.25 51.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.948 0.404 . . . . 0.0 110.759 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -107.51 171.28 7.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.648 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.639 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 10.9 m-85 -110.34 126.39 54.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -128.78 108.74 10.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 121.607 0.717 . . . . 0.0 110.859 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.639 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 21.3 t -59.11 136.1 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.811 0.339 . . . . 0.0 111.166 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -84.07 138.41 33.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.931 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.487 HD22 ' N ' ' A' ' 69' ' ' VAL . 2.6 tm? -119.98 124.21 45.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.954 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.613 HG22 ' HG2' ' A' ' 70' ' ' GLU . 6.2 p -147.32 121.84 2.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.165 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.613 ' HG2' HG22 ' A' ' 69' ' ' VAL . 8.5 mm-40 58.36 22.52 9.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.872 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.72 -24.78 22.16 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.491 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.528 HG22 ' HB ' ' A' ' 37' ' ' THR . 3.9 mt -82.54 115.69 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.794 0.331 . . . . 0.0 111.134 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.848 HD23 HG21 ' A' ' 43' ' ' VAL . 4.2 mm? -75.69 111.62 11.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.966 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.609 ' HA ' HG22 ' A' ' 37' ' ' THR . 6.7 t60 -86.45 135.97 33.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.614 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -84.84 160.07 56.38 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.589 0.709 . . . . 0.0 111.135 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.559 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.6 Cg_endo -70.0 -173.37 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.702 2.268 . . . . 0.0 112.35 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.3 -2.41 34.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.3 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.78 -28.69 9.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.136 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.78 -169.23 13.78 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.444 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.614 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 98.0 m95 -82.87 -58.79 2.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.851 0.358 . . . . 0.0 110.935 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.04 -160.91 34.1 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.43 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -127.36 37.19 4.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.821 0.343 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.543 HD23 HG12 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -91.57 -175.71 4.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.914 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.59 HG22 HG23 ' A' ' 20' ' ' THR . 47.0 t -100.04 140.07 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.631 ' CE2' HD12 ' A' ' 53' ' ' LEU . 2.9 p90 -105.62 146.12 30.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.011 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 87.4 t -103.92 124.91 58.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.107 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.0 t -69.83 147.39 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.147 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -145.21 96.71 2.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.95 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.913 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.4 p90 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.843 0.354 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.752 HG23 HG13 ' A' ' 30' ' ' ILE . 6.1 tt -119.48 122.95 70.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.222 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.2 103.84 10.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.107 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.462 ' O ' HG22 ' A' ' 28' ' ' ILE . 6.7 m -147.61 153.18 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.33 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.581 ' CG2' HG22 ' A' ' 84' ' ' VAL . 0.6 OUTLIER -126.77 149.78 49.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.067 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.51 -50.0 15.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -101.88 149.66 23.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -75.32 -31.5 60.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.139 0.495 . . . . 0.0 111.215 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -66.93 -26.69 66.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.89 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -87.46 -175.92 5.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.88 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -107.27 159.69 29.2 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.374 0.606 . . . . 0.0 111.304 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.92 118.98 6.0 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.686 2.257 . . . . 0.0 112.386 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.859 HD11 HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -85.27 143.52 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.156 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.69 121.28 43.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.89 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.859 HG23 HD11 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -127.1 159.95 62.19 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.71 . . . . 0.0 111.213 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 148.84 65.79 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.658 2.239 . . . . 0.0 112.326 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.548 ' HB3' HG22 ' A' ' 38' ' ' VAL . 1.3 m -140.35 168.41 19.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.889 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -75.71 158.34 32.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -65.82 -29.61 70.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.856 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -65.28 -19.42 65.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.885 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 113.4 -14.26 23.0 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.466 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.489 ' HB ' HG22 ' A' ' 72' ' ' ILE . 22.3 p -85.24 -176.77 6.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.761 0.315 . . . . 0.0 111.222 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.622 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 70.0 t -138.23 122.57 21.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.176 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 30.3 mt -58.88 146.77 36.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.4 ' O ' HG23 ' A' ' 44' ' ' THR . 22.6 tp -62.76 -23.25 67.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.952 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.8 t -65.1 -33.51 76.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.934 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.2 m -82.9 -29.64 29.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.199 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.839 HG21 HD23 ' A' ' 73' ' ' LEU . 40.0 t -66.99 -40.96 86.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.985 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 40' ' ' LEU . 30.8 p -76.88 -14.81 59.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.533 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.79 -47.77 79.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.915 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -112.12 -20.34 11.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.998 0.428 . . . . 0.0 111.325 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -124.38 75.4 61.53 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.639 0.733 . . . . 0.0 110.857 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 131.91 22.22 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.72 2.28 . . . . 0.0 112.339 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.17 6.33 89.25 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.524 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.708 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -86.81 107.76 18.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.78 0.324 . . . . 0.0 111.094 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.5 t -93.72 -52.93 4.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.554 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -118.9 129.12 7.97 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.477 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.708 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -115.69 136.85 52.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.02 0.438 . . . . 0.0 110.65 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.7 ttm-85 -107.39 171.17 7.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.779 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -105.96 126.34 52.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.91 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -128.43 103.62 7.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.478 ' OD1' HD12 ' A' ' 83' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 121.703 0.764 . . . . 0.0 110.863 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.23 142.57 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.889 0.376 . . . . 0.0 111.132 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -91.21 138.54 31.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.775 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.476 HD13 ' C ' ' A' ' 68' ' ' LEU . 2.4 tm? -116.15 117.13 29.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.641 HG22 ' HG3' ' A' ' 70' ' ' GLU . 6.2 p -138.07 122.18 21.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.123 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.641 ' HG3' HG22 ' A' ' 69' ' ' VAL . 5.2 mt-10 57.65 22.64 8.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.424 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . 92.65 -24.8 21.83 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.538 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.489 HG22 ' HB ' ' A' ' 37' ' ' THR . 3.4 mt -82.53 112.79 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.822 0.344 . . . . 0.0 111.127 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.839 HD23 HG21 ' A' ' 43' ' ' VAL . 4.2 mm? -73.18 111.22 8.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.473 ' HA ' HG22 ' A' ' 37' ' ' THR . 5.6 t60 -84.65 135.58 34.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.557 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -88.83 159.74 45.33 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.516 0.674 . . . . 0.0 111.174 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.557 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.5 Cg_endo -69.92 -173.12 0.68 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.698 2.266 . . . . 0.0 112.387 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -77.28 -2.12 33.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.272 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.13 -30.27 8.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.101 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.55 -164.69 15.47 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.521 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.622 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 95.1 m95 -85.64 -59.54 2.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.807 0.337 . . . . 0.0 110.918 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.16 -165.63 30.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.585 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -128.44 38.5 3.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.873 0.368 . . . . 0.0 110.908 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.704 HD13 ' H ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.42 -175.66 3.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.919 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.581 HG22 ' CG2' ' A' ' 20' ' ' THR . 45.6 t -95.43 140.39 17.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.162 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.618 ' CE2' HD12 ' A' ' 53' ' ' LEU . 7.2 p90 -109.9 145.46 36.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.979 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.3 t -101.28 119.77 49.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.051 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.2 m -66.63 150.98 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.092 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -145.06 102.5 3.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 -179.915 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.5 p90 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.876 0.37 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.716 HG23 HG13 ' A' ' 30' ' ' ILE . 6.3 tt -121.2 123.29 69.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.149 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.21 103.89 10.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.45 ' O ' HG22 ' A' ' 28' ' ' ILE . 9.6 m -147.49 150.17 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.262 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.421 HG23 HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -124.12 148.92 46.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.197 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -72.56 -49.56 31.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -114.49 139.55 49.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.858 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.69 -18.27 58.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -73.87 -26.57 60.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.67 137.42 41.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.902 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -58.32 159.85 10.73 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.589 0.709 . . . . 0.0 110.925 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.405 ' HA ' ' HB ' ' A' ' 20' ' ' THR . 54.3 Cg_endo -69.68 124.27 10.94 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.612 2.208 . . . . 0.0 112.339 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.871 HD11 HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -85.34 143.53 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.144 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -105.89 121.45 44.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.871 HG23 HD11 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -127.15 159.6 64.14 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.611 0.72 . . . . 0.0 111.124 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 153.72 68.77 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.675 2.25 . . . . 0.0 112.373 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.579 ' HB2' HG22 ' A' ' 38' ' ' VAL . 1.1 p -142.25 162.4 35.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.818 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -68.9 159.59 32.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -65.65 -26.41 67.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -68.93 -19.38 64.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 113.08 -16.13 22.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.48 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.6 HG22 ' HA ' ' A' ' 74' ' ' HIS . 38.7 p -82.23 -172.44 3.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.815 0.34 . . . . 0.0 111.162 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.624 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 67.9 t -139.39 119.08 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.119 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.43 148.54 27.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.744 HD12 ' CA ' ' A' ' 71' ' ' GLY . 1.7 tt -63.02 -23.08 67.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.922 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.8 p -65.22 -36.41 84.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.2 m -80.13 -27.93 39.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.119 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.914 HG21 HD23 ' A' ' 73' ' ' LEU . 41.2 t -67.89 -42.03 85.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.027 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.546 HG23 HD23 ' A' ' 40' ' ' LEU . 30.1 p -76.12 -14.62 60.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.567 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.16 -48.0 77.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.902 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -112.13 -17.4 12.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.335 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -127.88 75.49 78.17 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.564 0.697 . . . . 0.0 110.853 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.78 131.44 21.22 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.701 2.267 . . . . 0.0 112.33 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.48 6.27 89.39 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.531 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.638 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -88.17 107.01 18.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.826 0.346 . . . . 0.0 111.099 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.6 t -91.78 -53.07 4.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.874 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.583 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -119.34 130.74 8.67 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.514 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.638 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -115.28 139.74 49.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.082 0.468 . . . . 0.0 110.664 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.39 171.07 7.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.751 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -106.14 126.81 52.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.921 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -125.5 103.75 8.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.808 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.454 ' OD1' HD12 ' A' ' 83' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 121.597 0.713 . . . . 0.0 110.94 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.385 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.9 t -68.31 144.2 14.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 0.0 111.188 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -90.03 138.94 31.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.465 HD13 ' C ' ' A' ' 68' ' ' LEU . 2.2 tm? -122.23 116.48 24.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.887 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.581 HG22 ' HG2' ' A' ' 70' ' ' GLU . 7.0 p -137.82 123.47 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.174 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.581 ' HG2' HG22 ' A' ' 69' ' ' VAL . 29.5 mm-40 58.6 22.75 10.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.817 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.744 ' CA ' HD12 ' A' ' 40' ' ' LEU . . . 92.47 -24.99 20.29 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.529 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.549 HG22 ' HB ' ' A' ' 37' ' ' THR . 3.8 mp -82.01 115.34 24.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.841 0.353 . . . . 0.0 111.146 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.914 HD23 HG21 ' A' ' 43' ' ' VAL . 4.1 mm? -74.23 108.75 7.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.948 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.6 ' HA ' HG22 ' A' ' 37' ' ' THR . 6.3 t60 -85.9 135.76 33.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.568 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -84.22 159.74 58.75 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.604 0.716 . . . . 0.0 111.054 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.556 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.8 Cg_endo -70.0 -172.88 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.677 2.251 . . . . 0.0 112.286 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -77.17 -2.0 32.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.301 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.38 -30.45 8.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.108 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.16 -169.21 16.24 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.505 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.624 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 77.4 m95 -81.24 -59.29 2.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.792 0.33 . . . . 0.0 110.895 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.71 -170.14 36.31 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.473 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -127.1 38.51 4.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.863 0.363 . . . . 0.0 110.901 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.699 HD13 ' H ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.25 -175.0 3.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.982 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.421 HG22 HG23 ' A' ' 20' ' ' THR . 20.6 t -94.61 145.2 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.129 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.556 ' CE2' HD12 ' A' ' 53' ' ' LEU . 5.9 p90 -116.14 146.05 42.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.988 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 99.0 t -101.44 120.91 51.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.103 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.2 m -67.48 148.98 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -145.01 107.07 4.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.93 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.895 -179.886 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 35.6 p90 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.885 0.374 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.73 HG23 HG13 ' A' ' 30' ' ' ILE . 5.5 tt -120.14 123.39 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.138 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.95 104.41 10.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.112 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.585 HG12 HD12 ' A' ' 83' ' ' LEU . 5.9 m -144.96 157.42 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.367 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 1.083 HG23 HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -138.61 146.67 42.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.173 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.428 ' CG ' HG13 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -74.22 -50.12 20.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.842 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -102.42 137.52 40.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -69.49 -26.63 64.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -66.55 -26.33 67.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -91.74 -174.61 3.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.99 154.95 37.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.64 0.733 . . . . 0.0 110.907 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 110.84 2.66 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.738 2.292 . . . . 0.0 112.27 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.879 HD11 HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -72.18 144.2 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.189 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.21 122.26 46.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.862 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.879 HG23 HD11 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -127.32 159.98 62.5 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.624 0.725 . . . . 0.0 111.153 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.424 ' O ' HG21 ' A' ' 42' ' ' THR . 53.6 Cg_endo -69.74 147.95 64.11 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.717 2.278 . . . . 0.0 112.347 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.518 ' HB3' HG22 ' A' ' 38' ' ' VAL . 1.1 m -139.42 163.62 32.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -67.1 164.75 17.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.839 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -71.58 -28.07 63.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.897 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -68.44 -19.29 64.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.855 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.14 -14.43 21.24 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.452 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.41 ' HB ' HG22 ' A' ' 72' ' ' ILE . 18.0 p -82.93 -177.55 6.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.814 0.34 . . . . 0.0 111.111 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.602 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 57.5 t -138.09 125.81 29.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.124 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 tp -63.44 146.2 54.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.9 tp -61.52 -27.96 68.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.4 m -64.02 -30.13 71.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.795 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 31' ' ' PRO . 16.5 m -84.48 -24.71 29.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.51 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.669 HG21 HD23 ' A' ' 73' ' ' LEU . 38.7 t -72.54 -50.13 36.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.112 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.5 p -67.69 -13.78 62.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.183 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.49 -47.81 80.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.96 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -112.17 -8.8 13.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.233 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -138.35 75.9 38.5 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.621 0.724 . . . . 0.0 110.834 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.87 127.04 13.95 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.613 2.208 . . . . 0.0 112.345 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.18 -16.4 57.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.498 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.633 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -67.95 98.11 0.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.712 0.292 . . . . 0.0 111.13 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 t -84.41 -52.64 6.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.946 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.598 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -115.01 129.71 8.77 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.465 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.633 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -115.07 134.81 54.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.072 0.463 . . . . 0.0 110.683 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -108.88 167.68 9.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.709 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.645 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 9.9 m-85 -104.77 125.98 51.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.964 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.693 ' HB3' HG23 ' A' ' 84' ' ' VAL . 19.7 tpt180 -129.32 109.07 10.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.94 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 121.613 0.721 . . . . 0.0 110.912 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.645 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 41.5 t -61.65 135.53 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 111.192 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -81.22 138.77 35.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.861 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.5 HD22 ' N ' ' A' ' 69' ' ' VAL . 2.4 tm? -120.17 122.37 40.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.951 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.67 HG22 ' HG2' ' A' ' 70' ' ' GLU . 6.1 p -145.72 121.36 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.67 ' HG2' HG22 ' A' ' 69' ' ' VAL . 29.7 mm-40 58.01 22.86 9.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.19 -25.17 18.62 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.482 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.41 HG22 ' HB ' ' A' ' 37' ' ' THR . 3.3 mt -82.03 112.64 20.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.805 0.336 . . . . 0.0 111.212 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.669 HD23 HG21 ' A' ' 43' ' ' VAL . 4.2 mm? -73.88 120.0 18.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -92.32 135.59 33.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.558 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -87.65 159.74 48.86 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.487 0.66 . . . . 0.0 111.201 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.558 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.2 Cg_endo -69.98 -173.43 0.75 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.644 2.229 . . . . 0.0 112.332 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -77.07 -2.56 34.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.263 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.72 -28.4 9.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.118 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.56 -169.11 13.66 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.51 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.602 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 97.4 m95 -81.38 -58.98 2.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.835 0.35 . . . . 0.0 110.893 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.77 -159.89 30.81 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.453 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -127.83 37.86 4.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.864 0.364 . . . . 0.0 110.814 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.585 HD12 HG12 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -90.22 -176.27 4.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 1.083 HG12 HG23 ' A' ' 20' ' ' THR . 3.4 m -100.96 135.97 34.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.096 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.502 ' CD2' HD12 ' A' ' 53' ' ' LEU . 5.2 p90 -99.84 144.2 29.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.3 t -101.7 118.16 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.119 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.428 HG13 ' CG ' ' A' ' 21' ' ' GLU . 13.9 m -66.82 137.03 25.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.168 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -145.17 127.6 15.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.901 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.5 p90 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.932 -179.942 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 34.9 p90 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.857 0.36 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.731 HG23 HG13 ' A' ' 30' ' ' ILE . 5.3 tt -116.75 124.08 72.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.076 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.17 103.77 10.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.023 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.563 HG12 HD12 ' A' ' 83' ' ' LEU . 7.8 m -147.0 155.54 11.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.38 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.558 ' CG2' HG22 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -129.94 151.8 50.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.215 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.502 ' HG2' HG13 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -77.37 -50.07 13.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -107.01 143.11 35.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.51 -25.45 65.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.834 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -72.31 -26.45 61.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.85 -176.98 5.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.881 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -103.97 155.49 37.01 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.426 0.631 . . . . 0.0 111.218 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.87 106.82 1.75 Allowed 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.718 2.278 . . . . 0.0 112.309 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.862 HD11 HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -74.45 142.87 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.155 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -109.57 123.91 50.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.862 HG23 HD11 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -127.21 159.75 63.49 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.626 0.727 . . . . 0.0 111.092 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 134.36 27.86 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.743 2.295 . . . . 0.0 112.334 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.558 ' HB2' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -126.04 158.19 35.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.806 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -61.82 159.86 13.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.9 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -65.63 -27.39 68.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.803 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -67.62 -19.47 65.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.86 1.25 32.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.534 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.48 ' HB ' HG22 ' A' ' 72' ' ' ILE . 19.6 p -97.25 -176.07 3.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.855 0.359 . . . . 0.0 111.158 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.62 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 73.7 t -136.07 121.54 28.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.129 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.71 146.37 36.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.685 HD13 ' O ' ' A' ' 40' ' ' LEU . 3.3 tm? -60.69 -29.16 69.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.2 t -64.2 -39.89 94.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.4 m -73.29 -29.67 62.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.995 HG21 HD23 ' A' ' 73' ' ' LEU . 25.0 t -66.42 -37.8 80.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.013 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 67.2 p -78.09 -15.21 59.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.525 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.76 -47.9 81.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.965 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -112.59 -19.68 11.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.038 0.447 . . . . 0.0 111.294 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -126.75 75.34 75.37 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.651 0.739 . . . . 0.0 110.84 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.87 131.62 21.47 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.668 2.246 . . . . 0.0 112.28 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.21 6.79 89.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.49 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.681 ' HB1' HD21 ' A' ' 53' ' ' LEU . . . -88.17 107.95 19.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.735 0.302 . . . . 0.0 111.072 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.4 t -95.41 -53.24 3.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.936 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.56 ' O ' HD23 ' A' ' 53' ' ' LEU . . . -115.8 131.32 9.58 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.478 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.681 HD21 ' HB1' ' A' ' 50' ' ' ALA . 12.4 mt -120.88 140.83 51.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.017 0.437 . . . . 0.0 110.756 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.418 ' HB2' ' HB ' ' A' ' 86' ' ' VAL . 49.0 mtm180 -107.33 171.86 7.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.705 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.662 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 11.4 m-85 -111.06 126.9 55.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.1 tpm_? -127.91 103.61 7.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.878 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 121.567 0.699 . . . . 0.0 110.951 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.376 0 N-CA-C 112.584 -0.207 . . . . 0.0 112.584 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.662 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 21.9 t -69.1 142.72 15.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.78 0.324 . . . . 0.0 111.155 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -92.28 137.56 32.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.476 HD13 ' C ' ' A' ' 68' ' ' LEU . 2.7 tm? -116.25 115.72 26.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.9 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.582 HG22 ' HG2' ' A' ' 70' ' ' GLU . 5.8 p -138.46 121.18 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.172 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.582 ' HG2' HG22 ' A' ' 69' ' ' VAL . 31.9 mm-40 58.65 22.71 10.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.871 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.67 -24.64 22.65 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.489 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.48 HG22 ' HB ' ' A' ' 37' ' ' THR . 4.4 mt -81.41 114.8 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.842 0.353 . . . . 0.0 111.198 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.995 HD23 HG21 ' A' ' 43' ' ' VAL . 4.2 mm? -73.77 101.82 3.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.903 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -75.16 143.21 43.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.83 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.564 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -93.57 159.98 33.83 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.573 0.702 . . . . 0.0 111.133 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.564 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.7 Cg_endo -70.06 -173.45 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.689 2.259 . . . . 0.0 112.294 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -77.12 -2.37 33.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.327 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.42 -31.23 8.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.086 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.9 -164.84 16.96 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.426 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.62 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 82.7 m95 -84.91 -59.58 2.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.749 0.309 . . . . 0.0 110.9 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.55 -162.79 36.52 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.488 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.22 37.93 4.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.912 0.387 . . . . 0.0 110.909 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.563 HD12 HG12 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -90.14 -175.8 4.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.914 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.558 HG22 ' CG2' ' A' ' 20' ' ' THR . 40.3 t -102.05 131.94 49.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.074 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.679 ' CD2' HD13 ' A' ' 53' ' ' LEU . 4.6 p90 -97.24 141.62 30.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.935 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 54' ' ' ARG . 15.5 t -99.64 115.31 40.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.118 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.502 HG13 ' HG2' ' A' ' 21' ' ' GLU . 17.3 m -61.8 145.14 13.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.064 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -145.05 110.78 5.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.96 -179.898 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.7 p90 . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.786 0.327 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.727 HG23 HG13 ' A' ' 30' ' ' ILE . 5.9 tt -122.85 123.38 68.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.169 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.58 103.44 9.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.066 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.499 HG12 ' CD2' ' A' ' 83' ' ' LEU . 6.4 m -147.31 155.66 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.308 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.558 ' CG2' HG22 ' A' ' 84' ' ' VAL . 0.7 OUTLIER -130.66 153.34 49.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.215 179.679 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.53 -49.64 14.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.839 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -100.78 147.49 26.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.26 -34.21 72.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -68.99 -25.4 64.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -85.11 164.5 18.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -89.93 155.13 47.68 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.619 0.724 . . . . 0.0 110.925 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 112.34 3.05 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.661 2.24 . . . . 0.0 112.343 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.51 HD12 ' H ' ' A' ' 29' ' ' GLU . 5.0 tp -76.67 140.01 17.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.51 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -102.92 116.57 32.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.704 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.727 HG13 HG23 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -123.52 160.13 52.14 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.61 0.719 . . . . 0.0 111.151 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 154.11 68.25 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.69 2.26 . . . . 0.0 112.341 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.642 ' HB2' HG22 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -140.15 163.98 31.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -64.16 165.78 8.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -66.17 -38.33 87.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.873 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.77 -19.29 64.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.61 -29.26 6.71 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.505 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.554 HG22 ' CG ' ' A' ' 74' ' ' HIS . 29.2 p -64.66 -176.24 0.24 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 0.0 111.137 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.642 HG22 ' HB2' ' A' ' 32' ' ' SER . 55.6 t -131.67 125.76 56.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.146 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.518 HD23 ' HB2' ' A' ' 41' ' ' SER . 13.8 tp -62.11 143.25 56.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.646 ' O ' HG23 ' A' ' 44' ' ' THR . 3.0 tm? -59.85 -23.97 63.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.88 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.518 ' HB2' HD23 ' A' ' 39' ' ' LEU . 19.0 m -67.72 -45.97 73.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.832 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.3 m -69.13 -30.32 68.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.138 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.878 HG21 HD23 ' A' ' 73' ' ' LEU . 23.3 t -65.82 -35.93 76.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.992 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.646 HG23 ' O ' ' A' ' 40' ' ' LEU . 22.4 p -79.04 -15.65 57.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.036 0.446 . . . . 0.0 111.629 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.26 -45.57 87.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.896 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -112.09 -24.16 10.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.092 0.472 . . . . 0.0 111.243 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -126.56 76.95 73.83 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 121.659 0.742 . . . . 0.0 110.87 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 134.5 28.05 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.696 2.264 . . . . 0.0 112.322 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.92 6.75 86.03 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.542 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.578 ' HB1' HD21 ' A' ' 53' ' ' LEU . . . -86.19 112.54 21.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.847 0.356 . . . . 0.0 111.094 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.9 t -99.13 -53.31 3.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.888 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.67 ' O ' HD23 ' A' ' 53' ' ' LEU . . . -116.9 134.72 11.47 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.52 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.67 HD23 ' O ' ' A' ' 52' ' ' GLY . 12.4 mt -124.06 141.2 52.25 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.048 0.452 . . . . 0.0 110.672 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -107.52 171.29 7.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.722 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.447 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 9.0 m-85 -108.83 125.53 52.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.962 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -129.3 99.62 5.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.869 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.3 t30 . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 121.634 0.731 . . . . 0.0 110.869 179.969 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.447 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 95.8 t -62.2 144.43 14.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.817 0.342 . . . . 0.0 111.155 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -95.27 138.64 32.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.877 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 69' ' ' VAL . 2.3 tm? -114.83 121.44 43.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.509 ' N ' HD22 ' A' ' 68' ' ' LEU . 6.0 p -139.12 120.22 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.119 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.475 ' HG2' HG22 ' A' ' 69' ' ' VAL . 57.1 mm-40 55.42 25.9 8.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.907 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.433 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . 93.21 -23.24 30.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.475 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.503 HG22 ' HB ' ' A' ' 37' ' ' THR . 5.3 mp -82.15 116.74 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.877 0.37 . . . . 0.0 111.103 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.878 HD23 HG21 ' A' ' 43' ' ' VAL . 4.1 mm? -79.24 101.58 8.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.554 ' CG ' HG22 ' A' ' 37' ' ' THR . 5.7 t-80 -76.37 141.94 41.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.83 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.536 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -91.6 159.37 38.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.553 0.692 . . . . 0.0 111.102 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.536 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.7 Cg_endo -70.03 -173.46 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.635 2.223 . . . . 0.0 112.32 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -77.27 -1.99 32.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.242 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.23 -30.13 8.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.094 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.48 -165.35 15.23 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.487 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.605 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 90.5 m95 -85.67 -59.79 2.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.851 0.358 . . . . 0.0 110.917 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.82 -163.88 32.35 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.487 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -128.09 38.55 3.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.827 0.346 . . . . 0.0 110.876 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.707 HD13 ' H ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -95.31 -175.76 3.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.963 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.558 HG22 ' CG2' ' A' ' 20' ' ' THR . 41.5 t -98.15 136.23 29.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.665 ' CD2' HD13 ' A' ' 53' ' ' LEU . 5.6 p90 -101.53 141.35 34.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.96 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.0 t -96.34 114.39 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.4 m -60.77 142.25 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.09 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -144.97 109.9 5.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.851 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.931 -179.986 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.3 p90 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.849 0.357 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.724 HG23 HG13 ' A' ' 30' ' ' ILE . 5.4 tt -119.43 122.92 70.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.089 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.02 103.57 9.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.043 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.52 HG12 ' CD2' ' A' ' 83' ' ' LEU . 11.8 m -146.87 154.28 12.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.327 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.56 155.81 41.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.187 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.51 -50.04 19.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -114.45 146.7 40.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -64.63 -26.82 68.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.848 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -68.99 -25.15 64.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -95.4 159.64 14.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.869 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -81.73 154.9 70.98 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.639 0.733 . . . . 0.0 110.887 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 114.99 3.9 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.687 2.258 . . . . 0.0 112.283 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 19' ' ' VAL . 5.3 tp -80.33 136.65 22.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.32 120.18 39.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.745 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.724 HG13 HG23 ' A' ' 17' ' ' ILE . 0.6 OUTLIER -126.61 159.63 62.63 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.616 0.722 . . . . 0.0 111.093 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.8 147.64 63.09 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.65 2.233 . . . . 0.0 112.351 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.544 ' CB ' HG22 ' A' ' 38' ' ' VAL . 53.8 p -133.18 179.05 6.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.829 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -80.53 166.11 21.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -71.82 -33.53 68.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -66.21 -18.79 65.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.853 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.66 -20.93 11.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.46 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 74' ' ' HIS . 20.2 p -78.51 -175.45 4.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.855 0.36 . . . . 0.0 111.139 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.582 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 55.4 t -138.61 120.51 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.104 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.8 147.96 21.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.905 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.562 ' O ' HG23 ' A' ' 44' ' ' THR . 21.8 tp -62.57 -20.22 64.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.9 m -66.06 -36.58 83.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.7 m -80.01 -34.04 38.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.183 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.903 HG21 HD23 ' A' ' 73' ' ' LEU . 31.1 t -64.31 -36.31 76.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.984 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 40' ' ' LEU . 34.5 p -80.25 -15.52 56.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.579 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.5 -44.98 85.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.947 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -111.86 -23.58 10.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.069 0.462 . . . . 0.0 111.245 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -124.73 75.1 64.57 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 121.66 0.743 . . . . 0.0 110.903 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 133.23 25.04 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.645 2.23 . . . . 0.0 112.324 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.34 4.07 89.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.508 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.648 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -82.6 118.22 23.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.322 . . . . 0.0 111.103 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.8 m -102.19 -52.81 3.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.562 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -120.03 129.15 7.83 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.532 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.669 HD12 ' CE1' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -115.97 138.26 51.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.038 0.447 . . . . 0.0 110.663 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -107.32 170.8 7.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.665 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.562 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 12.4 m-85 -110.47 126.06 53.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.976 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.727 ' HB3' HG13 ' A' ' 84' ' ' VAL . 15.8 tpt180 -129.14 103.78 7.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.864 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 121.567 0.699 . . . . 0.0 110.991 -179.946 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.562 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 92.4 t -69.86 144.58 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.839 0.352 . . . . 0.0 111.086 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -92.27 138.29 31.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.873 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.505 HD22 ' N ' ' A' ' 69' ' ' VAL . 2.3 tm? -118.01 121.7 41.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.614 HG22 ' HG3' ' A' ' 70' ' ' GLU . 6.0 p -142.67 121.36 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.614 ' HG3' HG22 ' A' ' 69' ' ' VAL . 10.2 mt-10 57.06 23.9 8.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.03 -24.93 22.39 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.529 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.452 HG22 ' HB ' ' A' ' 37' ' ' THR . 3.5 mp -81.05 117.49 27.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.912 0.387 . . . . 0.0 111.079 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.903 HD23 HG21 ' A' ' 43' ' ' VAL . 4.1 mm? -79.63 111.73 16.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.934 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.478 ' HA ' HG22 ' A' ' 37' ' ' THR . 5.8 t60 -84.66 135.84 34.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.946 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.56 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -87.86 159.75 48.24 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.572 0.701 . . . . 0.0 111.151 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.56 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.6 Cg_endo -69.94 -173.82 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.72 2.28 . . . . 0.0 112.325 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -77.32 -2.42 34.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.264 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -108.37 -27.6 9.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.053 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 118.15 -172.49 14.45 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.479 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.582 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 97.2 m95 -77.77 -59.3 2.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.775 0.322 . . . . 0.0 110.922 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.55 -162.76 30.7 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.498 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.91 38.1 4.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.877 0.37 . . . . 0.0 110.876 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.702 HD13 ' H ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -94.64 -175.72 3.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.727 HG13 ' HB3' ' A' ' 56' ' ' ARG . 4.0 p -100.57 132.31 46.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.15 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.669 ' CE1' HD12 ' A' ' 53' ' ' LEU . 2.9 p90 -99.86 145.64 27.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.947 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.2 t -102.04 120.08 51.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.103 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.9 m -64.94 145.79 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.123 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -145.02 99.89 3.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 45.9 p90 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 -179.894 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 27.6 p90 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.826 0.346 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.751 HG23 HG13 ' A' ' 30' ' ' ILE . 4.7 tt -117.1 123.58 72.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.138 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -119.9 104.03 9.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.063 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.543 HG12 HD23 ' A' ' 83' ' ' LEU . 25.2 m -147.6 152.23 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.37 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.12 152.95 42.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.151 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.8 -48.06 60.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -128.89 155.95 44.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.815 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -63.32 -26.19 68.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -66.59 -26.39 67.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.849 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -104.01 139.54 38.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -65.42 160.17 61.23 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.68 0.752 . . . . 0.0 110.841 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 114.76 3.82 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.687 2.258 . . . . 0.0 112.345 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.465 HD12 ' H ' ' A' ' 29' ' ' GLU . 4.5 tp -81.5 136.51 22.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.85 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.465 ' H ' HD12 ' A' ' 28' ' ' ILE . 11.3 pt-20 -101.7 120.39 40.27 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.735 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.751 HG13 HG23 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -126.71 159.22 65.06 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.662 0.744 . . . . 0.0 111.084 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.428 ' O ' HG21 ' A' ' 42' ' ' THR . 53.6 Cg_endo -69.72 147.72 63.75 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.649 2.233 . . . . 0.0 112.367 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.552 ' HB2' HG22 ' A' ' 38' ' ' VAL . 4.5 p -137.58 163.93 30.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.855 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -64.09 159.31 20.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.954 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.13 -29.23 69.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.877 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.84 -19.37 65.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.895 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.7 -8.37 27.95 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.499 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.505 HG22 ' HA ' ' A' ' 74' ' ' HIS . 32.7 p -90.01 179.9 5.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.825 0.345 . . . . 0.0 111.12 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.577 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 68.9 t -133.58 118.18 29.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.121 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.503 HD13 HG12 ' A' ' 72' ' ' ILE . 4.5 mm? -62.14 149.54 41.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.793 HD12 ' HA3' ' A' ' 71' ' ' GLY . 0.9 OUTLIER -60.3 -19.42 55.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.936 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 t -66.47 -39.22 88.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.989 0.423 . . . . 0.0 110.924 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.428 HG21 ' O ' ' A' ' 31' ' ' PRO . 10.0 m -78.63 -32.34 47.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.124 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.921 HG21 HD23 ' A' ' 73' ' ' LEU . 34.3 t -64.69 -36.68 78.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.981 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 40' ' ' LEU . 43.2 p -79.99 -15.32 57.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.55 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.92 -45.92 83.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.939 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -111.94 -24.51 9.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.979 0.418 . . . . 0.0 111.198 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -122.89 74.39 47.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.631 0.729 . . . . 0.0 110.933 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 129.07 16.93 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.663 2.242 . . . . 0.0 112.345 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.79 6.37 82.79 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.491 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.39 113.79 22.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 111.165 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.6 t -95.78 -53.32 3.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.705 ' C ' HD12 ' A' ' 53' ' ' LEU . . . -120.69 140.09 14.01 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.512 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.705 HD12 ' C ' ' A' ' 52' ' ' GLY . 8.4 mp -127.8 138.25 52.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.06 0.457 . . . . 0.0 110.682 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -106.73 170.39 7.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.702 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.694 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 13.6 m-85 -110.38 124.69 52.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.897 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.675 ' HB3' HG13 ' A' ' 84' ' ' VAL . 3.4 tmt_? -130.45 109.01 10.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.897 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 t30 . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 121.666 0.746 . . . . 0.0 110.885 -179.981 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.694 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 15.9 t -67.74 151.15 10.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.79 0.329 . . . . 0.0 111.15 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.539 ' HE ' HG23 ' A' ' 69' ' ' VAL . 1.7 tpt180 -97.96 119.32 36.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.49 HD13 ' C ' ' A' ' 68' ' ' LEU . 3.4 tm? -94.25 106.47 18.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.943 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.539 HG23 ' HE ' ' A' ' 67' ' ' ARG . 4.3 t -119.17 106.94 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.141 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 51.62 34.96 13.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.935 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.793 ' HA3' HD12 ' A' ' 40' ' ' LEU . . . 92.13 -24.99 19.15 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.516 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.503 HG12 HD13 ' A' ' 39' ' ' LEU . 3.1 mp -81.34 108.32 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.822 0.344 . . . . 0.0 111.083 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.921 HD23 HG21 ' A' ' 43' ' ' VAL . 3.9 mm? -73.69 102.45 3.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.505 ' HA ' HG22 ' A' ' 37' ' ' THR . 5.6 t60 -78.72 135.55 37.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.577 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -82.52 160.39 61.98 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.641 0.734 . . . . 0.0 111.046 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.577 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.3 Cg_endo -70.0 -173.55 0.78 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.722 2.281 . . . . 0.0 112.297 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -77.32 -1.99 32.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.322 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.67 -29.48 9.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.073 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.25 -170.36 15.09 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.441 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.577 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 93.0 m95 -81.45 -59.18 2.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.775 0.322 . . . . 0.0 110.941 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.36 -161.94 36.05 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.488 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.44 37.01 4.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.84 0.353 . . . . 0.0 110.854 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.558 HD11 ' HD1' ' A' ' 55' ' ' TYR . 1.1 pt? -88.2 -174.75 4.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.675 HG13 ' HB3' ' A' ' 56' ' ' ARG . 4.6 p -104.03 131.11 53.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.151 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.61 ' HE1' HG22 ' A' ' 87' ' ' VAL . 7.5 p90 -95.77 146.62 24.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.922 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 68.9 t -106.34 114.67 46.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.192 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.61 HG22 ' HE1' ' A' ' 85' ' ' TYR . 13.2 t -57.87 154.75 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.095 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -145.41 88.14 1.84 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.91 -179.9 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.3 p90 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.831 0.348 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.748 HG23 HG13 ' A' ' 30' ' ' ILE . 6.8 tt -106.16 123.17 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.099 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -121.25 103.73 9.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.049 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.602 HG12 HD23 ' A' ' 83' ' ' LEU . 13.1 m -148.03 151.74 13.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.281 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.749 HG23 HG13 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -118.35 154.75 31.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.175 179.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.25 -41.2 94.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.855 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -139.36 167.37 22.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -75.95 -24.15 55.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.108 0.48 . . . . 0.0 111.318 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -66.4 -26.51 67.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.85 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -98.66 -175.5 3.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.823 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.6 mp0 -103.83 157.07 34.69 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.611 0.72 . . . . 0.0 110.918 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 126.95 13.92 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.655 2.237 . . . . 0.0 112.416 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.5 tp -100.36 131.64 47.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.795 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -97.07 122.46 40.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.722 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.748 HG13 HG23 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -127.23 159.74 63.56 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.643 0.735 . . . . 0.0 111.14 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.68 145.89 59.02 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.714 2.276 . . . . 0.0 112.345 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.536 ' HB2' HG22 ' A' ' 38' ' ' VAL . 1.2 p -130.12 176.82 7.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -77.84 166.41 22.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.938 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -72.19 -27.44 62.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.873 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.86 -19.19 60.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.921 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.21 -15.03 13.42 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.484 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.622 HG22 ' CG ' ' A' ' 74' ' ' HIS . 16.1 p -80.62 -171.09 2.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.923 0.392 . . . . 0.0 111.092 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.595 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 53.4 t -140.12 118.99 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.139 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.8 mt -56.47 139.43 49.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.484 ' O ' HG23 ' A' ' 44' ' ' THR . 28.4 tp -57.98 -22.1 47.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.952 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -66.72 -34.64 78.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.2 m -81.6 -32.88 31.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.127 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.768 HG21 HD23 ' A' ' 73' ' ' LEU . 24.4 t -63.94 -36.0 75.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.032 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 40' ' ' LEU . 38.5 p -79.4 -15.46 57.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.501 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.09 -46.63 83.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.933 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -112.02 -22.62 10.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.25 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -126.37 75.85 73.4 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.626 0.727 . . . . 0.0 110.914 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 131.19 20.67 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.656 2.238 . . . . 0.0 112.302 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.81 6.47 88.98 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.416 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.621 ' HB1' HD21 ' A' ' 53' ' ' LEU . . . -87.32 111.93 21.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.726 0.298 . . . . 0.0 111.108 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.1 t -99.3 -53.41 3.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.644 ' O ' HD23 ' A' ' 53' ' ' LEU . . . -115.8 132.76 10.44 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.539 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.672 HD22 ' CE2' ' A' ' 85' ' ' TYR . 12.8 mt -123.81 141.1 52.34 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.979 0.419 . . . . 0.0 110.734 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.4 ' HB2' ' HB ' ' A' ' 86' ' ' VAL . 45.5 mtt-85 -108.73 171.84 7.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.673 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.532 ' CD1' HD11 ' A' ' 83' ' ' LEU . 6.2 m-85 -107.66 125.36 51.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.63 110.16 11.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.0 t30 . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 121.596 0.712 . . . . 0.0 110.878 -179.958 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.527 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 92.9 t -59.0 144.97 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.845 0.355 . . . . 0.0 111.12 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -96.64 138.58 34.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 69' ' ' VAL . 1.4 tm? -111.9 114.24 27.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.534 ' N ' HD22 ' A' ' 68' ' ' LEU . 5.4 p -127.13 127.35 69.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.153 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 69' ' ' VAL . 7.2 pt-20 45.92 32.0 1.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.515 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . 89.36 -29.18 6.27 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.517 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.4 mp -79.5 112.91 18.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.821 0.343 . . . . 0.0 111.113 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.768 HD23 HG21 ' A' ' 43' ' ' VAL . 4.2 mm? -72.62 106.58 4.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.622 ' CG ' HG22 ' A' ' 37' ' ' THR . 5.4 t-80 -82.42 137.44 34.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.613 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -87.86 160.21 47.28 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.591 0.71 . . . . 0.0 111.064 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.564 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.4 Cg_endo -69.96 -173.33 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.667 2.245 . . . . 0.0 112.343 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -77.31 -2.02 32.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.222 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.17 -30.22 8.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.115 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.77 -165.25 15.47 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.473 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.613 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 98.1 m95 -87.23 -59.89 2.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.799 0.333 . . . . 0.0 110.869 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.0 -166.74 30.07 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.443 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -124.36 36.99 4.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.89 0.376 . . . . 0.0 110.922 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.602 HD23 HG12 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -94.42 -173.08 2.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.749 HG13 HG23 ' A' ' 20' ' ' THR . 25.7 t -102.26 131.95 49.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.134 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.672 ' CE2' HD22 ' A' ' 53' ' ' LEU . 5.2 p90 -96.23 142.49 28.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.95 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 54' ' ' ARG . 15.1 t -95.54 114.88 33.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.093 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.8 m -61.59 135.55 26.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.153 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -144.98 103.21 3.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 -179.847 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 14.7 p90 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.925 0.393 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.752 HG23 HG13 ' A' ' 30' ' ' ILE . 6.2 tt -95.21 122.71 46.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.131 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.403 ' HB3' ' HA ' ' A' ' 82' ' ' ASN . 1.8 mtp180 -116.33 103.44 10.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.143 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.488 HG12 ' CD2' ' A' ' 83' ' ' LEU . 11.8 m -147.15 147.7 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.38 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.4 t -122.94 158.8 29.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.807 0.337 . . . . 0.0 111.153 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.81 -47.37 19.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.879 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.86 163.24 13.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -79.96 -30.31 39.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.223 0.535 . . . . 0.0 111.292 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.8 m-20 -66.49 -24.43 66.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.91 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -101.54 141.09 34.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.866 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.53 160.91 77.45 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.598 0.714 . . . . 0.0 110.893 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 133.68 26.02 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.639 2.226 . . . . 0.0 112.333 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.413 HD12 ' H ' ' A' ' 29' ' ' GLU . 4.3 tp -97.13 133.72 37.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.868 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.413 ' H ' HD12 ' A' ' 28' ' ' ILE . 2.1 tm-20 -93.54 122.62 36.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.735 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.752 HG13 HG23 ' A' ' 17' ' ' ILE . 0.2 OUTLIER -126.87 159.95 61.65 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.649 0.737 . . . . 0.0 111.086 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.595 ' O ' HG21 ' A' ' 42' ' ' THR . 53.5 Cg_endo -69.76 133.34 25.33 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.627 2.218 . . . . 0.0 112.345 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.589 ' HB2' HG22 ' A' ' 38' ' ' VAL . 17.2 p -122.05 -175.53 3.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -85.22 174.29 9.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -79.16 -33.39 44.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.83 -19.3 65.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.44 -11.18 19.28 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.489 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.62 HG22 ' HA ' ' A' ' 74' ' ' HIS . 30.2 p -86.21 -176.1 5.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.799 0.333 . . . . 0.0 111.138 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.63 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 66.9 t -138.46 121.37 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.4 mt -59.25 149.7 27.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.689 HD12 ' HA3' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -62.31 -21.98 65.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.911 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.1 p -66.55 -37.6 85.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.812 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.595 HG21 ' O ' ' A' ' 31' ' ' PRO . 10.5 m -76.56 -35.02 58.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.154 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.82 HG21 HD23 ' A' ' 73' ' ' LEU . 25.4 t -64.88 -37.89 81.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.043 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 40' ' ' LEU . 32.8 p -77.96 -15.55 58.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.57 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.97 -46.69 83.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.974 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -112.05 -15.96 13.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.313 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -132.88 76.69 70.16 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.622 0.725 . . . . 0.0 110.822 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 128.14 15.58 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.686 2.257 . . . . 0.0 112.332 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.83 -15.96 57.91 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.462 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.658 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -64.04 108.89 1.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.766 0.317 . . . . 0.0 111.1 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.4 t -94.5 -52.79 4.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.592 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -117.83 128.53 7.83 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.522 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.702 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -114.99 137.97 51.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.022 0.439 . . . . 0.0 110.679 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -107.3 170.43 7.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.759 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.579 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 9.5 m-85 -109.64 125.62 52.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.736 ' HB3' HG13 ' A' ' 84' ' ' VAL . 8.9 tpm_? -129.38 108.72 10.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.893 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.509 ' N ' ' HE ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 121.635 0.731 . . . . 0.0 110.907 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.579 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 22.3 t -56.6 139.18 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 111.129 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -88.63 136.88 32.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.496 HD13 ' C ' ' A' ' 68' ' ' LEU . 3.2 tm? -114.56 122.48 46.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.741 HG22 ' HG3' ' A' ' 70' ' ' GLU . 6.5 p -146.4 122.42 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.164 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.741 ' HG3' HG22 ' A' ' 69' ' ' VAL . 9.5 mt-10 58.0 22.62 9.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.864 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.689 ' HA3' HD12 ' A' ' 40' ' ' LEU . . . 92.46 -25.03 20.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.453 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.561 HG22 ' HB ' ' A' ' 37' ' ' THR . 3.1 mp -83.07 123.39 38.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.349 . . . . 0.0 111.195 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.82 HD23 HG21 ' A' ' 43' ' ' VAL . 4.0 mm? -81.33 115.57 20.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.946 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.62 ' HA ' HG22 ' A' ' 37' ' ' THR . 6.2 t60 -88.41 135.84 33.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.881 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.564 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -86.46 159.84 52.18 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.58 0.705 . . . . 0.0 111.132 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.564 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.3 Cg_endo -70.07 -172.64 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.68 2.253 . . . . 0.0 112.28 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -77.06 -2.6 34.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.299 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.18 -29.53 9.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.11 -167.39 14.69 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.461 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.63 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 85.0 m95 -81.77 -59.39 2.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.854 0.359 . . . . 0.0 110.913 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.75 -167.66 38.76 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.538 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 18' ' ' ARG . 4.8 m-20 -125.0 38.31 4.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.918 0.389 . . . . 0.0 110.916 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.721 HD13 ' H ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -93.44 -175.48 3.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.935 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.736 HG13 ' HB3' ' A' ' 56' ' ' ARG . 4.0 p -99.6 138.56 23.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.157 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.702 ' CE2' HD12 ' A' ' 53' ' ' LEU . 3.2 p90 -108.36 146.28 33.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.954 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 68.3 t -99.53 125.03 53.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.111 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.3 m -74.84 135.85 26.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -145.62 139.49 26.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.913 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 35.7 p90 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.816 0.341 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.748 HG23 HG13 ' A' ' 30' ' ' ILE . 5.5 tt -120.13 122.87 69.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.092 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.14 103.65 9.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.039 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.478 HG12 ' CD2' ' A' ' 83' ' ' LEU . 13.4 m -147.29 153.5 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.344 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.83 153.55 40.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.199 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.407 ' HG2' HG13 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -65.72 -39.14 90.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -139.23 -177.42 4.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -83.66 -29.43 27.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.194 0.521 . . . . 0.0 111.333 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -66.43 -24.16 66.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.887 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -105.4 128.81 53.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.789 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -57.91 159.69 9.87 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.554 0.693 . . . . 0.0 110.846 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 122.85 9.51 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.645 2.23 . . . . 0.0 112.349 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.472 HD12 ' H ' ' A' ' 29' ' ' GLU . 4.7 tp -91.46 137.11 22.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.931 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.472 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -101.54 121.77 42.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.812 179.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.748 HG13 HG23 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -127.16 159.44 65.01 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.594 0.712 . . . . 0.0 111.179 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.436 ' O ' HG21 ' A' ' 42' ' ' THR . 53.3 Cg_endo -69.8 141.65 45.62 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.638 2.225 . . . . 0.0 112.345 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.544 ' HB2' HG22 ' A' ' 38' ' ' VAL . 14.2 p -129.77 -179.64 5.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.82 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -82.86 159.94 22.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -67.72 -29.83 69.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -68.62 -19.5 64.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.57 -12.1 21.12 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.443 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.472 ' HB ' HG22 ' A' ' 72' ' ' ILE . 19.4 p -86.19 -175.41 5.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.863 0.363 . . . . 0.0 111.135 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.602 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 55.8 t -139.78 120.26 14.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.109 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.576 HD23 HG12 ' A' ' 72' ' ' ILE . 12.7 mt -60.31 146.6 43.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.514 ' O ' HG23 ' A' ' 44' ' ' THR . 22.2 tp -60.84 -20.8 62.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.6 t -65.62 -35.49 80.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.804 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.436 HG21 ' O ' ' A' ' 31' ' ' PRO . 12.4 m -82.23 -32.31 29.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.148 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.713 HG21 HD23 ' A' ' 73' ' ' LEU . 25.6 t -64.12 -35.53 74.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.004 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 40' ' ' LEU . 33.3 p -80.45 -15.36 56.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.006 0.431 . . . . 0.0 111.612 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.59 -45.25 83.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.909 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -112.0 -22.75 10.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.094 0.473 . . . . 0.0 111.282 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -127.04 75.17 76.75 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 121.608 0.718 . . . . 0.0 110.854 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 130.46 19.29 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.652 2.235 . . . . 0.0 112.363 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.49 6.07 87.89 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.448 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.66 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -85.61 115.69 23.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.348 . . . . 0.0 111.122 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 2.0 m -98.98 -52.9 3.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.569 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -121.25 130.74 8.31 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.501 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.66 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -116.46 142.08 47.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.824 0.345 . . . . 0.0 110.856 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -108.27 170.71 7.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.846 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -110.11 126.03 53.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.942 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.731 ' HB3' HG13 ' A' ' 84' ' ' VAL . 17.0 tpt180 -129.27 105.58 8.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.542 ' OD1' HD12 ' A' ' 83' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 121.552 0.691 . . . . 0.0 110.941 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.668 HG12 HD12 ' A' ' 73' ' ' LEU . 34.8 t -52.2 147.4 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 0.0 111.164 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -101.06 124.08 46.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.904 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.558 ' HA ' HD13 ' A' ' 73' ' ' LEU . 2.5 tm? -97.46 114.88 26.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.426 ' O ' ' CG ' ' A' ' 70' ' ' GLU . 6.3 p -135.15 128.78 49.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.12 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.591 ' CD ' HD12 ' A' ' 72' ' ' ILE . 7.6 pt-20 45.9 29.95 0.81 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.24 -28.04 6.48 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.543 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.591 HD12 ' CD ' ' A' ' 70' ' ' GLU . 6.0 mt -83.99 118.64 31.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.916 0.389 . . . . 0.0 111.177 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.713 HD23 HG21 ' A' ' 43' ' ' VAL . 4.3 mm? -76.49 118.89 19.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -90.61 135.56 33.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.884 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.599 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -86.36 160.66 50.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.63 0.728 . . . . 0.0 111.039 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.591 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.1 Cg_endo -69.98 -173.67 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.662 2.241 . . . . 0.0 112.311 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.09 -2.07 32.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.332 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -108.68 -27.55 9.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.103 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 118.53 -172.44 14.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.523 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.602 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 97.2 m95 -78.49 -59.71 2.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.812 0.339 . . . . 0.0 110.905 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.86 -162.94 30.44 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.464 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -127.78 38.16 4.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.867 0.365 . . . . 0.0 110.893 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.708 HD13 ' H ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -95.95 -175.25 3.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.731 HG13 ' HB3' ' A' ' 56' ' ' ARG . 3.2 p -98.37 140.46 18.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.187 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.657 ' CE1' HD12 ' A' ' 53' ' ' LEU . 3.0 p90 -110.05 145.79 36.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 53.7 t -98.05 121.08 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.137 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.407 HG13 ' HG2' ' A' ' 21' ' ' GLU . 14.6 m -68.78 141.93 16.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.126 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -144.02 119.5 10.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.938 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.866 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 mtp . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.786 0.327 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.57 41.43 7.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.103 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -157.51 122.87 1.21 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.467 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.9 m -140.66 145.67 36.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.893 0.378 . . . . 0.0 110.863 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.0 m170 -67.9 -26.39 65.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -57.07 -27.53 61.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -62.17 107.33 0.87 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.029 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -146.55 133.96 20.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -126.62 166.33 17.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.719 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -74.08 142.35 45.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.843 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.1 20.98 16.56 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.448 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.8 t -56.9 144.51 33.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.862 0.363 . . . . 0.0 110.843 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.5 ptm -111.36 164.47 12.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m -133.7 124.8 27.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.875 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.49 -171.91 2.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.859 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -122.0 161.88 22.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.91 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.752 HG23 HG13 ' A' ' 30' ' ' ILE . 6.1 tt -108.49 123.48 64.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.153 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.68 104.16 11.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.054 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.672 HG12 HD12 ' A' ' 83' ' ' LEU . 6.3 m -145.43 154.33 13.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.344 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.522 ' CG2' HG22 ' A' ' 84' ' ' VAL . 0.6 OUTLIER -128.9 152.23 48.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.128 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.86 -49.46 15.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.848 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -100.42 158.46 15.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -82.21 -31.89 30.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.223 0.535 . . . . 0.0 111.314 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -69.64 -26.56 64.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.874 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.65 -178.93 7.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.847 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -105.14 158.52 31.93 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.398 0.618 . . . . 0.0 111.266 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.9 114.66 3.8 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.38 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 19' ' ' VAL . 5.4 tp -79.51 141.36 15.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.919 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.443 ' H ' HD12 ' A' ' 28' ' ' ILE . 2.6 mt-10 -99.17 119.59 38.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.738 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.752 HG13 HG23 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -126.96 160.21 60.5 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.632 0.73 . . . . 0.0 111.122 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 155.35 66.06 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.699 2.266 . . . . 0.0 112.32 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.554 ' HB3' HG22 ' A' ' 38' ' ' VAL . 1.5 m -143.88 -175.99 4.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.839 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -88.63 172.96 8.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.945 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -78.49 -35.31 46.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.827 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -64.61 -19.03 65.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.853 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.69 -13.66 14.98 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.499 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.643 HG22 ' HA ' ' A' ' 74' ' ' HIS . 28.8 p -82.62 -174.08 5.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.851 0.357 . . . . 0.0 111.142 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.596 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 54.3 t -139.46 125.24 22.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.143 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.22 141.94 58.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.767 HD12 ' CA ' ' A' ' 71' ' ' GLY . 1.7 tt -60.56 -22.76 64.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.6 p -64.43 -29.72 70.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.788 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 58.0 m -87.1 -30.55 21.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.538 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.494 HG21 HD23 ' A' ' 73' ' ' LEU . 38.5 t -65.14 -39.91 87.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.992 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.582 HG23 HD23 ' A' ' 40' ' ' LEU . 42.9 p -77.41 -14.86 59.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.011 0.434 . . . . 0.0 111.569 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.04 -47.02 81.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.959 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 63.2 mm-40 -111.88 -21.71 11.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.116 0.484 . . . . 0.0 111.367 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -123.84 74.67 56.24 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 121.662 0.744 . . . . 0.0 110.878 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 129.99 18.61 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.66 2.24 . . . . 0.0 112.386 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.56 -9.68 70.07 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.51 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.688 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -67.73 99.27 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.744 0.307 . . . . 0.0 111.075 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.9 t -82.5 -43.77 16.78 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.093 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.575 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -130.27 134.82 8.0 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.399 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.688 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -115.68 130.02 56.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.074 0.464 . . . . 0.0 110.623 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -107.13 170.35 8.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.705 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.519 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 7.4 m-85 -106.16 126.09 51.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -129.27 121.53 27.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.907 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -138.63 118.49 9.68 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.609 0.718 . . . . 0.0 110.897 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -27.88 25.85 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.644 2.23 . . . . 0.0 112.328 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.5 m -86.58 -29.23 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.125 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.3 m -88.11 -27.24 22.04 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.061 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 59.75 22.42 11.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.046 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 6.7 m -90.69 -179.25 5.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.866 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.3 ptm -142.28 27.28 1.76 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.005 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -56.07 177.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.735 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.99 143.09 9.7 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.484 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.519 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 21.2 t -67.61 134.39 30.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.818 0.342 . . . . 0.0 111.143 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -77.43 138.46 39.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.478 HD13 ' C ' ' A' ' 68' ' ' LEU . 2.7 tm? -121.33 124.43 44.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.948 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.459 ' N ' HD22 ' A' ' 68' ' ' LEU . 7.6 p -149.47 124.41 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.114 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.446 ' HG3' HG22 ' A' ' 69' ' ' VAL . 11.0 mt-10 57.92 22.62 8.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.767 ' CA ' HD12 ' A' ' 40' ' ' LEU . . . 92.23 -24.88 20.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.496 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.512 HG22 ' HB ' ' A' ' 37' ' ' THR . 3.2 mt -82.8 122.79 37.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 0.0 111.139 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.673 ' HG ' HD23 ' A' ' 53' ' ' LEU . 4.3 mm? -82.22 119.56 24.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.936 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.643 ' HA ' HG22 ' A' ' 37' ' ' THR . 41.9 t60 -91.88 135.76 33.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.568 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -87.68 160.05 48.15 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.55 0.69 . . . . 0.0 111.107 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.568 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.5 Cg_endo -69.99 -172.59 0.62 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.678 2.252 . . . . 0.0 112.306 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -77.16 -2.28 33.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.224 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.23 -31.52 8.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.95 -164.38 15.93 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.499 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.596 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 86.2 m95 -85.28 -59.24 2.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.758 0.313 . . . . 0.0 110.933 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.55 -161.77 37.27 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.456 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -125.91 37.75 4.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.906 0.384 . . . . 0.0 110.919 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.672 HD12 HG12 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -87.75 -175.85 5.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.522 HG22 ' CG2' ' A' ' 20' ' ' THR . 40.5 t -102.46 136.07 36.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.155 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.576 ' CD2' HD12 ' A' ' 53' ' ' LEU . 3.7 p90 -102.56 146.28 28.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.986 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 84.6 t -106.89 131.0 57.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.061 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.475 HG22 ' CE2' ' A' ' 85' ' ' TYR . 2.4 t -81.51 132.48 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.129 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -145.85 140.81 27.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.973 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 ptm . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.768 0.318 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.4 109.1 20.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.148 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.47 58.57 1.62 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.53 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.8 p -106.45 -35.76 7.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.867 0.365 . . . . 0.0 110.852 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -104.86 33.92 3.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -105.31 -35.11 7.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.871 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -156.47 167.45 30.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.895 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -106.62 158.83 16.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.721 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 -101.02 -30.68 11.48 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.604 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -69.31 -27.75 65.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.834 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.91 159.39 22.89 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.508 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -99.33 141.46 32.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.807 0.337 . . . . 0.0 110.818 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.4 ptt? -57.93 171.4 0.51 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.864 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.0 p -98.32 143.36 28.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -96.07 -177.79 4.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.893 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -128.99 168.42 16.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.932 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.77 HG23 HG13 ' A' ' 30' ' ' ILE . 6.1 tt -120.44 123.48 70.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.086 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -120.29 104.1 9.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.042 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.476 ' O ' HG22 ' A' ' 28' ' ' ILE . 6.1 m -145.0 152.29 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.351 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.528 HG23 HG22 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -127.31 157.47 39.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.138 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.42 -49.95 10.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.838 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -101.27 163.11 12.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -84.39 -29.71 25.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.211 0.529 . . . . 0.0 111.265 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -67.53 -26.6 66.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.868 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -94.41 163.43 13.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.871 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -89.16 159.92 44.01 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.677 0.751 . . . . 0.0 110.888 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.86 116.77 4.72 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.63 2.22 . . . . 0.0 112.367 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.476 HG22 ' O ' ' A' ' 19' ' ' VAL . 5.3 tp -76.68 137.98 21.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.867 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.05 119.77 37.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.802 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.77 HG13 HG23 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -126.43 159.89 60.77 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.627 0.727 . . . . 0.0 111.159 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.406 ' O ' HG21 ' A' ' 42' ' ' THR . 54.2 Cg_endo -69.73 148.82 66.08 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.643 2.229 . . . . 0.0 112.307 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.534 ' HB2' HG22 ' A' ' 38' ' ' VAL . 19.8 p -133.29 -175.69 3.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -84.66 169.94 13.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -75.57 -30.55 59.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -72.34 -17.5 61.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.787 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.13 -20.84 11.24 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.451 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.524 ' HB ' HG22 ' A' ' 72' ' ' ILE . 22.7 p -75.57 -174.24 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.796 0.331 . . . . 0.0 111.181 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.586 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 50.5 t -141.0 119.53 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.141 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.2 tp -56.94 145.34 30.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.874 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.737 HD12 ' CA ' ' A' ' 71' ' ' GLY . 1.3 tt -61.44 -19.61 62.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.9 t -66.29 -37.72 86.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.406 HG21 ' O ' ' A' ' 31' ' ' PRO . 8.9 m -77.06 -34.87 57.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.136 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.598 HG21 HD23 ' A' ' 73' ' ' LEU . 22.4 t -64.3 -34.94 72.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.027 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.579 HG23 ' O ' ' A' ' 40' ' ' LEU . 39.0 p -80.06 -15.78 56.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.559 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.65 -43.65 88.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.995 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -111.92 -23.95 10.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.305 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -129.69 75.66 79.47 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.647 0.736 . . . . 0.0 110.918 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 125.28 11.95 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.675 2.25 . . . . 0.0 112.382 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.46 6.5 64.26 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.517 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.718 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -82.13 116.11 21.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.774 0.321 . . . . 0.0 111.135 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.8 t -100.45 -52.92 3.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.633 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -122.08 127.04 6.66 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.545 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.778 HD12 ' CE1' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -115.31 139.73 49.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.953 0.406 . . . . 0.0 110.759 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -112.21 171.0 7.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.692 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -104.13 126.04 50.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.946 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.1 tpt180 -128.94 103.32 6.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -139.17 119.15 9.41 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.635 0.731 . . . . 0.0 110.935 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 -23.73 30.45 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.727 2.285 . . . . 0.0 112.295 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.7 m -84.31 -27.68 7.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.178 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.2 m -84.28 -27.0 28.17 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.013 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 59.16 23.55 11.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.058 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 21.9 p -108.85 165.38 11.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.8 ptt? -125.18 26.15 7.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.651 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -59.34 176.5 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.706 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.71 145.63 12.71 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.528 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.7 t -62.79 143.33 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.786 0.326 . . . . 0.0 111.151 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -91.97 138.55 31.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.885 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.482 HD22 ' N ' ' A' ' 69' ' ' VAL . 2.2 tm? -118.03 117.98 30.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.682 HG22 ' HG2' ' A' ' 70' ' ' GLU . 6.7 p -138.93 122.8 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.138 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.682 ' HG2' HG22 ' A' ' 69' ' ' VAL . 36.3 mm-40 58.12 22.58 9.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.737 ' CA ' HD12 ' A' ' 40' ' ' LEU . . . 92.33 -25.08 19.44 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.516 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.524 HG22 ' HB ' ' A' ' 37' ' ' THR . 4.3 mp -83.32 114.13 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.889 0.376 . . . . 0.0 111.076 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.598 HD23 HG21 ' A' ' 43' ' ' VAL . 4.1 mm? -73.78 116.09 13.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.956 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.46 ' HA ' HG22 ' A' ' 37' ' ' THR . 5.5 t60 -91.33 135.7 33.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.607 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -86.08 158.85 55.18 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.554 0.692 . . . . 0.0 111.124 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.525 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.9 Cg_endo -69.89 -172.94 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.689 2.26 . . . . 0.0 112.325 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -77.32 -2.15 33.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.266 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.74 -29.45 9.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.114 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.94 -168.86 14.65 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.514 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.607 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 98.0 m95 -82.49 -59.47 2.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.774 0.321 . . . . 0.0 110.866 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.11 -167.54 29.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.525 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -128.03 38.48 4.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.844 0.354 . . . . 0.0 110.895 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.677 HD13 ' H ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.61 -175.55 3.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.528 HG22 HG23 ' A' ' 20' ' ' THR . 21.9 t -93.58 144.28 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.106 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.778 ' CE1' HD12 ' A' ' 53' ' ' LEU . 1.7 p90 -111.31 146.35 37.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.959 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.5 t -95.48 125.55 48.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.139 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 t -74.48 135.98 26.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.108 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -145.11 106.48 4.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.884 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.976 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 mtt . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.783 0.325 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.97 -63.11 1.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.155 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -169.15 -103.95 0.17 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.509 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.5 m -117.52 132.56 56.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.937 0.398 . . . . 0.0 110.81 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 -86.23 -55.87 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.811 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -88.58 165.77 14.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.65 -27.56 58.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.757 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -148.5 165.05 32.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.989 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -67.37 105.45 1.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.693 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -85.88 -42.7 13.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -162.51 167.29 36.97 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.503 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -116.43 135.81 53.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.884 0.373 . . . . 0.0 110.911 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -64.59 -24.96 67.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.895 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.7 p -60.89 153.56 24.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.774 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -108.82 -176.62 3.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.942 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -129.75 166.9 18.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.932 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.75 HG23 HG13 ' A' ' 30' ' ' ILE . 6.0 tt -120.78 123.3 69.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.138 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -120.65 104.44 9.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.058 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.456 ' O ' HG22 ' A' ' 28' ' ' ILE . 10.2 m -146.3 153.31 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.371 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.561 HG23 HG22 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -126.91 156.63 41.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.176 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.15 -50.18 13.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -102.54 166.44 10.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.912 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -79.53 -32.85 42.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.152 0.501 . . . . 0.0 111.279 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -74.75 -25.79 59.33 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.855 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -86.28 129.01 35.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.921 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -60.46 155.0 51.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.638 0.732 . . . . 0.0 110.884 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 114.91 3.85 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.717 2.278 . . . . 0.0 112.317 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.474 HD12 ' H ' ' A' ' 29' ' ' GLU . 4.9 tp -76.75 139.43 18.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.474 ' H ' HD12 ' A' ' 28' ' ' ILE . 1.7 pm0 -102.04 120.06 39.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.712 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.75 HG13 HG23 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -125.91 159.7 60.33 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.692 0.758 . . . . 0.0 111.051 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.409 ' O ' HG21 ' A' ' 42' ' ' THR . 53.7 Cg_endo -69.71 142.77 49.05 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.652 2.235 . . . . 0.0 112.349 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.565 ' CB ' HG22 ' A' ' 38' ' ' VAL . 53.5 p -132.94 161.63 33.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.831 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -61.11 162.74 6.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.82 -31.85 65.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.849 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -65.2 -18.4 65.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.36 -19.37 11.68 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.461 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.457 ' HB ' HG22 ' A' ' 72' ' ' ILE . 20.5 p -81.05 -174.38 4.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.348 . . . . 0.0 111.145 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.608 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 53.5 t -137.76 124.56 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.154 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.8 tp -59.49 146.88 38.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.623 HD13 ' O ' ' A' ' 40' ' ' LEU . 3.1 tm? -63.06 -25.19 68.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.7 t -64.44 -39.13 93.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.409 HG21 ' O ' ' A' ' 31' ' ' PRO . 10.7 m -74.13 -31.02 62.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.176 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.909 HG21 HD23 ' A' ' 73' ' ' LEU . 17.7 t -66.16 -37.22 79.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.011 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.1 p -79.09 -15.84 57.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.578 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.13 -44.81 87.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.983 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -112.14 -20.86 11.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.118 0.485 . . . . 0.0 111.352 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -131.38 75.45 77.3 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 121.643 0.735 . . . . 0.0 110.849 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 131.87 22.19 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.619 2.213 . . . . 0.0 112.415 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.36 -8.87 72.57 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.518 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.593 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -71.06 119.73 15.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.807 0.337 . . . . 0.0 111.139 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.4 t -102.05 -53.01 3.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.584 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -121.07 130.25 8.14 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.494 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.709 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -115.69 137.81 51.71 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.992 0.425 . . . . 0.0 110.678 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -108.64 170.71 7.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.735 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -105.29 125.69 51.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -129.56 105.28 7.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -138.67 118.65 9.69 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.551 0.691 . . . . 0.0 110.909 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -24.67 29.3 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.687 2.258 . . . . 0.0 112.323 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.1 m -85.03 -29.49 6.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.045 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.1 t -87.83 -27.29 22.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.047 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 58.0 22.35 8.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.022 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 2.1 t -93.55 160.31 14.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.894 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 58.7 mmm -125.19 26.89 6.79 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.745 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.98 174.56 3.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.668 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.18 136.06 5.26 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.511 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 64.5 t -54.77 138.62 14.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.748 0.309 . . . . 0.0 111.181 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -88.15 138.49 31.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.517 HD21 ' HA2' ' A' ' 71' ' ' GLY . 2.2 tm? -117.3 115.05 24.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.555 HG22 ' HG2' ' A' ' 70' ' ' GLU . 5.6 p -134.32 120.28 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.141 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.555 ' HG2' HG22 ' A' ' 69' ' ' VAL . 17.4 mm-40 57.51 23.53 9.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.9 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.517 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . 93.39 -24.93 23.13 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.467 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.457 HG22 ' HB ' ' A' ' 37' ' ' THR . 4.2 mp -80.83 112.72 19.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.973 0.416 . . . . 0.0 111.089 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.909 HD23 HG21 ' A' ' 43' ' ' VAL . 4.1 mm? -74.72 111.24 9.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.911 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -86.65 135.41 33.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.649 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -87.98 159.87 47.64 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.467 0.651 . . . . 0.0 111.209 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.557 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.2 Cg_endo -69.94 -173.09 0.67 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.698 2.265 . . . . 0.0 112.285 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -77.2 -2.25 33.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.244 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.27 -29.81 9.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.99 -165.35 14.85 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.469 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.649 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 97.5 m95 -86.71 -59.6 2.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.82 0.343 . . . . 0.0 110.849 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.72 -165.8 29.83 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.466 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -128.16 38.24 4.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 0.0 110.861 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.693 HD13 ' H ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.29 -175.81 3.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.912 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.561 HG22 HG23 ' A' ' 20' ' ' THR . 38.3 t -93.85 144.44 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.191 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.709 ' CE2' HD12 ' A' ' 53' ' ' LEU . 3.6 p90 -114.61 145.9 41.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.939 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.4 t -99.65 126.74 52.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.121 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.8 t -72.58 145.35 12.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.17 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -145.08 87.75 1.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.963 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.4 p90 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 -179.883 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttp . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.776 0.322 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.48 -35.23 3.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.095 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 152.04 -150.13 21.94 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.517 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.6 t -99.2 109.0 21.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.844 0.354 . . . . 0.0 110.878 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -55.18 -63.79 1.04 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.809 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.39 165.46 23.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.806 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -94.34 145.71 24.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.3 t60 -81.91 -35.42 29.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.936 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -64.45 152.19 42.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -76.22 139.21 41.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.834 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.16 107.91 2.16 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.537 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -83.74 -27.51 28.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.908 0.385 . . . . 0.0 110.866 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.3 tpt -80.2 112.92 17.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.83 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.3 m -63.74 144.35 57.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.881 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -89.85 140.53 29.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -91.27 167.76 12.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.881 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.707 HG23 HG13 ' A' ' 30' ' ' ILE . 6.1 tt -119.35 123.47 71.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.098 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.4 mtm180 -119.48 104.69 10.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.109 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.543 HG12 HD23 ' A' ' 83' ' ' LEU . 6.5 m -145.71 153.44 13.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.3 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.716 ' CG2' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -124.76 155.33 39.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.167 179.701 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.06 -49.73 22.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.928 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -105.31 173.43 6.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.861 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -79.21 -46.6 17.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.283 0.564 . . . . 0.0 111.283 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -68.84 -26.8 65.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.878 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -72.79 126.98 31.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.93 149.89 63.27 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.695 0.759 . . . . 0.0 110.856 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.78 120.2 7.02 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.763 2.308 . . . . 0.0 112.311 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 19' ' ' VAL . 6.1 tp -87.54 143.4 11.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.99 123.15 48.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.707 HG13 HG23 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -127.39 160.57 59.5 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.656 0.741 . . . . 0.0 111.151 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.67 144.65 55.19 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.704 2.269 . . . . 0.0 112.426 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.571 ' HB3' HG22 ' A' ' 38' ' ' VAL . 1.5 m -133.18 -175.88 3.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.859 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -86.06 174.25 9.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.836 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -80.68 -35.39 33.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.806 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -63.36 -19.83 64.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.827 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.43 -12.55 13.87 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.441 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.439 ' HB ' HG22 ' A' ' 72' ' ' ILE . 20.6 p -85.38 -174.72 5.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.829 0.347 . . . . 0.0 111.182 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.606 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 53.7 t -136.7 135.08 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.208 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 tp -70.81 141.39 51.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.696 HD13 ' O ' ' A' ' 40' ' ' LEU . 2.6 tm? -59.48 -31.95 69.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.965 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -58.85 -29.23 66.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.792 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.4 m -83.97 -30.86 25.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.156 0.503 . . . . 0.0 111.619 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.618 HG21 HD23 ' A' ' 73' ' ' LEU . 20.1 t -65.16 -35.29 75.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.025 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.3 p -79.7 -15.39 57.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.465 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.26 -45.33 84.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.982 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -111.97 -18.28 12.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.016 0.436 . . . . 0.0 111.287 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -134.11 74.55 67.78 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.633 0.73 . . . . 0.0 110.864 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 129.5 17.75 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.698 2.265 . . . . 0.0 112.39 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.26 6.03 78.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.522 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.657 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -81.78 114.96 20.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.758 0.314 . . . . 0.0 111.129 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.2 t -95.79 -53.05 3.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.598 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -124.81 132.06 8.02 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.559 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.684 HD12 ' CE1' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -115.41 138.86 50.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.986 0.422 . . . . 0.0 110.745 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.17 170.78 7.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.715 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.696 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 10.3 m-85 -111.07 125.75 54.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.974 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -129.41 104.01 7.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.934 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -139.18 118.6 9.25 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.632 0.73 . . . . 0.0 110.902 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 -34.97 13.35 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.681 2.254 . . . . 0.0 112.355 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.0 m -74.08 -34.05 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.14 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.2 t -80.79 -27.09 36.78 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.026 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 60.07 20.11 9.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.092 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 22.7 m -83.84 162.94 20.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.924 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.5 28.24 3.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.043 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.06 -177.52 4.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.676 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.5 155.47 26.36 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.462 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.696 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 21.6 t -58.29 135.7 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.828 0.347 . . . . 0.0 111.069 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -83.26 138.54 33.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.867 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.49 HD13 ' C ' ' A' ' 68' ' ' LEU . 3.2 tm? -118.62 120.8 38.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.666 HG22 ' HG2' ' A' ' 70' ' ' GLU . 6.1 p -145.21 121.56 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.173 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.666 ' HG2' HG22 ' A' ' 69' ' ' VAL . 10.7 mm-40 58.16 22.53 9.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.858 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.96 -25.23 17.64 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.466 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.439 HG22 ' HB ' ' A' ' 37' ' ' THR . 2.1 mp -82.29 114.57 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.847 0.356 . . . . 0.0 111.144 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.618 HD23 HG21 ' A' ' 43' ' ' VAL . 4.1 mm? -73.86 120.54 19.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.428 ' HA ' HG22 ' A' ' 37' ' ' THR . 47.8 t60 -91.4 139.48 30.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.582 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -91.55 160.22 37.14 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.575 0.702 . . . . 0.0 111.092 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.582 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.2 Cg_endo -69.88 -172.79 0.63 Allowed 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.687 2.258 . . . . 0.0 112.304 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -77.02 -2.56 34.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.269 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.44 -29.43 9.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.78 -164.72 14.06 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.526 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.606 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 94.7 m95 -85.59 -59.42 2.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.775 0.322 . . . . 0.0 110.861 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.92 -162.17 38.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.493 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.49 36.99 4.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.851 0.358 . . . . 0.0 110.883 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.543 HD23 HG12 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -88.91 -173.85 4.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.891 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.716 HG22 ' CG2' ' A' ' 20' ' ' THR . 61.3 t -104.07 138.31 29.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.079 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.684 ' CE1' HD12 ' A' ' 53' ' ' LEU . 2.7 p90 -108.31 146.05 33.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.6 t -100.8 127.22 54.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.14 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.3 t -71.1 146.24 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.145 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -145.11 104.01 3.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.953 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.959 -179.888 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ptt? . . . . . 0 CA--C 1.526 0.032 0 CA-C-O 120.777 0.322 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.31 106.14 0.18 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.109 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 96.04 69.01 1.01 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.448 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.9 m -63.35 -55.19 26.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.893 0.377 . . . . 0.0 110.838 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -81.87 -66.05 0.94 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -152.61 176.53 11.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -61.94 135.07 57.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.983 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -149.27 116.22 5.99 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -157.15 153.96 28.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.761 0.315 . . . . 0.0 110.881 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -124.5 176.56 6.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.844 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.66 47.62 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.499 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.8 m -147.7 166.81 26.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.858 0.361 . . . . 0.0 110.854 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.0 tpt -113.71 117.47 31.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.93 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.5 m -56.76 139.41 50.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.799 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -96.42 -178.38 4.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -129.31 153.9 47.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.869 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.738 HG23 HG13 ' A' ' 30' ' ' ILE . 6.5 tt -109.1 123.16 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.095 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -118.45 104.51 10.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.005 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.57 HG12 HD12 ' A' ' 83' ' ' LEU . 7.4 m -147.35 153.17 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.336 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.579 ' CG2' HG22 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -127.1 151.18 48.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.082 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.07 -49.11 30.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -106.65 167.32 9.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.942 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -78.9 -38.05 38.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.202 0.525 . . . . 0.0 111.34 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -69.25 -26.57 64.84 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.936 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.85 130.47 34.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -62.15 156.26 60.28 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.603 0.715 . . . . 0.0 110.918 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 119.14 6.14 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.656 2.237 . . . . 0.0 112.388 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.843 HD11 HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -83.49 142.72 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.156 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -106.82 122.71 46.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.82 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.843 HG23 HD11 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -127.2 159.56 64.47 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.641 0.734 . . . . 0.0 111.092 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.86 145.59 57.03 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.667 2.245 . . . . 0.0 112.31 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.579 ' HB2' HG22 ' A' ' 38' ' ' VAL . 1.1 p -135.73 171.7 14.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.403 ' HG2' HD23 ' A' ' 39' ' ' LEU . 7.7 mm-40 -74.2 167.09 22.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -73.41 -27.34 61.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.847 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -71.03 -19.58 62.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.857 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.84 -8.28 21.67 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.448 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.488 ' HB ' HG22 ' A' ' 72' ' ' ILE . 20.0 p -86.18 -178.04 6.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.9 0.381 . . . . 0.0 111.125 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.608 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 55.4 t -135.35 127.68 47.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.186 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.403 HD23 ' HG2' ' A' ' 33' ' ' GLU . 3.6 mm? -63.0 143.78 57.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.693 HD13 ' O ' ' A' ' 40' ' ' LEU . 3.3 tm? -61.67 -30.44 70.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.0 t -62.8 -37.24 85.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.863 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 17.9 m -76.24 -23.51 54.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.094 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.828 HG21 HD23 ' A' ' 73' ' ' LEU . 25.6 t -72.25 -38.68 62.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.188 0.518 . . . . 0.0 111.341 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.9 p -77.82 -15.2 59.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.575 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.12 -46.69 86.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.941 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -112.18 -21.13 11.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.094 0.473 . . . . 0.0 111.265 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -124.98 75.01 66.83 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 121.647 0.737 . . . . 0.0 110.896 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.77 131.12 20.55 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.647 2.231 . . . . 0.0 112.379 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.76 5.91 89.46 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.488 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.572 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -86.98 114.3 23.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 0.0 111.093 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 m -98.86 -53.03 3.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.547 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -119.14 130.92 8.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.49 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.584 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -115.79 139.96 49.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.026 0.441 . . . . 0.0 110.705 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -109.04 170.74 7.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.751 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.45 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 7.8 m-85 -107.48 126.7 52.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.86 103.04 7.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -139.22 121.89 10.45 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.654 0.74 . . . . 0.0 110.926 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -49.09 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.678 2.252 . . . . 0.0 112.333 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.1 m -61.58 -37.01 76.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.111 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.5 t -67.89 -26.68 66.12 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.01 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 58.28 23.76 10.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.08 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 64.5 m -116.12 -179.15 3.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 28.0 ttp -145.17 38.41 1.17 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -178.97 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.746 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.02 134.43 4.44 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.488 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.45 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 59.6 t -58.12 136.94 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.878 0.371 . . . . 0.0 111.104 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -86.32 138.41 31.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.481 HD21 ' HA2' ' A' ' 71' ' ' GLY . 2.2 tm? -119.16 114.29 22.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.884 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.662 HG22 ' HG3' ' A' ' 70' ' ' GLU . 5.9 p -135.46 121.05 30.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.181 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.662 ' HG3' HG22 ' A' ' 69' ' ' VAL . 4.1 mt-10 57.77 23.05 9.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.481 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . 92.94 -24.84 22.56 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.509 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.488 HG22 ' HB ' ' A' ' 37' ' ' THR . 4.2 mp -80.22 111.52 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 111.173 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.828 HD23 HG21 ' A' ' 43' ' ' VAL . 4.1 mm? -73.12 109.06 6.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.924 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -84.24 137.22 33.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.625 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -89.29 160.32 42.81 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.552 0.691 . . . . 0.0 111.104 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.572 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.0 Cg_endo -69.92 -172.92 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.724 2.283 . . . . 0.0 112.292 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -76.98 -2.45 33.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.317 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.33 -29.64 9.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.097 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.38 -164.87 14.46 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.496 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.625 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 94.5 m95 -86.75 -59.42 2.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.758 0.313 . . . . 0.0 110.898 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.08 -163.19 32.98 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.484 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.34 37.69 4.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.806 0.336 . . . . 0.0 110.9 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.57 HD12 HG12 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -92.42 -175.8 4.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.579 HG22 ' CG2' ' A' ' 20' ' ' THR . 43.8 t -99.47 136.2 31.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.099 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.584 ' CE2' HD12 ' A' ' 53' ' ' LEU . 6.4 p90 -104.16 145.86 29.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.969 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.7 t -101.8 116.59 45.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.087 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.7 m -63.21 143.23 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.156 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -144.96 106.08 4.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.938 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 -179.909 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.793 0.33 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.18 148.17 22.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.111 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 73.0 62.42 3.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.442 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.4 m -85.78 -51.05 6.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.904 0.383 . . . . 0.0 110.841 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -130.65 125.54 34.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.86 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -72.36 -36.57 68.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -107.52 150.97 26.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.811 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -92.33 123.3 35.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -90.43 -26.75 19.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -69.2 145.07 53.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.64 35.12 3.36 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.472 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.8 t -126.24 145.3 50.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.91 0.386 . . . . 0.0 110.846 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.4 171.89 4.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.925 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.7 p -160.62 152.05 19.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -119.84 179.45 4.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.931 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -120.52 163.36 18.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.934 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.754 HG23 HG13 ' A' ' 30' ' ' ILE . 5.7 tt -109.91 123.83 66.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.103 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.66 103.64 10.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.042 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.528 HG12 HD23 ' A' ' 83' ' ' LEU . 8.3 m -147.91 155.32 10.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.38 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.601 ' CG2' HG22 ' A' ' 84' ' ' VAL . 0.8 OUTLIER -129.41 153.57 47.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.11 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.568 ' HG2' HG13 ' A' ' 87' ' ' VAL . 0.5 OUTLIER -79.79 -49.88 11.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.41 143.61 32.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -67.9 -30.8 70.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.929 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -67.04 -26.55 66.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.876 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -90.14 170.23 10.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.832 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -94.37 159.61 33.54 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.662 0.744 . . . . 0.0 110.853 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 112.85 3.2 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.675 2.25 . . . . 0.0 112.367 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.512 HD12 ' H ' ' A' ' 29' ' ' GLU . 5.0 tp -77.72 140.13 17.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.898 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.512 ' H ' HD12 ' A' ' 28' ' ' ILE . 3.0 mp0 -101.77 117.52 35.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.762 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.754 HG13 HG23 ' A' ' 17' ' ' ILE . 0.6 OUTLIER -123.94 159.58 55.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.645 0.736 . . . . 0.0 111.148 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 152.13 68.82 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.659 2.239 . . . . 0.0 112.357 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.653 ' HB2' HG22 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -142.3 155.91 45.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.863 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.597 ' HG2' HD23 ' A' ' 39' ' ' LEU . 4.0 mm-40 -57.51 166.4 1.28 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -70.18 -33.19 71.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -63.68 -20.25 65.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 113.57 -12.94 23.09 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.451 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.577 HG22 ' HA ' ' A' ' 74' ' ' HIS . 33.2 p -82.48 -177.16 6.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.833 0.349 . . . . 0.0 111.128 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.653 HG22 ' HB2' ' A' ' 32' ' ' SER . 53.3 t -130.9 123.3 53.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.179 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.597 HD23 ' HG2' ' A' ' 33' ' ' GLU . 1.9 mm? -61.89 145.57 52.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.64 ' O ' HG23 ' A' ' 44' ' ' THR . 3.0 tm? -61.04 -24.24 66.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.901 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.8 p -67.52 -44.16 79.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.5 m -71.16 -30.42 66.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.156 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.859 HG21 HD23 ' A' ' 73' ' ' LEU . 21.3 t -65.47 -35.2 74.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.989 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.64 HG23 ' O ' ' A' ' 40' ' ' LEU . 21.7 p -79.6 -15.74 57.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.581 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.12 90.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -112.11 -25.57 9.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.091 0.472 . . . . 0.0 111.342 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -125.35 75.63 68.68 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.609 0.719 . . . . 0.0 110.89 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 133.03 24.62 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.694 2.263 . . . . 0.0 112.311 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.33 6.02 89.46 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.511 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.578 ' HB1' HD21 ' A' ' 53' ' ' LEU . . . -84.02 117.22 23.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.8 0.333 . . . . 0.0 111.083 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 2.4 m -101.22 -53.22 3.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.846 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.611 ' O ' HD23 ' A' ' 53' ' ' LEU . . . -121.23 135.0 10.39 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.427 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.665 HD13 ' CD2' ' A' ' 85' ' ' TYR . 12.9 mt -122.93 146.27 47.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.781 0.324 . . . . 0.0 110.919 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.404 ' HB2' ' HB ' ' A' ' 86' ' ' VAL . 24.5 mtt180 -116.59 171.71 7.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.648 ' CD1' HD11 ' A' ' 83' ' ' LEU . 5.6 m-85 -106.06 126.65 52.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.95 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -128.3 107.23 9.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.842 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -140.1 148.74 55.85 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.684 0.754 . . . . 0.0 110.866 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.67 -40.54 5.35 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.711 2.274 . . . . 0.0 112.396 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.4 m -85.73 -22.71 7.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.057 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.0 m -87.97 -20.98 25.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.87 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.459 ' O ' ' C ' ' A' ' 62' ' ' CYS . 10.1 mm100 62.04 35.54 15.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.934 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 61' ' ' GLN . 26.9 p 32.87 49.77 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.921 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 5.4 tpt -92.39 -16.31 26.1 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.999 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.32 -175.11 2.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.731 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.78 168.45 39.64 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.492 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.533 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 91.3 t -85.11 143.05 12.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.784 0.326 . . . . 0.0 111.133 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -99.62 138.56 36.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.836 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.522 HD21 ' HA2' ' A' ' 71' ' ' GLY . 1.9 tm? -116.28 115.97 26.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.669 HG22 ' HG3' ' A' ' 70' ' ' GLU . 6.0 p -134.03 121.12 37.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.147 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.669 ' HG3' HG22 ' A' ' 69' ' ' VAL . 4.1 mt-10 58.92 23.65 11.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.522 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . 93.19 -24.56 24.43 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.509 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.575 HG22 ' HB ' ' A' ' 37' ' ' THR . 4.6 mp -82.73 114.62 23.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.857 0.36 . . . . 0.0 111.151 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.859 HD23 HG21 ' A' ' 43' ' ' VAL . 4.0 mm? -74.64 100.29 3.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.969 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.577 ' HA ' HG22 ' A' ' 37' ' ' THR . 6.4 t60 -76.96 136.48 38.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.845 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.553 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -85.36 159.67 55.68 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.582 0.706 . . . . 0.0 111.092 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.553 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.8 Cg_endo -70.02 -173.22 0.71 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.618 2.212 . . . . 0.0 112.317 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -77.32 -1.98 32.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.182 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.91 -32.95 8.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.108 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.17 -165.18 19.47 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.51 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.621 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 83.8 m95 -86.64 -59.55 2.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.868 0.366 . . . . 0.0 110.844 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.71 -164.37 32.81 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.491 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -127.68 36.73 4.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.851 0.358 . . . . 0.0 110.858 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.648 HD11 ' CD1' ' A' ' 55' ' ' TYR . 0.8 OUTLIER -91.87 -173.71 3.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.907 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.601 HG22 ' CG2' ' A' ' 20' ' ' THR . 42.9 t -101.12 136.69 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.121 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.665 ' CD2' HD13 ' A' ' 53' ' ' LEU . 4.4 p90 -101.33 139.59 36.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.943 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 54' ' ' ARG . 20.5 t -97.49 114.76 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.149 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.568 HG13 ' HG2' ' A' ' 21' ' ' GLU . 23.3 m -61.29 147.82 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.108 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -145.36 96.8 2.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.916 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 45.6 p90 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.933 -179.922 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.6 mmt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.747 0.308 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.71 153.05 37.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.092 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -137.87 -164.47 10.01 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.499 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.2 p -134.66 170.02 16.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.883 0.373 . . . . 0.0 110.836 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -158.25 158.17 33.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.913 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.33 162.6 37.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -129.34 174.7 9.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.95 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -137.15 132.5 34.07 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.859 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -151.49 117.67 5.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.784 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 23.3 m170 -74.8 166.07 24.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -163.66 -49.91 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.407 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.2 m -115.94 176.25 5.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.355 . . . . 0.0 110.845 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 18.4 ttt -85.42 128.62 34.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.7 t -61.01 135.01 57.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.791 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -103.38 147.45 27.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.856 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -102.31 160.7 14.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.991 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.763 HG23 HG13 ' A' ' 30' ' ' ILE . 5.1 tt -121.46 123.32 69.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.098 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -121.97 103.76 9.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.095 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.732 HG12 HD12 ' A' ' 83' ' ' LEU . 16.3 m -143.53 149.64 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.355 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.558 HG23 HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -121.18 151.13 40.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.145 179.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.411 ' CG ' HG13 ' A' ' 87' ' ' VAL . 0.5 OUTLIER -79.59 -49.97 11.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.951 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.28 139.49 37.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -65.67 -33.34 75.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.829 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -71.78 -26.51 62.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -78.31 -171.01 2.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.79 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.4 154.92 43.55 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.382 0.611 . . . . 0.0 111.273 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.87 126.15 12.9 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.806 2.338 . . . . 0.0 112.362 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.413 HD12 ' H ' ' A' ' 29' ' ' GLU . 3.7 tp -98.69 131.92 44.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.413 ' H ' HD12 ' A' ' 28' ' ' ILE . 16.1 pt-20 -99.03 123.12 43.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.724 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.763 HG13 HG23 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -127.02 159.67 63.5 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.614 0.721 . . . . 0.0 111.093 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 152.32 69.43 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.663 2.242 . . . . 0.0 112.374 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.658 ' HB2' HG22 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -141.98 163.37 33.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -68.34 161.56 27.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -67.09 -27.17 67.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.803 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.63 -18.9 65.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.799 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.04 -12.81 34.32 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.481 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.517 HG22 ' HA ' ' A' ' 74' ' ' HIS . 43.2 p -83.65 -172.42 4.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.853 0.359 . . . . 0.0 111.102 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.658 HG22 ' HB2' ' A' ' 32' ' ' SER . 45.0 t -137.66 119.23 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.089 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.3 tp -59.71 142.4 53.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.937 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 44' ' ' THR . 23.0 tp -59.0 -21.12 58.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.953 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.4 t -68.39 -34.69 76.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.947 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.8 m -80.57 -30.65 36.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.179 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.959 HG21 HD23 ' A' ' 73' ' ' LEU . 25.5 t -64.84 -36.43 77.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.032 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 40' ' ' LEU . 32.1 p -79.95 -15.46 57.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.537 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.74 -44.64 85.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.956 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -111.35 -23.59 10.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.003 0.43 . . . . 0.0 111.261 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -124.82 74.9 65.33 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.669 0.747 . . . . 0.0 110.896 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 131.52 21.41 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.627 2.218 . . . . 0.0 112.326 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.9 5.52 89.71 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.431 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.56 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -84.69 114.86 22.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.724 0.297 . . . . 0.0 111.059 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 2.5 t -91.64 -52.87 4.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.881 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.533 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -127.18 136.17 9.19 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.543 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.576 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.8 OUTLIER -115.65 137.56 51.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.052 0.453 . . . . 0.0 110.652 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -107.47 170.41 7.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.682 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.593 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 9.8 m-85 -108.0 126.37 52.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.957 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -128.68 122.22 30.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -138.99 118.8 9.44 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.544 0.687 . . . . 0.0 110.877 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.74 -28.51 25.26 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.657 2.238 . . . . 0.0 112.366 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.6 m -86.37 -29.4 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.176 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.8 m -87.69 -27.75 22.23 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.991 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 59.82 24.87 13.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.023 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -98.37 168.7 10.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.958 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 13.3 mtt -129.85 33.6 4.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.669 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.8 ttt85 -57.32 179.51 0.05 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.698 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.83 147.35 16.58 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.613 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.593 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 50.5 t -72.36 134.95 28.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.849 0.357 . . . . 0.0 111.11 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.458 ' HE ' HG23 ' A' ' 69' ' ' VAL . 4.4 tpt180 -77.2 138.77 39.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.867 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.504 HD13 ' C ' ' A' ' 68' ' ' LEU . 3.3 tm? -116.38 107.56 14.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.458 HG23 ' HE ' ' A' ' 67' ' ' ARG . 15.1 t -115.77 105.96 19.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.19 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 50.52 40.19 22.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.436 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . 90.31 -25.9 11.55 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.537 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.461 HG22 ' HB ' ' A' ' 37' ' ' THR . 2.7 mp -78.18 110.38 13.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.842 0.353 . . . . 0.0 111.116 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.959 HD23 HG21 ' A' ' 43' ' ' VAL . 4.1 mm? -73.93 102.97 4.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.517 ' HA ' HG22 ' A' ' 37' ' ' THR . 6.6 t60 -83.61 136.25 34.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.809 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.649 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -84.4 160.15 57.4 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.594 0.711 . . . . 0.0 111.108 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.569 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.2 Cg_endo -69.95 -171.85 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.711 2.274 . . . . 0.0 112.302 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.12 -2.32 33.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.294 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.86 -30.95 8.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.125 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.86 -165.73 14.7 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.441 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.649 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 95.4 m95 -86.59 -59.18 2.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.807 0.337 . . . . 0.0 110.936 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.2 -167.13 48.96 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.456 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -117.88 38.81 3.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.896 0.379 . . . . 0.0 110.862 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.732 HD12 HG12 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -87.22 -175.33 5.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.993 179.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.558 HG22 HG23 ' A' ' 20' ' ' THR . 39.6 t -106.71 134.33 48.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.102 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.576 ' CE2' HD12 ' A' ' 53' ' ' LEU . 3.7 p90 -100.75 146.03 27.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 63.4 t -106.47 112.77 40.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.089 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.411 HG13 ' CG ' ' A' ' 21' ' ' GLU . 4.7 m -53.87 143.73 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.135 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -145.13 105.68 4.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.915 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.817 0.341 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.13 126.8 3.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.155 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -172.96 66.29 0.12 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.453 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.4 p -158.64 -48.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.959 0.409 . . . . 0.0 110.84 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.5 m80 -71.04 146.92 49.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 57.28 93.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -60.04 148.8 34.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -119.27 112.55 19.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -151.95 155.08 37.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -129.28 141.87 50.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.857 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.56 112.77 0.46 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.481 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 93.7 p -174.8 121.69 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.816 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.4 ptt? -139.95 147.53 40.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.891 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.4 p -175.59 158.93 2.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.818 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -84.75 156.99 21.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -116.18 163.7 15.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.86 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.735 HG23 HG13 ' A' ' 30' ' ' ILE . 7.0 tt -126.95 121.28 57.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.024 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -119.32 101.53 8.04 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.231 0.539 . . . . 0.0 110.442 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.595 HG12 ' CD2' ' A' ' 83' ' ' LEU . 6.7 m -139.77 159.84 27.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.062 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.19 156.95 47.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.155 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.429 ' OE2' HG22 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -83.7 -57.87 3.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.28 164.26 14.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -85.35 -28.5 25.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.099 0.476 . . . . 0.0 111.287 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -70.05 -44.42 69.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.839 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -65.02 -170.57 0.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.841 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -116.96 160.53 36.61 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.383 0.611 . . . . 0.0 111.297 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.94 106.45 1.7 Allowed 'Trans proline' 0 C--O 1.23 0.109 0 C-N-CA 122.664 2.243 . . . . 0.0 112.255 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.477 HD12 ' H ' ' A' ' 29' ' ' GLU . 5.0 tp -74.65 138.5 20.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.929 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.477 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -101.02 118.62 37.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.732 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.735 HG13 HG23 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -123.44 159.22 56.02 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.594 0.711 . . . . 0.0 111.174 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.42 ' O ' HG21 ' A' ' 42' ' ' THR . 54.2 Cg_endo -69.79 162.46 42.0 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.727 2.285 . . . . 0.0 112.338 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.593 ' HB2' HG22 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -149.55 175.4 11.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -75.11 178.83 5.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.843 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -81.47 -34.5 31.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.047 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.5 -29.94 70.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.105 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 121.47 16.67 4.15 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.601 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.651 HG22 ' HA ' ' A' ' 74' ' ' HIS . 52.4 p -111.18 178.84 4.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.851 0.358 . . . . 0.0 111.166 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.649 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 73.3 t -133.75 106.04 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.086 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.63 144.18 22.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.001 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.542 HD12 ' HA3' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -50.23 -31.25 13.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.946 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.0 p -52.81 -45.13 67.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.913 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.42 HG21 ' O ' ' A' ' 31' ' ' PRO . 14.4 m -75.39 -30.92 60.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.123 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.962 HG21 HD23 ' A' ' 73' ' ' LEU . 40.3 t -66.92 -43.14 89.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.986 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.2 p -74.42 -6.34 47.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.501 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.53 -46.62 63.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.949 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -114.85 -23.34 9.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.314 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -119.2 74.93 15.03 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.601 0.715 . . . . 0.0 110.852 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 130.25 19.06 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.706 2.271 . . . . 0.0 112.307 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.34 3.76 89.85 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.446 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.605 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -83.9 118.91 24.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.782 0.325 . . . . 0.0 111.077 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.3 m -100.51 -58.14 1.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.91 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.564 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -117.75 130.17 8.65 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.514 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.666 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.5 OUTLIER -114.5 140.96 48.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.93 0.395 . . . . 0.0 110.738 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.42 176.09 5.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.83 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.427 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 10.4 m-85 -111.73 134.69 53.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.932 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -144.31 117.93 9.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -177.99 148.51 0.66 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.734 0.778 . . . . 0.0 110.887 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -46.84 1.09 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.642 2.228 . . . . 0.0 112.362 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.1 m -64.65 -18.26 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.181 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.1 t -68.73 -40.42 79.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.105 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 62.18 25.35 15.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.097 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.72 164.46 33.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 14.8 ttt -115.77 36.33 4.05 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.076 0.465 . . . . 0.0 110.801 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.01 173.42 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.723 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -145.64 131.52 4.2 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.414 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.456 HG12 HD12 ' A' ' 73' ' ' LEU . 27.3 t -54.5 128.77 14.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.819 0.343 . . . . 0.0 111.152 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -77.91 149.77 34.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 69' ' ' VAL . 2.7 tm? -127.61 126.37 41.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.936 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.507 HG22 ' HG2' ' A' ' 70' ' ' GLU . 6.9 p -149.01 123.42 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.172 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.507 ' HG2' HG22 ' A' ' 69' ' ' VAL . 72.8 mm-40 58.11 22.81 9.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.877 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.542 ' HA3' HD12 ' A' ' 40' ' ' LEU . . . 88.91 -14.63 59.87 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.526 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.524 HG22 ' HB ' ' A' ' 37' ' ' THR . 2.0 mp -92.94 110.37 22.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.808 0.337 . . . . 0.0 111.131 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.962 HD23 HG21 ' A' ' 43' ' ' VAL . 4.2 mm? -66.18 121.67 15.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.998 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.651 ' HA ' HG22 ' A' ' 37' ' ' THR . 2.8 t60 -93.42 126.56 38.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.597 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -67.81 160.48 73.28 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.587 0.708 . . . . 0.0 111.195 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.597 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.1 Cg_endo -69.94 -170.92 0.44 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.69 2.26 . . . . 0.0 112.331 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.12 53.48 2.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.278 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -173.79 -40.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.837 0.351 . . . . 0.0 111.136 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.68 -176.03 21.73 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.439 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.649 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 90.9 m95 -76.09 -74.96 0.2 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.743 0.306 . . . . 0.0 110.91 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.27 -161.78 24.44 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.476 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.573 ' C ' HD13 ' A' ' 83' ' ' LEU . 2.2 m-20 -127.0 95.81 4.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 110.96 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.629 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -151.26 -176.23 5.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.986 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.8 p -101.65 127.83 54.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.128 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.666 ' CE2' HD12 ' A' ' 53' ' ' LEU . 3.4 p90 -98.62 156.25 16.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.921 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.8 t -113.14 122.37 67.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.203 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.429 HG22 ' OE2' ' A' ' 21' ' ' GLU . 27.9 m -66.54 150.81 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.161 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -144.51 92.14 2.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 44.4 p90 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.954 -179.885 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.769 0.319 . . . . 0.0 110.815 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.74 -178.88 6.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.6 160.59 19.42 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.553 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.2 t -69.88 108.98 4.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.919 0.39 . . . . 0.0 110.816 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -86.42 -26.49 24.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -113.07 173.97 6.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.807 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -122.79 165.9 15.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.96 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 26.3 p-80 -127.26 136.9 52.63 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.969 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -102.95 163.25 12.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.685 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -84.07 -41.5 17.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.59 113.89 0.51 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.518 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.7 p -145.61 140.49 27.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.819 0.342 . . . . 0.0 110.863 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.59 161.4 12.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.805 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.7 p -145.51 142.09 28.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.842 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -85.91 -174.54 5.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -134.35 160.95 36.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.956 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.753 HG23 HG13 ' A' ' 30' ' ' ILE . 6.1 tt -118.14 123.28 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.105 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.43 103.82 10.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.09 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.416 ' O ' HG22 ' A' ' 28' ' ' ILE . 12.4 m -147.49 150.79 14.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.409 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.698 ' CG2' HG22 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -121.06 155.83 33.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.195 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -71.28 -48.32 51.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.1 170.85 8.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.923 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -87.18 -24.52 24.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.207 0.527 . . . . 0.0 111.447 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -66.15 -26.29 67.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.836 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -96.68 -171.42 2.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.809 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -108.72 159.36 31.23 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.343 0.592 . . . . 0.0 111.309 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.96 124.63 11.18 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.671 2.247 . . . . 0.0 112.367 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.484 HD12 ' H ' ' A' ' 29' ' ' GLU . 4.6 tp -92.83 137.41 22.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.897 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.484 ' H ' HD12 ' A' ' 28' ' ' ILE . 1.4 pp20? -99.31 122.02 41.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.731 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.753 HG13 HG23 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -126.82 159.9 61.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.616 0.722 . . . . 0.0 111.11 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 142.55 48.39 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.731 2.287 . . . . 0.0 112.361 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.543 ' HB2' HG22 ' A' ' 38' ' ' VAL . 6.3 p -131.63 168.45 17.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.835 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -72.31 156.7 38.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -64.87 -30.49 71.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -67.01 -19.46 65.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.63 -16.35 16.64 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.469 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.578 ' HB ' HG22 ' A' ' 72' ' ' ILE . 30.6 p -81.54 -172.84 4.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.362 . . . . 0.0 111.134 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.6 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 55.9 t -140.74 120.45 12.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.1 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.8 mt -58.7 144.0 44.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.762 HD12 ' CA ' ' A' ' 71' ' ' GLY . 1.6 tt -61.23 -21.99 64.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.944 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.8 m -65.61 -37.65 87.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.7 m -77.51 -30.43 52.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.15 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.728 HG21 HD23 ' A' ' 73' ' ' LEU . 25.6 t -65.58 -37.71 80.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.048 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 40' ' ' LEU . 33.8 p -78.19 -15.32 58.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.614 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.02 -45.98 83.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.887 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -111.94 -16.96 13.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.969 0.414 . . . . 0.0 111.223 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -132.39 75.22 74.48 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.62 0.724 . . . . 0.0 110.887 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 127.54 14.73 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.737 2.291 . . . . 0.0 112.323 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.7 -15.89 59.39 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.538 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.517 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -62.35 110.18 1.57 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.697 0.284 . . . . 0.0 111.096 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.7 t -92.87 -42.86 9.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.187 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.686 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -129.43 137.29 9.47 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.406 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.792 HD12 ' CE1' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -120.27 133.34 55.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.988 0.423 . . . . 0.0 110.707 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -107.02 171.91 7.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.71 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -107.99 125.75 51.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.918 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -129.22 104.22 7.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.499 ' OD1' HD12 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -122.36 117.41 29.23 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.615 0.721 . . . . 0.0 110.88 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 -27.09 27.24 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.695 2.263 . . . . 0.0 112.371 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.7 m -86.17 -29.4 6.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.131 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.1 m -88.88 -27.31 21.1 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.009 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 59.39 25.85 14.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.039 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.8 m -94.1 176.15 6.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 23.7 mtp -135.2 29.37 3.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.923 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -60.4 -174.61 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.755 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.3 143.18 8.25 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.526 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.78 143.14 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.839 0.352 . . . . 0.0 111.087 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -90.63 130.72 36.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.497 HD13 ' C ' ' A' ' 68' ' ' LEU . 2.8 tm? -110.93 114.54 27.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.69 HG22 ' HG2' ' A' ' 70' ' ' GLU . 7.7 p -137.82 124.68 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.125 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.69 ' HG2' HG22 ' A' ' 69' ' ' VAL . 5.3 mm-40 57.17 22.77 7.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.762 ' CA ' HD12 ' A' ' 40' ' ' LEU . . . 91.97 -24.94 18.87 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.501 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.578 HG22 ' HB ' ' A' ' 37' ' ' THR . 3.3 mp -83.05 121.05 35.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.816 0.341 . . . . 0.0 111.176 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.728 HD23 HG21 ' A' ' 43' ' ' VAL . 3.9 mm? -80.13 109.85 14.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.913 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.55 ' HA ' HG22 ' A' ' 37' ' ' THR . 6.0 t60 -86.76 135.54 33.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.596 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -84.09 159.85 58.87 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.543 0.687 . . . . 0.0 111.199 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.562 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.6 Cg_endo -69.84 -172.26 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.72 2.28 . . . . 0.0 112.376 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -76.98 -2.49 34.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.253 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.92 -29.09 9.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.21 -168.07 14.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.527 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.6 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 93.8 m95 -82.78 -59.23 2.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.809 0.338 . . . . 0.0 110.875 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.35 -166.61 32.06 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.492 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -127.91 38.28 4.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 0.0 110.9 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.692 HD13 ' H ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.55 -175.73 3.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.698 HG22 ' CG2' ' A' ' 20' ' ' THR . 48.2 t -94.64 146.92 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.792 ' CE1' HD12 ' A' ' 53' ' ' LEU . 3.4 p90 -116.9 146.15 43.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.976 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 88.8 t -96.41 130.18 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.113 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.51 HG22 ' CE1' ' A' ' 85' ' ' TYR . 2.1 t -85.16 133.08 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.084 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -145.39 136.17 24.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.883 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.975 -179.943 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.841 0.353 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.54 123.56 25.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.108 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 157.12 -84.96 0.13 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.511 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.3 p -80.44 121.18 25.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.866 0.365 . . . . 0.0 110.892 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -113.77 118.0 33.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -85.55 136.81 33.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.841 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -123.85 115.56 21.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.907 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -92.45 -27.04 17.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 59.1 42.08 19.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.85 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -149.49 164.52 34.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.6 140.34 45.8 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.451 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -136.47 162.51 32.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.9 0.381 . . . . 0.0 110.858 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 mpp? -112.45 26.07 10.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.838 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.6 t -66.99 -69.71 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -148.24 130.07 15.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.88 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -86.22 162.61 18.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.4 ' CG2' HG13 ' A' ' 30' ' ' ILE . 2.6 tt -115.54 125.51 72.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.153 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -120.64 104.99 10.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.01 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.543 HG12 HD23 ' A' ' 83' ' ' LEU . 16.1 m -148.74 148.01 16.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.325 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.59 HG23 HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -122.46 153.81 38.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.11 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.9 -49.73 23.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -115.4 144.17 44.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -63.89 -25.27 68.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -72.5 -26.71 61.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -88.93 172.3 9.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.825 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -89.92 153.34 47.24 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.658 0.742 . . . . 0.0 110.864 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.425 ' HA ' ' HB ' ' A' ' 20' ' ' THR . 53.3 Cg_endo -69.79 116.44 4.57 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.697 2.264 . . . . 0.0 112.284 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.537 HD13 ' HG3' ' A' ' 46' ' ' GLN . 1.0 OUTLIER -72.12 162.48 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.119 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.431 ' N ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -136.77 111.66 8.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.437 HD12 HG22 ' A' ' 42' ' ' THR . 6.7 pt -126.79 155.6 75.02 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.648 0.737 . . . . 0.0 111.076 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 145.6 57.51 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.631 2.221 . . . . 0.0 112.319 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.477 ' HB2' HG22 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -119.68 171.45 8.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -67.62 -179.32 1.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -73.24 -43.56 60.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.986 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -65.33 -17.04 64.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.855 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.17 -24.57 9.23 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.536 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.609 HG22 ' HA ' ' A' ' 74' ' ' HIS . 43.6 p -61.78 -173.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.801 0.334 . . . . 0.0 111.166 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.601 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 47.1 t -137.21 122.13 24.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.5 tp -61.12 146.57 46.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.682 HD13 ' O ' ' A' ' 40' ' ' LEU . 2.6 tm? -62.34 -34.24 76.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.851 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.5 t -60.91 -27.89 68.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.796 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.437 HG22 HD12 ' A' ' 30' ' ' ILE . 8.8 m -87.35 -26.65 23.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.101 0.477 . . . . 0.0 111.549 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.848 HG21 HD23 ' A' ' 73' ' ' LEU . 12.2 t -66.87 -40.06 84.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.061 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.2 p -71.91 -13.58 61.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.169 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.98 -48.49 81.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.537 ' HG3' HD13 ' A' ' 28' ' ' ILE . 66.7 mm-40 -112.36 -19.14 12.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.298 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -125.44 74.96 69.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.623 0.725 . . . . 0.0 110.901 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 136.28 32.8 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.703 2.269 . . . . 0.0 112.343 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.71 6.44 66.89 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.487 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.52 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -83.52 123.01 29.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.722 0.296 . . . . 0.0 111.134 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.1 m -101.07 -52.88 3.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.893 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.577 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -122.35 132.69 8.91 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.458 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.631 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -115.24 138.25 51.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.948 0.404 . . . . 0.0 110.759 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -107.51 171.28 7.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.648 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.639 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 10.9 m-85 -110.34 126.39 54.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -128.78 108.74 10.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.7 114.79 26.84 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.607 0.717 . . . . 0.0 110.859 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -26.12 27.79 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.659 2.24 . . . . 0.0 112.326 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.2 m -86.34 -30.4 6.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.2 t -86.18 -27.11 24.75 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.031 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 61.64 26.04 15.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.061 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 63.0 m -101.04 176.27 5.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.8 ptt? -135.75 40.41 2.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -174.33 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.701 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.79 134.78 3.63 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.464 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.639 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 21.3 t -59.11 136.1 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.811 0.339 . . . . 0.0 111.166 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -84.07 138.41 33.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.931 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.487 HD22 ' N ' ' A' ' 69' ' ' VAL . 2.6 tm? -119.98 124.21 45.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.954 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.613 HG22 ' HG2' ' A' ' 70' ' ' GLU . 6.2 p -147.32 121.84 2.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.165 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.613 ' HG2' HG22 ' A' ' 69' ' ' VAL . 8.5 mm-40 58.36 22.52 9.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.872 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.72 -24.78 22.16 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.491 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.528 HG22 ' HB ' ' A' ' 37' ' ' THR . 3.9 mt -82.54 115.69 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.794 0.331 . . . . 0.0 111.134 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.848 HD23 HG21 ' A' ' 43' ' ' VAL . 4.2 mm? -75.69 111.62 11.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.966 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.609 ' HA ' HG22 ' A' ' 37' ' ' THR . 6.7 t60 -86.45 135.97 33.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.614 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -84.84 160.07 56.38 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.589 0.709 . . . . 0.0 111.135 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.559 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.6 Cg_endo -70.0 -173.37 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.702 2.268 . . . . 0.0 112.35 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.3 -2.41 34.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.3 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.78 -28.69 9.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.136 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.78 -169.23 13.78 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.444 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.614 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 98.0 m95 -82.87 -58.79 2.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.851 0.358 . . . . 0.0 110.935 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.04 -160.91 34.1 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.43 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -127.36 37.19 4.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.821 0.343 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.543 HD23 HG12 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -91.57 -175.71 4.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.914 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.59 HG22 HG23 ' A' ' 20' ' ' THR . 47.0 t -100.04 140.07 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.631 ' CE2' HD12 ' A' ' 53' ' ' LEU . 2.9 p90 -105.62 146.12 30.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.011 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 87.4 t -103.92 124.91 58.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.107 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.0 t -69.83 147.39 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.147 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -145.21 96.71 2.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.95 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.913 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.5 ttp . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.723 0.297 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.75 -67.9 0.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 132.53 -140.28 11.68 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.521 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.3 t -61.35 161.14 9.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.932 0.396 . . . . 0.0 110.866 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -85.98 -26.69 25.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.865 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -52.15 161.05 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.829 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -62.17 149.39 41.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.838 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -91.02 -25.93 19.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -58.15 114.97 2.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.831 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -115.19 26.05 10.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.836 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.16 141.37 37.49 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.503 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.2 p -132.82 171.05 14.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 0.0 110.85 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 10.8 ptm -52.63 137.57 30.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.807 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.8 p -151.5 153.39 34.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -96.76 132.71 42.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -86.53 172.42 10.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.752 HG23 HG13 ' A' ' 30' ' ' ILE . 6.1 tt -119.48 122.95 70.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.222 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.2 103.84 10.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.107 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.462 ' O ' HG22 ' A' ' 28' ' ' ILE . 6.7 m -147.61 153.18 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.33 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.581 ' CG2' HG22 ' A' ' 84' ' ' VAL . 0.6 OUTLIER -126.77 149.78 49.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.067 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.51 -50.0 15.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -101.88 149.66 23.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -75.32 -31.5 60.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.139 0.495 . . . . 0.0 111.215 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -66.93 -26.69 66.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.89 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -87.46 -175.92 5.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.88 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -107.27 159.69 29.2 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.374 0.606 . . . . 0.0 111.304 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.92 118.98 6.0 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.686 2.257 . . . . 0.0 112.386 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.859 HD11 HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -85.27 143.52 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.156 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.69 121.28 43.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.89 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.859 HG23 HD11 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -127.1 159.95 62.19 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.71 . . . . 0.0 111.213 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 148.84 65.79 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.658 2.239 . . . . 0.0 112.326 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.548 ' HB3' HG22 ' A' ' 38' ' ' VAL . 1.3 m -140.35 168.41 19.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.889 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -75.71 158.34 32.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -65.82 -29.61 70.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.856 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -65.28 -19.42 65.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.885 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 113.4 -14.26 23.0 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.466 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.489 ' HB ' HG22 ' A' ' 72' ' ' ILE . 22.3 p -85.24 -176.77 6.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.761 0.315 . . . . 0.0 111.222 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.622 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 70.0 t -138.23 122.57 21.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.176 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 30.3 mt -58.88 146.77 36.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.4 ' O ' HG23 ' A' ' 44' ' ' THR . 22.6 tp -62.76 -23.25 67.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.952 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.8 t -65.1 -33.51 76.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.934 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.2 m -82.9 -29.64 29.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.199 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.839 HG21 HD23 ' A' ' 73' ' ' LEU . 40.0 t -66.99 -40.96 86.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.985 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 40' ' ' LEU . 30.8 p -76.88 -14.81 59.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.533 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.79 -47.77 79.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.915 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -112.12 -20.34 11.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.998 0.428 . . . . 0.0 111.325 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -124.38 75.4 61.53 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.639 0.733 . . . . 0.0 110.857 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 131.91 22.22 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.72 2.28 . . . . 0.0 112.339 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.17 6.33 89.25 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.524 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.708 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -86.81 107.76 18.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.78 0.324 . . . . 0.0 111.094 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.5 t -93.72 -52.93 4.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.554 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -118.9 129.12 7.97 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.477 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.708 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -115.69 136.85 52.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.02 0.438 . . . . 0.0 110.65 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.7 ttm-85 -107.39 171.17 7.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.779 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -105.96 126.34 52.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.91 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -128.43 103.62 7.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.478 ' OD1' HD12 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -125.8 115.29 24.58 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.703 0.764 . . . . 0.0 110.863 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -25.78 28.2 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.623 2.215 . . . . 0.0 112.365 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.4 m -86.4 -29.75 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.18 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.0 m -88.15 -27.16 22.05 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.107 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 60.36 26.22 15.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.097 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.4 t -96.86 167.14 11.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.875 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -126.93 25.57 6.27 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.704 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.5 ttt-85 -58.06 179.28 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.785 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.09 142.48 8.12 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.524 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.23 142.57 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.889 0.376 . . . . 0.0 111.132 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -91.21 138.54 31.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.775 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.476 HD13 ' C ' ' A' ' 68' ' ' LEU . 2.4 tm? -116.15 117.13 29.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.641 HG22 ' HG3' ' A' ' 70' ' ' GLU . 6.2 p -138.07 122.18 21.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.123 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.641 ' HG3' HG22 ' A' ' 69' ' ' VAL . 5.2 mt-10 57.65 22.64 8.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.424 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . 92.65 -24.8 21.83 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.538 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.489 HG22 ' HB ' ' A' ' 37' ' ' THR . 3.4 mt -82.53 112.79 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.822 0.344 . . . . 0.0 111.127 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.839 HD23 HG21 ' A' ' 43' ' ' VAL . 4.2 mm? -73.18 111.22 8.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.473 ' HA ' HG22 ' A' ' 37' ' ' THR . 5.6 t60 -84.65 135.58 34.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.557 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -88.83 159.74 45.33 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.516 0.674 . . . . 0.0 111.174 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.557 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.5 Cg_endo -69.92 -173.12 0.68 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.698 2.266 . . . . 0.0 112.387 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -77.28 -2.12 33.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.272 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.13 -30.27 8.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.101 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.55 -164.69 15.47 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.521 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.622 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 95.1 m95 -85.64 -59.54 2.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.807 0.337 . . . . 0.0 110.918 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.16 -165.63 30.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.585 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -128.44 38.5 3.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.873 0.368 . . . . 0.0 110.908 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.704 HD13 ' H ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.42 -175.66 3.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.919 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.581 HG22 ' CG2' ' A' ' 20' ' ' THR . 45.6 t -95.43 140.39 17.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.162 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.618 ' CE2' HD12 ' A' ' 53' ' ' LEU . 7.2 p90 -109.9 145.46 36.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.979 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.3 t -101.28 119.77 49.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.051 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.2 m -66.63 150.98 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.092 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -145.06 102.5 3.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 -179.915 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 tpt . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.723 0.297 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.79 176.74 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.097 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -156.03 -150.39 5.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.528 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 t -137.35 152.05 49.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.905 0.384 . . . . 0.0 110.869 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -115.6 156.57 25.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.869 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -112.34 152.29 28.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.821 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -138.16 148.18 44.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.905 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -110.86 156.55 20.99 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.697 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -81.39 159.87 24.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.673 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 26.7 p80 -104.71 -30.0 10.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.856 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -53.66 166.7 1.75 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.455 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.1 t -76.14 158.27 31.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 110.919 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.8 ptp -85.91 154.27 21.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 94.3 p -103.48 159.86 15.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.85 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -93.09 -176.15 4.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -134.1 165.17 25.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.984 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.716 HG23 HG13 ' A' ' 30' ' ' ILE . 6.3 tt -121.2 123.29 69.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.149 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.21 103.89 10.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.45 ' O ' HG22 ' A' ' 28' ' ' ILE . 9.6 m -147.49 150.17 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.262 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.421 HG23 HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -124.12 148.92 46.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.197 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -72.56 -49.56 31.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -114.49 139.55 49.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.858 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.69 -18.27 58.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -73.87 -26.57 60.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.67 137.42 41.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.902 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -58.32 159.85 10.73 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.589 0.709 . . . . 0.0 110.925 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.405 ' HA ' ' HB ' ' A' ' 20' ' ' THR . 54.3 Cg_endo -69.68 124.27 10.94 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.612 2.208 . . . . 0.0 112.339 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.871 HD11 HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -85.34 143.53 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.144 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -105.89 121.45 44.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.871 HG23 HD11 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -127.15 159.6 64.14 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.611 0.72 . . . . 0.0 111.124 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 153.72 68.77 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.675 2.25 . . . . 0.0 112.373 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.579 ' HB2' HG22 ' A' ' 38' ' ' VAL . 1.1 p -142.25 162.4 35.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.818 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -68.9 159.59 32.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -65.65 -26.41 67.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -68.93 -19.38 64.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 113.08 -16.13 22.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.48 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.6 HG22 ' HA ' ' A' ' 74' ' ' HIS . 38.7 p -82.23 -172.44 3.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.815 0.34 . . . . 0.0 111.162 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.624 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 67.9 t -139.39 119.08 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.119 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.43 148.54 27.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.744 HD12 ' CA ' ' A' ' 71' ' ' GLY . 1.7 tt -63.02 -23.08 67.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.922 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.8 p -65.22 -36.41 84.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.2 m -80.13 -27.93 39.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.119 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.914 HG21 HD23 ' A' ' 73' ' ' LEU . 41.2 t -67.89 -42.03 85.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.027 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.546 HG23 HD23 ' A' ' 40' ' ' LEU . 30.1 p -76.12 -14.62 60.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.567 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.16 -48.0 77.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.902 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -112.13 -17.4 12.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.335 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -127.88 75.49 78.17 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.564 0.697 . . . . 0.0 110.853 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.78 131.44 21.22 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.701 2.267 . . . . 0.0 112.33 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.48 6.27 89.39 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.531 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.638 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -88.17 107.01 18.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.826 0.346 . . . . 0.0 111.099 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.6 t -91.78 -53.07 4.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.874 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.583 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -119.34 130.74 8.67 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.514 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.638 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -115.28 139.74 49.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.082 0.468 . . . . 0.0 110.664 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.39 171.07 7.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.751 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -106.14 126.81 52.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.921 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -125.5 103.75 8.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.808 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.454 ' OD1' HD12 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -132.44 105.32 13.26 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.597 0.713 . . . . 0.0 110.94 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 57' ' ' ASN . 53.7 Cg_endo -69.66 -21.31 34.13 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.696 2.264 . . . . 0.0 112.405 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.6 m -86.64 -16.65 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.128 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 62.0 m -89.64 -27.06 20.42 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.041 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 62.17 32.78 17.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.114 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 37.5 m -131.42 -177.14 4.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.861 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -139.44 98.57 3.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.197 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.59 -174.2 2.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.817 0.341 . . . . 0.0 110.901 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.26 142.84 8.15 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.499 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.9 t -68.31 144.2 14.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 0.0 111.188 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -90.03 138.94 31.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.465 HD13 ' C ' ' A' ' 68' ' ' LEU . 2.2 tm? -122.23 116.48 24.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.887 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.581 HG22 ' HG2' ' A' ' 70' ' ' GLU . 7.0 p -137.82 123.47 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.174 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.581 ' HG2' HG22 ' A' ' 69' ' ' VAL . 29.5 mm-40 58.6 22.75 10.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.817 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.744 ' CA ' HD12 ' A' ' 40' ' ' LEU . . . 92.47 -24.99 20.29 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.529 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.549 HG22 ' HB ' ' A' ' 37' ' ' THR . 3.8 mp -82.01 115.34 24.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.841 0.353 . . . . 0.0 111.146 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.914 HD23 HG21 ' A' ' 43' ' ' VAL . 4.1 mm? -74.23 108.75 7.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.948 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.6 ' HA ' HG22 ' A' ' 37' ' ' THR . 6.3 t60 -85.9 135.76 33.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.568 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -84.22 159.74 58.75 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.604 0.716 . . . . 0.0 111.054 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.556 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.8 Cg_endo -70.0 -172.88 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.677 2.251 . . . . 0.0 112.286 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -77.17 -2.0 32.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.301 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.38 -30.45 8.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.108 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.16 -169.21 16.24 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.505 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.624 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 77.4 m95 -81.24 -59.29 2.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.792 0.33 . . . . 0.0 110.895 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.71 -170.14 36.31 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.473 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -127.1 38.51 4.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.863 0.363 . . . . 0.0 110.901 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.699 HD13 ' H ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.25 -175.0 3.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.982 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.421 HG22 HG23 ' A' ' 20' ' ' THR . 20.6 t -94.61 145.2 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.129 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.556 ' CE2' HD12 ' A' ' 53' ' ' LEU . 5.9 p90 -116.14 146.05 42.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.988 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 99.0 t -101.44 120.91 51.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.103 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.2 m -67.48 148.98 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -145.01 107.07 4.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.93 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.895 -179.886 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 mtt . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.797 0.332 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.3 160.27 11.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.104 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.83 -72.16 1.24 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.479 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 p -82.72 172.73 12.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.886 0.374 . . . . 0.0 110.874 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -83.14 110.92 18.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.819 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.9 m170 -79.37 120.47 23.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.851 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -88.76 -53.87 4.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.739 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -154.93 139.09 16.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.756 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -141.5 155.44 45.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.744 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -61.66 -37.08 82.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -54.62 149.12 20.47 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.543 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.0 t -116.29 120.44 38.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.892 0.377 . . . . 0.0 110.88 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.3 ptm -92.81 -29.01 16.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.901 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 87.6 p -63.01 117.09 5.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.839 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -92.15 145.83 24.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.919 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -89.8 174.1 7.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.959 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.73 HG23 HG13 ' A' ' 30' ' ' ILE . 5.5 tt -120.14 123.39 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.138 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.95 104.41 10.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.112 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.585 HG12 HD12 ' A' ' 83' ' ' LEU . 5.9 m -144.96 157.42 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.367 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 1.083 HG23 HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -138.61 146.67 42.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.173 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.428 ' CG ' HG13 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -74.22 -50.12 20.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.842 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -102.42 137.52 40.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -69.49 -26.63 64.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -66.55 -26.33 67.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -91.74 -174.61 3.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.99 154.95 37.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.64 0.733 . . . . 0.0 110.907 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 110.84 2.66 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.738 2.292 . . . . 0.0 112.27 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.879 HD11 HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -72.18 144.2 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.189 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.21 122.26 46.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.862 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.879 HG23 HD11 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -127.32 159.98 62.5 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.624 0.725 . . . . 0.0 111.153 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.424 ' O ' HG21 ' A' ' 42' ' ' THR . 53.6 Cg_endo -69.74 147.95 64.11 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.717 2.278 . . . . 0.0 112.347 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.518 ' HB3' HG22 ' A' ' 38' ' ' VAL . 1.1 m -139.42 163.62 32.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -67.1 164.75 17.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.839 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -71.58 -28.07 63.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.897 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -68.44 -19.29 64.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.855 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.14 -14.43 21.24 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.452 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.41 ' HB ' HG22 ' A' ' 72' ' ' ILE . 18.0 p -82.93 -177.55 6.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.814 0.34 . . . . 0.0 111.111 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.602 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 57.5 t -138.09 125.81 29.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.124 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 tp -63.44 146.2 54.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.9 tp -61.52 -27.96 68.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.4 m -64.02 -30.13 71.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.795 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 31' ' ' PRO . 16.5 m -84.48 -24.71 29.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.51 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.669 HG21 HD23 ' A' ' 73' ' ' LEU . 38.7 t -72.54 -50.13 36.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.112 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.5 p -67.69 -13.78 62.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.183 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.49 -47.81 80.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.96 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -112.17 -8.8 13.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.233 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -138.35 75.9 38.5 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.621 0.724 . . . . 0.0 110.834 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.87 127.04 13.95 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.613 2.208 . . . . 0.0 112.345 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.18 -16.4 57.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.498 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.633 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -67.95 98.11 0.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.712 0.292 . . . . 0.0 111.13 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 t -84.41 -52.64 6.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.946 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.598 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -115.01 129.71 8.77 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.465 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.633 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -115.07 134.81 54.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.072 0.463 . . . . 0.0 110.683 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -108.88 167.68 9.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.709 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.645 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 9.9 m-85 -104.77 125.98 51.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.964 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.693 ' HB3' HG23 ' A' ' 84' ' ' VAL . 19.7 tpt180 -129.32 109.07 10.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.94 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.489 ' ND2' HG22 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -132.46 109.32 13.51 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.613 0.721 . . . . 0.0 110.912 -179.885 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 57' ' ' ASN . 53.7 Cg_endo -69.78 -22.5 31.9 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.699 2.266 . . . . 0.0 112.29 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.489 HG22 ' ND2' ' A' ' 57' ' ' ASN . 18.6 m -86.31 -18.78 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.6 m -92.52 -24.99 18.59 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.991 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 60.62 22.14 11.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.007 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -111.83 -177.41 3.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.84 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -144.3 94.55 2.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.087 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.14 -175.02 2.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.897 0.379 . . . . 0.0 110.834 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.34 133.62 3.43 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.504 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.645 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 41.5 t -61.65 135.53 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 111.192 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -81.22 138.77 35.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.861 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.5 HD22 ' N ' ' A' ' 69' ' ' VAL . 2.4 tm? -120.17 122.37 40.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.951 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.67 HG22 ' HG2' ' A' ' 70' ' ' GLU . 6.1 p -145.72 121.36 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.67 ' HG2' HG22 ' A' ' 69' ' ' VAL . 29.7 mm-40 58.01 22.86 9.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.19 -25.17 18.62 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.482 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.41 HG22 ' HB ' ' A' ' 37' ' ' THR . 3.3 mt -82.03 112.64 20.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.805 0.336 . . . . 0.0 111.212 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.669 HD23 HG21 ' A' ' 43' ' ' VAL . 4.2 mm? -73.88 120.0 18.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -92.32 135.59 33.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.558 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -87.65 159.74 48.86 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.487 0.66 . . . . 0.0 111.201 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.558 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.2 Cg_endo -69.98 -173.43 0.75 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.644 2.229 . . . . 0.0 112.332 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -77.07 -2.56 34.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.263 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.72 -28.4 9.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.118 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.56 -169.11 13.66 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.51 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.602 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 97.4 m95 -81.38 -58.98 2.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.835 0.35 . . . . 0.0 110.893 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.77 -159.89 30.81 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.453 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -127.83 37.86 4.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.864 0.364 . . . . 0.0 110.814 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.585 HD12 HG12 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -90.22 -176.27 4.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 1.083 HG12 HG23 ' A' ' 20' ' ' THR . 3.4 m -100.96 135.97 34.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.096 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.502 ' CD2' HD12 ' A' ' 53' ' ' LEU . 5.2 p90 -99.84 144.2 29.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.3 t -101.7 118.16 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.119 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.428 HG13 ' CG ' ' A' ' 21' ' ' GLU . 13.9 m -66.82 137.03 25.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.168 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -145.17 127.6 15.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.901 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.5 p90 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.932 -179.942 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 ptm . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.745 0.307 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.52 -36.31 9.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.57 -115.04 4.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.447 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.0 m -148.9 125.63 11.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.969 0.414 . . . . 0.0 110.81 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -111.59 -26.43 9.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.881 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -56.44 163.91 1.57 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.79 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -89.65 -33.77 16.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 50.0 m170 -60.43 159.16 10.69 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.712 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -136.0 158.03 45.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.794 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -80.55 -41.56 23.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.83 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.28 164.31 24.25 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.553 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 t -90.01 112.26 23.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.832 0.349 . . . . 0.0 110.843 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 34.4 tpp -113.81 -26.54 8.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.896 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.9 p -73.56 152.75 40.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -93.55 173.54 7.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -122.83 159.89 27.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.912 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.731 HG23 HG13 ' A' ' 30' ' ' ILE . 5.3 tt -116.75 124.08 72.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.076 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.17 103.77 10.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.023 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.563 HG12 HD12 ' A' ' 83' ' ' LEU . 7.8 m -147.0 155.54 11.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.38 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.558 ' CG2' HG22 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -129.94 151.8 50.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.215 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.502 ' HG2' HG13 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -77.37 -50.07 13.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -107.01 143.11 35.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.51 -25.45 65.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.834 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -72.31 -26.45 61.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.85 -176.98 5.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.881 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -103.97 155.49 37.01 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.426 0.631 . . . . 0.0 111.218 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.87 106.82 1.75 Allowed 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.718 2.278 . . . . 0.0 112.309 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.862 HD11 HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -74.45 142.87 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.155 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -109.57 123.91 50.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.862 HG23 HD11 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -127.21 159.75 63.49 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.626 0.727 . . . . 0.0 111.092 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 134.36 27.86 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.743 2.295 . . . . 0.0 112.334 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.558 ' HB2' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -126.04 158.19 35.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.806 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -61.82 159.86 13.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.9 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -65.63 -27.39 68.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.803 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -67.62 -19.47 65.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.86 1.25 32.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.534 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.48 ' HB ' HG22 ' A' ' 72' ' ' ILE . 19.6 p -97.25 -176.07 3.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.855 0.359 . . . . 0.0 111.158 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.62 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 73.7 t -136.07 121.54 28.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.129 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.71 146.37 36.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.685 HD13 ' O ' ' A' ' 40' ' ' LEU . 3.3 tm? -60.69 -29.16 69.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.2 t -64.2 -39.89 94.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.4 m -73.29 -29.67 62.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.995 HG21 HD23 ' A' ' 73' ' ' LEU . 25.0 t -66.42 -37.8 80.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.013 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 67.2 p -78.09 -15.21 59.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.525 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.76 -47.9 81.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.965 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -112.59 -19.68 11.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.038 0.447 . . . . 0.0 111.294 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -126.75 75.34 75.37 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.651 0.739 . . . . 0.0 110.84 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.87 131.62 21.47 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.668 2.246 . . . . 0.0 112.28 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.21 6.79 89.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.49 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.681 ' HB1' HD21 ' A' ' 53' ' ' LEU . . . -88.17 107.95 19.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.735 0.302 . . . . 0.0 111.072 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.4 t -95.41 -53.24 3.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.936 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.56 ' O ' HD23 ' A' ' 53' ' ' LEU . . . -115.8 131.32 9.58 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.478 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.681 HD21 ' HB1' ' A' ' 50' ' ' ALA . 12.4 mt -120.88 140.83 51.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.017 0.437 . . . . 0.0 110.756 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.418 ' HB2' ' HB ' ' A' ' 86' ' ' VAL . 49.0 mtm180 -107.33 171.86 7.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.705 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.662 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 11.4 m-85 -111.06 126.9 55.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.1 tpm_? -127.91 103.61 7.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.878 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.551 ' ND2' HG22 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -130.79 110.58 15.89 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.567 0.699 . . . . 0.0 110.951 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 57' ' ' ASN . 54.0 Cg_endo -69.74 -22.81 31.66 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.665 2.243 . . . . 0.0 112.348 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.551 HG22 ' ND2' ' A' ' 57' ' ' ASN . 30.6 m -86.96 -20.75 7.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.163 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.1 m -93.87 -27.47 16.39 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.078 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 61.21 25.76 15.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.132 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 2.2 m -93.89 179.1 5.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 7.3 ttm -144.91 37.27 1.16 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.989 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.3 ptp85 -88.81 -177.14 5.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.752 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.82 160.26 28.93 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.584 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.662 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 21.9 t -69.1 142.72 15.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.78 0.324 . . . . 0.0 111.155 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -92.28 137.56 32.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.476 HD13 ' C ' ' A' ' 68' ' ' LEU . 2.7 tm? -116.25 115.72 26.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.9 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.582 HG22 ' HG2' ' A' ' 70' ' ' GLU . 5.8 p -138.46 121.18 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.172 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.582 ' HG2' HG22 ' A' ' 69' ' ' VAL . 31.9 mm-40 58.65 22.71 10.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.871 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.67 -24.64 22.65 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.489 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.48 HG22 ' HB ' ' A' ' 37' ' ' THR . 4.4 mt -81.41 114.8 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.842 0.353 . . . . 0.0 111.198 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.995 HD23 HG21 ' A' ' 43' ' ' VAL . 4.2 mm? -73.77 101.82 3.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.903 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -75.16 143.21 43.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.83 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.564 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -93.57 159.98 33.83 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.573 0.702 . . . . 0.0 111.133 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.564 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.7 Cg_endo -70.06 -173.45 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.689 2.259 . . . . 0.0 112.294 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -77.12 -2.37 33.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.327 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.42 -31.23 8.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.086 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.9 -164.84 16.96 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.426 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.62 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 82.7 m95 -84.91 -59.58 2.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.749 0.309 . . . . 0.0 110.9 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.55 -162.79 36.52 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.488 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.22 37.93 4.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.912 0.387 . . . . 0.0 110.909 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.563 HD12 HG12 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -90.14 -175.8 4.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.914 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.558 HG22 ' CG2' ' A' ' 20' ' ' THR . 40.3 t -102.05 131.94 49.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.074 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.679 ' CD2' HD13 ' A' ' 53' ' ' LEU . 4.6 p90 -97.24 141.62 30.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.935 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 54' ' ' ARG . 15.5 t -99.64 115.31 40.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.118 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.502 HG13 ' HG2' ' A' ' 21' ' ' GLU . 17.3 m -61.8 145.14 13.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.064 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -145.05 110.78 5.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.96 -179.898 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.9 mmt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.802 0.334 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.35 37.26 24.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.167 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -113.53 120.77 5.26 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.536 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m -81.0 145.67 31.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.366 . . . . 0.0 110.817 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -100.91 -32.8 10.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.822 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -62.05 161.41 10.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.853 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -136.19 149.9 48.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.853 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 -82.89 151.88 25.79 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.687 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -60.85 130.81 48.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.712 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -86.51 119.06 26.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.861 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 166.92 73.73 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.487 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.2 t -161.38 159.78 28.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 0.0 110.874 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 14.8 tpt -110.51 141.25 43.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.843 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.3 t -84.67 137.64 33.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -92.59 150.95 20.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.823 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -103.08 165.31 11.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.934 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.727 HG23 HG13 ' A' ' 30' ' ' ILE . 5.9 tt -122.85 123.38 68.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.169 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.58 103.44 9.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.066 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.499 HG12 ' CD2' ' A' ' 83' ' ' LEU . 6.4 m -147.31 155.66 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.308 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.558 ' CG2' HG22 ' A' ' 84' ' ' VAL . 0.7 OUTLIER -130.66 153.34 49.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.215 179.679 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.53 -49.64 14.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.839 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -100.78 147.49 26.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.26 -34.21 72.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -68.99 -25.4 64.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -85.11 164.5 18.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -89.93 155.13 47.68 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.619 0.724 . . . . 0.0 110.925 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 112.34 3.05 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.661 2.24 . . . . 0.0 112.343 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.51 HD12 ' H ' ' A' ' 29' ' ' GLU . 5.0 tp -76.67 140.01 17.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.51 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -102.92 116.57 32.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.704 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.727 HG13 HG23 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -123.52 160.13 52.14 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.61 0.719 . . . . 0.0 111.151 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 154.11 68.25 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.69 2.26 . . . . 0.0 112.341 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.642 ' HB2' HG22 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -140.15 163.98 31.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -64.16 165.78 8.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -66.17 -38.33 87.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.873 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.77 -19.29 64.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.61 -29.26 6.71 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.505 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.554 HG22 ' CG ' ' A' ' 74' ' ' HIS . 29.2 p -64.66 -176.24 0.24 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 0.0 111.137 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.642 HG22 ' HB2' ' A' ' 32' ' ' SER . 55.6 t -131.67 125.76 56.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.146 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.518 HD23 ' HB2' ' A' ' 41' ' ' SER . 13.8 tp -62.11 143.25 56.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.646 ' O ' HG23 ' A' ' 44' ' ' THR . 3.0 tm? -59.85 -23.97 63.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.88 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.518 ' HB2' HD23 ' A' ' 39' ' ' LEU . 19.0 m -67.72 -45.97 73.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.832 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.3 m -69.13 -30.32 68.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.138 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.878 HG21 HD23 ' A' ' 73' ' ' LEU . 23.3 t -65.82 -35.93 76.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.992 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.646 HG23 ' O ' ' A' ' 40' ' ' LEU . 22.4 p -79.04 -15.65 57.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.036 0.446 . . . . 0.0 111.629 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.26 -45.57 87.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.896 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -112.09 -24.16 10.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.092 0.472 . . . . 0.0 111.243 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -126.56 76.95 73.83 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 121.659 0.742 . . . . 0.0 110.87 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 134.5 28.05 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.696 2.264 . . . . 0.0 112.322 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.92 6.75 86.03 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.542 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.578 ' HB1' HD21 ' A' ' 53' ' ' LEU . . . -86.19 112.54 21.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.847 0.356 . . . . 0.0 111.094 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.9 t -99.13 -53.31 3.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.888 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.67 ' O ' HD23 ' A' ' 53' ' ' LEU . . . -116.9 134.72 11.47 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.52 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.67 HD23 ' O ' ' A' ' 52' ' ' GLY . 12.4 mt -124.06 141.2 52.25 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.048 0.452 . . . . 0.0 110.672 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -107.52 171.29 7.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.722 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.447 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 9.0 m-85 -108.83 125.53 52.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.962 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -129.3 99.62 5.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.869 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -139.43 119.45 9.32 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.634 0.731 . . . . 0.0 110.869 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.87 -22.61 31.36 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.651 2.234 . . . . 0.0 112.331 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.9 m -85.56 -31.9 6.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.136 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.2 m -77.15 -27.28 53.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.01 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 58.92 21.69 9.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.069 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 97.6 m -102.2 162.5 12.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.916 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 36.5 mtm -129.14 26.5 5.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.765 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -78.94 -176.56 5.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.712 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.82 154.92 25.84 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.52 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.447 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 95.8 t -62.2 144.43 14.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.817 0.342 . . . . 0.0 111.155 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -95.27 138.64 32.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.877 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 69' ' ' VAL . 2.3 tm? -114.83 121.44 43.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.509 ' N ' HD22 ' A' ' 68' ' ' LEU . 6.0 p -139.12 120.22 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.119 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.475 ' HG2' HG22 ' A' ' 69' ' ' VAL . 57.1 mm-40 55.42 25.9 8.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.907 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.433 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . 93.21 -23.24 30.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.475 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.503 HG22 ' HB ' ' A' ' 37' ' ' THR . 5.3 mp -82.15 116.74 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.877 0.37 . . . . 0.0 111.103 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.878 HD23 HG21 ' A' ' 43' ' ' VAL . 4.1 mm? -79.24 101.58 8.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.554 ' CG ' HG22 ' A' ' 37' ' ' THR . 5.7 t-80 -76.37 141.94 41.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.83 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.536 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -91.6 159.37 38.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.553 0.692 . . . . 0.0 111.102 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.536 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.7 Cg_endo -70.03 -173.46 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.635 2.223 . . . . 0.0 112.32 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -77.27 -1.99 32.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.242 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.23 -30.13 8.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.094 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.48 -165.35 15.23 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.487 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.605 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 90.5 m95 -85.67 -59.79 2.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.851 0.358 . . . . 0.0 110.917 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.82 -163.88 32.35 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.487 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -128.09 38.55 3.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.827 0.346 . . . . 0.0 110.876 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.707 HD13 ' H ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -95.31 -175.76 3.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.963 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.558 HG22 ' CG2' ' A' ' 20' ' ' THR . 41.5 t -98.15 136.23 29.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.665 ' CD2' HD13 ' A' ' 53' ' ' LEU . 5.6 p90 -101.53 141.35 34.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.96 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.0 t -96.34 114.39 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.4 m -60.77 142.25 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.09 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -144.97 109.9 5.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.851 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.931 -179.986 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.0 mtm . . . . . 0 N--CA 1.46 0.051 0 CA-C-O 120.841 0.353 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.7 -64.23 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.139 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.72 -24.76 3.3 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.519 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.6 p -142.56 152.23 42.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.988 0.423 . . . . 0.0 110.838 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -117.27 140.45 49.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -82.35 161.63 22.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -85.04 136.6 33.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.869 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.1 m170 -64.72 -66.06 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.77 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -69.95 170.71 10.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -68.02 -38.74 82.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 74.77 171.82 28.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.481 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.59 156.82 1.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.829 0.347 . . . . 0.0 110.908 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.9 ttt -128.77 117.94 21.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.0 m -142.88 123.6 14.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.837 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -109.56 -172.32 2.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -129.8 165.66 21.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.867 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.724 HG23 HG13 ' A' ' 30' ' ' ILE . 5.4 tt -119.43 122.92 70.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.089 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.02 103.57 9.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.043 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.52 HG12 ' CD2' ' A' ' 83' ' ' LEU . 11.8 m -146.87 154.28 12.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.327 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.56 155.81 41.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.187 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.51 -50.04 19.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -114.45 146.7 40.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -64.63 -26.82 68.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.848 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -68.99 -25.15 64.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -95.4 159.64 14.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.869 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -81.73 154.9 70.98 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.639 0.733 . . . . 0.0 110.887 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 114.99 3.9 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.687 2.258 . . . . 0.0 112.283 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 19' ' ' VAL . 5.3 tp -80.33 136.65 22.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.32 120.18 39.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.745 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.724 HG13 HG23 ' A' ' 17' ' ' ILE . 0.6 OUTLIER -126.61 159.63 62.63 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.616 0.722 . . . . 0.0 111.093 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.8 147.64 63.09 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.65 2.233 . . . . 0.0 112.351 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.544 ' CB ' HG22 ' A' ' 38' ' ' VAL . 53.8 p -133.18 179.05 6.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.829 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -80.53 166.11 21.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -71.82 -33.53 68.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -66.21 -18.79 65.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.853 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.66 -20.93 11.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.46 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 74' ' ' HIS . 20.2 p -78.51 -175.45 4.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.855 0.36 . . . . 0.0 111.139 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.582 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 55.4 t -138.61 120.51 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.104 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.8 147.96 21.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.905 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.562 ' O ' HG23 ' A' ' 44' ' ' THR . 21.8 tp -62.57 -20.22 64.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.9 m -66.06 -36.58 83.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.7 m -80.01 -34.04 38.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.183 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.903 HG21 HD23 ' A' ' 73' ' ' LEU . 31.1 t -64.31 -36.31 76.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.984 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 40' ' ' LEU . 34.5 p -80.25 -15.52 56.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.579 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.5 -44.98 85.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.947 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -111.86 -23.58 10.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.069 0.462 . . . . 0.0 111.245 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -124.73 75.1 64.57 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 121.66 0.743 . . . . 0.0 110.903 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 133.23 25.04 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.645 2.23 . . . . 0.0 112.324 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.34 4.07 89.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.508 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.648 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -82.6 118.22 23.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.322 . . . . 0.0 111.103 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.8 m -102.19 -52.81 3.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.562 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -120.03 129.15 7.83 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.532 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.669 HD12 ' CE1' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -115.97 138.26 51.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.038 0.447 . . . . 0.0 110.663 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -107.32 170.8 7.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.665 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.562 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 12.4 m-85 -110.47 126.06 53.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.976 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.727 ' HB3' HG13 ' A' ' 84' ' ' VAL . 15.8 tpt180 -129.14 103.78 7.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.864 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.407 ' HB3' ' HB3' ' A' ' 60' ' ' SER . 3.8 t-20 -140.26 121.63 9.43 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.567 0.699 . . . . 0.0 110.991 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -49.11 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.673 2.248 . . . . 0.0 112.332 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.0 m -61.4 -36.81 75.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.122 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.407 ' HB3' ' HB3' ' A' ' 57' ' ' ASN . 7.5 t -68.42 -27.11 65.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.053 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 60.28 24.46 13.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.066 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 28.8 p -110.06 178.25 4.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.887 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.82 38.66 0.68 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -81.71 -174.3 4.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.763 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -149.78 154.78 25.92 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.52 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.562 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 92.4 t -69.86 144.58 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.839 0.352 . . . . 0.0 111.086 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -92.27 138.29 31.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.873 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.505 HD22 ' N ' ' A' ' 69' ' ' VAL . 2.3 tm? -118.01 121.7 41.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.614 HG22 ' HG3' ' A' ' 70' ' ' GLU . 6.0 p -142.67 121.36 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.614 ' HG3' HG22 ' A' ' 69' ' ' VAL . 10.2 mt-10 57.06 23.9 8.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.03 -24.93 22.39 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.529 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.452 HG22 ' HB ' ' A' ' 37' ' ' THR . 3.5 mp -81.05 117.49 27.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.912 0.387 . . . . 0.0 111.079 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.903 HD23 HG21 ' A' ' 43' ' ' VAL . 4.1 mm? -79.63 111.73 16.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.934 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.478 ' HA ' HG22 ' A' ' 37' ' ' THR . 5.8 t60 -84.66 135.84 34.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.946 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.56 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -87.86 159.75 48.24 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.572 0.701 . . . . 0.0 111.151 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.56 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.6 Cg_endo -69.94 -173.82 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.72 2.28 . . . . 0.0 112.325 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -77.32 -2.42 34.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.264 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -108.37 -27.6 9.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.053 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 118.15 -172.49 14.45 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.479 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.582 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 97.2 m95 -77.77 -59.3 2.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.775 0.322 . . . . 0.0 110.922 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.55 -162.76 30.7 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.498 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.91 38.1 4.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.877 0.37 . . . . 0.0 110.876 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.702 HD13 ' H ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -94.64 -175.72 3.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.727 HG13 ' HB3' ' A' ' 56' ' ' ARG . 4.0 p -100.57 132.31 46.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.15 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.669 ' CE1' HD12 ' A' ' 53' ' ' LEU . 2.9 p90 -99.86 145.64 27.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.947 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.2 t -102.04 120.08 51.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.103 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.9 m -64.94 145.79 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.123 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -145.02 99.89 3.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 45.9 p90 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 -179.894 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.743 0.306 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.26 102.03 9.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.153 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.77 -75.26 0.96 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.478 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.2 m -66.56 129.27 39.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.86 0.362 . . . . 0.0 110.84 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -119.98 116.4 25.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -61.64 120.31 10.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -154.1 166.51 32.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.911 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -67.28 -38.2 84.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.822 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -55.83 -26.21 45.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.846 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -52.5 -44.74 65.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.862 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.2 82.72 0.32 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.522 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.8 t -156.61 161.22 39.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.859 0.361 . . . . 0.0 110.822 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 15.8 ptt? -63.57 168.17 4.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.902 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.5 m -64.72 133.2 51.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.847 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -86.22 179.75 6.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -124.74 163.26 22.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.944 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.751 HG23 HG13 ' A' ' 30' ' ' ILE . 4.7 tt -117.1 123.58 72.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.138 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -119.9 104.03 9.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.063 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.543 HG12 HD23 ' A' ' 83' ' ' LEU . 25.2 m -147.6 152.23 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.37 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.12 152.95 42.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.151 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.8 -48.06 60.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -128.89 155.95 44.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.815 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -63.32 -26.19 68.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -66.59 -26.39 67.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.849 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -104.01 139.54 38.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -65.42 160.17 61.23 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.68 0.752 . . . . 0.0 110.841 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 114.76 3.82 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.687 2.258 . . . . 0.0 112.345 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.465 HD12 ' H ' ' A' ' 29' ' ' GLU . 4.5 tp -81.5 136.51 22.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.85 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.465 ' H ' HD12 ' A' ' 28' ' ' ILE . 11.3 pt-20 -101.7 120.39 40.27 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.735 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.751 HG13 HG23 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -126.71 159.22 65.06 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.662 0.744 . . . . 0.0 111.084 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.428 ' O ' HG21 ' A' ' 42' ' ' THR . 53.6 Cg_endo -69.72 147.72 63.75 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.649 2.233 . . . . 0.0 112.367 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.552 ' HB2' HG22 ' A' ' 38' ' ' VAL . 4.5 p -137.58 163.93 30.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.855 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -64.09 159.31 20.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.954 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.13 -29.23 69.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.877 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.84 -19.37 65.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.895 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.7 -8.37 27.95 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.499 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.505 HG22 ' HA ' ' A' ' 74' ' ' HIS . 32.7 p -90.01 179.9 5.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.825 0.345 . . . . 0.0 111.12 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.577 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 68.9 t -133.58 118.18 29.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.121 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.503 HD13 HG12 ' A' ' 72' ' ' ILE . 4.5 mm? -62.14 149.54 41.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.793 HD12 ' HA3' ' A' ' 71' ' ' GLY . 0.9 OUTLIER -60.3 -19.42 55.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.936 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 t -66.47 -39.22 88.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.989 0.423 . . . . 0.0 110.924 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.428 HG21 ' O ' ' A' ' 31' ' ' PRO . 10.0 m -78.63 -32.34 47.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.124 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.921 HG21 HD23 ' A' ' 73' ' ' LEU . 34.3 t -64.69 -36.68 78.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.981 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 40' ' ' LEU . 43.2 p -79.99 -15.32 57.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.55 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.92 -45.92 83.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.939 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -111.94 -24.51 9.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.979 0.418 . . . . 0.0 111.198 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -122.89 74.39 47.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.631 0.729 . . . . 0.0 110.933 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 129.07 16.93 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.663 2.242 . . . . 0.0 112.345 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.79 6.37 82.79 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.491 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.39 113.79 22.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 111.165 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.6 t -95.78 -53.32 3.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.705 ' C ' HD12 ' A' ' 53' ' ' LEU . . . -120.69 140.09 14.01 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.512 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.705 HD12 ' C ' ' A' ' 52' ' ' GLY . 8.4 mp -127.8 138.25 52.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.06 0.457 . . . . 0.0 110.682 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -106.73 170.39 7.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.702 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.694 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 13.6 m-85 -110.38 124.69 52.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.897 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.675 ' HB3' HG13 ' A' ' 84' ' ' VAL . 3.4 tmt_? -130.45 109.01 10.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.897 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -139.35 118.82 9.18 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.666 0.746 . . . . 0.0 110.885 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -24.38 30.01 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.689 2.259 . . . . 0.0 112.375 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.2 m -85.04 -32.02 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.116 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.1 t -79.7 -26.82 40.78 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.069 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 61.96 23.73 14.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.047 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.9 t -106.53 159.91 15.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -128.2 27.63 5.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.68 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.78 -179.94 2.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.656 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -145.41 160.54 28.1 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.507 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.694 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 15.9 t -67.74 151.15 10.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.79 0.329 . . . . 0.0 111.15 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.539 ' HE ' HG23 ' A' ' 69' ' ' VAL . 1.7 tpt180 -97.96 119.32 36.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.49 HD13 ' C ' ' A' ' 68' ' ' LEU . 3.4 tm? -94.25 106.47 18.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.943 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.539 HG23 ' HE ' ' A' ' 67' ' ' ARG . 4.3 t -119.17 106.94 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.141 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 51.62 34.96 13.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.935 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.793 ' HA3' HD12 ' A' ' 40' ' ' LEU . . . 92.13 -24.99 19.15 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.516 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.503 HG12 HD13 ' A' ' 39' ' ' LEU . 3.1 mp -81.34 108.32 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.822 0.344 . . . . 0.0 111.083 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.921 HD23 HG21 ' A' ' 43' ' ' VAL . 3.9 mm? -73.69 102.45 3.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.505 ' HA ' HG22 ' A' ' 37' ' ' THR . 5.6 t60 -78.72 135.55 37.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.577 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -82.52 160.39 61.98 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.641 0.734 . . . . 0.0 111.046 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.577 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.3 Cg_endo -70.0 -173.55 0.78 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.722 2.281 . . . . 0.0 112.297 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -77.32 -1.99 32.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.322 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.67 -29.48 9.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.073 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.25 -170.36 15.09 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.441 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.577 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 93.0 m95 -81.45 -59.18 2.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.775 0.322 . . . . 0.0 110.941 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.36 -161.94 36.05 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.488 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.44 37.01 4.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.84 0.353 . . . . 0.0 110.854 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.558 HD11 ' HD1' ' A' ' 55' ' ' TYR . 1.1 pt? -88.2 -174.75 4.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.675 HG13 ' HB3' ' A' ' 56' ' ' ARG . 4.6 p -104.03 131.11 53.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.151 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.61 ' HE1' HG22 ' A' ' 87' ' ' VAL . 7.5 p90 -95.77 146.62 24.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.922 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 68.9 t -106.34 114.67 46.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.192 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.61 HG22 ' HE1' ' A' ' 85' ' ' TYR . 13.2 t -57.87 154.75 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.095 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -145.41 88.14 1.84 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.91 -179.9 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 mmt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.806 0.336 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.53 120.02 28.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.103 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.03 -69.89 1.28 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.472 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.4 m -83.09 118.98 23.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.955 0.407 . . . . 0.0 110.821 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -129.37 166.27 19.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.849 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 52.1 47.34 24.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -83.36 -57.2 3.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.832 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -63.44 178.5 0.55 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.828 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -155.01 162.95 40.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -155.66 142.94 19.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.849 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -112.08 85.9 0.41 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.5 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.0 m -66.32 -52.39 47.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 0.0 110.81 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.9 mtp -72.59 -34.96 67.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.2 m -69.42 132.7 46.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -121.35 149.96 42.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -85.93 160.34 19.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.947 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.748 HG23 HG13 ' A' ' 30' ' ' ILE . 6.8 tt -106.16 123.17 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.099 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -121.25 103.73 9.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.049 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.602 HG12 HD23 ' A' ' 83' ' ' LEU . 13.1 m -148.03 151.74 13.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.281 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.749 HG23 HG13 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -118.35 154.75 31.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.175 179.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.25 -41.2 94.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.855 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -139.36 167.37 22.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -75.95 -24.15 55.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.108 0.48 . . . . 0.0 111.318 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -66.4 -26.51 67.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.85 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -98.66 -175.5 3.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.823 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.6 mp0 -103.83 157.07 34.69 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.611 0.72 . . . . 0.0 110.918 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 126.95 13.92 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.655 2.237 . . . . 0.0 112.416 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.5 tp -100.36 131.64 47.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.795 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -97.07 122.46 40.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.722 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.748 HG13 HG23 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -127.23 159.74 63.56 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.643 0.735 . . . . 0.0 111.14 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.68 145.89 59.02 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.714 2.276 . . . . 0.0 112.345 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.536 ' HB2' HG22 ' A' ' 38' ' ' VAL . 1.2 p -130.12 176.82 7.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -77.84 166.41 22.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.938 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -72.19 -27.44 62.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.873 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.86 -19.19 60.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.921 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.21 -15.03 13.42 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.484 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.622 HG22 ' CG ' ' A' ' 74' ' ' HIS . 16.1 p -80.62 -171.09 2.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.923 0.392 . . . . 0.0 111.092 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.595 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 53.4 t -140.12 118.99 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.139 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.8 mt -56.47 139.43 49.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.484 ' O ' HG23 ' A' ' 44' ' ' THR . 28.4 tp -57.98 -22.1 47.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.952 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -66.72 -34.64 78.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.2 m -81.6 -32.88 31.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.127 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.768 HG21 HD23 ' A' ' 73' ' ' LEU . 24.4 t -63.94 -36.0 75.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.032 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 40' ' ' LEU . 38.5 p -79.4 -15.46 57.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.501 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.09 -46.63 83.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.933 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -112.02 -22.62 10.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.25 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -126.37 75.85 73.4 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.626 0.727 . . . . 0.0 110.914 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 131.19 20.67 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.656 2.238 . . . . 0.0 112.302 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.81 6.47 88.98 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.416 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.621 ' HB1' HD21 ' A' ' 53' ' ' LEU . . . -87.32 111.93 21.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.726 0.298 . . . . 0.0 111.108 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.1 t -99.3 -53.41 3.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.644 ' O ' HD23 ' A' ' 53' ' ' LEU . . . -115.8 132.76 10.44 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.539 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.672 HD22 ' CE2' ' A' ' 85' ' ' TYR . 12.8 mt -123.81 141.1 52.34 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.979 0.419 . . . . 0.0 110.734 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.4 ' HB2' ' HB ' ' A' ' 86' ' ' VAL . 45.5 mtt-85 -108.73 171.84 7.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.673 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.532 ' CD1' HD11 ' A' ' 83' ' ' LEU . 6.2 m-85 -107.66 125.36 51.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.63 110.16 11.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -139.19 119.3 9.45 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.596 0.712 . . . . 0.0 110.878 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -23.21 31.22 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.701 2.267 . . . . 0.0 112.371 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.0 m -85.79 -31.09 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.16 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.1 m -86.89 -27.29 23.49 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.983 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 58.61 22.77 10.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.028 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 32.8 m -95.24 164.31 12.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 4.7 tpt -124.84 25.46 7.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.793 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -178.78 0.14 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.722 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.68 138.29 5.28 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.495 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.527 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 92.9 t -59.0 144.97 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.845 0.355 . . . . 0.0 111.12 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -96.64 138.58 34.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 69' ' ' VAL . 1.4 tm? -111.9 114.24 27.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.534 ' N ' HD22 ' A' ' 68' ' ' LEU . 5.4 p -127.13 127.35 69.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.153 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 69' ' ' VAL . 7.2 pt-20 45.92 32.0 1.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.515 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . 89.36 -29.18 6.27 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.517 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.4 mp -79.5 112.91 18.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.821 0.343 . . . . 0.0 111.113 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.768 HD23 HG21 ' A' ' 43' ' ' VAL . 4.2 mm? -72.62 106.58 4.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.622 ' CG ' HG22 ' A' ' 37' ' ' THR . 5.4 t-80 -82.42 137.44 34.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.613 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -87.86 160.21 47.28 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.591 0.71 . . . . 0.0 111.064 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.564 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.4 Cg_endo -69.96 -173.33 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.667 2.245 . . . . 0.0 112.343 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -77.31 -2.02 32.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.222 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.17 -30.22 8.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.115 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.77 -165.25 15.47 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.473 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.613 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 98.1 m95 -87.23 -59.89 2.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.799 0.333 . . . . 0.0 110.869 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.0 -166.74 30.07 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.443 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -124.36 36.99 4.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.89 0.376 . . . . 0.0 110.922 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.602 HD23 HG12 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -94.42 -173.08 2.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.749 HG13 HG23 ' A' ' 20' ' ' THR . 25.7 t -102.26 131.95 49.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.134 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.672 ' CE2' HD22 ' A' ' 53' ' ' LEU . 5.2 p90 -96.23 142.49 28.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.95 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 54' ' ' ARG . 15.1 t -95.54 114.88 33.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.093 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.8 m -61.59 135.55 26.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.153 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -144.98 103.21 3.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 -179.847 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 tpp . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.73 0.3 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.04 178.55 6.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.145 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 73.76 23.96 75.43 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.503 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 p -64.62 -32.15 73.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.938 0.399 . . . . 0.0 110.869 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -79.39 158.5 27.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.2 m170 53.97 47.72 22.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.832 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -128.31 147.96 50.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.832 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -72.47 127.96 34.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -141.41 151.09 43.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.86 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -110.54 165.69 11.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.849 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.47 55.84 0.54 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.481 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 m -75.43 -34.99 61.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.84 0.352 . . . . 0.0 110.813 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.4 ptp -96.02 -25.9 15.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.875 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.9 m -53.62 148.24 9.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.831 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -94.95 179.78 5.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.891 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -120.68 140.13 52.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.752 HG23 HG13 ' A' ' 30' ' ' ILE . 6.2 tt -95.21 122.71 46.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.131 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.403 ' HB3' ' HA ' ' A' ' 82' ' ' ASN . 1.8 mtp180 -116.33 103.44 10.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.143 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.488 HG12 ' CD2' ' A' ' 83' ' ' LEU . 11.8 m -147.15 147.7 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.38 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.4 t -122.94 158.8 29.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.807 0.337 . . . . 0.0 111.153 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.81 -47.37 19.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.879 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.86 163.24 13.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -79.96 -30.31 39.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.223 0.535 . . . . 0.0 111.292 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.8 m-20 -66.49 -24.43 66.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.91 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -101.54 141.09 34.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.866 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.53 160.91 77.45 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.598 0.714 . . . . 0.0 110.893 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 133.68 26.02 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.639 2.226 . . . . 0.0 112.333 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.413 HD12 ' H ' ' A' ' 29' ' ' GLU . 4.3 tp -97.13 133.72 37.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.868 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.413 ' H ' HD12 ' A' ' 28' ' ' ILE . 2.1 tm-20 -93.54 122.62 36.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.735 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.752 HG13 HG23 ' A' ' 17' ' ' ILE . 0.2 OUTLIER -126.87 159.95 61.65 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.649 0.737 . . . . 0.0 111.086 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.595 ' O ' HG21 ' A' ' 42' ' ' THR . 53.5 Cg_endo -69.76 133.34 25.33 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.627 2.218 . . . . 0.0 112.345 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.589 ' HB2' HG22 ' A' ' 38' ' ' VAL . 17.2 p -122.05 -175.53 3.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -85.22 174.29 9.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -79.16 -33.39 44.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.83 -19.3 65.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.44 -11.18 19.28 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.489 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.62 HG22 ' HA ' ' A' ' 74' ' ' HIS . 30.2 p -86.21 -176.1 5.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.799 0.333 . . . . 0.0 111.138 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.63 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 66.9 t -138.46 121.37 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.4 mt -59.25 149.7 27.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.689 HD12 ' HA3' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -62.31 -21.98 65.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.911 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.1 p -66.55 -37.6 85.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.812 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.595 HG21 ' O ' ' A' ' 31' ' ' PRO . 10.5 m -76.56 -35.02 58.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.154 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.82 HG21 HD23 ' A' ' 73' ' ' LEU . 25.4 t -64.88 -37.89 81.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.043 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 40' ' ' LEU . 32.8 p -77.96 -15.55 58.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.57 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.97 -46.69 83.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.974 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -112.05 -15.96 13.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.313 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -132.88 76.69 70.16 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.622 0.725 . . . . 0.0 110.822 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 128.14 15.58 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.686 2.257 . . . . 0.0 112.332 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.83 -15.96 57.91 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.462 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.658 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -64.04 108.89 1.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.766 0.317 . . . . 0.0 111.1 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.4 t -94.5 -52.79 4.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.592 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -117.83 128.53 7.83 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.522 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.702 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -114.99 137.97 51.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.022 0.439 . . . . 0.0 110.679 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -107.3 170.43 7.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.759 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.579 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 9.5 m-85 -109.64 125.62 52.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.736 ' HB3' HG13 ' A' ' 84' ' ' VAL . 8.9 tpm_? -129.38 108.72 10.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.893 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.509 ' N ' ' HE ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -128.75 113.79 19.1 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.635 0.731 . . . . 0.0 110.907 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -23.55 30.53 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.695 2.264 . . . . 0.0 112.343 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.8 m -86.87 -27.36 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.199 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.5 t -90.28 -27.53 19.38 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.064 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 60.7 23.59 13.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.121 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 18.2 m -96.19 174.03 7.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.924 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.0 ttt -135.45 54.43 1.92 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.838 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.44 -174.8 5.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.679 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.52 135.59 3.87 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.492 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.579 HG22 ' CZ ' ' A' ' 55' ' ' TYR . 22.3 t -56.6 139.18 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 111.129 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -88.63 136.88 32.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.496 HD13 ' C ' ' A' ' 68' ' ' LEU . 3.2 tm? -114.56 122.48 46.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.741 HG22 ' HG3' ' A' ' 70' ' ' GLU . 6.5 p -146.4 122.42 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.164 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.741 ' HG3' HG22 ' A' ' 69' ' ' VAL . 9.5 mt-10 58.0 22.62 9.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.864 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.689 ' HA3' HD12 ' A' ' 40' ' ' LEU . . . 92.46 -25.03 20.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.453 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.561 HG22 ' HB ' ' A' ' 37' ' ' THR . 3.1 mp -83.07 123.39 38.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.349 . . . . 0.0 111.195 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.82 HD23 HG21 ' A' ' 43' ' ' VAL . 4.0 mm? -81.33 115.57 20.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.946 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.62 ' HA ' HG22 ' A' ' 37' ' ' THR . 6.2 t60 -88.41 135.84 33.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.881 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.564 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -86.46 159.84 52.18 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.58 0.705 . . . . 0.0 111.132 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.564 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 53.3 Cg_endo -70.07 -172.64 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.68 2.253 . . . . 0.0 112.28 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -77.06 -2.6 34.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.299 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.18 -29.53 9.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.11 -167.39 14.69 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.461 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.63 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 85.0 m95 -81.77 -59.39 2.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.854 0.359 . . . . 0.0 110.913 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.75 -167.66 38.76 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.538 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 18' ' ' ARG . 4.8 m-20 -125.0 38.31 4.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.918 0.389 . . . . 0.0 110.916 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.721 HD13 ' H ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -93.44 -175.48 3.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.935 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.736 HG13 ' HB3' ' A' ' 56' ' ' ARG . 4.0 p -99.6 138.56 23.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.157 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.702 ' CE2' HD12 ' A' ' 53' ' ' LEU . 3.2 p90 -108.36 146.28 33.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.954 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 68.3 t -99.53 125.03 53.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.111 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.3 m -74.84 135.85 26.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -145.62 139.49 26.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.913 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.854 0.359 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.98 148.96 1.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.34 -145.46 12.14 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.462 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.0 m -110.15 113.29 25.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.927 0.394 . . . . 0.0 110.876 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -104.3 30.69 5.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.842 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -118.95 133.43 55.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 55.5 m80 -98.84 154.82 17.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.843 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -80.39 137.78 36.57 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.595 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -109.09 27.57 9.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.747 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -68.11 -33.93 75.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.847 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.7 -145.09 0.21 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.455 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.1 p -120.63 174.45 6.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.856 0.36 . . . . 0.0 110.869 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 14.8 mtt -93.14 133.18 36.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 93.8 p -62.54 126.15 26.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.91 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -97.48 -176.46 3.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.895 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -124.69 170.23 11.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.95 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.748 HG23 HG13 ' A' ' 30' ' ' ILE . 5.5 tt -120.13 122.87 69.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.092 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.14 103.65 9.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.039 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.478 HG12 ' CD2' ' A' ' 83' ' ' LEU . 13.4 m -147.29 153.5 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.344 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.83 153.55 40.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.199 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.407 ' HG2' HG13 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -65.72 -39.14 90.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -139.23 -177.42 4.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -83.66 -29.43 27.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.194 0.521 . . . . 0.0 111.333 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -66.43 -24.16 66.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.887 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -105.4 128.81 53.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.789 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -57.91 159.69 9.87 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.554 0.693 . . . . 0.0 110.846 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 122.85 9.51 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.645 2.23 . . . . 0.0 112.349 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.472 HD12 ' H ' ' A' ' 29' ' ' GLU . 4.7 tp -91.46 137.11 22.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.931 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.472 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -101.54 121.77 42.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.812 179.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.748 HG13 HG23 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -127.16 159.44 65.01 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.594 0.712 . . . . 0.0 111.179 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.436 ' O ' HG21 ' A' ' 42' ' ' THR . 53.3 Cg_endo -69.8 141.65 45.62 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.638 2.225 . . . . 0.0 112.345 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.544 ' HB2' HG22 ' A' ' 38' ' ' VAL . 14.2 p -129.77 -179.64 5.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.82 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -82.86 159.94 22.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -67.72 -29.83 69.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -68.62 -19.5 64.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.57 -12.1 21.12 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.443 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.472 ' HB ' HG22 ' A' ' 72' ' ' ILE . 19.4 p -86.19 -175.41 5.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.863 0.363 . . . . 0.0 111.135 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.602 HG23 ' CZ2' ' A' ' 80' ' ' TRP . 55.8 t -139.78 120.26 14.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.109 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.576 HD23 HG12 ' A' ' 72' ' ' ILE . 12.7 mt -60.31 146.6 43.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.514 ' O ' HG23 ' A' ' 44' ' ' THR . 22.2 tp -60.84 -20.8 62.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.6 t -65.62 -35.49 80.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.804 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.436 HG21 ' O ' ' A' ' 31' ' ' PRO . 12.4 m -82.23 -32.31 29.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.148 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.713 HG21 HD23 ' A' ' 73' ' ' LEU . 25.6 t -64.12 -35.53 74.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.004 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 40' ' ' LEU . 33.3 p -80.45 -15.36 56.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.006 0.431 . . . . 0.0 111.612 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.59 -45.25 83.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.909 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -112.0 -22.75 10.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.094 0.473 . . . . 0.0 111.282 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -127.04 75.17 76.75 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 121.608 0.718 . . . . 0.0 110.854 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 130.46 19.29 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.652 2.235 . . . . 0.0 112.363 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.49 6.07 87.89 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.448 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.66 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -85.61 115.69 23.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.348 . . . . 0.0 111.122 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 2.0 m -98.98 -52.9 3.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.569 ' C ' HD13 ' A' ' 53' ' ' LEU . . . -121.25 130.74 8.31 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.501 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.66 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -116.46 142.08 47.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.824 0.345 . . . . 0.0 110.856 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -108.27 170.71 7.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.846 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -110.11 126.03 53.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.942 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.731 ' HB3' HG13 ' A' ' 84' ' ' VAL . 17.0 tpt180 -129.27 105.58 8.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.542 ' OD1' HD12 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -126.75 115.75 22.52 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.552 0.691 . . . . 0.0 110.941 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 -24.94 28.95 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.607 2.205 . . . . 0.0 112.354 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.1 m -86.63 -30.79 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.119 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.7 m -85.56 -27.16 25.73 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.028 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 59.97 24.04 13.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.016 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 84.4 m -94.0 -176.79 4.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.88 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.9 ptt? -143.67 32.26 1.3 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.926 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -174.56 0.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.715 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.01 135.55 3.75 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.488 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.668 HG12 HD12 ' A' ' 73' ' ' LEU . 34.8 t -52.2 147.4 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 0.0 111.164 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -101.06 124.08 46.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.904 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.558 ' HA ' HD13 ' A' ' 73' ' ' LEU . 2.5 tm? -97.46 114.88 26.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.426 ' O ' ' CG ' ' A' ' 70' ' ' GLU . 6.3 p -135.15 128.78 49.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.12 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.591 ' CD ' HD12 ' A' ' 72' ' ' ILE . 7.6 pt-20 45.9 29.95 0.81 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.24 -28.04 6.48 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.543 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.591 HD12 ' CD ' ' A' ' 70' ' ' GLU . 6.0 mt -83.99 118.64 31.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.916 0.389 . . . . 0.0 111.177 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.713 HD23 HG21 ' A' ' 43' ' ' VAL . 4.3 mm? -76.49 118.89 19.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -90.61 135.56 33.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.884 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.599 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . . . -86.36 160.66 50.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.63 0.728 . . . . 0.0 111.039 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.591 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 54.1 Cg_endo -69.98 -173.67 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.662 2.241 . . . . 0.0 112.311 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.09 -2.07 32.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.332 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -108.68 -27.55 9.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.103 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 118.53 -172.44 14.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.523 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.602 ' CZ2' HG23 ' A' ' 38' ' ' VAL . 97.2 m95 -78.49 -59.71 2.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.812 0.339 . . . . 0.0 110.905 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.86 -162.94 30.44 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.464 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -127.78 38.16 4.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.867 0.365 . . . . 0.0 110.893 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.708 HD13 ' H ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -95.95 -175.25 3.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.731 HG13 ' HB3' ' A' ' 56' ' ' ARG . 3.2 p -98.37 140.46 18.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.187 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.657 ' CE1' HD12 ' A' ' 53' ' ' LEU . 3.0 p90 -110.05 145.79 36.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 53.7 t -98.05 121.08 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.137 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.407 HG13 ' HG2' ' A' ' 21' ' ' GLU . 14.6 m -68.78 141.93 16.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.126 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -144.02 119.5 10.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.938 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.866 . . . . . . . . 0 0 . 1 stop_ save_